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SUMMARY
This thes is  considers aspects o f equine welfare which have 
received l i t t l e  a ttention in the U.K.
Skin disease, p a r t ic u la r ly  bacteria l skin disease, was highlighted 
as an area g iv ing r ise  to concern with respect to equine welfare. 
Dermatophilosis was examined in de ta i l  as one of the commoner 
bacte r ia l skin conditions responsible fo r  animal su ffe ring , and 
one fo r  which management is often d i f f i c u l t .
Essential fa t ty  acids (EFAs) were evaluated as a d ie tary 
supplement in an a lte rna tive  approach to the management o f equine 
dermatophilosis. The pharmacokinetics o f EFAs in the horse were 
investigated, with EFAs supplemented as evening primrose o i l  
(EPO), containing l in o le ic  acid (LA) and gamma-1inolenic acid 
(GLA). A very slow conversion of LA to i t s  active metabolites was 
found in the horse compared to other species. A da ily  dose regime 
o f 20g o f 80% EPO and 20% f ish  o i l  and vitamin E was adopted fo r 
the consequent treatment and prophylactic studies.
In a placebo-controlled, double b lind treatment study no 
s ig n i f ic a n t  e f fe c t  was seen on severity  or extent of d is t r ib u t io n  
o f lesions o f dermatophilosis when horses received EFAs o ra l ly .  
When EFAs were supplemented over the t ra d i t io n a l autumn high 
dermatophilosis r is k  period in a con tro lled prophylactic study, 
they did not prevent development of lesions or reduce incidence of 
in fe c t io n .  No s ig n if ic a n t improvement was afforded by EFAs on the 
condition o f the coat, mane, t a i l  or hooves, nor on general body 
cond it ion . EFAs were not harmful and exerted no e ffe c t ,  adverse or 
b e n e f ic ia l ,  on haematological or biochemical parameters.
The cha rac te r is t ics  of D. congolensis were examined in re la t ion  to 
the s i te  and severity of lesions o f dermatophilosis, but no 
co rre la t io n  was found. A ll isolates were d i f fe re n t  when examined 
by d i f fe re n t ia l  bacterio logica l growth cha rac te ris t ics  and sodium 
dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE). 
P ro te o ly t ic  enzyme production by D. congolensis was investigated 
w ith regard to the virulence o f the organism, and several isolates
x i i
demonstrated e x tra c e l lu la r  protease a c t iv i t y .
The c l in ic a l  and haematological consequences o f bleeding horses at 
regular in te rva ls  were monitored in a group o f animals maintained 
fo r  commercial blood production. No adverse e f fe c t  was recorded on 
c l in ic a l ,  prote in or haematological p ro f i le s  when 8 l i t r e s  of 
blood were removed every three weeks. Thoroughbred animals 
supported regular bleeding better than non-Thoroughbred animals.
A re la t ion a l database system was created as a management tool fo r  
the manager o f the horse herd. The information contained w ith in 
the system, regarding horse d e ta i ls ,  bloodroom records and farm 
laboratory records, could be constantly updated. Rapid detection 
o f poor performers or anaemic animals could permit prompt 
in s t ig a t io n  o f correc tive  action, avoiding undue animal d is tress.
I t  is  hoped tha t some of the work w ith in  th is  thesis has made a 
worthwhile con tr ibu tion  to the extension o f knowledge concerning 
the welfare o f horses in the U.K.
INTRODUCTION
BACKGROUND
SKIN DISEASE IN THE HORSE
A PERSPECTIVE OF DERMATOPHILOSIS IN THE HORSE
ESSENTIAL FATTY ACIDS (EFAs): THE RATIONALE FOR POSSIBLE USE TO
MANAGE EQUINE DERMATOPHILOSIS
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BACKGROUND
This thesis considers aspects o f welfare o f horses which to date 
have been given l i t t l e  a tten tion  in the United Kingdom. Skin 
disease, and in p a r t ic u la r  dermatophilosis, is  a common, 
d e b i l i ta t in g  problem in horses, and a new approach to management 
o f the condition using essential fa t ty  acids was investigated. In 
order to put the condition in to  perspective the problem o f skin 
disease in the horse as a whole is  reviewed p r io r  to a more 
deta iled consideration of dermatophilosis in subsequent chapters. 
In addition , the cha rac te r is t ics  of Dermatophilus congolensis were 
examined in re la t ion  to the s i te  and severity  o f lesions, leading 
to an investiga tion  o f an ex trace l1u la r protease.
The horses under study were being kept fo r  commercial blood 
production and as such were subjected to regular, repeated blood 
harvest, thus presenting an unique opportunity to assess the 
welfare consequences of such a procedure. To aid and improve the 
management o f the large numbers o f horses encountered in the work 
o f th is  thes is , an equine management database was created.
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SKIN DISEASE IN THE HORSE
The horse's skin is  the largest organ in i t s  body (Scott, 1988) 
and i t  is  the point o f contact between in terna l and external
environments. The skin is  a good ind ica to r o f general health and 
i t  performs the important functions o f protection from trauma and 
prevention o f invasion by micro-organisms or chemical compounds 
and i t  allows sensation of external s t im u li such as temperature, 
touch, i tc h ,  pain and pressure. Skin pigmentation protects against 
so lar rad ia tion  and vitamin synthesis occurs in the skin in
response to solar rad ia t ion . Temperature regulation in the body is 
provided by evaporation of sweat from the skin.
Disease o f the skin is  read ily  noticed and is  f ru s tra t in g  fo r  the
animal, the owner and the veterinary surgeon as i t  often causes
discomfort, disfigurement and may preclude use fo r  work, showing 
or r id in g  (Fadok and Mullowney, 1983).
The horse's comfort is grossly affected fo r  example by generalised 
p ru r itu s  and s e l f  in f l ic te d  trauma and excoriation resu lt ing  from 
a l le rg ic  reactions to foods, drugs, insects, plants and numerous 
inhaled allergens. Localised p ru r itus  can be in f l ic te d  by a range 
o f ectoparasites, such as mane and t a i l  in fes ta t ion  by l ic e  or 
Cul ico ides,  t a i l  region affected by Oxyuris e q u i , extrem ities by 
harvest mites, and loca lised areas affected by ringworm. 
Discomfort to the extent o f hyperaesthesia and pain, with 
secondary bacteria l in fec t ion , can be a consequence o f 
dermatophilosis, f o l l i c u l i t i s  and furunculosis, f l y  in fes ta t ions , 
contact derm atit is , or u lceration o f the surface o f cutaneous 
neoplasms.
The appearance of the horse, and consequently i t s  use as a show 
animal, can be d ra s t ic a l ly  affected by s e l f - in f l i c te d  trauma a fte r  
p r u r i t i c  episodes, by the alopecia and crusting a f te r  ectoparasite 
or ringworm in fe c t ion , and permanent scarring may re su lt  from 
f o l l i c u l i t i s ,  furunculosis or dermatophilosis. Cutaneous 
neoplasms: sarcoids, papillomas, melanomas and squamous ce ll
carcinomas; nodular skin disease; environmental diseases such as
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photosensitisa tion; seborrhoea; purpura haemorrhagica v a s c u l it is  
and Streptococcus equi in fec t ion  can a l l  render an animal 
uns ightly .
A horse's use as a r id in g  or working animal is  affected by 
conditions such as ringworm, dermatophilosis, contact de rm atit is , 
nodular skin disease and sarcoids, as they can p ro h ib it  the use o f 
tack, depending on s i te  of lesions.
Skin conditions that can be transferred to other animals or to man 
prevent useful work, e .g .,  a horse su ffe ring  from zoonotic 
ringworm in fe c t ion  may be prohib ited from racing and from shows 
(Thomsett, 1979). Dermatophilosis can be spread from horse to 
horse where there is  close contact, and is  also a zoonosis. 5. 
equi in fe c t io n ,  "s trang les", is  h ighly contagious to other horses 
and systemic involvement precludes useful work.
Skin conditions o f very d i f fe re n t  aetio log ies may have a s im ila r  
c l in ic a l  appearance (Evans and Stannard, 1986). Also, the skin has 
l im ite d  responses to external and in terna l challenge and the 
development of secondary lesions which often accompany chronic 
skin disease tend to complicate diagnosis (August, 1986). Early 
recognition and ins t ig a t ion  o f therapy in equine skin disease is 
thus highly important (Thomsett, 1979).
Specific  equine dermatoses can be bac te r ia l,  p a ra s it ic ,  v i r a l ,  
fungal, neoplastic, a l le rg ic  or immune-mediated, miscellaneous, 
environmental or congenital. The commoner conditions from each 
category are now reviewed.
Parasitic Skin Disease
Ectoparasit ic  in fections o f the skin are the most common skin 
diseases o f large animals, including the horse (Scott, 1988). 
There is  often a great degree o f su ffe ring  by annoyance, 
i r r i t a t i o n ,  i tch , disfigurement, secondary in fec t ion  and f l y  
s t r ik e .  Concentration loss owing to discomfort may preclude the 
horse's use fo r  work and weight loss can re su lt  from lowered food
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intake. Viruses, bacteria , fungi, helminths and protozoa may be 
transmitted by ectoparasites (Scott, 1988). As with endoparasite 
in fe c t io n ,  ec toparas it ic  in fec t ion  is  a group problem, ra ther than 
one o f ind iv idua l animals. Healthy, properly fed, well-managed 
animals have increased resistance to the invasion and
establishment of parasites. Improper feeding and grazing, 
overstocking, insan ita ry  conditions and poor a tten tion  to i l ln e ss  
in th e i r  early  stages a l l  favour ec toparas it ic  in fec t ion  (Naviaux, 
1985).
Some o f the commoner p a ra s it ic  skin conditions encountered in the 
U.K. include l ic e ,  Culicoides spp. hypersens it iv ity  ("sweet 
i t c h " ) ,  f l y  in fes ta t ions , harvest mites, and Oxyuris equi
in fe c t io n .
B it ing  (Damalinia equ i) and sucking (Haematopinus a s in i )  l ic e
cause c l in ic a l  signs which are more obvious during the w inter when 
animals gather fo r  warmth, when the haircoats are longer and when 
animals are stressed by the cold (Fadok and Mullowney, 1983; 
Fadok, 1987). In southern regions of the U.K. in fes ta tions  can 
occur at any time of year. The presenting sign is  p ru r itus  seen as 
s e l f - in f l i c te d  trauma, erythema and ha ir loss (Pascoe, 1973), and 
the coat is  frequently du ll with scales present. Affected animals 
are often restless and weight loss may re su lt  as appetite can be 
poor. D. equ i , the b it in g  louse, is  small in size and pale brown 
in colour and prefers the dorsolateral trunk (Scott, 1988). Heavy 
in fes ta t ions  by the blue-grey coloured sucking louse, H. a s i n i , 
may cause anaemia. Sucking l ic e  tend to prefer the fe t locks and 
the mane and t a i l  (Scott, 1988).
N its , the eggs, are cemented to the host's ha ir by the adult 
females and hatch to nymphs. Lice spend th e i r  en tire  l i f e  on the 
host and are extremely host spec if ic . In fection  is  by close 
contact with other infested animals or via infested boxes, tack, 
blankets and grooming k i t ,  as the adults can l iv e  o f f  the host fo r  
up to two weeks (Soulsby, 1982).
Culico ides  hypersens it iv ity , or "sweet i tch "  is  a common, 
well-recognised c l in ic a l  condition which occurs a l l  over the world
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as well as in the U.K.. The incidence varies w ith in  countries and 
between geographical locations (Fadok, 1987; McCaig, 1973). I t  is  
a recurring seasonal derm atit is  o f ind iv idua l horses and ponies 
during the warmer times of the year (Soulsby, 1982).
Affected animals develop a l le rg ic  reactions to the b ites of
Culico ides  species, b i t in g  midges (Baker and Quinn, 1978; Mellor, 
1974; Pascoe, 1973). The ind iv idual species o f Culico ides  which 
feed on horses causing the p r u r i t ic  condition have been id e n t i f ie d  
and corre lated with the s ite  and seasonal occurrence o f lesions, 
and geographical loca tion . In the U.K. there are over 20 species 
o f C ul ico ides , according to Baker & Quinn (1978), each with a 
ch a ra c te r is t ic  habitat and preferred host fo r  blood meals.
Generally, Cul ico ides  breed in s t i l l  or slowly running water, 
t y p ic a l ly  lakes, marshy areas and small pools o f water. The 
insects inhab it decaying plant material and manure (McMullan,
1982), p a r t ic u la r ly  on sandy or a lka line  so ils  (Fadok & Mullowney,
1983).
A B r i t is h  Equine Veterinary Association survey carried out 
between 1962 and 1963 placed the U.K. incidence at 2%, while
McCaig (1973) found i t  to be 2.79% in ponies. McCaig (1973)
reported regional varia tions in incidence with few cases in 
regions over 1000 fee t.
Typ ica lly  there is loca lised p ru r itus  characterised by rubbing o f 
the mane and t a i l .  Excoriations, crusts, scaling, alopecia and 
erythema are seen on the forehead, w ithers, shoulders, rump and 
ta ilbase  regions (Fadok & Mullowney, 1983). Mane and t a i l  hairs 
are often broken and matted as a re su lt  o f s e l f - in f l i c te d  trauma. 
Severity o f the disease varies between horses, and worsens with 
age. The condition has been seen in one and two year olds, but 
most ponies were noted by McCaig (1973) to show signs o f the 
condition during th e ir  th ird  or fourth summer.
A complex hypersens it iv ity  to b ites o f do rsa lly  feeding Culicoides  
spp. is the pathogenesis o f the condition (Pascoe, 1973; Mellor, 
1974; Baker and Quinn, 1978). There is an hereditary 
predisposition (Fadok and Mullowney, 1983). I n i t i a l l y  the
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condition coincides with the f l y  season, usually between A pri l  and 
November in the U.K., with peaks in May and November in Southern 
regions (McCaig, 1973).
Affected horses spend a large proportion o f th e i r  time rubbing 
against s ta tionary objects. Some horses show involvement o f the 
en t ire  dorsal m idline, and cases involv ing p ru r itus  o f the ventral 
m id line, pectoral and inguinal regions and lower limbs have been 
reported. When the condition becomes chronic, lesions involve 
la rger body areas. I n i t i a l l y  hyperaesthesia is marked, ha ir 
becomes tu f ted  and papules are seen. Lesions heal and ha ir  grows 
back the f i r s t  w in ter, however the papules and p ru r itus  return 
with warmer weather (McMullan, 1982). C h a ra c te r is t ica l ly ,  with 
recurrent attacks affected areas become alopecic with transverse 
r idg ing o f the skin, hyperkeratin isation , marked acanthosis and 
d if fu se  scaliness. The proximal th i rd  o f the t a i l  and the mane are 
often denuded. According to Baker and Quinn (1978) the disease 
should be regarded as an unsoundness, as animals su ffe ring  from 
severe in fec tions cannot be worked.
Many d i f fe re n t  f l ie s  attack horses, often leading to i r r i t a t i o n ,  
especia lly  in young horses which may take f r ig h t  and cause 
themselves in ju ry  (Naviaux, 1985; Pascoe, 1973). There is  reduced 
concentration fo r  work as a consequence o f i r r i t a t i o n ,  and b ites , 
often pa in fu l,  tend to induce a l le rg ic  reactions (Fadok, 1987). 
When f l i e s  are present in large numbers they can cause s ig n if ic a n t  
blood loss (Naviaux, 1985).
B ite lesions are most often seen during the summer and are usually 
p r u r i t i c  (R o ll ins , 1981) and re su lt  in s e l f - in f l i c te d  trauma
evidenced by alopecia, excoriation and 1ich e n if ica t io n .  Bites from 
stable f l i e s ,  Stomoxys c a l c i t r a n s , are pa in fu l,  re f le c t in g  the 
v ic ious mouthparts o f the species (Pascoe, 1973); and robust horse 
f l i e s ,  Tabanids and Hybometra, and deer f l i e s ,  Chrysops, also 
i n f l i c t  painful b ites which develop in to  large wheals (Fadok, 
1987). Horn f l ie s ,  Haematoba i r r i t a n s , cause the focal ventral
midline derm atit is  syndrome in the horse, characterised by
alopecia, erythema, depigmentation, scaling, serous oozing 
crusting and excoriation which is loca lised to the umbilical
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region (R o ll ins , 1981). Simul ium, or black f l i e s ,  attack other 
sparsely-haired ear, intermandibular, pectoral and inguinal 
regions; and Habronema microstoma larvae, which cause cutaneous 
habronemiasis or "summer sores", use stable f l i e s  as an 
intermediate host (Fadok, 1987).
Harvest mite in fes ta t ions , or trom b icu lias is , coincide with the 
la te  summer and autumn harvest season (Fadok and Mullowney, 1983; 
Soulsby, 1982) and are seen mainly in horses kept at pasture or 
exercised through infested f ie ld s  and woods, p a r t ic u la r ly  on 
chalky so i ls  (Thomsett, 1979). Papular lesions become crusted and 
tend to occur on areas in contact with vegetation, ty p ic a l ly  on 
the extrem ities , face, neck and sometimes the thorax. Lesions may 
be very i tchy . Neotrombicula autumnal is  larvae pa ras it ize  small 
rodents while nymphs and adults are f re e - l iv in g  (Soulsby, 1982). 
Larvae attach to the horse and sa liva ry  components hydrolyse the 
epidermis allowing tissue f lu id  extraction (Soulsby, 1982). Larvae 
hatch to adults o f f  the host. According to Thomsett (1979), 
th in-skinned breeds and types are at highest r is k  o f in fe c t ion .
Oxyuriasis in fec tion  tends to be seen only amongst young horses on 
a poor anthelm intic programme (Foreman, 1987). Dermatological 
signs secondary to anal p ru r itus  are caused by in fec tion  by the 
nematode parasite , Oxyuris equ i , commonly known as the pinworm. 
Adult female worms reside in the caecum and colon and feed on 
in te s t in a l contents, migrating out o f the anus to deposit eggs in 
the perineal region. There is rapid development o f the eggs, 
w ith in  three to f ive  days, and p ru r itus  is the re su lt  o f skin 
i r r i t a t i o n  in i t ia te d  by the gelatinous material which encases the 
eggs. In fec tion  is by ingestion o f in fe c t ive  eggs in contaminated 
feed or bedding (Soulsby, 1982).
Constant rubbing o f the t a i l  base lead to broken, matted t a i l  
ha irs , erosions and ulcers, producing a " ra t  t a i l "  appearance in 
severely affected animals (Fadok and Mullowney, 1983).
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Bacterial Skin Disease
In the absence o f agents or disease causing suppression o f the 
immune system, and when no defect occurs in the protective 
b a rr ie r ,  the skin o f healthy animals is  not normally susceptible 
to in fe c t io n  by the extensive range o f micro-organisms with which 
i t  contacts d a i ly  (Scott, 1988). Organisms may penetrate through 
damaged skin via ha ir f o l l i c le s  or sweat or sebaceous gland ducts, 
or they may reach the skin by haematogenous or lymphatic routes 
(K ra i, 1962).
The main bacteria l in fec tions o f skin in horses in the U.K. are 
dermatophilosis, f o l l i c u l i t i s  and furunculosis, and 5. equi 
in fe c t io n , "strangles" (Thomsett, 1979). While i t  is  generally 
considered tha t these are less common than p a ra s it ic  disease, they 
are an increasing welfare problem because they are seen more 
commonly under poorer management systems and can be d i f f i c u l t  to 
t re a t  and manage, in p a r t ic u la r  dermatophilosis. As 
dermatophilosis is a major component o f th is  thesis i t  is  dealt 
w ith only b r ie f ly  as part o f bacteria l skin disease and is  
reviewed at length in a la te r  section o f th is  in troduction .
Dermatophilosis is an in fec tion  of the epidermis which resu lts  in 
exudative ep iderm itis with scab formation (Van Saceghem, 1915). I t  
is  worldwide in d is t r ib u t io n  and c l in ic a l  in fec t ion  is  most severe 
in tro p ica l climates, but i t  is also a major problem in more 
temperate regions, p a r t ic u la r ly  where ra in fa l l  is high (Stewart, 
1972a).
Suppurative inflammation o f the ha ir f o l l i c le s  is  known as 
f o l l i c u l i t i s  and when the suppurative process extends in to  the 
surrounding dermis and subcutis the condition is  referred to as 
furunculosis (Dietz and Wiesner, 1984). Bacterial f o l l i c u l i t i s  and 
furunculosis are often caused by bacteria, most commonly D. 
congolensis and Staphylococcus aureus (Dietz and Wiesner, 1984); 
but Pascoe (1984) reported involvement o f Corynebacterium 
pseudotuberculosis,  Rodococcus equi and Ba c i l lu s  spp. and 5. 
hyicus has also been isolated from such lesions (Devriese, 
Vlaminck, Nuytten and De Keersmaecker, 1983). Fungi and parasites
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can also be causative agents. Mechanical trauma, resu lt ing  from 
b it in g  insects and tack, warmth, moisture and unhygienic 
environmental conditions predispose animals to f o l l i c u l i t i s  and 
furunculosis.
Bacterial f o l l i c u l i t i s  and furunculosis is  most frequently 
encountered in spring and summer, and is  also referred to as acne, 
heat rash or summer rash (Mullowney and Fadok, 1984a). In fection 
is  seen commonly in ch ild ren 's  ponies which are not ca re fu l ly  
tended, and where tack is badly maintained, and tends to be more 
severe and widespread in horses that have a long or poorly groomed 
haircoat (Pascoe, 1973). Once in fec t ion  becomes established in a 
stable, well attended horses are also susceptible. Furunculoses 
can be very re s is tan t to treatment, and healing may take weeks or 
months, and recurrences and re in fec tions  are l i k e ly  (Dietz and 
Wiesner, 1984).
Pascoe (1984) found single abscesses at the commissures o f the 
l ip s  and on the cheeks, but reported m u lt ip le  lesions a ffec ting  
the saddle, lo in  and chest areas as common. The area between the 
hindlegs may also be involved (Kra i, 1962). I n i t i a l  lesions are 
small, pa infu l papules, enlarging over a couple o f days to 5 or 10 
mm diameter with serum exudation and scab formation. Although 
sometimes there is s ig n if ic a n t  oedema which can lead to la rger, 
painfu l swellings, l i t t l e  pus is reported (Pascoe, 1984). Owing to 
acute pain, the affected animal is often u n f i t  fo r  ridden work 
(Pascoe, 1973; Roberts, 1967a).
Streptococcus equi in fe c t ion , or "strang les", although not a true 
skin in fe c t ion , can cause submaxillary and pharyngeal lymph node 
abscesses. There may be thinning and loss o f ha ir ,  focal necrosis, 
and subsequent rupture o f lymph nodes to discharge th ick ,  creamy 
pus through the skin (Thomsett, 1979).
Fungal Skin Disease
In fec tion  o f keratin ised tissue, n a i l ,  ha ir  or stratum corneum by 
a fungal species, such as Microsporum or Trichophyton , is  known as
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dermatophytosis (Kra i, 1962). Dermatophytes are believed to be 
loca lised to keratin ised tissues owing to lack o f ava ilab le iron 
elsewhere (B iberste in , 1990). Fortunately, o f the vast numbers of 
fungi present in the horse's environment, few are pathogenic 
(Scott, 1988). Diagnosis o f fungal skin in fe c t ion  is  hampered by 
the huge va r ia t ion  in c l in ic a l  manifestation.
Fungal in fec tions  can be transmitted between animals, from animals 
to humans, and from humans to animals. The progression of 
in fe c t ion  by zooph il ic , or animal-related fungi, such as 
Trichophyton equinum, T. mentagrophytes, or Microsporum equinum, 
is  often prevented by an acute inflammatory reaction in a human 
host. In the animal host, however, the fungus exis ts  in harmony 
with i t s  host and inflammation is  rare (Scott, 1988).
Ringworm is  one of the most common skin conditions (Saunders, 
1981) and is  one of the most important in fec tious diseases of the 
horse in the U.K. (Thomsett, 1979). I t  is  also an important 
zoonosis. In fec tion  often precludes useful work as the animal may 
be prohib ited from racing, from shows and from sale rings 
(Thomsett, 1979). Outbreaks in r id in g  and racing stables are 
common and most cases occur in autumn and w inter, often where the 
environment is unhygienic, overcrowded, warm, damp, and where 
there is  l i t t l e  sunshine (Pascoe, 1984). Once in fec t ion  is 
established in a stable i t  can be very d i f f i c u l t  to manage. 
Zoophilic species, such as T. equinum and T. mentagrophytes, are 
most frequently  diagnosed, accounting fo r  over h a lf  o f equine 
ringworm cases, but T. verrucosum, M. equinum and M.gypseum may be 
involved (Johnston, 1986; Mullowney and Fadok, 1984b; Pascoe and 
Connole, 1974).
Fungal spores germinate near a f o l l i c u la r  o r i f ic e ,  and hyphal 
strands grow in to  ha ir f o l l i c le s  along the outer root sheaths and 
invade growing hairs near the l iv in g  root ce l ls  (B iberste in, 
1990). Hyphae grow w ith in  the ha ir cortex. Colonisation may cause 
hypertrophy o f the stratum corneum, resu lt ing  in accelerated 
ke ra tin isa tion  and e x fo l ia t io n ,  producing a scurfy appearance and 
ha ir loss (B iberste in , 1990). I t  is  usually by the second week 
tha t inflammation begins, at the margin o f the parasitised area,
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with manifestations ranging from erythema to vesicu lopustular 
reactions and suppuration.
Abrasion by tack, especia lly by g ir th s  in the racing world, 
f a c i l i t a t e  fungal invasion. The incubation period is  normally
between four and 30 days (Pascoe, 1979), and ha ir  loss occurs
a f te r  three to 10 days (Johnston, 1986).
C lin ica l appearance of the condition varies according to the 
response by the host as well as to the causative fungal species, 
as antibody- and cel 1-mediated hyperse ns it iv i t ies  occur in the 
course o f in fe c t ion  (B iberste in , 1990).
Transmission of 7. mentagrophytes involves rodents (Krai 1962). 
Lesion d is t r ib u t io n  is  mainly on the head, neck, t a i l  base and 
extrem ities . Lesions are alopecic with heavy grey crusting (Krai, 
1962). Hair regrowth begins in the lesion centre, and active
papules, vesicles and pustules are seen periphera lly . The degree 
o f p ru r itu s  varies, but is  less than that associated with 7.
equinum or "g i r th  itch "  lesions, which are intensely p r u r i t i c
(K ra i, 1962). 7. equinum lesions range in diameter from 0.5 to 2
cm, and are alopecic and scaly. Vesicles are palpable at the edge 
o f lesions.
7. verrucosum lesions are s im ila r  to those o f 7. equinum and are 
commonly seen in horses grazed w ith, or which have had access to 
bu ild ings which housed, ringworm infected c a t t le  (Johnston, 1986).
M. gypseum lesions are commonly found on the dorsal body areas, 
and tend to be associated with damp surroundings and b it in g  
insects (Pascoe and Connole, 1974). Inflammation around lesions is 
greater than fo r  ringworm induced by other species, and crusting
is  heavy and grey. On removal o f crust there is  a moist, reddish
ulcer (Johnston, 1986).
Lesions induced by M. canis often respond poorly to therapy and 
heal when the weather is warmer and sunnier (Kra i, 1962). Areas 
under tack are those most commonly affected.
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Ringworm in fe c t ion  may be d i re c t ly  or in d ire c t ly  transmitted 
(Pascoe, 1973), as fungi may pe rs is t on tack, grooming k i t ,  
c lippers and infected s ta l ls  and t r a i le r s  or on human c lo th ing 
(K ra i, 1962). Lack o f previous in fec tion  predisposes younger 
animals to in fe c t io n , and age resistance develops so tha t although 
adults may su ffe r re in fe c t io n , in fec tions are milder (Scott,
1983).
Neoplastic Skin Disease
Cutaneous tumours are the most common form o f neoplasm in the 
horse, and there are only a l im ited  number o f important cutaneous 
neoplasms in the horse (Thomsett, 1979). In other species, skin 
tumours are associated with increasing age but th is  is  not true 
fo r  the horse (Scott, 1988). Sex and breed pred ilec t ions ex is t ,  
e .g .,  mastocytoma in male horses (A ltera and Clark, 1970), and 
melanoma in Arabs and Percherons (Scott, 1988). Sarcoids, followed 
by papillomas, squamous ce ll carcinomas and then melanomas are the 
most frequently encountered cutaneous neoplasms in the horse 
(Pascoe, 1973; Pascoe and Summers, 1981).
The equine sarcoid is a lo c a l ly  aggressive f ib ro b la s t ic  tumour, 
and is the commonest tumour of the horse (Pascoe, 1973; Pascoe and 
Summers, 1981; Ragland, Keown and Spencer, 1968; Tarwid, Fretz and 
Clark, 1985), the donkey and the mule (Pascoe, 1984). Sundberg, 
Burnstein, Page, Kirkham and Robinson (1977) reported the tumour 
to account fo r  over 43% of a l l  equine neoplasms. In a 21-year 
survey o f equine tumours (Pascoe and Summers, 1981), 142 out of
409 tumours were sarcoids. Sarcoids accounted fo r  55.6% of a l l  
neoplasms in horses and ponies in another survey over a 10-year 
period (Strafuss, Smith, Dennis and Anthony, 1973). No 
p red ilec t ion  exists fo r  breed, sex, coat colour or season o f the 
year, but there is a d e f in i te  tendency fo r  the tumour to be 
encountered in younger horses (s ix  years old or less) compared to 
other malignancies that occur in horses (Tarwid, Fretz and Clark, 
1985). The tumour has e p ith e l ia l  and f ib ro b la s t ic  components 
(Mullowney and Fadok, 1984a).
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Aetiology is  not certa in  but is  considered to be v i ra l  (Tarwid, 
Fretz and Clark, 1985). Recent hybrid iza tion  work confirms tha t 
the sarcoid contains papillomaviral DNA. Studies carried out on 
donkey derived sarcoid tumours have resulted in the id e n t i f ic a t io n  
o f two types o f v ira l  DNA, one which is  s im ila r  to bovine 
papillomavirus type 1 (BPV-1), and another s im ila r  to BPV-2 (Reid, 
unpublished data). The strongest evidence of papillomaviruses in 
the aetio logy of the disease is  the unique iso la t io n  of 
pap il lom a v ira l-1 ike v ir ions  from an equine sarcoid. Although 
re t ro v ira l  elements have been id e n t i f ie d  in a sarcoid derived ce ll 
l in e ,  the s ign if icance is unclear and the re trov iru s  is  presumed 
to be endogenous (Reid, unpublished data). Familial tendencies 
have been observed (Strafuss, Smith, Dennis and Anthony, 1973) and 
equine leucocyte antigen (ELA) studies suggest connection o f the 
predisposition to sarcoid with the major h is to com p a tib i l i ty  
complex (Scott, 1988).
A horse can have a s o l i ta ry  sarcoid, but between one th i rd  and one 
h a lf  (Pascoe, 1984; Mullowney and Fadok, 1984a) up to over 80% 
(Tarwid, Fretz and Clark, 1985) o f cases have m u lt ip le  lesions. 
The most common locations are the extrem ities; the head, 
p a r t ic u la r ly  pe r iocu la r ly , on the pinnae and on the commissures of 
the l ip s ;  and the ventral abdomen, on the prepuce and inner thighs 
(Strafuss, Smith, Dennis and Anthony, 1973). These areas are often 
subjected to trauma, and the tumour commonly occurs at scar s ites 
(Mullowney and Fadok, 1984a; Tarwid, Fretz and Clark, 1985). 
Sarcoids do not metastasise but may spread by b it in g  or rubbing of 
the lesion by the horse (Wyman, Rings, Tarr and Alden, 1977). 
Transmission is believed to be by contaminated tack, grooming 
equipment and surgical instruments, and epizootic forms have been 
seen w ith in  herds (Ragland, Keown and Spencer, 1968).
There are four gross types o f equine sarcoid: the verrucous or
warty type (type I ) ;  the f ib ro b la s t ic  or proud f le s h - l ik e  type 
(type I I ) ;  the mixed verrucous and f ib ro b la s t ic  (Type I I I ) ,  and 
the f l a t  or occult type (type IV), (Pascoe and Summers, 1981; 
Tarwid, Fretz and Clark, 1985). Verrucous sarcoids are small, 
sessile or pedunculated, with a dry, horny c a u l i f lo w e r- l ik e  
surface which frequently resembles a papilloma (Tarwid, Fretz and
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Clark, 1985). The appearance o f the f ib ro b la s t ic  sarcoid varies 
more, w ith some lesions circumscribed and nodular, occurring in 
the dermis and subcutis, while others may be over 25 cm in 
diameter w ith ulcerated, easily-traumatised surfaces. Occult 
sarcoids are found most often around the head, especia lly  the ears 
and eyelids (Tarwid, Fretz and Clark, 1985). They may remain 
s ta t ic  fo r  extended periods as c i rc u la r ,  alopecic areas with 
scaling and crusting, then papules and nodules may develop w ith in  
the ha irless regions (Pascoe and Summers, 1981). Surgical 
in te rven tion  resu lts  in rapid transformation to the f ib ro b la s t ic  
type o f sarcoid (Tarwid, Fretz and Clark, 1985).
The equine sarcoid is  notoriously d i f f i c u l t  to t re a t (Murphy, 
Severin, Lavach, Hepler and Lueker, 1979): spontaneous regression 
is  rare, and there is  a very high recurrence rate fo llow ing to ta l 
surgical excision, rad ia tion  treatment and cryosurgery. Success of 
autogenous and heterologous vaccines has been of a varying degree 
(Wyman et a l . ,  1977). Reticuloendothelial stim ula tion using
B ac il le  Calmette-Guerin (BCG), is a popular and e ffec t ive  
treatment (Rebhun, 1987). When BCG is inoculated in to  the lesion 
the regression o f tumour ce l ls  is dependent on the a b i l i t y  o f the 
host to develop a delayed type hypersens it iv ity . This involves the 
s tim ula tion o f normal T and B lymphocytes and the generation o f a 
population o f activated macrophages with a potent c y to ly t ic  
a c t iv i t y  against sarcoid ce l ls  (Howarth, 1990). Unfortunately the 
treatment leads to intense inflammation, and i t  has caused 
anaphylactic deaths (Rebhun, 1987).
Papillomatosis, warts or in fectious verrucae, caused by a 
hos t-spec if ic  DNA papovavirus (Scott, 1988), is  p r im a ri ly  a 
condition o f young horses (Duhaime, 1981), predominantly one and 
two year old animals (Fadok and Mullowney, 1984a; Pascoe and 
Summers, 1981), although older horses may be affected (Pascoe,
1984) and a congenital form has also been reported (Garma-Avina, 
V a l l i  and Lumsden, 1981). A higher incidence o f papillomatosis was 
reported when numbers of young stock were increased on brood mare 
farms during the breeding season and p r io r  to sales (Pascoe,
1984).
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M ult ip le  lesions, often over 100 warts, are commonest, but single 
lesions may be seen. Transmission is  v ia fomites and the v irus , 
which is  re la t iv e ly  re s is tan t,  uses skin abrasions and wounds as 
porta ls  o f entry (Fadok and Mullowney, 1984a). The primary s i te  of 
lesions is  the muzzle (Duhaime, 1981; Pascoe, 1984), followed by 
the legs, prepuce and ventral body w a ll.  Involvement o f the nose, 
eye lids, jowl and neck were reported by Pascoe (1984). Pascoe 
(1973) reported tha t warts usually appear suddenly, in small 
numbers which soon m u lt ip ly  rap id ly  to cover most o f the nasal 
area. Warts tha t pe rs is t as m u lt ip le  lesions on the inner surface 
o f the ears and the legs and on the ventral body wall and prepuce 
may be a consequence of trans fe r of v irus by grooming equipment or 
by rubbing o f the face on the legs (Fadok and Mullowney, 1984a).
Thomsett (1979) described lesions beginning as raised, dome-like 
epidermal areas, single or in c lus te rs , then p ro l i fe ra t in g  to 
spherical masses up to 2 cm diameter. According to Pascoe (1984) 
they are grey with fibrous s ta lks . Surface o f lesions may be 
rough, wrinkled or smooth, and grey red in colour (Fadok and 
Mullowney, 1984a). Papillomatous scratches may be a consequence of 
chronic inflammation in i t ia te d  by mechanical or chemical 
i r r i t a n t s .  Pascoe (1984) believed that maturation occurred over a 
three to four month period, with associated change in colour to 
pink, and that lesions regressed and sloughed three or four weeks 
la te r .  Spontaneous regression o f lesions tends to occur from the 
muzzle o f young horses two to three months a f te r  appearance is 
f i r s t  recorded (Duhaime, 1981; Pascoe and Summers, 1981).
A 60 to 90 day incubation period was reported during experimental 
in fe c t ion  by Fadok and Mullowney (1984a) with regression in most 
cases a f te r  60 days. The so lid  immunity resu lt ing  a f te r  natural 
in fe c t ion  is  not always induced by experimental in fe c t ion .
Small raised areas o f depigmented papillomatous skin are commonly 
seen in the ears o f horses, o f a l l  breeds and o f both sexes, 
causing no disturbance. They are seldom seen in horses under a 
year old (Stannard, 1972) and although aetiology is  unconfirmed 
(Thomsett, 1979), papilloma virus has been iso lated.
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The greyish p laque-like lesions may coalesce from several mm 
diameter to cover a large proportion o f the inner pinnal surface, 
and are eas ily  dislodged. These plaques have never been proven to 
contribu te to the head shaking syndrome, and although they tend to 
pe rs is t in d e f in i te ly ,  they are unimportant. S im ilar lesions have 
been found in the anal and vulval regions (Stannard, 1972).
Squamous ce ll  carcinoma accounted fo r  20% of a l l  equine neoplasms 
in one survey (Strafuss, 1976). Forty-three percent occurred on 
the head, eye and ocular adnexa, 45% were on the external male 
g e n ita l ia ,  and 12% were in the female perineal region. Pascoe and 
Summers (1981) found tha t squamous ce ll  carcinoma accounted fo r  55 
out o f 409 equine tumours over a 21 year survey. Of these 55 
les ions, 35 involved ocular tissues, and 16 were recorded on the 
external g e n ita l ia .  I t  is the commonest penile tumour o f the horse 
(Stafuss, 1976).
Predisposing factors are unpigmented skin (McMullan, 1982), and, 
when the tumour is located around the eye, chronic exudate from a 
weeping eye (Foreman, 1987). The cornea and sclera are less 
frequently  affected than the eye lid , and there is  often aggressive 
spread to the m axilla ry  sinuses or lacrimal duct from the th ird  
eye lid . Development is usually at mucocutaneous junctions
(McMullan, 1982) and areas such as the nasal cav ity , tongue, 
stomach, m axil la ry  sinus, t a i l ,  limbs, anal sphincter, hard
palate, peritoneum, l ip s  and nose have been invaded (Mullowney, 
1985a). Carcinomas of the vulva and c l i t o r i s  occur more frequently 
in older than in young mares (Pascoe and Summers, 1981).
C lin ica l appearance varies from papillomatous to ulcerated,
c a u l i f lo w e r- l ik e  tumours, and growth rate is variab le . Metastasis 
is  rare but local invasion can be aggressive. The mean age 
affected is  12 years (Mullowney, 1985a; Strafuss, 1976; Sundberg 
et a / . ,  1977). Foreman (1987) reported a predisposition in
Appaloosas, usually in horses over f iv e  years, and commonest in
unpigmented areas.
Murray, Ladds and Campbell (1978) recorded a 6.7% incidence of
squamous ce ll carcinoma, while Mullowney (1985a) found i t  to be
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16.4% (329 o f 2005 skin tumours) and Sundberg et a l . (1977)
described i t  as higher, at 24.6%.
Melanomas are common, easily-recognised neoplasms. Although 
encountered most frequently in greys, melanomas have been reported 
in horses o f other colours, bays fo r  example (Foreman, 1987; 
Pascoe and Summers, 1981). They are rare in animals under s ix  
years old, although congenital melanoma has been reported 
(Hamilton and Byerly, 1974). The high incidence o f the tumour in 
Arabs and Percherons may be due to the high numbers o f greys 
w ith in  these breeds. No sex predisposition occurs. Although 
melanomas are seen on the legs, neck, eyelids, ears and vulva, the 
primary s ites  are the parotid gland area and the perineum and 
underside o f the t a i l  (Dietz and Wiesner, 1984; Pascoe and 
Summers, 1981).
Melanomas may remain benign, growing very slowly, fo r  as long as 
20 years, but prognosis is hopeless once there is  involvement o f 
in te rna l organs (McMullan 1982). Dystokia and problems in 
defaecation are l i k e ly  consequences (Pascoe, 1984).
Sundberg et a l . (1977) reported melanoma to account fo r  3.8% of
a l l  equine neoplasms diagnosed, with an age range o f two to 20 
years, and mean o f ju s t  over e ight years. Incidence o f melanomas 
was 2% o f a l l  granulomatous and neoplastic lesions in equine skin 
in a survey by Murray, Ladds and Campbell (1978) and Mullowney 
(1985a) found an incidence o f 5.3% (106 o f 2005 skin tumours).
Allergic and Immune-Mediated Skin Disease
When an adaptive immune response occurs in an exaggerated or 
inappropriate form resu lt ing  in tissue damage, the term 
hypersens it iv ity  is applied (R o it t ,  B rosto ff and Male, 1989). 
H ypersensit iv ity  is a cha rac te r is t ic  o f the ind iv idua l and is 
expressed on second contact with the spec if ic  antigen inducing 
hypersens it iv ity . A l le rg ic  or hypersens it iv ity  reactions have 
been c la ss if ie d  in to  four types on an immunopathological basis by 
Gell and Coombs (1975): type I or immediate hypersens it iv ity , type
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I I  or antibody-dependent hyp e rsens it iv ity , type I I I  or 
complex-mediated hypersens it iv ity , and type IV or delayed 
hyp erse ns it iv ity . In practice these types do not always occur in 
iso la t io n  from each other (R o it t ,  B rosto ff and Male, 1989). These 
reactions are simply manifestations o f the benefic ia l immune 
responses causing inflammatory reactions and tissue damage 
expressions. A l le rg ic  or hypersens it iv ity  reactions are often seen 
in the skin o f the horse.
A l le rg ic  skin disease is  a common, f ru s tra t in g  problem of 
ind iv idua l horses, which can occur a l l  year round, but during the 
summer months insect hype rsens it iv i t ies  are extremely prevalent.
A l le rg ic  contact derm atit is  in the horse involves delayed, or type 
IV hypersens it iv i ty  (Tizard, 1987). The causative agents, which 
must contact the skin d i re c t ly ,  range from drugs and chemicals, 
inse c tic id e , heavy metal, soap or f l y  spray, fo r  example; to 
blankets or wool bedding, and plants such as poison ivy (Tizard, 
1987). These agents normally act as haptens which bind with skin 
prote in to become complete antigens (Manning and Sweeney, 1986). 
The agent may have been present in the environment fo r  years 
before a l le rg ic  contact derm atit is  develops (Stannard, 1972; 
Manning and Sweeney, 1986). A fte r an incubation period of one to 
four weeks, hypersens it iv ity  develops and pers ists in d e f in i te ly ,  
with the re su lt  that inflammation w i l l  be seen w ith in  one to three 
days i f  the allergen is contacted (Mullowney, 1985b).
The lesions of a l le rg ic  contact derm atit is  vary g rea tly  in 
severity , ranging from mild erythema to severe, erythematous 
ves icu la tion (Tizard, 1987). Erythematous, vesicu lar, p laque-like 
swellings are seen on the skin in early stages and i f  there is 
pers is ten t allergen exposure alopecia, desquamation and 
1ich e n if ica t io n  re su lt ,  usually confined to the epidermal and 
dermal areas (Manning and Sweeney, 1986). Because o f the intense 
p ru r i tu s ,  self-trauma, excoriation, u lceration and secondary 
pyoderma often mask the true nature o f the lesion (Tizard, 1987). 
D is tr ib u t io n  of the dermatitis  depends on the s ite  o f contact of 
a llergens, but the head, extrem ities, ventral body surfaces and 
t a i l  areas are frequently affected. Genetic predisposition, the
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nature o f the a llergen, damage to the skin and mechanical fac tors , 
s i te  on the body, sweat and sebaceous gland function , skin pH, and 
immunological competence are a l l  believed by Mullowney (1985b) to 
be involved in the l ike l iho od  o f a horse developing
hypersens it iv ity  reactions.
Acute but trans ien t loca lised or generalised formation o f wheals 
or plaques are cha rac te r is t ic  o f u r t ic a r ia  (Dietz and Wiesner, 
1984). The nose, l ip s ,  neck and trunk are usually involved.
Chemical mediators are produced as mast ce l ls  degranulate in 
response to th is  immediate or type I hypersens it iv ity  reaction. 
Areas o f dermal oedema are produced due to altered ca p i l la ry
permeability and p i t  on d ig i ta l  pressure.
Immunological, pharmacological, psychological and physical 
u r t ic a r ia s  are recognised in the horse by Manning and Sweeney 
(1986). Immunological u r t ic a r ia  can then be subgrouped as reagin 
mediated (type I ) ,  cyto toxic antibody (type I I )  and immune complex 
(type I I I ) .  The u r t ic a r ia l  syndrome is  a common problem but the 
responsible agent is often undetermined. Lesions are extremely 
i r r i t a t i n g  because o f the histamine released and consequently the 
true nature o f the lesion may be masked by scratching (Tizard, 
1987). U rt ica r ia  is not always a l le rg ic ,  and when i t  is  a l le rg ic  
i t  is  not always IgE mediated (Manning and Sweeney, 1986).
Drugs such as g lucocorticoids (Dietz and Wiesner, 1984), 
p e n ic i l l in ,  and streptomycin (Kra i, 1962), te tracyc l ine , and 
pethidine (Pascoe, 1984); vaccines such as influenza and tetanus 
a n t ito x in  (Pascoe, 1984); foods; additives; in fec tions by bacteria 
(5. equi ) ,  fungi (7. equinum) and parasites (Onchocerca 
ce rv ica l  i s )  (Kra i, 1962); b ites ; stings; inhaled allergens (Evans, 
1987), and systemic disease such as purpura haemorrhagica (Manning 
and Sweeney, 1986), have a l l  caused u r t ic a r ia l  reactions in 
horses.
The most e f f ic ie n t  reaginic or homocytotropic antibodies, 
responsible fo r  type I hypersens it iv ity , belong to the IgE 
immunoglobulin class (R o it t ,  1984). However recent studies in the 
horse demonstrate that certa in IgG subclasses also f i t  th is
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descrip tion  (Manning and Sweeney, 1986). IgE has been described 
s p e c i f ic a l ly  in the horse, but although experiments in cutaneous 
anaphylaxis have demonstrated the presence o f reagin ic antibody in 
horses, the immunoglobulin class has not been characterised 
(Manning and Sweeney, 1986).
Small, p r u r i t i c  lumps predominantly a ffec t ing  the thorax, but 
sometimes extending to the head and neck are often a ttr ibu ted  to 
food a lle rgy , and these signs may be accompanied by severe t a i l  
rubbing (Pascoe, 1973). Self in f l i c te d  trauma and secondary 
bacteria l in fe c t ion  are possible consequences. Ingestion of 
excessively high protein d ie t  (Pascoe, 1973), or o f potatoes, 
d i s t i l l e r y  wastes, malt, beet pulp, c lover, St. John's wort, 
glucose, wheat, oats, barley, bran and chicory (Mullowney, 1985b) 
often lead to u r t ic a r ia l  reaction .
The mucous membranes o f the nose, mouth, anus and vulva may become
involved in u r t ic a r ia l  lesions, and in frequently  the pharynx and 
larynx are affected, with impaired swallowing and breathing 
(Thomsett, 1979).
V ascu lit is  may occur at any location in the body and is commonly a 
secondary sign o f a disorder elsewhere (Morris, 1987). The most 
commonly diagnosed cutaneous v a s c u l i t ic  syndrome in the horse is 
purpura haemorrhagica (Morris, 1987). I t  is  an uncommon sequel to 
5. equi or 5. zooepidemicus in fec tion  (Manning and Sweeney, 1986), 
characterised by extensive oedematous and haemorrhagic swellings 
in subcutaneous tissues, accompanied by haemorrhages in the 
mucosae and viscera (Blood and Radostits, 1989a). I t  has 
c la s s ic a l ly  been described as a nonthrombocytopaenic purpura, as 
p la te le t  counts are normal in affected horses (Reef, 1987). I t  
ty p ic a l ly  occurs between two and four weeks a f te r  resp ira tory
in fec t ion  o f streptococcal o r ig in , but may be associated with
previous and/or concurrent beta-haemolytic streptococcal 
in fe c t io n , influenza, or to drug-induced a l le rg ies  (Reef, 1987). 
The condition is considered to be a s ig n if ic a n t problem although 
incidence is low (<10% of streptococcal resp ira tory  in fections and 
<1% of influenza cases)(Manning and Sweeney, 1986). Incidence is 
reported to be highest in large groups o f horses used fo r  m i l i ta ry
21
purposes, or during and a f te r  shipment (Blood and Radostits,
1989a).
Clearly circumscribed oedematous areas o f the dermis and subcutis 
are seen about the face and muzzle but are often present on other 
parts o f the body and are not necessarily symmetrical in
d is t r ib u t io n  (Blood and Radostits, 1989a). Cutaneous in fa rc t io n ,  
necrosis and serum exudation are l i k e ly  consequences. At th is
po in t, the condition may increase in severity , or may resolve in a 
week. Great va r ia t ion  thus exists in the severity  o f purpura 
haemorrhagica (Manning and Sweeney, 1986). One or more legs may be 
affected, and the prepuce and ventral abdomen are other common
s ite s .  Progression of lesions and m o rta l i ty  rate are variab le, 
w ith mild lesions healing in seven to 10 days, but recovery may 
extend to a week in severe cases, and to two or three months where 
skin necrosis occurs. Blood and Radostits (1989a) reported that 
most severely affected animals die o f the disease.
Morris (1987) studied 19 horses showing cutaneous v a s c u l i t ic  
syndrome and noted tha t almost three-quarters o f cases were 
between three and 10 years old, and Reef (1987) also reported the 
condition as p r im ari ly  one o f young adults. Three-quarters o f the 
cases studied by Morris (1987) were female. Just over one th i rd  of 
the cases had a h is to ry  o f 5. equi in fe c t ion , but fo r  another 
th i rd  there was no h is to ry  involv ing any o f the generally accepted 
predisposing causes.
Although a l le rg ic  reaction to antigens o f streptococcal or v ira l  
o r ig in  is  believed to cause purpura haemorrhagica, th is  has not 
been proven. Antigen-anti body complexes containing 5. equi M 
protein and IgA have been id e n t i f ie d  in affected animals (Blood 
and Radostits, 1989a; Tizard, 1987). Some authors suspect 
involvement o f a type I I  or cyto toxic hypersens it iv ity  in addition 
to immediate, or type I ,  and immune complex, or type I I I ,  
hyp e rse ns it iv i t ies  (Manning and Sweeney, 1986).
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Miscellaneous Skin Disease
Many skin conditions ex is t fo r  which the cause and pathogenesis 
are complex or poorly defined. The most important o f these is  
equine nodular skin disease, nodules being the most frequently 
encountered skin lesion o f the species (Scott, 1987). Skin biopsy 
is  the only d e f in i t iv e  diagnostic method, and treatment o f the 
condition may be problematic. S im ila r ly ,  seborrhoea is  another 
condition o f uncertain and multi fa c to r ia l  aetiology where 
management can prove extremely d i f f i c u l t  (Dietz and Wiesner, 
1984).
Nodular collagenous granuloma or nodular necrobiosis, a x i l la r y  
nodular necrosis, un i la te ra l papular dermatosis, s te r i le  nodular 
p a n n ic u l i t is ,  mastocytoma and cutaneous amyloidosis are 
c o l le c t iv e ly  c la ss if ie d  as "nodular skin disease" (Scott, 1987).
Nodules are c le a r ly  demarcated, f irm , normally spherical 
s tructures and are la rger than a centimetre in diameter; tha t may 
appear raised or may be contained in the dermis or the subcutis. 
They may be a re su lt  o f hyperplastic reaction by the dermis or 
epidermis, or they may be composed of inflammatory or neoplastic 
in f i l t r a t e s  or l i p id  (Scott, 1987). Although hypersens it iv ity  to 
b i t in g  insects or migrating nematode larvae, and mechanical trauma 
by tack have been incriminated, aetiology is uncertain (McMullan, 
1982).
Nodular necrobiosis or col 1agenolytic or eosinophilic  granuloma 
tends to be seen most often in r id in g  horses and ponies 
(Mullowney, 1985a), usually developing f i r s t  in warmer weather 
(McMullan, 1982). Nodules begin as oedematous areas o f the dermis 
in the upper thoracic and saddle regions, with possible extension 
to the neck, shoulder, f lank, proximal hindlimbs and croup areas. 
The skin overlying the painless, freely-moveable nodules, often 
several cm in diameter, is normal and there is  no itch  (Scott, 
1987).
A x i l la ry  nodular necrosis is a rare condition o f unknown cause and 
pathogenesis (Scott, 1987), which comprises one or two c lea r ly
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demarcated, f irm , painless nodules tha t are s ituated in the g ir th  
and a x i l la r y  areas.
U nila te ra l papular dermatosis is  another uncommon nodular 
condition which develops in warmer months, fea tur ing m u lt ip le , 30 
to 300, papules and nodules which a f fe c t  only one side o f the 
trunk (McMullan, 1982)
An uncommon, complex inflammatory condition of subcutaneous fa t  is  
known as s te r i le  nodular p a n n icu l i t is  (Scott, 1987). In ju ry  to
the sensitive l ipocytes induces release o f l i p id  which is
hydrolysed to fa t ty  acids, which are powerful inflammatory agents. 
The nodules are deep-seated and they vary in appearance and 
consistency. They occur e ith e r s ing ly  or in groups in the region 
o f the chest, the a x i l la e  and the shoulders. Systemic involvement, 
such as inappetence, dullness, lethargy and pyrexia, has been 
reported (Scott, 1987).
Mastocytoma is  a misnomer because although the cause o f the 
condition is  unknown, a reactive, hyperplastic rather than a 
neoplastic pathogenesis is suspected (A ltera and Clark, 1970). 
Transmission between horses has been unsuccessful (Scott, 1987).
Mastocytoma is  nearly f ive  times as l i k e ly  to occur in male 
animals than in females (A ltera and Clark, 1970), but no age or 
breed pred ilec t ion  is found (Scott, 1987).
Most cases e xh ib it  single lesions, two to 20 cm in diameter,
developing on the limbs and on the head (A ltera and Clark, 1970). 
Head lesions tend to be c le a r ly  demarcated and so ft ,  in contrast 
to the f irm , poorly-defined forms seen on the limbs. Hair loss may 
occur over the nodules, which may be painful and p r u r i t i c .  Nodules 
are s e l f - l im i t in g  and are reported not to metastasise (McMullan, 
1982).
The cause o f equine mastocytoma is unknown, but has been suggested 
to be chronic inflammation, pa ras it ic  in fes ta t ion  or local 
antigen-antibody reaction (Nyrop, Coffman and Johnston, 1986).
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Wheals which show temporary response to therapy then develop in to  
nodules are typ ica l o f cutaneous amyloidosis (Mullowney, 1985a). 
The aetio logy o f the nodules, which contain granulomatous 
material interspersed with the f i b r i l l a r  prote in , amyloid, is  not 
well understood (Scott, 1988).
Although i t  may occur as a primary atypical form, the condition 
is  more commonly a secondary consequence of chronic purulent 
inflammation such as tubercu losis, "s trang les", chronic 
g a s tro e n te r i t is ,  or i t  may fo llow  vaccination (Mullowney, 1985a).
The condition is  slowly progressive, with the appearance o f f irm , 
painless nodules varying from 2 to over 10 cm diameter in the skin 
over the pectoral areas and the head and neck. Internal organs are 
not involved in the primary form of the condition (Scott, 1988).
Seborrhoea is  hypersecretion o f sebaceous secretion or sebum. 
Sebum is  necessary to prevent cutaneous dehydration and to 
maintain skin softness (Mullowney, 1985a). I t  permeates over ha ir 
shafts from the sebaceous glands of the ha ir f o l l i c le s  and gives 
the coat i t s  shine. Ectoparasites, systemic disorders, 
environmental, c l im a tic  (Mullowney, 1985a) or n u tr i t io n a l 
(Carpenter, 1981) factors may lead to a higher than normal level 
o f sebum production, which may be loca lised or generalised, and 
which may be manifest as crusting or as o i ly  exudate. The 
aetio logy o f seborrhoea is unknown, but genetic predisposition may 
be involved (Dietz and Wiesner, 1984).
Seborrhoea is  not uncommon, and is an important condition in the 
horse (Carpenter, 1981). Most cases o f equine seborrhoea are 
generalised (Krai, 1962), with a crusted ra ther than an o i ly  
appearance to the coat (Stannard, 1972). Foul-smelling, powdery 
greasy bran- like  flakes are seen in the coat and the skin below is 
reddened, sometimes l ic h e n if ie d ,  and folded. Secondary bacteria l 
in fe c t ion  may be caused by the build-up o f sweat and keratinous 
m ateria l. In rare cases, seborrhoeic skin lesions are confined to 
the mane and t a i l  (Krai, 1962).
The prognosis fo r  the condition is guarded as the disease is
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chronic in character and usually pers ists fo r  l i f e  (Dietz and 
Wiesner, 1984). The horse gradually loses condition (Dietz and 
Wiesner, 1984; Kra i, 1962) and is  less capable o f work. Response 
to treatment is  generally poor and euthanasia often resu lts  (Dietz 
and Wiesner, 1984).
Environmental Skin Disease
Environmental skin conditions are often encountered among large 
animals including the horse (Scott, 1988). The c l in ic a l
manifestations produced in cases o f chemical and hepatic plant
to x ic i t ie s  are often spectacular.
Photosensitisation is an aberrant reaction w ith in  the skin in 
response to u l t r a v io le t  (UV) l ig h t  (Stannard, 1972). The 
pathogenesis o f the syndrome is  variab le , but a l l  types of
photosensitisation have common features: the presence o f a
photodynamic agent in the skin concomitant with exposure to UV 
l ig h t  o f the A range (320 to 400 nm), the absorption o f which is  
fa c i l i t a te d  by defic iency o f melanin pigment in the skin and 
haircoat (White, 1987).
Photodynamic agents (PDAs) are activated by a spec if ic  wavelength 
o f l ig h t  and transmit rad ia tion  to adjacent ce l ls  (Kra i, 1962),
causing inflammation and eruption o f unpigmented skin, accompanied 
by oedema, congestion, necrosis, cracking and sloughing (Pascoe, 
1973). There may be superimposed secondary bacteria l in fec tion  in 
severe cases (Stannard, 1972).
PDAs can occur outwith or w ith in  the animals's body (Kra i, 1962). 
Ingested feeds, components w ith in  plants such as St. John's wort, 
and drugs such as phenothiazines, te tracyc lines and sulphonamides 
(McMullan, 1982) are the commonest exogenous agents; while 
phy lloe ry th r in  is the predominant endogenous PDA (Krai, 1962; 
White, 1987). In secondary or hepatogenous photosensitisation, the 
PDA phy lloe ry th r in  is formed when chlorophyll is  degraded by 
in te s t in a l bacteria. Excretion of phy lloe ry th r in  is  greatly  
reduced where there is hepatic compromise, and i t  accumulates in
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t issues and may reach leve ls in the skin which cause the skin to 
become l ig h t  sensitive (Dietz and Wiesner, 1984). Approximately a 
quarter o f horses suffering  from l i v e r  disease have excessively 
high leve ls o f ph l lo e ry th r in  c irc u la t in g  to the cutaneous leve l.  
Ingestion o f plants, such as ragwort, groundsel, ta r -  or 
rattle-weeds, which contain p y r ro l iz id in e  a lka lo ids , is  one o f the 
commonest causes o f hepatic dysfunction with resu ltan t 
accumulation o f ph y l lo e ry th r in , but hepatotoxic drugs and 
obstructive b i l ia r y  diseases are other p o s s ib i l i t ie s  (White, 
1987).
Rape, a l fa l fa  and leguminous plants, p a r t ic u la r ly  lucerne and 
as like  c lover, have been connected with ph o tosens it iv ity , but the 
PDA responsible and the pathogenesis are unclear (Dietz and 
Wiesner, 1984).
When skin is  exposed to sunlight o f the UV B range, 290 to 320 nm, 
excessively, the normal response is  sunburn. Sunburn is  normally 
seen only in white or 1ightly-pigmented horses, and depends on the 
length o f time spent in the sun and on the level o f melanin in the 
skin and haircoat (White, 1987).
The i r r i t a n t  form of contact derm atit is  is seen more often than 
the a l le rg ic  form of the condition (Stannard, 1972; Mullowney, 
1985a). Despite s im i la r i t y  in c l in ic a l  appearance, pathogenesis of 
the two forms o f contact derm atit is  is  very d i f fe re n t .  There is  no 
involvement o f the immune mechanism in i r r i t a n t  contact derm atit is  
(Scott, 1988), rather the d ire c t  action o f the i r r i t a n t .  The 
i r r i t a n t  may be a body secretion, a wound excretion, a strong acid 
or a lk a l i ,  a plant such as the n e tt le ,  a top ica l drug such as 
mercury compounds used in b l is te rs ,  or i t  may be crude o i l ,  
d iese l, turpentine, or leather preservative (Scott, 1988). The 
head, extrem ities, ventral body surfaces and areas under tack are 
those most commonly affected (Mullowney, 1985a).
The skin becomes reddened and p r u r i t i c ,  with oozing or 
ves icu la tion , and crusting. Hair may be lo s t  due to s e l f  
m u ti la t ion  or damage to ha ir f o l l i c le s ,  and depigmentation o f ha ir 
and skin may pers is t in d e f in i te ly  (Mullowney, 1985a).
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When the epidermal b a rr ie r  is  compromised by moisture there is  
greater contact between the i r r i t a n t  and the skin, so where horses 
experience muddy conditions underfoot there is  increased r is k  o f 
derm atit is  o f the fee t. Previous skin damage, length o f time o f 
contact and the concentration o f the i r r i t a n t  dose a l l  influence 
the development o f contact derm atit is  (Scott, 1988).
Skin re lated to x ic i t ie s  have been reported a f te r  ingestion o f 
excessive amounts o f compounds such as selenium, mercury and 
pentachlorophenol (Mullowney, 1985a; Pascoe, 1973; Scott, 1988). 
Lesions o f the skin and the ha ir are often the presenting signs, 
in the form o f extensive ha ir loss from the mane and the t a i l ,  and 
in some cases, progressive generalised alopecia (Scott, 1988). 
Signs o f systemic and gas tro in tes t ina l involvement are usually 
also seen, and in chronic selenium to x ic i t y  or a lk a l i  disease 
there is  lameness; in severe cases the hooves may slough (Blood 
and Radostits, 1989b; Pascoe, 1973). Acute selenium to x ic i t y  may 
re s u lt  in death (Mullowney, 1985a).
Ingestion o f cereals grown on seleniferous s o i ls ,  or of 
selenium-accumulating plants such as M o r i n d a y  Astra lgus  or
Xy lo r rh iza  spp are causes of selenium to x ic i t y  (Blood and
Radostits, 1989b). Mercurial poisoning is usually a consequence of 
accidental feeding of cereal treated with antifungal organic 
mercurials (Pascoe, 1973), although overdosing of 
mercury-containing medicaments and percutaneous absorption from 
skin dressings and b l is te rs  have been known (Blood and Radostits, 
1989b; Pascoe, 1973; Scott, 1988). Pentachlorophenols are used as 
fungicides, mol 1uscicides, wood preservatives, and are components 
o f waste motor o i l .  Signs of to x ic i t y  followed the use o f waste
o i l  to s e t t le  dust in a r id in g  arena (Mullowney, 1985a). The
resu lt ing  derm atit is  was s im ila r to contact derm atit is  and
involved the mucous membranes o f the l ip s ,  mouth and nasal
passages, resembling a chronic resp ira tory  in fe c t ion .
Congenital Skin Disease
Although congenital abnormalities involving the skin o f the horse
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are rare, they are s t r ik in g  and are often d is f ig u r in g ,  precluding 
use as show animals.
Albinism re fers  to a congenital absence o f melanin tha t also 
a ffec ts  the hooves and the eyes. The occurrence o f true equine
albinism is  disputed (Dietz and Wiesner, 1984), and p a r t ia l
albinism only is  seen, as most horses have pigmented ir id e s ,  
although the coat is white. The condition is  believed to be 
re la ted to an autosomal dominant gene (Scott, 1988).
Angiomatosis or verrucous haemangioma, which is  s im ila r  to the 
"strawberry birthmark" o f humans, is  an eas ily  traumatised lesion 
which bleeds profusely i f  damaged. I t  is  an alopecic, usually 
s o l i ta ry  les ion, tending to occur on an extremity. In contrast to 
the human les ion, regression is  un like ly  (Mullowney, 1985a).
Firm, clearly-demarcated painless nodular lesions up to 12 cm in 
diameter are occasionally found in the subcutis adjacent to 
jo in ts  or tendon sheaths, commonly la te ra l to the s t i f l e  jo in t  
(McMullan, 1982; Scott, 1988). These are known as calc inosis 
c ircumscripta or tumoural ca lc inos is . They are c a lc i f ie d  deposits 
which induce a fibrous granuloma and are normally seen in animals
younger than four years old. Aetiology is suggested to be repeated
trauma (McMullan, 1982), or an autosomal recessively transmitted 
defect o f phosphorous metabolism (Mullowney, 1985a).
Congenital and hereditary cysts o f the skin have been reported in 
the horse (Scott, 1988). These include epidermoid or e p ith e l ia l  
cysts, and dermoid cysts, which are c l in i c a l l y  s im ila r .  Both are 
characterised by an e p ith e l ia l  wall and keratinous contents. 
Neither type of cyst is thought to be neoplastic or preneoplastic 
(Mullowney, 1985a). In one survey (Pascoe and Summers, 1981), a l l  
cases were Thoroughbreds, but there is no age pred ilec t ion  
(Scott, 1988).
Epidermoid or e p ith e l ia l  cysts resu lt  from f i r s t  branchial c le f t  
abnormality (Mullowney, 1985a), in the form o f un ila te ra l 
pouch-like outgrowths which contain embryonic teeth, ha ir , keratin 
and ha ir and sebaceous and sweat gland secretions. Epithelium
29
becomes aberrantly s ituated, e ith e r by congenital ectopic 
development or by traumatic implantation or ha ir  f o l l i c l e  
occlusion (Pascoe, 1973). The size o f the cyst increases as 
keratinous material builds up inside i t .  They are situated at the 
ear base, f i rm ly  adherent to underlying bone or ca r t i la g e , and 
tend to become f is tu lo u s  (Mullowney, 1985a).
Dermoid cysts occur along the dorsal midline between the withers 
and the rump (Pascoe and Summers, 1981). The cysts are 
characterised h is to lo g ic a l ly  by an epidermal l in in g  tha t contains 
adnexa (Scott, 1988).
Conclusion
Even today skin disease in the horse is  poorly diagnosed and 
frequently  mistreated, resu lt ing  in undue su ffe r ing . As a 
consequence skin disease must be considered a major welfare 
problem in the horse.
Skin disease in the horse was reviewed in th is  chapter. I t  was
seen as a s ig n if ic a n t ,  common complaint which often precludes use
o f the animal fo r  the purpose fo r  which i t  is  kept. Various causes 
o f skin disorders have been considered, and attempt was made to 
h ig h l ig h t  the most important conditions, although information 
regarding the re la t iv e  incidences of the equine skin disorders is
not re ad ily  ava ilab le . Bacterial skin disease was shown to be
common in the horse and dermatophilosis has been put in to  
perspective as one o f the most frequently encountered equine 
bacteria l skin in fec tions.
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A PERSPECTIVE OF DERMATOPHILOSIS IN THE HORSE
Skin disease, and in p a r t ic u la r  bacteria l skin disease, was shown 
in the preceding chapter to be an increasing equine welfare 
problem. Many cases re su lt  from poor management, unhygienic l iv in g  
conditions, d i r t y  tack and lack o f close a tten tion , p a r t ic u la r ly  
i f  animals are housed outside fo r  most o f the year.
Dermatophilosis is  one o f the commonest bacteria l skin conditions 
o f the horse, and is  encountered most often in horses and ponies, 
o f a l l  types and o f a l l  breeds, which are outwintered. These 
animals are exposed to prolonged, excessive wetting, p a r t ic u la r ly  
in the West o f Scotland, conditions which are known to predispose 
to dermatophilosis in fe c t ion . Under these circumstances o f 
outwintering close inspection may be infrequent, and early  cases 
o f dermatophilosis, where the coat simply appears soaked, are 
often missed or overlooked. In fection  is l i k e ly  to be advanced 
before i t  gives cause fo r  concern.
By the time the severity  of the condition is appreciated lesions 
may be extremely pa in fu l,  and there may be complicating secondary 
bacteria l in fe c t ion , p a r t ic u la r ly  where lesions o f the lower limbs 
are involved and where the horses are constantly standing in damp, 
muddy conditions underfoot. This obviously leads to concern fo r  
the welfare o f such animals. Housing, which, as described in the 
fo llow ing chapter, often leads to spontaneous healing o f the 
le s io n s , is  not always possible. The s i te  o f the lesions, with the 
typ ica l dorsal d is t r ib u t io n  where the coat is wettest, and th e ir  
painfu l nature, often p roh ib its  the use o f a saddle and so the 
horse can not be used fo r  ridden work.
This chapter describes equine dermatophilosis in more de ta il and 
the features o f the condition in the horse are compared to those 
found in other species. Consideration is then given to the nature 
and the e ff icacy  o f the regimes which are cu rren tly  practised in 
treatment, control and prophylaxis o f the disease.
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The c l in ic a l  manifestations o f Dermatophi losis congolensis 
in fe c t ion  vary g rea tly  in the wide range o f species which the 
organism in fec ts  (Stewart, 1972a). There are few veterinary
pathogens which are encountered quite as un iversa lly  or where 
in fe c t ion  advances as imperceptibly as D. congolensis.  
Dermatophilosis was thought fo r  decades to be a condition o f 
horses, c a t t le ,  sheep and goats, found only in the trop ics . 
Reports frequently o r ig ina te  from the African continent, but the 
disease is  much more common than o r ig in a l ly  thought in more 
temperate regions such as the U.K., Europe, Eire, A ustra lia , New 
Zealand and North and South America. The disease is  worldwide in 
d is t r ib u t io n ,  although the in te n s ity  o f c l in ic a l  in fec t ion  tends 
to be most severe in countries with a less temperate climate 
(Stewart, 1972a).
Dermatophilosis is  a major, d e b i l i ta t in g  problem tha t is  d i f f i c u l t  
to manage in the horse. Although the m o rta l i ty  is  low, morbidity 
may be as high as 80%, p a r t ic u la r ly  under crowded stable
conditions (Ford, Cairns and Short, 1974). Considerable weight
losses have been recorded, and even death has been reported which 
was a t t r ibu ted  to widespread alopecia and e p ith e l ia l  destruction 
subsequent to the in fec tion  (Ford, Cairns and Short, 1974). The 
disease is  also o f enormous economic importance in countries where 
ra is ing  lives tock  is a primary industry, e.g. ovine in fec t ion  in 
countries such as Austra lia . Downgrading of fleeces, p a r t ic u la r ly  
in fine-wooled breeds is a major loss of revenue (Austwick and 
Davies, 1958). Bovine dermatophilosis, although worldwide in 
d is t r ib u t io n ,  is of greatest importance economically in trop ica l 
regions, especia lly Madagascar and Central and Western A fr ica , 
where huge d e f ic i ts  are incurred each year owing to damaged hides, 
chronic i l l t h r i  f t , reduced production, increased c u l l in g  and 
m o rta l i ty  (Lloyd, 1976; Bida, unpublished data). In Nigeria, i t  
was estimated tha t, annually, around 11 per cent o f a to ta l c a tt le  
population o f 11 m il l io n  (Food and Agricu lture  Organisation, 1973) 
were c l in i c a l l y  affected during the rainy season and approximately 
f iv e  per cent during the dry season (Oduye, 1975; Lloyd, 1976). 
The economic losses from spoilage of leather from c a t t le ,  sheep, 
swine and goats is in the region o f $ 37.4 m il l io n  per annum in 
Nigeria (Arowolo, Amakiri and Nwufoh, 1987). According to Macadam
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(1964b), during the rains morbidity reached 50 per cent and the 
m o rta l i ty  f iv e  per cent. Bovine dermatophilosis has also become 
more important in recent years due to i t s  disastrous e f fe c t  on 
imported, high producing breeds. I t  d ra s t ic a l ly  hinders selective 
crossbreeding and improvement o f indigenous c a t t le  under intensive 
systems o f management (Ilemobade, Gyang, Bida & Addo, 1979).
The spectacular lesions of bovine dermatophilosis f i r s t  drew the 
a tten tion  o f c l in ic ia n s  (Stewart, 1972a). D. congolensis in fec tion  
was i n i t i a l l y  described in c a t t le  in the then Belgian Congo, now 
Zaire, by Van Saceghem (1915). He reported an exudative 
derm atit is  with small raised scabs containing embedded ha ir, 
epidermal c e l ls ,  leucocytes and coagulated serum. Removal o f these 
crusts revealed a concave p u s - f i l le d  area beneath the scab. These 
crusts and the pus harboured the organisms which appeared as 
branching mycelial elements. Hyphae divided in a transverse 
fashion without separating, to form coccoid elements. As the 
filament widened, long itud ina l and transverse d iv is ions  were seen, 
often up to e ight cocci across. Thompson (1954), c ited by Stewart 
(1972b), reported formation o f motile spores from these cocci. 
Broth cu ltu re  growths showed i n i t i a l  hyphal formation, with la te r  
growth predominantly coccoid in form. D. congolensis was 
established as aerobic, gram-positive, and non-acid fa s t ,  and was 
found to possess l im ited  capacity to ferment sugars (Thompson, 
1954).
The Organism
C lass if ica t io n  o f the organism is :  Class: Schizomycetes
(Cruickshank, 1955); Order: Actinomycetales (Austwick, 1958,
c ited  by Stewart, 1972b); Family: Dermatophilaceae (Austwick,
1958, c ited  by Stewart, 1972b); Genus: Dermatophilus (Van
Saceghem, 1915); Species: Congolensis (Gordon, 1964; Roberts,
1965). Edwards and Gordon (1962), carried out electron 
microscopical studies which showed that the Actinomycetales have 
no s truc tu ra l re la tionsh ip  with the Eumycetes, or true fungi, and 
tha t they show s im i la r i t ie s  to the Eubacter ia les.
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Scanning electron microscopy (SEM) studies by Abu-Samra and Walton 
(1977) indicated tha t germinating zoospores developed w ith in  
certa in  hyphae and were subsequently released, w h i ls t  the coccoid 
forms were produced by budding from a d i f fe re n t  type o f hyphae. 
Colonies were found to have both vegetative and aeria l hyphae. The 
various patterns o f mycelial a c t iv i t y  and s tructure tha t were seen 
raised serious doubts about the e a r l ie r  ideas on the method o f 
growth and therefore the c la s s i f ic a t io n  o f Dermatophilus w ith in  
the Actinomycetales (Abu-Samra and Walton, 1977).
The Disease
Although much o f the l i te ra tu re  records cases in c a t t le  and sheep, 
the in fe c t ion  has been described in the horse from the e a r l ie s t  o f 
reports. The disease was f i r s t  reported in horses and c a t t le  by 
Van Saceghem (1915); then in sheep in South A fr ica  (Bekker, 1928) 
and in Austra lia  (B u ll,  1929; Seddon, 1929, c ited  by Austwick and 
Davies, 1958). In the U.K. the f i r s t  report in sheep was from 
Scotland by Harriss (1948). Beaton (1928), c ited  by Stewart, 
1972a, described the condition in goats. Cases are recorded in a 
wide va r ie ty  of domestic animals and w i ld l i f e  species. Dogs 
(Chastian, Carithers, Hogle, Abou-Gabal, Graham and Branstetter, 
1976) and a cat (Carakostas, M i l le r  and Woodward, 1984) have been 
in fected, and Lomax and Cole (1983) reported the condition in 
pigs. W ild l i fe  species infected include, deer (Salkin, Gordon and 
Stone, 1975); owl monkeys (Fox, Campbell, Reed, Snyder and Soave, 
1973); t i t i  monkeys (Migaki & Seibold, 1976, Washington); rabbits 
(Shotts and Kistner, 1970); hares, hedgehogs and gerb ils  
(Kusel'tan, 1967); chamois (N icole t, Klinger and Fey, 1967, 
Switzerland); Australian bearded liza rds  (Montali, Smith, 
Davenport and Bush, 1975, Washington); polar bears (Newman, Cook, 
Appelhof and Kitchen, 1975, D e tro it ) ;  w ild  raccoons (Salkin, 
Gordon and Stone, 1976, New York), and camels have been 
experimentally infected (Abu-Samra, Imbabi and Mahgoub, 1976). The 
domestic fowl, on the other hand, appears to be completely 
res is tan t to dermatophilosis in fec tion  (Abu-Samra, Imbabi and 
Mahgoub, 1976).
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Man has also been infected, from infected deer (Dean, Gordon, 
Severinghaus, K ro ll and R e il ly ,  1961, c ited  by Stewart, 1972a); 
experimentally, from cultures (Memery and Thiery, 1960, c ited  by 
Stewart, 1972a) and from experimental exposure to infected horses 
(Ford, Cairns and Short, 1974).
Van Saceghem (1915) f i r s t  id e n t i f ie d  the disease in horses in 
A fr ica . Hudson (1937) observed lesions in the horse s im ila r  to 
those in c a t t le ,  again in A fr ica , and the disease was reported in 
the U.K. in the same year by Stableforth (1937). Since then, 
there have been many reports o f the disease a ffec t ing  equines. 
Scarnell (1961) again drew attention  to the condition in B r i t is h  
horses and transmitted the condition to other horses. 
Dermatophilosis was id e n t i f ie d  among mares and foals in Austra lia  
by Edgar and Keast (1940) while on the North American continent 
Bentinck-Smith, Fox and Baker (1961) and Searcy and Hulland (1968) 
diagnosed the disease in horses in America and Canada, 
respective ly . Green (1960) id e n t i f ie d  lesions seen on donkey and 
zebra skins in Kenya, and Lloyd (1971) made c l in ic a l  observations 
on s tre p to th r ico s is  in the domestic donkey in Nigeria. The disease 
was reported fo r  the f i r s t  time in East or South East Asia in 
horses in Hong Kong by Munro (1977). Bussieras, Chermette and 
Marchand recorded the disease in horses in France in 1978.
S tableforth (1937) described lesions which developed over the rump 
and hindquarters as "paintbrush" formations o f matted hairs with 
scab formation and large co rn if ied  areas. In a review o f 10 
natural and 48 experimental cases, Scarnell (1961) noted acute and 
chronic forms o f the disease. In the acute form lesions often 
went unnoticed fo r  long periods, p a r t ic u la r ly  in pastured horses. 
Small lesions developed and there was insidious spread over the 
body u n t i l  the coat looked soaked. Crusty lesions could be 
palpated below the haircoat. Scabs th icke r than 0.5 cm and over 
2.5 cm in diameter were noted. These were frequently grey, 
sometimes confluent, with tu f ts  o f protruding ha ir.  The underside 
o f the scab was ty p ic a l ly  concave with protruberant hairs and a 
club-shaped ha ir root. B i la te ra l ly  symmetrical lesions were seen 
most often on the dorsal surfaces of the body, from the poll to 
the t a i l  root. The limbs, p a r t ic u la r ly  the d is ta l areas, were also
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affected. The muzzle and face were affected by the no n -p ru r it ic  
lesions (Edgar and Keast, 1940; Macadam, 1964c), and the underside 
o f the abdomen was involved in some cases (Macadam, 1964c). 
Bentinck-Smith, Fox and Baker (1961) described lesions as an 
exudative derm atit is  with hyperaesthesia, a ffec t ing  the back and 
croup, and also noted the absence o f p ru r itu s .
The chronic form of the condition consisted mainly o f plaque-like 
hard lesions o f raised ha ir and f lak ing  skin. Scarnell (1961) 
suggested tha t these reduced skin e la s t ic i t y  and contributed to 
"cracked heels". Chronic lesions were common over the saddle area 
and on the pasterns. He believed there was connection with "mud 
feve r". McCaig (1967) also described the loca lised form o f the 
disease in horses. Lesions affected the lower limbs up to the 
region o f the fe t lo ck , in p a r t icu la r  the fro n t legs in hunters. 
The lesions were more noticeable where there was white ha ir .  In 
severe cases the area under the body, where mud splashed, was also 
affected. Lameness may be the presenting sign in "mud rash", owing 
to deep f issures and heavy scabbing of skin around the coronet, 
heels and pastern, as a consequence of the inflammation. Oedema, 
which was very slow to resolve, was reported by Bentinck-Smith, 
Fox and Baker (1961).
The lesions described by Scarnell (1961) began to develop a fte r  
pers is ten t wet weather and the acute form resembled "ra in  scald". 
Pascoe (1971) also noted the major con tr ibu ting  cause to the 
severity  o f dermatophilosis in horses to be excessive wet, cloudy 
weather (Pascoe, 1971) and the condition occurs most commonly in 
horses and ponies kept outdoors. In the U.K. the largest number o f 
cases are seen in autumn and w inter (Mullowney and Fadok, 1984a).
Untreated horses have become anorexic and d e b i l i ta te d , and have 
lo s t  as much as 130 kg in weight (Ford, Cairns and Short, 1974). 
Approximately 60 per cent o f the horses studied by the same 
authors developed dermatophilosis during outbreaks in two 
successive years. The la t te r  authors state that there is  potentia l 
fo r  annual outbreaks w ith in  large horse groups which are stabled.
Lesions in untreated horses can pers is t fo r  up to s ix  months or
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longer, depending on the severity  (Ford, Cairns and Short, 1974). 
According to Lloyd (1971), lesions in the donkey are s im ila r ,  
invo lv ing very th ick  scabs that are f i rm ly  adherent to the mane 
and t a i l .  Pinnal margins and the muzzle are often affected.
D. congolensis in fec t ion  in c a t t le  is seen mainly on the African 
continent where i t  is  o f major importance (Stewart, 1972a). The 
West African N'dama and Muturu are believed to be highly res is tan t 
to in fe c t ion  (Coleman, 1967; Macadam, 1970; 1976) whereas European 
breeds are p a r t ic u la r ly  susceptible (Lloyd, 1976). Jersey c a t t le  
imported to A fr ica  are very susceptible and, i f  t i c k  infested, 
re ad ily  die (Stewart, 1972a). Up to 70 per cent o f a herd can be 
affected (Stewart, 1972a). The resistance of Brahman c a t t le  was
compared with tha t o f African Zebus and th e i r  crosses, and i t  was
shown tha t Brahmans were highly susceptible, and tha t Brahman 
bu lls  transferred varying s u s c e p t ib i l i ty  to th e i r  progeny (Dumas, 
Lhoste, Chabeuf and Blancou, 1971). An hereditary predisposition 
has been suggested to ex is t among Shorthorns (Stewart, 1972a).
Cattle  o f a l l  ages are affected, but great v a r ia b i l i t y  ex ists 
w ith in  infected herds (Stewart, 1972a). The cha rac te r is t ic  lesion 
is  an exudative epidermitis which causes crust formation. Lesions 
become alopecic and are often so th ick  that they resemble horn. 
This typ ica l scab formation was described by Z lo tn ik  (1955) as
"crocodile sk in". Lesions are papular and pustular i n i t i a l l y ,  and 
la te r  coalesce to form extensive scabs. Four forms o f bovine
lesion were described by Mornet and Thiery (1955). The ich thyo tic  
form is the commonly seen scab-like les ion; while the nodular form 
is  invariab ly  associated with concurrent Demodex bovis 
in fe s ta t io n , and nodules may be as large as 12 cm and 2 cm th ick . 
A tumourous form, o r ig ina t ing  from histioma development around a 
ha ir  f o l l i c l e  bulb is described, and a lepro id form exists where 
dermal i n f i l t r a t i o n  by inflammatory c e l ls ,  with f o l l i c u l i t i s ,  is 
seen. Tongue lesions, hyperplastic lymph nodes, tox ic  hepa tit is  
and nephrit is  have been recorded in c a t t le  by Mornet and Thiery 
(1955). Considerable loss of condition is often reported as a 
consequence o f reduced m ob il i ty  in severe cases, and o f d i f f i c u l t y  
in prehension of food owing to lesions involving the l ip s  and 
muzzle (Plowright, 1956). Weight gains in recovered animals are
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often very poor (Macadam, 1970).
Lesions o f dermatophilosis ty p ic a l ly  a ffec t the dorsal surfaces: 
along the neck, the back, and the hindquarters, and there is  often 
chest and f lank  involvement. This d is t r ib u t io n  re f le c ts  the range 
o f environmental skin insu lts  which f a c i l i t a t e  permeability by the 
organism. Lesions coincide with t ic k  p red ilec t ion  s ite s , s ites 
damaged by vegetation, maceration, and b it in g  f l i e s  (Scott, 1988). 
Transmission o f in fec t ion  has occurred by b it in g  and non-biting 
f l i e s  (Richard and Pier, 1966) and has been associated with t icks  
(Macadam, 1962; Plowright, 1956).
In A fr ica , bovine lesions may pers is t fo r  many months and may 
carry over to the next ra iny season (Macadam, 1964a). In the U.K. 
lesions in c a t t le  lasted eight months (Roberts and V a lle ly ,  1962).
In sheep, although most breeds seem to be susceptible, f ine  wooled 
breeds are more severely affected (Smith and Austwick, 1975; Hart,
1976). In A ustra lia , Merino-cross lambs su ffe r severely and there
may be high m o rta l i ty  (Stewart, 1972a). Dermatophilosis is  not 
always read ily  detected: in one report in the U.K. (Austwick and
Davies, 1958), nearly 80 per cent o f one f lo ck  o f ewes was
affected, and the owners o f 30 affected flocks were unaware o f the 
existence o f the disease.
Lesions in sheep are variable, and depend la rge ly  on the
geographical loca tion, c l im a tic  factors , pathogenicity o f the 
s tra in  o f the organism and the exact part o f the animal affected. 
Three forms o f the condition are seen: lesions on the wool-covered 
parts, mainly the back, body sides and neck regions are known as 
"mycotic derm atit is" (Seddon, 1929, c ited by Austwick and Davies, 
1958), synonymous with "lumpy wool" (Bekker, 1928). Lesions may 
also occur on the hair-covered areas o f the head, especia lly the 
ears, commissures of the l ip s  and the ha ir over the nasal bones, 
and in rams there may be scrotal involvement. A lte rn a t ive ly ,  i f  
lesions are associated with the ha ir o f the legs from the coronet 
or hock jo in ts  the condition is known as "strawberry foot ro t"  
(SFR), f i r s t  described by Harriss (1948).
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The lesions o f these forms are bas ica lly  the same, but the 
appearance is  altered by the degree o f covering o f ha ir  or wool 
(Stewart, 1972a). Lesions begin as small, hyperaemic areas o f up 
to two weeks duration (Seddon, 1929, c ited by Austwick and Davies, 
1958), which progress to re su lt  in exudation and encrustation. 
Exudation is  continued by la te ra l extension o f the les ion, 
c o rn i f ic a t io n  takes place and scab material separates from the 
underlying epidermis. Re-infection occurs in the newly-formed 
epidermal layer and the process is perpetuated. In chronic cases 
the crust detaches from the skin and is  held in the adjacent 
fleece as a conical mass. Sometimes wool f ib res  w i l l  break o f f  
revealing alopecic areas with black pigmentation o f the skin. In 
affected animals there is frequently a dry, white appearance to 
the fleece, and disordered wool f ib res  are seen around lesions 
(Austwick and Davies, 1958).
Lesions o f the haired areas are f l a t t e r  than fleece lesions and 
develop from amber-coloured scabs. They are thickened, alopecic 
regions o f skin, with greasy appearance to the surface. These 
lesions are often seen in lambs o f a few days old (Hudson 1937), 
where secondary bacteria l invasion may fo llow  and death may 
re s u lt .
In "strawberry foot ro t"  (SFR), described by Harriss (1948), a l l  
four legs may be affected simultaneously. The typ ica l small, th ick  
scab develops and extends to form a rough, verrucous growth, which 
eventually extends over the en tire  leg. Further exudation forms a 
f irm  casing which can lead to swelling and inflammation o f the 
coronet. I f  scabs are removed shallow, haemorrhagic ulcers which 
resemble strawberries are seen. Pruritus and lameness are present 
only i f  secondary bacteria l in fec tion  develops. In the absence of 
secondary in fec tion  there is no pru r itus  and no lameness. Sheep of 
a l l  ages were affected (Harriss, 1948). In pasture where there 
were no abrasive whins, Harriss (1948) found SFR to be 
nonexistent.
SFR lesions are c l in ic a l l y  s im ila r to the lesions o f contagious 
pustular derm atit is  (CPD) or o r f  (Harriss, 1948). Severe lesions 
s im ila r  to f ie ld  SFR infections were produced when lambs were
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experimentally infected simultaneously with o r f  v irus and D. 
congolensis. These lesions were not seen, however, when only one 
organism was inoculated, suggesting tha t in f ie ld  circumstances, 
D. congolensis acts syn e rg is t ica lly  with other organisms to 
produce severe generalised lesions (Abu-Samra and Walton, 1981).
In natural dermatophilosis cases in sheep, duration o f lesions has 
varied from one week to over two months before the "lumpy wool" 
scabs have l i f t e d  o f f  (Austwick and Davies, 1958). Harriss (1948) 
stated tha t the duration of SFR cases was up to 25 weeks, with 
most lesions healing in f iv e  to s ix  weeks.
In caprine in fec t ions , lesions in kids may be seen as early as 
four to f iv e  days a f te r  b i r th ,  as scabs which are detected on the 
inner surface o f the pinna, or as crusty lesions on the smooth
skin on the ventral aspect o f the t a i l  (Munro, 1978). Lesions
enlarge to two or three centimetres in diameter and reach 
approximately one m il l im e tre  th ick .  Scabs, which are read ily  
removed to reveal smooth l ig h t  coloured areas, are dark in colour 
and may resemble warts (Munro, 1978).
Adult goats may have lesions on th e i r  ears, s im ila r  to those seen 
in kids, and adherent scabs are found on the nose. Removal of 
scabs causes discomfort and leaves a raw, bleeding surface (Munro, 
1978).
Two three week old p ig le ts  presented with m u lt ip le  to confluent 
yellow crusts and scabs on the ears, face and over the dorsum 
(Lomax and Cole, 1983). 5. hyicus and D. congolensis organisms
were id e n t i f ie d  from the lesions. The p ig le ts  were housed with 
th e i r  dams in farrowing crates in a concrete-floored farrowing
house, and the moist and disrupted epidermal surface was thought
to have provided a s u f f ic ie n t ly  favourable environment fo r  
secondary in fec tion  with D. congolensis (Lomax and Cole, 1983).
Natural in fec tion  (Chastain, Carithers, Hogle, Abou-Gabal, Graham 
and Branstetter, 1976) and experimental in fec tion  (Richard, Pier 
and Cysewski, 1973) in the dog have resulted in s im ila r lesions: 
erythematous, suppurative u lceration, which was encrusted. Of the
40
natural in fec t ions , one dog demonstrated posterio r dorsal midline 
lesions which had been present fo r  two months (Chastain et  a/ . ,
1976). The dog was anorexic, depressed and had become
progressively emaciated over a s ix  month period. Another dog 
su ffe ring  from natural in fec t ion  presented with a h is to ry  o f 
patches o f alopecia and skin encrustation (Chastain et  a7., 1976). 
The la te ra l femoral and dorsal scapular regions were involved and 
lesions appeared as th ick ,  hard, encrusted lesions up to four 
centimetres in diameter. No sign o f systemic i l ln e ss  was evident. 
In ne ither case was the source o f in fec t ion  traced.
Mild focal p ru r itus  was reported in the experimental
dermatophilosis in fections (Richard et a l . ,  1973), and although no 
systemic signs o f in fec t ion  were seen, there were deaths following 
progressive emaciation.
Contamination o f in ju r ie s  or inoculation by an infected claw was 
assumed to be the o r ig in  o f in fec t ion  in a case o f subcutaneous 
dermatophilosis in a cat (Carakostas, M i l le r  and Woodward, 1984). 
The cat presented with two dra in ing, f irm , subcutaneous masses, 
in the phalanx and poplitea l lymph node regions, respective ly. 
Thick, grey, purulent material drained through tra c ts  which
extended to the skin surface. The surrounding areas were ha ir less.
Raised, golden-brown cutaneous nodules were described on the 
heads, bodies and extremities o f three Austra lian bearded l iza rds 
on a rr iva l at a Washington zoo a f te r  a lengthy journey (Montali, 
Smith, Davenport and Bush, 1975). Lesions were up to f ive
m ill im etres in diameter, although several were larger and
confluent, p a r t ic u la r ly  at pressure points on the limbs. D. 
congolensis organisms were iso lated. The generalised nature o f the 
in fec tion  was believed to be associated with stress p r io r  to 
a r r iva l at the zoo (Montali et a7., 1975).
In a study by Ford, Cairns and Short (1974), four people were
experimentally exposed to active lesions o f infected horses, while
four control persons were exposed to skin and ha ir o f non-infected 
horses. Within 36 to 48 hours a fte r  exposure, the four people 
exposed to active lesions developed d iscre te , erythematous,
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p r u r i t i c  pustules, from which D. congolensis was iso la ted. Lesions 
persisted from two weeks to two months. One case o f natural 
transmission occurred from horse to man over the two-year study: 
numerous d iscre te pustules developed over the handler's forearm 48 
hours a f te r  handling a severely infected horse.
Ford et a l . (1974) obtained biopsies from human and equine
in fec tions . Lesions in both hosts were consistent with a mixed 
nonspecific ep iderm itis ; the dermis was only s u p e r f ic ia l ly  
involved.
A fte r  s c a r i f ic a t io n  o f the skin, D. congolensis cu ltu re  was 
applied to the skin o f the forearm by Memery and Thiery (1960), 
c ited  by Stewart (1972a), and pustules appeared in two days. Scab 
formation was then seen, and a f te r  e ight days a n t ib io t ic s  were 
administered.
Two men who had dressed an infected deer carcase, and two others 
who had handled i t ,  developed furunculosis o f the dorsal surfaces 
o f the hands (Dean et a l . ,  1961, c ited by Stewart, 1972a).
Incubation ranged from two to seven days, and lesions began as 
m u lt ip le , non-painful white pimples or pustules up to 0.5 cm 
diameter with a serous, yellowish exudate. Pustules were 
surrounded by a hyperaemic zone and la te r  ruptured leaving a red 
c ra te r - l ik e  cav ity . There was no spread or coalescence, as seen in 
animals. A fte r three to 14 days lesions healed spontaneously. No 
systemic i l ln e ss  was recorded, nor was the condition contagious to 
human in-contacts.
Pathology and Pathogenesis
According to Lloyd (1984), natural immunity to dermatophilosis 
ex is ts  in varying degrees in domestic animals, and is  a heritab le  
ch a ra c te r is t ic .  V a r ia b i l i ty  in resistance has been recorded w ith in  
a species, between breeds. N'dama and Muturu c a t t le ,  fo r  example, 
are believed to be highly res is tan t to in fec tion  (Coleman, 1967), 
whereas Jersey c a t t le  (Stewart, 1972a) and Brahman c a t t le  were 
found to be highly susceptible, and s u s c e p t ib i l i ty  was transferred
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from Brahman bu lls  to th e i r  progeny (Dumas, Lhoste, Chabeuf and
Blancou, 1971). Species resistance is  believed to e x is t :  the
domestic fowl is  believed to be completely res is tan t to
dermatophilosis (Abu-Samra, Imbabi and Mahgoub, 1976).
The nature o f the haircoat, the s tructure o f the skin, and the
inherent a b i l i t y  o f the host animal to mount a rapid immune
response fo llow ing in fe c t ion , are factors determining natural 
immunity to dermatophilosis (Lloyd, 1984). When D. congolensis is 
inoculated in to  the epidermis the main ba rr ie r  to in fec tion  is  the 
outer stratum corneum and the sebaceous l i p id  which permeates i t  
(Roberts, 1967a; Lloyd and Jenkinson, 1980). Dermatophilus is
believed not to be a commensal bacterium (Macadam, 1970) and i t  
cannot penetrate in ta c t  corneocytes and fi lm s o f sebum (Roberts, 
1967a). Although sebaceous l i p id  from sheep is  tox ic  to D.
congolensis in v i t r o , the protective e ffe c t o f the l i p id  was shown 
to be physical (Roberts, 1967a). Recent work in c a t t le
demonstrated that th is  protection was very superf ic ia l and
possibly associated with changes in the nature of the l i p id  when 
i t  reached the skin surface (Lloyd and Jenkinson, 1980). Barrie r 
function may be compromised by trauma, ectoparasites, prolonged 
wetting and heavy ra in or sprays (Macadam, 1970). A lte ra tions in 
atmospheric temperature and humidity do not d i re c t ly  influence 
skin resistance (Lloyd and Jenkinson, 1980).
"Mycotic derm atit is" and "cutaneous s tre p to th r ico s is "  are
misnomers as the causal agent is bac te r ia l,  not fungal, in o r ig in  
(Roberts, 1967a). D. congolensis penetrates the stratum corneum 
and invades l iv in g  epidermis causing an acute inflammatory
reaction with neutrophil accumulation, accelerated kera tin isa tion  
and epidermal p ro l i fe ra t io n  immediately below the infected area 
(Roberts, 1965). The penetration of epidermal ce l ls  was believed
by Roberts (1967a) to be due to mechanical force, and to be 
independent o f known haemolysin, protease and phospholipase; he 
believed that no toxin was produced by the organism. The
accumulated neutrophils act to prevent invasion by Dermatophilus 
but in the i n i t i a l  in fec tion  stages the organism colonises the 
newly-formed epidermis by la te ra l extension from infected s ites . 
The organism m u lt ip l ies  in and destroys the ha ir f o l l i c l e  sheaths
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(Abu-Samra, Imbabi and Mahgoub, 1976) resu lt ing  in i n f i l t r a t i o n  o f 
the dermis by lymphocytes, macrophages, p ro l i fe ra t in g  f ib rob la s ts  
and connective tissue formation. Delayed hypersens it iv ity  
reactions to experimental inoculation o f D. congolensis have been 
recorded in domestic animals and in the rabb it (Roberts, 1966; 
Makinde and W ilk ie , 1979; Abu-Samra, Imbabi and Mahgoud, 1976). 
However, skin lesions are concluded to be the consequence o f 
nonspecific inflammation, resu lt ing  from the products o f c e l lu la r  
damage d if fu s in g  from the infected epidermis (Roberts, 1967a).
F lage lla r and somatic agglutin ins are produced in response to 
Dermatophilus; p re c ip i t in s  are only present a f te r  repeated or 
prolonged in fec t ion  or vaccination (Roberts, 1967b). Antibody has 
been id e n t i f ie d  on the skin surface in c a t t le  a f te r  intradermal 
vaccination (Lloyd and Jenkinson, 1981) and has also been 
demonstrated in the m ilk o f infected cows (Makinde, 1981). 
Repeated in fec t ion  or vaccination stimulates an anamnestic 
response (Makinde and Ezeh, 1981).
High serum antibody t i t r e  does not confer immunity to natural 
dermatophilosis (Perreau and Chambron, 1966) and although 
zoospores are agglutinated and immobilised in v i t r o  by such 
antibody, i t  does not k i l l  them (Roberts, 1964). Zoospore 
destruction fo llowing neutrophil phagocytosis is  enhanced by the 
presence o f high t i t r e  spec if ic  antibody in sheep and guinea pigs 
(Roberts, 1966) and the spec if ic  antibody g rea tly  increases 
resistance to experimental in fec tion  of sca r if ied  skin where there 
is  contact between inoculum and invading leucocytes.
Recent studies fo llowing the dose-response o f rabbits to D. 
congolensis in fec tion  (How and Lloyd, 1990) ind icate a degree of 
s t ra in -s p e c i f ic i ty  in immunity. Further work is  needed examine the 
antigenic v a r ia b i l i t y  of isolates and to determine s tra in -s p e c if ic  
antigens. To date (1990) there is no recognised method fo r 
serological or biochemical c la s s i f ic a t io n  o f D. congolensis
iso la tes. Cross-reacting antibody between two stra ins following
vaccination was demonstrated by enzyme-linked immunosorbent assay 
(ELISA) o f serum (How and Lloyd, 1990) but no d ire c t evidence
exists that antibody is protective .
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Diagnosis
C lin ica l lesions are quite d is t in c t iv e  in a l l  species. In the 
horse no other organism induces the c lass ic  "paintbrush les ions". 
The d is t r ib u t io n  o f lesions, coinciding with the areas most in 
contact w ith ra in , is  equally d is t in c t iv e .
Diagnosis is  usually based upon the id e n t i f ic a t io n  of 
ch a ra c te r is t ic  morphological elements in Giemsa stained smears 
from crusts and scabs, and growth o f bacteria with the cu ltu ra l 
features o f D. congolensis.  D irect smear is  made from pus on the 
underside o f scabs, or from serous exudate a f te r  scab removal, or 
from dried crusts emulsified in physiological saline or d is t i l le d  
water. Gram-positive hyphal elements, which branch transversely 
and lo n g itu d in a l ly ,  are seen, and consist o f up to e ight rows of 
cocci (Roberts, 1961). Organisms are often described as "ra ilroad  
tracks" on smear.
I f  the organism is demonstrated in smears, i t  can usually be 
cultu red. Grinding and powdering of scab material p r io r  to cu ltu re 
is  reported to improve iso la t io n  of D. congolensis , by allowing 
the release o f the organism from between the layers o f hard scab 
before inoculation on to cu ltu re medium (Abu-Samra and Walton,
1977). Selective medium containing polymixin B sulphate reduces 
contamination from f ie ld  samples but does not completely elim inate 
i t  (Abu-Samra and Walton, 1977). Pre-incubation with CO2 was not 
found to be essential fo r  growth. The optimal temperature fo r  
growth was 37°C (Edgar and Keast, 1940).
The use o f fluorescent antibody techniques has g rea tly  fa c i l i ta te d  
the detection of D. congolensis in suspensions of exudate (Pier, 
Richard and F a rre l l ,  1964).
Serum antibody t i t r e s  to D. congolensis were demonstrated by ELISA 
in c a t t le  in the west o f Scotland (Lloyd, 1981) allowing screening 
o f sera fo r  exposure to in fec tion  which may have otherwise gone 
unnoticed.
When counterimmunoelectrophoresis, passive haemagglutination, and
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agar gel d i f fu s io n  were compared, counterimmunoelectrophoresis, 
which is  spec if ic  and sens it ive , was found to be the most 
sa t is fa c to ry  method o f screening large numbers o f serum samples, 
w ith an antibody detection rate o f over 80 per cent (Makinde and 
Majiyagbe, 1982). C e llu la r antigens, p a r t ic u la r ly  ce ll  wall 
ex trac t, were more successful than e x tra c e l lu la r  antigen in 
antibody detection in sera.
A monoclonal antibody, produced from murine hybridoma cu ltu res, 
was used to demonstrate D. congolensis in c l in ic a l  material from 
confirmed bovine and ovine cases o f dermatophilosis by in d ire c t 
immunofluorescent s ta in ing (How, Lloyd and Lida, 1988).
Management
Two points c ited  by Stewart (1972b), put treatment o f 
dermatophilosis in to  perspective. In severe cases the thickness o f 
the crusts is  too great, and active hyphae are embedded too deep 
in the f o l l i c l e  sheaths, fo r  top ica l treatment to be e ithe r 
p rac tica l or e f fe c t ive  (Roberts, 1967b); and to allow top ica l 
treatment to penetrate even to the superf ic ia l areas of the 
les ion , scabs should be removed, and wholesale removal is  too 
harsh, very painful and inhumane (Coleman, 1967).
Roberts (1967b) stated that ra tiona l treatment should be large 
doses o f a n t ib io t ic  to which the organism is sensitive , 
remembering that many cases heal spontaneously. Dermatophilosis is 
reported, however, by some authors (Mullowney and Fadok, 1984a) to 
be highly sensitive to most an tibac te r ia l agents, and in mild 
cases to require only topical an tisep tic  therapy.
In the horse, Searcy and Hulland (1968) used top ica l application 
o f iodine solution in addition to parenteral 
p e n ic i l1 in-streptomycin combination treatment, and recovery was 
recorded w ith in  three weeks. Animals recovered but comparison to 
untreated cases made assessment of the e ff icacy  o f treatments 
d i f f i c u l t .  Horses were treated to p ic a l ly  with 0.1% solution of 
chlorhexidine digluconate with good resu lts  (Dykstra and Osinga,
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1969). Only p a r t ia l  response was recorded, however, to spraying o f 
lesions with magnesium f lu o s i l ic a te  in 70 severely affected equine 
cases (Pascoe, 1971). Parenteral pen ic il l in -s trep tom yc in  gave best 
resu lts  as judged by ha ir regrowth and loss o f i r r i t a t i o n  in 
affected areas. In a fu r the r outbreak involv ing 278 horses, Pascoe 
(1972) reported that recovery o f most cases occurred w ith in  seven 
days, whether treated with systemic or lo c a l ly  applied 
a n t ib io t ic s ,  p a r t ic u la r ly  0.5 % chloramphenicol used to p ic a l ly .  
Resistant cases were described as showing a better response to an 
o i ly  preparation of chloramphenicol, and parenteral a n t ib io t ic s  
(Pascoe, 1972).
Ford, Cairns and Short (1974) studied a herd o f over a hundred 
pleasure horses over a two year period, and recorded regression 
o f active lesions w ith in  four days o f f i r s t  treatment a fte r  
cleansing o f infected skin using povidone-iodine solution or 
commercial shampoo. Copper sulphate was an e f fe c t ive  topical 
(Watson and Walton, 1973), when used a f te r  d a i ly  currying and 
washing with water. Horses were treated once weekly fo r  two weeks. 
Iodophors, 0.5% zinc sulphate, 0.2% copper sulphate and 1% 
potassium aluminium sulphate (alum) are commonly used top ical 
solutions (Scott, 1988). Solutions are applied as to ta l body 
washes, sprays or dips fo r  three to f iv e  days and are then 
continued weekly u n t i l  healing occurs.
Infections o f unpigmented areas such as the muzzle or lower 
extrem ities commonly crack or f issure , resu lt ing  in c e l l u l i t i s  
causing severe pain or lameness in the horse. These respond best 
to combined a n t ib io t ic -s te ro id  ointments (Scheidt and Lloyd,
1987), but astringents such as white lo t io n  (20 g zinc sulphate 
and 30 g lead acetate in 50 ml water) applied d a i ly  fo r  f iv e  days 
reduce secondary swelling and inflammation o f the lower 
extrem ities (McCaig, 1967). McCaig (1967) also recommended 
triamcinolone acetonide and halquinol in a cream base in 
treatment, and the application o f emolient cream or Vaseline to 
the legs p r io r  to r id in g . He recorded e ff icacy  o f antihistamines 
in cases where there was severe inflammation o f the lower limbs.
For severe generalised in fec tions, parenteral a n t ib io t ic s  are
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required, such as procaine p e n ic i l l in  G (22,000 IU/kg) and 
streptomycin (11 mg/kg) intramuscularly twice d a i ly  fo r  seven days 
(Scott, 1988), although some authors f ind  a three to f iv e  day 
course to be adequate (Scheidt and Lloyd, 1987).
Successful therapy in horses depends also on removal predisposing 
factors (Scheidt and Lloyd, 1987): affected animals should be
confined to dry places, kept stabled, out o f ra in and wet 
pastures, or at least rugged. I f  the ra iny season is  not prolonged 
then the disease is  s e l f  l im i t in g .  Chronically affected animals 
are the primary source of in fec t ion  (Roberts, 1967a; Mullowney and 
Fadok, 1984a), and mechanical transmission of the disease occurs 
by both b it in g  and non-biting f l ie s  (Macadam, 1964a, 1964b;
Richard and Pier, 1966), t icks  (Macadam, 1961), and fomites such 
as grooming equipment and e le c t r ic  c lippers . Softening with
povidone-iodine soaks or chlorhexidine solution fa c i l i ta te s
removal o f the painful scabs which, along with crust and ha ir ,
should be eliminated from dis in fected premises to reduce
environmental contamination and therefore reduce the source of
re - in fe c t io n  (Scheidt and Lloyd, 1987). Other recommendations fo r  
control o f dermatophilosis include improved hygiene, n u tr i t io n a l 
and management practices; insect and arthropod con tro l; iso la t ion  
or c u l l in g  o f infected animals, and evasion of mechanical 
cutaneous trauma (Scott, 1988).
The e a r l ie s t  recorded topical treatments fo r  dermatophilosis in 
c a t t le  include 3% sodium arsenite solution (Van Saceghem, 1915), 
and tha t prescribed by Armfield (1918), who claimed "moderate 
success fo r  the fo llowing treatment in some cases: moisten crusts
with so ft soap and warm water. Then mix the fo llow ing: quick lime, 
1 lb ;  sulphur 2 lb ;  and water, 2 gallons. Simmer over a slow f i r e  
fo r  three hours and apply to the skin while warm". This treatment 
was to no avail in advanced cases. The use o f dressings was 
decried, as they spread the disease from one part o f the skin to 
another, and rather removing scabs and painting o f the underlying 
areas with one per cent p ic r ic  acid was recommended (Armfield, 
1918).
More recently , a single dose of a n t ib io t ic s  has proved e ffec t ive
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in treatment o f the bovine condition, 75,000 IU/kg p e n ic i l l in  and 
75 mg/kg streptomycin (Blancou, 1969). Recoveries o f over 80 per 
cent with treatment, but only 14 per cent w ithout, have been 
recorded. In A fr ica  a single intramuscular in je c t io n  of 
long-acting oxyte tracycline (20 mg/kg) was reported to be curative 
in over 90 per cent of animals treated (Ilemobade, Gyang, Bida and 
Addo, 1979; Gyang, Ilemobade and Shannon, 1980). Control measures, 
such as s ix  week quarantine of new animals; iso la t io n  o f affected 
animals and slaughter i f  there is no response a f te r  the animal has 
been housed fo r  six weeks, as the animal is l i k e ly  to be a 
permanent reservo ir o f in fe c t ion ; dehorning; avoidance o f skin 
branding; and segregation from sheep and horse; and ectoparasite 
con tro l,  were recommended in trop ica l countries by Macadam (1970). 
However, the t ra d i t io n a l migration patterns and nomadic management 
o f c a t t le  in countries l ik e  Nigeria render measures such as 
iso la t io n  and ectoparasite control v i r t u a l l y  impossible (Macadam,
1970). The discordant resu lts  obtained fo r  single and combination 
systemic treatments lead to a s itua tion  which ca l ls  fo r  a 
s c ie n t i f i c  search fo r  be tter drugs (Arowolo, Amakiri and Nwufoh,
1987). Other methods o f control or prevention are obviously 
desperately needed.
In problem flocks of sheep where e lim ination o f dermatophilosis is 
im practica l, routine summer and autumn protection dips with 0.5% 
zinc sulphate or 1% potassium aluminium sulphate are reported to 
be e ffe c t ive  (Lofstedt, 1983; Martin, 1983). Resistant cases were 
treated with e ithe r a single parenteral dose of 70,000 IU procaine 
p e n ic i l l in  G/kg and 70 mg/kg streptomycin, or f iv e  days treatment 
at 5,000 IU procaine p e n ic i l l in  G and 5mg/kg streptomycin da ily  
(Lofstedt, 1983).
Dermatophilosis is a disease which can be contro lled by the 
consistent use o f e ffec t ive  husbandry practices. However, where 
improvement o f management is impractical or impossible, a 
s itua t ion  which may be re la t iv e ly  common in poorly managed horses 
which are permanently at pasture, prophylaxis in the form of 
vaccination would be a very desirable method o f con tro l.
Also, fo r  domestic animals kept in large numbers such as large
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c a t t le  herds in the trop ics  and large flocks o f sheep in countries 
such as Austra lia  and New Zealand, and where losses o f 
p ro d u c t iv ity  is  o f major economic importance, and where control o f 
transmission factors is  impossible, vaccination is  the only 
r e a l is t i c  hope o f disease control (Lloyd, 1984).
Blancou (1976), c ited  by Lloyd (1984), evaluated the use o f l iv e  
intradermal vaccines in a herd of Brahman and Brahman-cross 
c a t t le ,  comparing matched experimental and control groups, and 
concluded tha t w h ils t  th is  approach reduced the disease severity , 
i t  had minimal e ffe c t on the incidence o f in fe c t io n . There have 
been no reports ind ica ting  the successful use vaccine o f th is  type 
since then.
I t  is  uncertain whether superf ic ia l epidermal defences or deeper 
secondary immune responses are more in f lu e n t ia l  in the prevention 
o f c l in ic a l  dermatophilosis. Following intradermal vaccination 
spe c if ic  antibodies to D. congolensis are secreted in to  the 
stratum corneum and protection may be mediated p a r t ly  by the 
immobilisation o f in fe c t ive  zoospores by f la g e l la r  agg lutin in
(Lloyd and Jenkinson, 1981). Local cutaneous humoral immune 
mechanisms may therefore be important and might explain the 
superior resu lts  obtained a fte r  intradermal vaccination. F lage lla r 
antigen v a r ia b i l i t y  between stra ins of D. congolensis may 
therefore be s ig n if ic a n t (Roberts, 1964). Live intradermal 
vaccination stimulates considerable f la g e l la r  agglutin in 
production (Lloyd, Jenkinson, Nimmo and Mackie, unpublished 
observations). Therefore the antigenic composition o f vaccinal 
s tra ins  may require to be ta i lo red  to predominant stra ins in a
spec if ic  area. I f  i t  is crucia l that superf ic ia l defences should
be avoided by vaccination through the stratum corneum, then other 
antigens may be more important in the stimulation o f an
appropriate immune response (Lloyd, 1984).
The promise o f l iv e  intradermal vaccination as an e ffec tive  
prophylactic have not then been f u l f i l l e d  (Arowolo, Amakiri, and 
Nwufoh, 1987; Lloyd, 1984), and the need fo r  a new approach to 
management o f dermatophilosis is greater than ever.
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Conclusion
Dermatophilosis is  now a s ig n if ic a n t  welfare problem in the horse 
in the U.K. I t  is  seen most commonly where horses are exposed to 
the elements, without provision fo r  she lte r. I t  tends therefore to 
be a disease o f the poorly managed horse. D e b il i ty  and 
considerable weight loss often accompany generalised cases of 
dermatophilosis.
Owing to the insidious onset o f in fec t ion  in horses kept at 
pasture, cases are often advanced before detection, and are 
p a r t ic u la r ly  re fra c t ive  to treatment. Spontaneous recovery can 
occur in horses on housing, but th is  is  often impossible. 
Although numerous therapies e x is t ,  response varies, p a r t ic u la r ly  
to top ica l treatment. Application o f such treatments, especia lly 
washes, can be d i f f i c u l t  and time consuming and, where the weather 
is  inclement or when large numbers o f animals are involved in an 
outbreak, i t  can be im practica l. Treatments are often required fo r  
prolonged periods during which zoonotic in fec t ion  may occur, and 
the recovery period fo r  dermatophilosis in horses is  often 
protracted.
The fac t tha t l iv e  intradermal vaccination has not proved to be an 
e f fe c t ive  means o f prophylaxis, the potentia l fo r  annual outbreaks 
w ith in  a stable, and the p o s s ib i l i ty  o f transmission o f in fec tion  
to humans and to domestic pets fu r the r strengthen the need fo r  
investiga tion  o f a l te rna tive  methods o f management o f 
dermatophilosis in horses, a need which was addressed in th is  
thes is .
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ESSENTIAL FATTY ACIDS (EFAs): THE RATIONALE FOR POSSIBLE USE TO 
MANAGE EQUINE DERMATOPHILOSIS
Background
Essential fa t t y  acids (EFAs), in p a r t ic u la r  gamma l in o le n ic  acid 
(GLA), are becoming increasingly widely used in c l in ic a l  medicine, 
including treatment and management o f skin disorders in man and in 
domestic animals. The metabolism and functions o f EFAs, and th e ir  
current relevance in medicine, with are reviewed in th is  chapter. 
Emphasis is  placed on th e i r  ro le in the skin and in dermatological 
disorders, as an in troduction to the ju s t i f i c a t io n  fo r  use as an 
a lte rn a t ive  approach to management of dermatophilosis in horses.
EFAs are d ie ta ry  factors which l ik e  vitamins or essential amino 
acids cannot be manufactured by the mammalian host but must be 
ingested with food (Horrobin, 1990a and 1990b). They are 
polyunsaturated fa ts , which means that they contain at least two 
double bonds. A ll EFAs are polyunsaturated fa t ty  acids (PUFAs) but 
many PUFAs are not EFAs, and those which are not may have adverse 
e ffec ts  (Horrobin, 1990b). There are two series o f EFAs, the n-6 
series derived from l in o le ic  acid (LA), and the n-3 series 
derived from alpha-1inole ic acid (ALA). LA, 18:2n-6, is  present
in most seed o i ls ,  sunflower o i l  fo r  example contains over 50% of 
fa t ty  acids as LA; and ALA, 18:3n-3, is the main fa t ty  acid in 
leaves, grass contains 64% of fa t ty  acids in th is  form. The 
nomenclature o f EFAs is given in shorthand, e.g. LA is 18:2n-6. 
The f i r s t  number, 18, is the number o f carbon atoms in the 
molecule, and the number a fte r  the colon is  the number o f double 
bonds in the molecule. The la s t n-3 or n-6 defines whether the 
fa t ty  acid is  from the n-3 or n-6 series, ind ica ting  the position 
o f the f i r s t  double bond from the methyl end o f the molecule: th is  
is  between the 3rd and 4th carbon atoms in the n-3 series and 
between the 6th and 7th carbon atoms in the n-6 series (Horrobin, 
1990b).
The n-6 series seems to be considerably more important, as when 
n-6 and n-3 EFAs are d e f ic ie n t,  abnormalities are quickly
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corrected by n-6 EFAs alone, however the supplementation o f n-3
EFAs correct none o f the abnormalities, and make several worse
(Ziboh and Chapkin, 1987). In the zebra, whose EFA intake is
almost a l l  n-3 ALA from grass, the ra t io  o f n-6 to n-3 EFAs in
tissues is  between 3 and 9:1. Although the metabolic enzymes 
appear to be very s im ila r ,  the n-3 and the n-6 series EFAs are not 
interchangeable.
LA and ALA have no b io log ica l a c t iv i t y  beyond oxidation to provide 
energy, and most EFA function requires th e ir  metabolism by
a lte rna ting  slow desaturation and rapid elongation steps, shown in 
Figure 1, resu lt ing  in the formation o f active metabolites. The 
l im ite d  e ffec ts  o f LA and ALA are shown by the stunted growth o f 
animals fed large amounts o f LA and ALA. I f  the ra te - l im i t in g  step 
o f 6-desaturation is bypassed by d ie ta ry  supplementation with n-6 
gamma-1inolenic acid (GLA) and n-3 eicosapentanoic acid (EPA) then 
normal growth is  again observed. The pr inc ipa l functions o f LA
i t s e l f  are maintenance of the in te g r i ty  o f the impermeable ba rr ie r 
formed by the epidermis to water, as well as an anti-thrombotic 
e f fe c t  o f endothelium (Horrobin, 1990b).
Considerable species va r ia tion  exists in EFA metabolism. In
p a r t ic u la r ,  the regulation o f the f i r s t ,  rate l im i t in g
desaturation step by de lta-6-desaturase enzyme a c t iv i t y  varies in 
rate from one species to another, as indicated by the ra t io  o f LA 
to i t s  metabolites in body tissues (Horrobin and Manku, 1990).
The 6-desaturation reaction is most rapid in the ra t ,  and slowest 
in the rabb it and in the guinea-pig (Horrobin and Manku, 1990). In
cats, the 6-desaturation is e ithe r absent or exceedingly slow 
(Frankel & Rivers, 1978). In humans the rate o f LA conversion is 
closest to rabbits  and guinea-pigs (Horrobin, Huang, Cunnane and 
Manku, 1984; S in c la ir ,  1985). As fa r  as can be determined, no 
information is  available on EFA metabolism in the horse.
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n-6 EFAs n-3 EFAs
Linoleic  
acid (LA)
18:2n-6
Gamma-1inolenic 
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Figure 1. Pathways of metabolism of the n-6 and n-3 essential 
fa tty  acids (EFAs)
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Functions of EFAs
Primary EFA functions re la te  to th e ir  roles in membrane structure 
and in biosynthesis o f short l ived  derivatives which regulate 
c e l lu la r  a c t iv i t y  (S in c la ir ,  1990).
Owing to th e i r  unsaturation EFAs confer f l u i d i t y ,  f l e x i b i l i t y ,  and 
permeability on a l l  membranes in the body. EFA defic iency has, fo r  
example, led to reduced oxygenation of tissues due to fa i lu re  of 
in f le x ib le  red blood ce l ls  to pass through c a p i l la r ie s  (Simpson,
1988). EFAs modulate the function o f membrane-bound proteins such 
as receptors, ATPases and ion channels and in EFA defic iency 
exaggerated e ffec ts  are seen when normal concentrations o f ligands 
such as oestrogens and progestins, angiotensin or opioids bind to 
receptor s ites  in membranes (Horrobin, 1990b).
The EFAs are the precursors fo r  short l ived  regulatory molecules, 
known as the eicosanoids, which are derived from 20 carbon EFAs, 
namely arachidonic acid (AA) and DGLA of the n-6 series, and 
eicosapentanoic acid (EPA) o f the n-3 series (S in c la ir ,  1990). 
These eicosanoids include prostaglandins (PGs), leukotrienes 
(LTs), and hydroxy-acids, which are a l l  produced and destroyed 
lo c a l ly ,  according to tissue requirements, and are involved in 
regulation o f calcium contractions w ith in  c e l ls ,  in smooth muscle 
contraction and re laxation, in control o f chemotaxis and in 
modulation o f cytokine production. The pathway fo r  AA metabolism 
is  shown in Figure 2.
The main enzymes involved in the metabolism o f the EFAs to 
eicosanoids are the cyclo-oxygenase and related systems, which 
give r ise  to prostaglandins and thromboxanes; and the 5-, 12- and
15-lipoxygenases, which give r ise  to a va r ie ty  o f oxygenated 
metabolites including the leukotrienes (Horrobin and Manku, 1990). 
AA derivatives formed by cyclo-oxygenase and by 5- and
12-lipoxygenases are believed to be o f p a r t icu la r  importance in 
inflammation.
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Arachidonic acid in membrane stores
Blocked by anti-inflammatory 
steroids and by PGEi
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Leukotrienes Prostaglandins and thromboxane A2
Figure 2. Pathway showing the formation of prostaglandins and 
leukotrienes from arachidonic acid
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PGEi, which is  derived from DGLA, has a wide range o f desirable 
e ffec ts  including in h ib i t io n  o f p la te le t  aggregation and 
inflammation, vasodila ta tion, reduction o f blood pressure, 
elevation o f cyc l ic  AMP leve ls , and in h ib i t io n  o f phospholipases. 
15-OH-DGLA, also derived from DGLA, in h ib i ts  5- and
12-lipoxygenases and therefore the formation o f proinflammatory 
metabolites from AA (Horrobin and Manku, 1990).
AA de riva tive  P G I2  (prostacyclin) and EPA deriva tive  P G I3  both 
have e ffec ts  s im ila r  to those of P G E i .  AA deriva tive  thromboxane 
A2 , a potent proaggregatory and vasoconstrictive agent is  rap id ly  
converted to a re la t iv e ly  in e r t  metabolite, thromboxane (Tx)B2 
(Horrobin and Manku, 1990). Leukotrienes from AA, which contract 
smooth muscle are strongly proinflammatory.
The n-6 EFAs are required fo r  maintenance o f the in te g r i ty  o f the 
impermeable b a rr ie r  to water which the skin provides. LA and GLA 
are the only EFAs capable of th is ,  probably by metabolism to
13-hydroxy deriva tives, which may also regulate permeability o f 
other barrie rs  throughout the body (Horrobin, 1990b). The skin is 
permeable to the passage of water and the transport o f many other 
substances, and when there are in s u f f ic ie n t  EFAs present water 
qu ick ly leaks through the skin, and the skin becomes waterlogged 
by osmosis when surrounded by water (Horrobin and Manku, 1990).
EFAs are involved in the transport and metabolism o f cho lestero l, 
which is  moved around the body predominantly as fa t ty  acid esters 
(Horrobin, 1990b). EFA esters are more soluble and more easily  
dispersed than unsaturated fa t ty  acid. EFAs of the n-6 series 
consis tently  lower plasma cholesterol, probably with e ffec t 
mediated by LA metabolites (Horrobin, 1990b).
I t  is  evident, thus, that the detrimental e ffec ts  o f EFA 
defic iency are l i k e ly  to manifest in a l l  body tissues (Horrobin, 
1990b).
EFA Deficiency in Animals 
Poor growth, unlike that seen in other de fic ienc ies, was observed 
in the ra t as one o f the i n i t i a l  manifestations o f EFA deficiency
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(S in c la ir ,  1952). When pa ir- fed  ra ts were studied a f te r  weaning 
onto a fa t - f re e  d ie t ,  male rats grew v i r t u a l l y  normally fo r  the 
f i r s t  f iv e  weeks post weaning, and females fo r  the f i r s t  10 
weeks. A fte r  a plateau at 13 weeks, the stunted ra ts  survived fo r  
long periods but showed increased s u s c e p t ib i l i ty  to in fec tions . 
Hyperkeratosis and acanthosis o f the epidermis were seen, with 
hypertrophy and atrophy of the sebaceous glands. The lesions in 
t ra n s it io n a l epidermal layers led to increased water permeability, 
with transepidermal water loss and scaliness shown to re su lt  from 
the same lesion (S in c la ir ,  1990). The signs were reversed by 
top ica l application of AA or LA.
Renal dysfunction has been observed in EFA defic iency in animals, 
with haematuria and renal tubule c a lc i f ic a t io n ,  induced by 
prostanoid defic iency (S in c la ir ,  1990). Connective tissue 
involvement has been noted, ca rt i lage  was grea tly  altered and 
osteoporosis was seen, and erythrocyte f r a g i l i t y  was increased, 
along with c a p i l la ry  permeability. Oxidative and phosphorylative 
reactions were uncoupled. Recent work has demonstrated a d e f in i te  
requirement o f animals and humans fo r  the n-3 ALA series EFAs: 
abnormalities have been demonstrated in re t in a l and brain function 
and in growth ar is ing  from n-3 defic iency only (Neuringer, 
Anderson and Connor, 1988).
EFA Deficiency in Man 
I t  was f i r s t  proven that EFAs were required by humans when o i ls  
were used in the treatment o f in fa n t i le  eczema (Hansen, Adam & 
Wiese, 1958). The r a r i t y  of EFA defic iency in humans has 
frequently been confirmed. Relative EFA defic iency, a low ra t io  of 
EFAs to antagonistic long-chain saturated fa t ty  acids and trans 
isomers, has been suggested by S in c la ir  (1990) to account fo r  
Western diseases such as coronary heart disease and 
atherosclerosis, producing a d i f fe re n t  syndrome than absolute 
defic iency: fo r  example, elevated plasma cholesterol levels are
recorded in re la t iv e ,  but not absolute defic iency.
Rationale fo r  Administration o f GLA 
Three main reasons ex is t fo r  GLA supplementation (Horrobin, 
1990b); in summary, i f  there is inadequate LA intake, or
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inadequate rate o f GLA formation, rate o f GLA formation from LA 
may be in s u f f ic ie n t  to supply enough GLA and fu r th e r metabolites. 
Excessive consumption o f LA metabolites may occur, fo r  example 
adequate oxygen and inadequate anti-ox idants re su lt  in EFA 
consumption and conversion to l i p id  peroxides; and where there is 
excessive inflammation AA is  converted to PGs and LTs at an 
abnormally high ra te . I f  ce l l  d iv is ion  is  rapid EFA provision may 
be inadequate to match the requirements o f d iv id ing  c e l ls .  The 
rate o f loss may be greater than the rate o f LA metabolism 
(Horrobin, 1990b).
In addition , at least two GLA metabolites have desirable actions. 
These are prostaglandin Ei (PGEi), formed by cyclo-oxygenase from 
DGLA, and 15-OH-DGLA, formed by 15-hydroxylation o f DGLA. PGEi 
in h ib i ts  inflammation, regulates the immune system, causes 
vasodila ta tion and lowers blood pressure, f lu id is e s  red ce ll 
membranes, causes induction o f insu lin  receptors and in h ib i ts  
p la te le t  aggregation and thrombosis. 15-OH-DGLA in h ib i ts  5- and 
12- lipoxygenases, which lead to pro-inflammatory metabolites from 
AA (Horrobin, 1990b).
Forms o f GLA Administration 
GLA can be administered as tr ig ly ce r id e s  e ith e r derived from 
natural o i ls  or a r t i f i c i a l l y  manufactured as free fa t ty  acids, 
ethyl or methyl esters or as phospholipids (Horrobin, 1990b). The 
nature o f other fa t ty  acids present, and the exact nature o f the 
molecule in to  which the fa t ty  acids are incorporated can both have 
important e ffec ts  on b io log ica l a c t iv i ty  (Lawson and Hughes,
1988). T r ig lyceride  structure is important in determining 
b io log ica l a c t iv i ty .
Evening primrose o i l  is a p a r t ic u la r ly  desirable source o f GLA: 7
to 10% o f i t s  fa t ty  acids consist o f GLA, and is  more e ffec tive  
than other o i ls  at increasing production o f desirable PGEi and 
prostacyclin . EPO is unique in containing no n-3 fa t ty  acids and 
almost no saturated fa t ty  acids, both o f which in te r fe re  with n-6 
EFA metabolism and b io logica l a c t iv i ty .
Methyl and ethyl esters are thought to be less e f fe c t iv e ly
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absorbed than triglycerides or free fa tty  acids (Horrobin, 1990b).
The Use of EFAs in Treatment of Skin Conditions in Man and in 
Companion Animals
The use o f EFAs in the management o f skin conditions is  be tter 
documented fo r  humans than fo r  our animals. The dermatological 
changes observed in atopic eczema bear a superf ic ia l resemblance 
to n-6 EFA defic iency (Wright, 1990); there is  inherited slow 
6-desaturation ra te , with low levels o f LA and ALA metabolites in 
umbilical cord blood, red ce lls  and plasma, m ilk , and adipose 
tissue (Horrobin, 1990b). There is no evidence o f reduced intake, 
absorption, or plasma levels o f LA in atopic eczema, rather LA 
leve ls are often elevated (Horrobin, 1990b). In cord blood, the 
severity  o f the LA abnormality is  p o s it ive ly  correlated with the 
degree o f elevation o f IgE, which indicates r is k  o f development 
o f atopy (Horrobin, 1990b). The fundamental aetiology o f atopy may 
be defective EFA metabolism, exerting d i f fe re n t  influences on the 
development o f the disorder.
Prophylactic measures, by ensuring adequate intake o f pre 
6-desaturated EFAs by in fants at r is k  from atopy, by adding GLA to 
a r t i f i c i a l  in fan t milks, already practised in Japan, or by 
increasing consumption o f GLA as EP0 by the breast-feeding mother, 
are proposed (Horrobin, 1990b).
IgE production is contro lled by T-lymphocytes (Wright, 1990). 
Deficiency o f 6-desaturated EFAs, as seen in atopy, may lead to an 
upset in the T-helper to T-suppressor ce ll ra t io ,  because th is  
balance is normally regulated by these EFAs. The T-suppressor to 
T-helper ra t io  is increased in atopic patients, usually due to low 
to ta l T-lymphocyte numbers (Wright, 1990). In combination with 
abnormal permeability o f the skin and the gut, T-ce ll imbalance 
w i l l  re su lt  in the adverse response by atopic patients to antigens 
which cause no response in normal ind iv iduals (Wright, 1990).
Atopic manifestations may therefore be associated d ire c t ly  with 
6-desaturated EFA deficiency on skin, membranes and smooth muscle,
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and in d ire c t ly  with the induction o f abnormal immune response 
consequent o f EFA defic iency.
In treatment o f atopic eczema using EPO, the mode o f action is 
uncertain (Burton, 1990), but improvement is  thought to be due
p a r t ly  to lowered production o f the pro-inflammatory 2 series
PGs, and also l ineo la te  forms an in tegra l part o f the ceramide 
molecule, essential fo r  the epidermal permeability ba rr ie r  which 
is  defective in atopic eczema (Burton, 1990). The increased 
transepidermal water loss in atopic eczema, and consequent drying 
of the skin, may be due to defective epidermal ceramides. EFAs 
might also modulate inflammation by an e ffe c t on the 
c e l l -s ig n a l l in g  system (Burton, 1990).
Evening primrose o i l  (Epogam or Efamol, Scotia Pharmaceuticals) 
has recently  received a product licence in the U.K. fo r  the 
treatment o f atopic eczema. In randomised double-blind placebo 
con tro lled t r i a l s  to ameliorate a l l  features o f the disease, 
especia lly  i tc h ,  and to reduce skin roughness, and to allow
substantial reduction in top ical s teroids, and oral stero ids,
antihistamines and a n t ib io t ic s  in some patients (Scha lin -Karr ila , 
M a tt i la ,  Jansen and U oti la , 1987). The treatment is very safe 
compared to conventional parenteral treatments such as 
prednisolone or azathioprine (Burton, 1990). Preliminary 
investigations using Efamol Marine, a combination o f n-6 and n-3 
EFAs, 80% EPO and 20% f ish  o i l ,  have shown be tter resu lts  than n-6 
EPO alone (Horrobin, 1990b).
Abnormal ke ra tin isa tion , classical o f EFA defic iency, along with 
inflammation are seen in acne and psoriasis, two very common, but 
c l in i c a l l y  diverse skin conditions (A llen, 1990).
Acne vu lgaris , inflammation o f the cutaneous pilosebaceous un it ,  
has a complex aetiology, with active sebum production and abnormal 
duct kera tin isa tion  as prerequisites (A llen, 1990). There may be 
absolute, re la t iv e ,  or local EFA defic iency, and as precursors of 
the proinflammatory leukotrienes and prostaglandins, spec if ic  
manipulation o f EFAs may modify inflammation (Allen, 1990).
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Aetiology o f psoriasis is  uncertain, but evidence ex is ts  tha t AA 
metabolism is  upset, with elevated free AA and LT leve ls (A llen, 
1990). GLA, supplemented in the d ie t or applied to p ic a l ly ,  might 
lead to  amelioration by cyclo-oxygenase a c t iv i t y  in h ib i t io n ,  or 
PGE1 or 15-OH-DGLA mediated spec if ic  anti-inflammatory e ffec t 
(A llen, 1990).
EFAs can improve skin texture (Marshall and Evans, 1990). T h ir ty  
seven patients with atopic eczema were recru ited in to  a 
randomized, double-blind, pa ra lle l t r i a l  to investigate the 
improvement o f skin roughness, using Efamol EPO compared to a 
placebo. Patients received EPO d a ily  fo r  three months and were 
assessed monthly. Th ir ty  one patients completed the t r i a l .  
Objective measurements to assess skin smoothness showed marked, 
consistent improvement, w ith in  one month and therea fte r 
maintained throughout the t r i a l ,  in patients receiving Efamol 
treatment (Marshall & Evans, 1990).
EFAs have been found to be helpful in the management o f anhidrosis 
in horses. Anhidrosis is re lated to the in a b i l i t y  to sweat in 
response to an adequate stimulus (Correa and Calderin, 1966). I t  
is  encountered most frequently in hot, humid trop ica l climates 
such as Puerto Rico, Austra lia  and New Zealand, Panama, South 
America and Hong Kong (Correa and Calderin, 1966).
Sweating is  the major method o f thermoregulation in the horse, and 
75 per cent of body heat is lo s t in th is  way. In anhidrotic horses 
the body temperature may r ise  to 107 or 108°F (42°C), and animals 
may collapse following exercise. Prevalances o f up to 20 per cent 
in Thoroughbred horses in some areas render the condition 
economically s ig n if ica n t (Mullowney, 1985b). Although several 
theories have been postulated regarding aetio logy, th is  is 
uncertain and treatment gives variable resu lts . Treatments fo r  the 
condition include sodium or potassium iodides, iodinated casein or 
thyro id  hormone, oral vitamin E, minimising concentrates in the 
d ie t ,  and adrenocorticotrophic hormone (ACTH) in jec t ions . 
Provision of a cooler environment with reduced humidity eases the 
d is tress , and soaking the horse to allow cooling by evaporation, 
and re s t r ic t io n  of exercise to the cooler times o f the day are a l l
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beneficial (Mullowney, 1985b).
However, in F lorida three chron ica lly  anhidrotic  horses were 
supplemented with EPO and safflower o i l ,  at d a i ly  doses o f 8g and 
2 oz, respective ly. A ll three horses had raised temperatures at 
res t. The owners o f the horses reported g rea tly  improved sweating 
a b i l i t y ,  and also noted improved condition o f ha ir and skin 
throughout the la te  summer, autumn and winter (Mayhew, 1985, 
personal communication).
Scurviness o f the skin, a dry, du ll coat, and loss o f ha ir  are 
seen when dogs are deprived o f fa ts .  Skin then becomes itchy , o i ly  
and susceptible to in fe c t ion . The epidermis peels, there is  o t i t i s  
externa, exudation between the d ig i t s ,  and skin becomes thickened 
(Hansen and Wiese, 1951). Cats show s im ila r  signs (Frankel and 
Rivers, 1978). The signs resemble skin disorders in the dog and 
the cat, but EFA defic iency is uncommon in these species. I f  there 
is  inadequate antioxidant in dried food, or high fa t ty  acid 
oxidation a f te r  prolonged storage or accidental exposure to high 
temperatures, the EFA supply in commercial pet foods which is 
usually ample may be depleted (Lloyd, 1990). In tes t ina l
malabsorption and hepatic disorders may also lead to EFA 
defic iency. Low levels o f cofactors in EFA metabolism, vitamin E 
or zinc, can induce c l in ic a l  signs s im ila r  to 
experimentally-induced EFA defic iency (Scott and Sheffy, 1987).
Cats lack 6-desaturase enzyme, and are therefore more dependent 
than the dog on GLA and i t s  metabolites. Contrary to expectation, 
EFA defic iency is extremely uncommon in the domestic cat, and skin 
disease in the domestic cat is ra rer than in the dog (Muller, K irk 
and Scott, 1983).
Results o f EFA supplementation in human atopic eczema have 
stimulated studies in to  the use o f EFAs in treatment o f skin
disorders in companion animals. A l le rg ic  skin disease and
seborrhoea in dogs and cats have been treated by EFA 
supplementation, and EPO, cold water marine f ish  o i l  and EPO/fish 
o i l  combinations have improved a l le rg ic  skin disease in open 
studies in dogs (Scott & Buerger, 1988). EPO was shown to be
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e ffe c t ive  against atopy in dogs in a double-blind, 
placebo-controlled, crossover study (Scarff & Lloyd, 1989, in 
prepara tion).
Results o f a study to investigate the e ff icacy  o f EPO 
supplementation in a m u lt i-centre  placebo contro lled study in 
general practice (Scarff, Harvey and McEwan, in preparation) 
mirrored extensive human studies in tha t i n i t i a l  improvements in 
canine atopic derm atit is , fo r  example improvements in scaling, 
p ru r i tu s ,  erythema, oedema, coat and overall condition, on high 
dose EPO therapy were substantial but tend to plateau by 12 weeks. 
I t  was thought l i k e ly  tha t maintenance o f the plateau might be 
achieved by lower dose long-term therapy.
EFA supplements containing mineral and vitamin cofactors such as 
zinc, magnesium, n iacin , and vitamins A and C, have also proved 
benefic ia l in the treatment o f p r u r i t i c  and seborrhoeic conditions 
in c l in ic a l  practice (Lloyd, 1990). Although anecdotal reports 
ind icate e ff icacy  o f EFAs in seborrhoea and m il ia ry  eczema, 
studies in cats have been l im ited  (Lloyd, 1990).
Other C lin ica l Uses o f EFAs
Cardiovascular Disease 
Elevated cholesterol leve ls , elevated t r ig ly c e r id e  leve ls , 
hypertension and p la te le t  aggregation are associated with 
increased r is k  o f coronary heart disease (CHD) and peripheral 
vascular disease, and diabetes enhances r isks  at lower levels o f 
these factors (Rosgengren, Wei in , Tsipogianni and Wilhelmsen,
1989).
Abnormal EFA intake and metabolism may be equally or more 
important than these r is k  factors, because low intake and low 
plasma and adipose tissue concentrations o f LA have been 
associated with high CHD r is k  (O liver, Riemersma, Thomson, Fulton, 
Abraham and Wood, 1990). There may be more d ire c t  involvement of 
LA metabolites than of LA i t s e l f ,  as low plasma and adipose DGLA 
and AA levels are strong markers of CHD. EFA levels were lower in
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patients who developed CHD, although no differences were seen in 
cho lestero l, t r ig ly c e r id e  or blood pressure (Wood, Butler, 
Riemersma et a l . 1984).
The current EFA hypothesis o f CHD is tha t the primary disorder is  
an inadequate, imbalanced n-6 EFA source (Horrobin, 1990b). 
Consequently there is  increased cholesterol and tr ig ly c e r id e  
biosynthesis, increased p la te le t  aggregation, raised blood 
pressure and reduced coronary s ta b i l i t y  with a higher r is k  o f 
arrhythmia, with possible spasm of the coronary vessels. These 
factors are consequent o f abnormal EFA metabolism and re su lt  in a 
higher r is k  o f death from coronary fa i lu re .  Supplementation o f 
6-desaturated n-6 and n-3 EFAs might correct the primary problem, 
whereas single fac to r therapies w i l l  be only moderately e ffec t ive  
(Horrobin, 1990b).
Rheumatoid A r th r i t i s  
Elevated PG and LT levels found in ce l ls  and inflammatory exudates 
in rheumatological disorders suggests tha t in h ib i t io n  o f th e ir  
synthesis might ameliorate the signs and symptoms o f these 
disorders (Belch, 1990). PGs and LTs can be inh ib ited  at numerous 
stages o f AA metabolism. A d ie t r ich  in AA leads to the formation 
of the 2 series PGs and 4 series LTs with proinflammatory e ffec ts , 
and EFA manipulation in the d ie t can modify some of these effects  
(Belch, 1990). Evening primrose o i l  (EPO), a source o f GLA, w i l l  
elevate DGLA leve ls , resu lt ing  in increased production o f the 1 
series PGs, including PGEi, which has been shown to in h ib i t  AA 
m obilisa tion , to in h ib i t  chemotaxis, to enhance T lymphocyte 
function, and consequently to suppress inflammation in a var ie ty  
o f animal models (Horrobin, 1990b).
In a prolonged EPO study in humans (Belch, Ansell, Madhock, O'Dowd 
& Sturrock, 1988) a proportion o f patients were able to reduce or 
stop adjunctive non-steroidal anti-inflammatory (NSAI) therapy 
a f te r  three months, and a fte r  a double blind phase fo r  12 months 
there was s ig n if ica n t d ifference between placebo and EPO or EPO 
and f ish  o i l  treated groups: in active treatment groups 90 per
cent o f patients reported improvement compared to only 30 per cent 
in the placebo group.
65
The use o f GLA and EPA to in h ib i t  AA metabolites thus enabled many 
patients to appreciate subjective improvement while simultaneously 
reducing NSAID dose, p a r t ic u la r ly  important where there is  renal 
compromise or gas tr ic  i r r i t a t i o n .
Psychiatr ic Disorders and Neuropathies
The EFAs comprise approximately one f i f t h  o f the dry weight o f the 
brain and peripheral nerves, and in contrast to other tissues, 
almost a l l  o f the EFAs present in nerve tissue are 6-desaturated 
(Horrobin, 1990a). The EFAs and th e ir  eicosanoid derivatives 
modulate nerve conduction, transm itte r release, transm itte r 
reuptake, and post synaptic transm itte r e ffec ts , and varying 
abnormalities o f EFA metabolism in blood and other tissues have 
been recorded in alcoholism, schizophrenia, depression and 
hyperac tiv ity  (Horrobin, 1990a). P a rt icu la r ly  in alcoholism, 
schizophrenia, and childhood depression and hyperactiv ity , 
attempts to modulate EFA levels have produced very mixed resu lts . 
A preparation containing zinc, pyridoxine, n iacin and vitamin C, 
co-factors known to be important in EFA metabolism, in supplement 
to EFAs, produced marked increase in n-6 and n-3 incorporation 
in to  red ce ll membranes, producing s ig n if ic a n t  c l in ic a l  
improvements in memory and schizophrenic symptoms (Vaddadi, 
G il leard , Courtney and Horrobin, 1990).
In diabetes m e ll i tus , hepatic c ir rh o s is , and alcoholism, where 
there is  abnormal EFA metabolism peripheral neuropathies are 
common, and some neurological damage may be a consequence of 
abnormal EFA biochemistry. Strong evidence ex is ts , fo r  example, o f 
acquired reduction in EFA 6- and 5- desaturation in diabetes, and 
reduced 6-desaturated EFA flow has been proposed to account fo r  
many long term adverse d iabetic  consequences (Horrobin, 1990b).
Cancer
Marked consistency now exists in work on the e ffec ts  of 
6-desaturated EFAs on cancer (Horrobin, 1990a). They have been 
demonstrated to k i l l  human and animal cancer ce l ls  in v i t r o  at 
concentrations safe to normal c e l ls ,  and can control the growth of 
animal cancers (Horrobin, 1990a). Growth o f human cancers 
implanted in to nude mice can be regulated by EFAs which may k i l l
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primary and metastatic cancer c e l ls ,  or may in h ib i t  the 
development o f metastases, or enhance the e ff icacy  o f rad ia tion  
and drugs (Pritchard and Mansel, 1990).
In order to monitor the e ffec ts  o f d ie tary  l ip id s  on growth o f 
human tumour xenografts athymic mice were studied (Pritchard and 
Mansel, 1990). A d ie t high in fa t  (20% corn o i l )  enhanced growth 
o f breast tumours compared with control d ie ts o f 5% and 10% corn 
o i l .  Both n-6 and n-3 series EFAs were supplemented as EPO and 
f is h  o i l  in the d ie t and tumour growth was s ig n i f ic a n t ly  
in h ib ite d . The growth o f human melanoma in mice was prevented by 
EPO and 5% f is h  o i l  5% d ie tary supplement. Human tumours are thus 
reported to be sensitive to l ip id s  and n u tr i t io n a l manipulation 
may influence the management o f some human malignancies (Pritchard 
& Mansel, 1990).
Renal Disease
The renal medulla is especia lly r ich  in the E series PG precursor, 
DGLA (Nissen and Bojesen, 1969), which is  thought to play an 
important ro le  in the maintenance o f high blood flow in the
kidney. Failure o f th is  control may re su lt  from PG in h ib i t io n  by
long term administration o f analgesics (Horrobin, 1990b). Toxic, 
cyclosporin-associated renal damage appears to be re lated to 
excess thromboxane A2 production without E series PG balance 
(Elzinga, Kelley, Houghton and Bennet, 1987).
EFA defic iency consistently  leads to urinary t ra c t  tumour 
development (Monis and Eynard, 1980). GLA, administered to enhance 
PGEi synthesis has prevented or attenuated renal damage in animal 
models, and EPA in f ish  o i l  has reduced cyclosporin induced renal
damage (Elzinga, Kelley, Houghton and Bennet, 1987).
Hepatic Disease
In patients suffering from hepatic disease i t  is  not surpris ing 
tha t LA concentration is s ig n if ic a n t ly  elevated w h ils t  LA 
metabolite levels are reduced, because the largest amount of 
6-desaturase in the body is found in the l iv e r  (Horrobin, 1990b). 
Hepatic compromise would be expected to lower to ta l body 
6-desaturase a c t iv i ty  (B iagi, H re lia , S tafan in i, Z u ra re l l i  and
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Bordoni, 1990).
GLA metabolite PGEi is  being used increasingly in treatment o f 
l i v e r  transplant patients and to promote the a b i l i t y  o f the l i v e r  
to e lim inate v i ra l  in fections (Horrobin, 1990b). Additional GLA 
would lengthen the duration o f these benefic ia l e ffec ts .
EPO (Efamol) inh ib ited  hepatic fa t ty  change fo llow ing carbon
te trach lo r ide  administration (Cunnane and Horrobin, 1983), and 
plasma l i v e r  enzyme levels were normalised more rap id ly  in 
alcoholics fo llow ing Efamol administration compared to contro ls. 
Pruritus was s ig n i f ic a n t ly  reduced in primary b i l ia r y  c ir rh o s is , 
and reduced n-6 EFA concentrations seen in plasma phospholipids
and t r ig ly c e r id e s  in these patients were restored to normal by
administration o f Efamol (T riger, 1990).
Premenstrual Syndrome, Mastalgia (Breast Pain) and Prostatic
Hypertrophy
Although the premenstrual syndrome (PMS), mastalgia and pros ta t ic  
hypertrophy are only observed in the presence o f gonadal hormones, 
abnormalities have not been recorded, and there is  thought to be 
excessive end organ s e n s i t iv i ty  to normal hormone levels 
(Horrobin, 1990b). High absolute or high saturated fa t  intake 
re la t iv e  to EFAs may be relevant in pathogenesis (Horrobin, 
1990b). E s te r i f ica t io n  of steroid hormones to fa t ty  acids occurs 
in target tissues, and saturated fa t ty  esters are more potent
oestrogens than EFA esters, so i f  l ip id s  in target tissue have
high saturated fa t  to EFA ra t io ,  normal c ircu la t in g  oestrogen
leve ls w i l l  have exaggerated actions (Larner, Eisenfeld and 
Hochberg, 1985). Saturated fats have higher receptor a f f in i t y  than 
unsaturated fa ts , so in membranes where steroid receptors are EFA 
d e f ic ie n t,  receptors bind steroid more av id ly , again with 
exaggerated e ffects  despite levels being normal. In DGLA or PGEi 
defic iency, actions of p ro lac tin , trophic fo r  the breast and the
prostate, are not modulated and normal levels have excessive 
e ffec ts  (Horrobin, 1990b).
The pattern seen fo r  these conditions is s im ila r  to tha t o f atopic 
eczema, and epidemiological association exists between atopic
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disorders and atopic eczema. In placebo contro lled studies 
physical and psychological aspects o f PMS improved fo r  patients 
receiving GLA (Puolakka, Makarainen, V iin ikka and Y likorka la , 
1985).
V ira l In fections and Post-Viral Fatigue Syndrome 
V ira l in fec tions are associated with low levels o f LA and impaired 
desaturation (Horrobin, 1990b). Reduced DGLA and AA formation 
re su lt  in reduced a b i l i t y  of in te rferon to exert a n t i -v i ra l  
e ffec ts . EFAs also have d ire c t  v iruc ida l actions, p a r t ic u la r ly  
against l i p id  envelopes. Supplementation o f 6-desaturated EFAs may 
therefore ass is t response to v ira l  in fections (Horrobin, 1990b). 
Red ce ll  membrane levels of n-3 and n-6 EFAs were found to be 
lowered, whereas elevated levels o f saturated and monounsaturated 
fa ts  were recorded in pos t-v ira l fa tigue syndrome (PVFS) patients. 
Symptoms o f muscle weakness, aches, pains, loss o f memory and 
concentration, exhaustion, depression, dizziness and vertigo were 
reported to improve when patients received 80% EPO and 20% f ish  
o i l  (Efamol Marine), compared to placebo (Behan and Behan, 1990). 
Patients showed normalisation of saturated and monounsaturated 
fa ts  and n-6 EFAs in red ce ll membranes, and elevation o f n-3 EFAs 
to leve ls above normal. GLA and EPA may thus be valuable adjuncts 
to a n t i - v i ra l  therapy (Horrobin, 1990b).
Adverse Events and Toxicology
Animal to x ic i t y  studies on Efamol EPO at doses o f up to 10 
ml/kg/day have covered reproductive performance, te ra togen ic ity , 
carc inogenic ity  and long term toxicology in dogs, ra ts , mice and 
rabbits  (Horrobin, 1990b). No tox ic  e ffects  a t t r ib u ta b le  to EPO 
were found, and in p a rt icu la r  there was no evidence o f 
carc inogenic ity  (Everett, Perry and Bayliss, 1988). In 
placebo-controlled studies involving over 3,000 patients receiving 
Efamol fo r  three months or more, no spec if ic  adverse event can be 
a ttr ibu ted  with any confidence to Efamol (Scotia Pharmaceuticals, 
1990, data on f i l e ) .
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Conclusion
This review d e ta i ls  the ra tiona le  fo r  the use o f EFAs in the 
management o f skin disorders such as atopic eczema, which probably 
involves a defect common to tha t which occurs in equine 
dermatophilosis, namely, impaired epidermal b a rr ie r  function. LA 
and GLA are required fo r  the maintenance of the in te g r i ty  o f the 
impermeable ba rr ie r  formed by the skin to water; and GLA 
metabolites in h ib i t  inflammation, regulate the immune system, and 
in h ib i t  the formation of pro-inflammatory metabolites from AA. 
Favourable resu lts  have been obtained using oral supplementation 
o f n-3 and n-6 EFAs in the treatment of the condition in man and 
in the dog. At the same time, improvement occurred in condition o f 
the coat o f horses which received EPO (containing LA and GLA) fo r  
the management o f anhidrosis. EFAs have been shown to be non-toxic 
and non-carcinogenic, and free from adverse events. On the basis 
o f the foregoing evidence an investiga tion  was carried out on the 
e ffec ts  o f the use o f EFAs, as a supplement to normal d ie tary  
intake, on the management o f dermatophilosis in horses.
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MATERIALS AND METHODS
Horses and Site
The horses used in th is  thesis were part o f a herd o f around 200 
mature horses kept at two farms s ituated in the West o f Scotland. 
Horses have been managed by the owner at Gartmorn H i l l  Farm, which 
spans 195 acres close to Dollar, since 1978, and at Burnhouse Farm 
which covers 125 acres near Bonnybridge, since 1981. Figure 3 
shows Burnhouse Farm. Both farms are w ith in  an hour's drive of the 
U n ivers ity  o f Glasgow Veterinary School.
The horses are in good health, but are unsound or re t ire d . Most of 
the horses belong to the owner o f the farms, but some are loaned 
fo r  temporary periods from other horse owners around the country. 
The owner o f the farm uses several o f the mares in the herd as 
brood mares. Most animals are Thoroughbred or Thoroughbred 
crosses, but there are also cobs and heavier types o f animal. The 
horses are mature and are over 14.2 hands in height. The herd 
comprises approximately equal numbers o f mares and geldings. The 
age ranges from four to over 20 years.
Blood Harvesting Procedures
The horses are kept fo r commercial blood production. Most o f the 
blood is  dispensed in the form of de fibrinated whole blood, fo r  
incorporation into microbiological cu ltu re  media. Serum is also 
used fo r  the production of media. The customers fo r  blood products 
are hospital laboratories and public health and private c l in ic a l  
labora tories also have a requirement fo r  blood fo r  diagnostic 
purposes.
Blood is  harvested every three weeks. Individuals donate 
approximately 8 l i t r e s  of blood at each harvest. This is around 
20% o f blood volume fo r a 500kg horse (Schalm, 1986). Blood is 
co llected via the jugular vein in the mid th ird  region o f the 
neck. A lternate jugulars are used at each harvest. P rior to 
harvest local anaesthetic is in f i l t r a te d  around the point of 
inse rt ion  o f the harvest needle. The harvest volume is drawn into 
a s te r i le  co llec t ion  vessel and de f ib r in a t ion  is performed.
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Figure 3. Burnhouse Farm, by Bonnybridge, the home o f part o f the
horse herd
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The horses are tethered q u ie t ly  and allowed to eat concentrates in 
a s ta l l  in the blood co llec t io n  room throughout the harvest. 
Immediately a f te r  blood co llec t ion  a loose cotton wool dressing 
or an tisep t ic  spray is  applied over the jugu la r area and the 
animals are tethered in an adjacent co l lec t ion  paddock to recover 
before return ing to the covered yard or to pasture.
In 1987 both farms were licensed by the Home O ffice , permitting 
blood harvest by the owner o f the herd, and by several o f the 
grooms. Each time blood is  co llected, the procedure is  overseen by 
the local veterinary surgeon. A ll premises are regu la r ly  examined 
by a Home Office Veterinary Inspector.
Management o f  Horses
The horses are managed together in groups o f 30 to 40 animals, 
housed in large, covered sheds at Burnhouse Farm as routine during 
the w inter, usually between September or October and March or 
A p r i l ,  depending on the weather. There are several loose boxes fo r  
new horses and fo r  animals requiring special a tten tion . While 
inside, animals are bedded on deep l i t t e r  straw, and were fed top 
q u a l i ty  round baled silage da ily  on an ad l i b .  basis, and some hay 
and q u a l i ty  feeding straw. Figures 4, 5, 6 and 7 i l lu s t r a te  th is  
group management system under conditions o f housing.
During the summer months the horses are grazed together in groups 
o f 20 to 30 on a pasture ro ta tion  system over the combined 320 
acres o f the farms. Figure 8 shows part o f the Burnhouse herd at 
grass, and one o f the brood mares is  photographed with her foal in 
Figure 9.
Veterinary A ttention
Veterinary attention fo r  the treatment o f disease and in ju ry ,  and 
vaccination o f the herd against tetanus, is  provided by the local 
veterinary surgeons, who v i s i t  the farm several times each week. 
Individual health record cards are kept fo r  each horse.
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Figures 4 and 5 show the group management system of the horse herd 
during housing at Burnhouse Farm
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Figures 6 and 7 show the group management system o f the horse herd 
at housing, w ith the deep l i t t e r  bedding and silage and hay
feeding
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Figure 8. Part o f the Burnhouse horse herd at grazing during the
summer
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Figure 9. One o f the Burnhouse Farm brood mares at grass with
foal
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An anthelm intic programme has been designed, and is  monitored, by 
the Department o f Parasitology in the Univers ity  o f Glasgow 
Veterinary School.
Parameters Assessed in the Current Study
Values fo r  a l l  c l in ic a l ,  haematological and biochemical 
parameters, and fo r  a l l  EFA estimations are presented with 
standard deviations and means fo r  each time po in t, and group 
means, in the appendices described in the te x t .
C lin ica l Monitoring
The condition o f the coat, the mane, the t a i l  and the hooves was 
recorded using subjective 1 to 10 numerical scales, with 1 being 
the poorest condition, and 10 being optimal condition. General 
body condition score was also monitored, on a 1 to 5 scale 
(Henneke, 1985). Assessment was based on palpation o f the fa t  
covering of the lower neck, thoracic and ta ilhead regions, 
s im ila r  to condition scoring in ca t t le .  Optimal condition score 
was 3 to 3.5, with 1 being an emaciated animal, 2 a th in  animal, 3 
ind ica ting  moderate condition, 4 a fleshy animal, and 5 ind ica ting  
obesity.
Where appropriate, the severity and d is t r ib u t io n  of 
dermatophilosis lesions were regularly  recorded by means o f a 
p ro f i le  mapping system, as shown in Figure 10. A dermatophilosis 
index was designated, on a 0 to 10 numerical scale, calculated by 
recording the presence in each case of features typ ica l o f 
dermatophilosis: "paintbrush" lesions, scabs, hyperaesthesia,
pain, secondary bacteria l in fec tion , oedema and c e l l u l i t i s .  
Severity of lesions then was graded from 0 to 10, a score o f 0 
indicated absence of in fec t ion , and a score of 10 indicated the 
most severe in fec tion . The d is t r ib u t io n  of lesions was recorded on 
the p ro f i le ,  using a gr id  to give crude percentage o f body surface 
area affected, from 0 to 100 per cent. The dorsum: withers, saddle 
area and the rump, and the dorsal surfaces of the hindlimb 
pasterns were the areas most l ik e ly  to be invaded by D. 
congolensis. The presence o f any incidental skin lesions was
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Figure 10. The horse p ro f i le  mapping system used in  c l in ic a l  
assessment
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noted, such as those caused by trauma, external parasites, fungi, 
viruses or other bacteria.
A l l  the c l in ic a l  measurements were made by the same c l in ic a l  
assessor, to minimise var ia tion  in resu lts .
Haematology and C lin ica l Biochemistry 
Peripheral blood samples were rou tine ly  collected by the farm 
owner from a l l  horses on the farms fo r  monitoring o f values fo r  
packed ce ll  volume. In the present studies these blood samples 
were examined by additional haematological tes t and biochemically, 
and were used fo r  EFA analyses.
Peripheral blood samples, 5 ml volume, were collected from the 
jugu la r vein, without the use o f a tourniquet, v ia 20 g needles 
in to  EDTA Vacutainer tubes. Routine haematological examination was 
performed on the blood in the University o f Glasgow Veterinary 
School Haematology Laboratory. Analyses performed were to ta l red 
ce l l  count (RCC), haemoglobin (Hb), packed ce ll volume (PCV), mean 
ce ll  volume (MCV), mean ce ll haemoglobin concentration (MCHC), 
p la te le t  count (PI) and to ta l white ce ll count (WCC).
Peripheral venous samples were collected fo r  c l in ic a l  biochemistry 
as fo r  haematology, into 10 ml volume Lithium heparinised 
Vacutainer tubes. Routine assays, performed in the University o f 
Glasgow Veterinary School Department of Biochemistry, were urea, 
sodium, potassium, calcium, chloride, magnesium, inorganic 
phosphate (i.phosphate), a lka line phosphatase (AP), aspartate 
aminotransaminase (AST), b i l i ru b in ,  to ta l plasma proteins (TPP), 
albumin and g lobulins. Gamma glutamyl transpeptidase (GGT), 
t r ig ly ce r id e s  (TG) and cholesterol were also assayed.
EFA Estimations
On return to the Veterinary School blood samples were centrifuged 
at 2500 rpm fo r  20 min at 4°C, and plasma removed. Red ce l ls  were 
then washed in equal volume 0.9% saline and centrifuged at 2500 
rpm at 4°C, and saline wash and buffy coat discarded. Plasma and 
red ce l ls  were stored separately at -20°C and sent as batches at 
the conclusion o f the studies to the Efamol Research In s t i tu te  in
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Nova Scotia, Canada, fo r  measurement o f fa t t y  acids in plasma
phospholipids and in red ce ll  membrane phospholipids. The fa t ty  
acid composition o f plasma tr ig lyce r id e s  and cholesterol esters
was also determined. Samples were sent fo r  analysis uncoded with 
regard to controls and to baseline samples.
Lipids were extracted from plasma and red c e l ls ,  and phospholipid 
and other l i p id  frac tions were separated by th in  layer
chromatography, then frac tions methylated and prepared by gas 
chromatography. Sampling was f u l l y  automated. The amount o f each 
fa t t y  acid present was calculated and prin ted out by computer, and 
transcribed on to standard data forms and returned to the c l in ic a l  
inves tiga to r.
Data Collected by the Farm Owner
Each horse is  id e n t i f ie d  to the farm owner by name, and by number: 
most horses are freeze-branded. Details o f ind iv idual horses are 
recorded, including the sex, age, breed or type, height, date and 
source o f acquis it ion , and any relevant information on health or 
temperament.
At each blood harvest, PCV and the volume of blood collected are 
recorded, and any relevant comments, e .g .,  the demeanour o f the 
animal during the harvest, and the appearance o f the blood 
co llected, are noted. The volume o f blood dispensed from the farm 
laboratory a f te r  each harvest, and the percentage o f blood lo s t  
during c lo t t in g ,  the waste, are recorded fo r  each ind iv idua l. The 
average weekly PCV is calculated fo r  the herd as a whole, to allow 
weekly and monthly comparisons to be drawn fo r  herd production 
from year to year.
Statistical Analyses
A repeated measures analysis of variance design was undertaken on 
the c l in ic a l  indices, on haematological and biochemical 
parameters, and on results of EFA estimations. The design provided
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tes ts  fo r  d ifferences between treatment groups, differences 
between times and in te rac tion  between treatment and time (Ott, 
1988). Significance levels o f 5% were used unless otherwise 
ind icated.
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SECTION 1. THE USE OF ESSENTIAL FATTY ACIDS (EFAs) IN THE 
MANAGEMENT OF DERMATOPHILOSIS IN HORSES
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Background
As reviewed in the in troduction, essential fa t ty  acids (EFAs) are 
d ie ta ry  factors which l ik e  vitamins and essential amino acids 
cannot be made by the mammalian host but must be ingested with 
food. As essential constituents o f a l l  membranes in a l l  body 
t issues, including the skin, they are v i ta l  in the determination 
o f b io log ica l properties o f these membranes. EFA defic iency leads 
to profound disturbances in a l l  tissues, and i t  is  known that EFAs 
are important in maintaining healthy skin and coat in several 
mammalian species including the horse, the dog and the cat, 
laboratory animals and man, as detailed in the in troduction.
Lipids and EFAs play an essential ro le in the maintenance of the 
epidermal ba rr ie r  (E lias, 1981). Lamellar bodies are ovoid 
organelles, synthesised in the stratum spinosum and stratum 
granulosum, which contain a var ie ty  of materials including l ip id s .  
One o f th e i r  most important functions appears to be the deposition 
o f l ip id - r i c h  in te rc e l lu la r  materia ls, such as ceramide, necessary 
fo r  maintenance o f the epidermal permeability ba rr ie r (Burton, 
1990). By providing the l ip id s  that impede the outward movement of 
water and water soluble components (E lias, 1981), lamellar bodies 
therefore contribute greatly  to the regulation o f skin 
permeability. In EFA defic iency, detailed in the in troduction, 
lamellar bodies are secreted in normal quantit ies but are la rge ly  
devoid o f l i p id  (Elias and Brown, 1978), and consequently the 
in te rc e l lu la r  spaces of the stratum granulosum are porous and 
allow the passage o f water soluble materia l.
In many dermatoses, such as atopic eczema, the epidermal 
permeability ba rr ie r function has been shown to be defective 
(Burton, 1990), and the in te g r i ty  of th is  ba rr ie r has been shown 
to be dependent upon the a v a i la b i l i t y  o f EFAs, p a r t ic u la r ly  
l in o le ic  and gamma-1inolenic acids (Burton, 1990; E lias, 1981; 
Elias and Brown, 1978; Wright, 1990). Fatty acids also play an 
important ro le in host defence mechanisms in that they are known 
to be tox ic  to many pathogenic microorganisms that come in contact 
with the skin (B iberstein, 1990).
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I t  is  possible tha t the excessive wetting and humidity 
predisposing to dermatophilosis in horses could lead to a 
defic iency o f skin l ip id s  and resu ltan t defective ba rr ie r  
function . By correction o f th is  defic iency i t  might be possible to 
restore skin in te g r i ty ,  normalise ba rr ie r  function and prevent 
establishment o f D. congolensis in fec t ion .
PGEi derived from DGLA in h ib i ts  inflammation, and PGI2 , derived 
from AA, and EPA deriva tive  PGI3 , have s im ila r  e ffects  to PGEi. 
15-OH-DGLA, formed by 15-hydroxlation o f DGLA, in h ib i ts  5- and 
12-lipoxygenases, which lead to p ro - in f1ammatory metabolites from 
AA. These mechanisms are shown in Figures 1 and 2 of the
in troductory section on EFAs. Thus, supplementation o f GLA in the 
form o f EPO, with f ish  o i l  and vitamin E (Efamol Marine, Scotia 
Pharmaceuticals), may cause in h ib i t io n  of the local inflammation 
involved in dermatophilosis lesions by supplementing levels of 
DGLA and by preventing the formation of proinflammatory mediators 
from AA. As the lesions of dermatophilosis are believed to be the 
re su lt  o f a nonspecific inflammatory response to D. congolensis 
organisms, once the epidermis is traumatised, the 
anti-inflammatory e ffects  o f EFAs may be p a r t ic u la r ly  relevant in 
treatment o f the condition.
EFA supplementation reduced p ru r itus , scaling, erythema, oedema 
and improved coat condition when used to tre a t canine atopic
derm atit is  (Scarff, Harvey and McEwan, unpublished data). When 
EFAs were used to t re a t anhidrotic horses in C a lifo rn ia , 
improvement was also recorded in the condition o f skin and o f the 
haircoat (Mayhew, 1985, personal communication). In humans and in 
animals, be tter resu lts  have been obtained when EFAs of the n-3 
and n-6 series have been used in combination, as Efamol Marine,
80% EPO and 20% f ish  o i l  and vitamin E, than when EPO is used
alone (Horrobin, 1990b).
The foregoing evidence would appear to ju s t i f y  an investigation on 
the e ffec ts  o f the use of EFAs, as a supplement to normal d ie tary 
intake, on the management of dermatophilosis in horses. Also, as 
discussed in the introductory section, EFAs have been shown to be 
non-toxic and non-carcinogenic, and free from adverse events
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(Scotia Pharmaceuticals, data on f i l e ) .
On two farms located approximately 30 miles northeast o f the
Univers ity  o f Glasgow Veterinary School there are around 200
horses, o f a l l  types and ages. Regular examination o f these horses 
id e n t i f ie d  the prevalence and re la t iv e  importance o f 
na tu ra lly -occurr ing  skin disorders. During the autumn and w inter 
o f 1986 the prevalence of Dermatophilus congolensis in fec tion  was 
approximately 60 per cent on these two farms. In around one th i rd  
o f these cases the in fec tion  was severe, a ffec ting  the dorsum and 
the lower limbs in p a rt icu la r .
The high prevalence o f D. congolensis in fec tion  occurred even 
though the ra in fa l l  during the summer and autumn period o f 1986 
was not above average fo r  the West o f Scotland. The summer and 
autumn o f 1985, however, was one of the wettest in the recorded 
h is to ry  o f Scotland and the owner o f the two farms stated tha t the
prevalence and severity  o f dermatophilosis in the horses was even
more severe than in 1986.
During the survey animals o f a l l  ages were affected with 
dermatophilosis, and the condition was seen to recur, with
ind iv idual horses appearing to be p a r t ic u la r ly  susceptible.
Moreover, although the in fec tion  was most severe during the autumn 
and w inter periods, lesions due to D. congolensis were recognised
throughout the year. The horses on both farms are at pasture
during the summer and early autumn, but are housed in groups o f 30 
to 40 in large covered yards during la te  autumn and the w inter 
months.
Around 200 outwintered ponies in the same region were studied 
during the same period and were found to have dermatophilosis 
during the winter of 1986. Many horses and most ponies in Scotland 
are kept unstabled during the winter.
I t  was thought that i f  the use o f EFAs could prevent the 
establishment or even reduce the severity of in fe c t ion , the 
welfare of the horse population in the West o f Scotland and 
subsequently throughout B r ita in  would be greatly  improved.
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Several studies were designed, therefore, with the i n i t i a l  aim o f 
establish ing baseline information concerning EFA metabolism in the 
horse, and comparing i t  to that in other species. The e ffec ts  o f 
EFAs, in the form of Efamol Marine (80% EPO and 20% f is h  o i l  and 
vitamin E), were studied f i r s t  as a treatment and then as a 
prophylactic approach to the management o f dermatophilosis in 
horses.
The size o f the horse herd, at around 200, and the system o f group 
management o f the horses, along with the h is to ry  o f a recurrently  
high prevalence o f dermatophilosis, were thought to provide a 
unique opportunity fo r  a series o f studies o f th is  type.
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The Pharmacokinetics of Essential Fatty Acids (EFAs) 1n Horses
Introduction
In the l i te ra tu re  which was reviewed in the in troductory section 
o f th is  thesis i t  was revealed that l in o le ic  acid (LA) must be 
converted to i t s  metabolites to exert the f u l l  range o f b io log ica l 
actions o f essential fa t ty  acids (EFAs) (Horrobin, 1990b). The 
f i r s t  step in EFA metabolism is  the 6-desaturation o f LA, which is  
rate l im i t in g ,  and is  contro lled by the 6-desaturase enzyme. The 
rate o f th is  reaction is known to vary between species as 
indicated by the ra t io  of LA to i t s  metabolites. Of the species 
which have been studied, the reaction rate is known to be fastest 
in the ra t ,  and slowest in the rabbit and the guinea pig 
(Horrobin, 1990b). As fa r  as can be determined, there is  no 
information available regarding EFA metabolism in the horse. The 
reaction rate o f 6-desaturation, fo r  example, is  unknown. This 
study was designed to ascertain the basal levels o f EFAs in the 
horse, to investigate the ra t io  of LA to i t s  active metabolites, 
dihomogammalinolenic (DGLA) and arachidonic acids (AA), and thus 
to estimate the 6-desaturase conversion rate in the horse. The 
ob jective o f the study was to determine a suitable dose rate fo r  
subsequent investigation in to  the use o f EFAs in the management o f 
dermatophilosis in horses.
Materials and Methods
Method o f Administration of EFAs 
EFAs and placebo treatments were formulated as ge la tin  capsules, 
o f 5 g weight. As the capsules were not read ily  to lerated by the 
horses without food, they were cut open and the contents disguised 
in a handful o f coarse mix. This proved an acceptable method o f 
supplementation to the animals, and each ind iv idual was fed the 
treatment and coarse mix from a hand-held scoop to ensure that the 
f u l l  EFA or placebo dose was received.
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EFA treatment capsules contained 80% evening primrose o i l  (EPO) 
and 20% f is h  o i l  and vitamin E (Efamol Marine, Scotia 
Pharmaceuticals). Efamol Marine contains EFAs o f both series: n-6
l in o le ic  acid (LA) and gamma-1 ino lenic acid (GLA) in the EPO, and 
n-3 eicosapentanoic acid (EPA) in the f ish  o i l .
Experimental Design 
Forty-e ight horses were randomly assigned to four groups o f 12 
animals, each receiving a d i f fe re n t  dose or dose regimen o f EFAs. 
One group received 5g EPO and 15g o live  o i l  d a i ly  (o live  o i l  was 
used to conserve equal dose volumes between groups); a second 
group received lOg EPO and lOg o live  o i l  every other day; a th i rd  
group received 20g EPO da ily  and a fourth group received 40g EPO 
every other day. The supplementation period spanned s ix weeks, 
from June through to July, while the horses were at grass. Horses 
did not receive any form of top ical or systemic medication 
throughout the study.
Parameters Monitored 
C lin ica l indices including the condition o f the coat, mane, t a i l  
and hooves, haematological and biochemical changes, and EFA 
estimations, were recorded at weeks 0, 3 and 6. Details are
contained in the general Materials and Methods section. Details of 
s ta t is t ic a l  analyses performed on the parameters are given in the 
general Materials and Methods section.
Results
C lin ica l Indices
Improvement o f condition of the coat, mane, t a i l  and hooves, was 
seen over the period o f study, as indices increased. Means fo r  the 
indices assigned at weeks 0, 3 and 6 are shown in Table 1. I t  is
evident that most values fo r  each o f the indices f e l l  between 5 
and 6 on the 1 to 10 numerical scale, ind ica ting  average or above 
average condition, and that only very small varia tions were seen 
between groups.
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Table 1. Mean values for clinical indices of condition of coat, 
mane, ta i l  and hooves at weeks 0, 3 and 6 of four groups of 12 
horses receiving different oral doses of n-3 and n-6 EFAs
Clinical index coat mane
condition condition
Week
Horse group
0 3 6 0 3 6
5g daily 5.0 5.8 7.0 4.7 5.9 6.0
lOg EOD 5.3 5.5 5.5 5.2 6.1 6.4
20g daily 4.9 5.8 6.6 4.8 5.9 6.3
40g EOD 4.4 6.4 6.9 4.4 5.7 6.4
Clinical index ta i l hoof
condition condition
Week 0 3 6 0 3 6
Horse group
5g daily 4.8 5.8 6.7 4.6 5.4 6.7
lOg EOD 5.2 6.3 6.8 4.8 6.3 7.1
20g daily 4.8 5.9 6.8 4.4 5.4 6.6
40g EOD 4.5 6.2 6.9 4.7 5.8 6.7
A fu ll  set of clinical results, with standard deviations 
indicated, is found in Tables I to IV in Appendix I .
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The improvements recorded over time fo r  condition o f the coat, 
mane, t a i l  and hooves were s t a t is t ic a l l y  s ig n if ic a n t .
The improvement o f the coat condition was s ig n i f ic a n t ly  less, 
however, fo r  the lOg EPO alternate day group than fo r  the other 
treatment groups. Analysis o f variance (ANOVA) tables used in 
s ta t is t ic a l  analyses o f the c l in ic a l  parameters are given in 
Appendix V.
Haematology
Although differences were found fo r  over time, and between the 
d i f fe re n t  EFA dose rate groups over time, fo r  some haematological 
parameters, these changes were very small. Mean values fo r  
haematological parameters fo r  the four treatment groups at weeks 
0, 3 and 6 are given in Table 2. Values were w ith in  normal ranges
with the exception o f several elevated white ce l l  counts, recorded 
fo r  one horse in the 5g EPO d a i ly  group at week 3, three horses in
the lOg EPO a lternate day therapy group at week 0, and one horse
in the 40g EPO alternate day group at week 0.
The values fo r  red ce ll counts, haemoglobin and packed ce ll 
volumes fo r  the horses receiving 40g EPO increased between week 0 
and week 6, whereas the values fo r  other groups dipped at week 3. 
This d ifference fo r  time patterns between groups was 
s ta t i s t i c a l l y  s ig n if ic a n t .
Values fo r  mean ce ll volume and mean ce ll haemoglobin fo r  a l l  
groups f e l l  over time, and these time differences were
s t a t is t ic a l l y  s ig n if ic a n t.  Mean ce ll haemoglobin concentration
values increased s l ig h t ly  at week 3, then dropped by week 6. 
S ta t is t ic a l  analysis showed values fo r  white ce ll counts to be 
s ig n i f ic a n t ly  higher fo r  the group of animals receiving lOg EPO 
than fo r  the other groups. P la te le t values f e l l  over time fo r  
animals receiving lOg and 20g doses o f EPO; and values fo r  the 5g 
group dipped at week 3 then rose towards week 6, while those fo r  
the 40g group peaked at week 3 then f e l l  towards week 6.
ANOVA tables used in s ta t is t ic a l  analyses o f haematological values 
are shown in Appendix V.
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Table 2. Mean values of haematological parameters of red cell 
count (RCC), haemoglobin (Hb), packed cell volume (PCV), mean cell 
volume (MCV), mean cell haemoglobin (MCH), mean cell haemoglobin 
concentration (MCHC), platelets and white cell count (NCC), at 
weeks 0, 3 and 6, of four groups of 12 horses receiving different
oral doses of n-3 and n-6 EFAs
Parameter RCC Hb
Week 0 3 6 0 3 6
5g daily 6.82 6.43 7.46 12.87 12.16 12.68
lOg EOD 7.28 6.47 8.07 13.31 11.76 13.12
20g daily 6.95 6.40 7.58 12.75 11.72 12.48
40g EOD 6.11 6.77 7.77 11.45 12.52 13.00
Parameter PCV MCV
Week 0 3 6 0 3 6
5g daily 0.377 0.354 0.381 53.34 55.13 51.17
lOg EOD 0.392 0.342 0.401 53.94 53.00 49.80
20g daily 0.375 0.343 0.379 54.03 53.76 50.16
40g EOD 0.336 0.365 0.394 55.17 54.17 50.52
Parameter MCH MCHC
Week 0 3 6 0 3 6
5g daily 18.92 18.93 17.04 34.15 34.33 33.32
lOg EOD 18.31 18.22 16.33 33.98 34.38 32.81
20g daily 18.49 18.38 16.68 34.03 34.14 33.01
40g EOD 18.78 18.58 16.70 34.05 34.29 33.08
Parameter Platelets wcc
Week 0 3 6 0 3 6
5g daily 162.3 157.7 165.3 8.43 9.65 8.45
lOg EOD 176.5 175.8 158.8 10.65 12.69 9.86
20g daily 172.8 160.8 138.1 9.40 9.15 9.83
40g EOD 166.0 172.5 149.3 9.53 10.28 8.40
A fu ll set of haematological results is found in Tables V to
in Appendix I .  Normal ranges and units o f measurement fo r  
haematological parameters are given in Appendix IV.
94
Biochemistry
As fo r  the haematological parameters, small changes were recorded 
over time and between groups over time, fo r  some biochemical 
parameters. Minor deviations from normal ranges were recorded fo r  
several biochemical parameters. Mean values at weeks 0, 3 and 6
fo r  biochemical parameters are shown in Table 3.
Several sodium values were marginally low: at week 0, two horses
in the 40g group (127 and 129 mmol/1); at week 3 two horses in 
each in the 5g and lOg groups (both 128 mmol/1); and at week 6 one 
horse from the lOg (131 mmol/1), and two horses from the 20g 
groups (131 and 129 mmol/1) and one from the 40g group (128 
mmol/1). Magnesium values were low fo r  several animals: at week 3, 
the value fo r  one horse in the 5g group, and one horse in the lOg 
group at 0.49 mmol/1 were marginally below the lower normal l im i t .  
Group means fo r  t r ig ly c e r id e  values were a l l  elevated above the 
normal range of between 0.12 and 0.35 mmol/1. High alka line 
phosphatase values were recorded fo r  several horses in each o f the 
groups at each time po int, but group means were w ith in  normal 
ranges. Total plasma proteins were elevated fo r  three animals in 
the 40g group at week 0 (103, 100 and 87 g /1); fo r  four animals in 
the 5g group (102, 91, 85 and 90 g/1), f ive  animals in the lOg
group (85, 89, 93, 96 and 90 g/1), one in the 20g group (91g/l)
and two in the 40g group at week 3 (90 and 117 g /1 ); and fo r  two 
horses in the 5g group (98 and 102 g/1) and three in the lOg group 
(87, 95 and 89 g/1) at week 6. These results  re flected increased
g lobulin  values.
Differences were found in the pattern over time between groups fo r  
values fo r  urea, magnesium, inorganic phosphate, AST, globulins 
and cholestero l. These changes were s ta t is t ic a l l y  s ig n if ic a n t .  The 
40g dose o f EFAs on alternate days led to increase in urea, 
magnesium, inorganic phosphate and cholesterol values over time. 
The urea values fo r  each group dropped between week 0 and week 3, 
and increased again towards week 6, and the 40 g group showed a 
sharper inc line  to week 6 than the other groups. A s im ila r trend 
was seen fo r  magnesium values, with decreases fo r  the 5g, lOg, and 
20g groups, whereas the 40g group showed a pattern o f increase 
between week 0 and week 6. Values fo r  the 40g group fo r  inorganic
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Table 3. Means values of biochemical parameters of urea, sodium, 
potassium, calcium, chloride, magnesium, inorganic phosphate, 
alkaline phosphatase, aspartate ami notransaminase, bilirubin, 
total plasma proteins, albumin, globulins, triglycerides and 
cholesterol, at weeks 0, 3 and 6, of four group of 12 horses
receiving different oral doses of n-3 and n-6 EFAs
Parameter urea sodium
Week 0 3 6 0 3 6
Horse group
5g daily 6.36 4.68 5.84 136.8 135.3 135.9
lOg EOD 5.89 4.03 5.84 135.8 134.3 133.8
20g daily 6.57 4.69 6.37 135.6 135.4 133.6
40g EOD 6.17 5.91 7.10 134.8 137.2 133.5
Parameter potassium calcium
Week 0 3 6 0 3 6
Horse group
5g daily 4.72 3.93 3.68 3.00 2.87 2.94
lOg EOD 4.48 3.99 3.59 2.95 2.88 2.99
20g daily 4.71 4.23 3.72 2.95 2.90 2.94
40g EOD 4.44 4.14 3.81 2.93 2.89 3.05
Parameter chloride magnesium
Week 0 3 6 0 3 6
Horse group
5g daily 97.3 95.7 96.3 0.63 0.60 0.67
lOg EOD 96.1 93.7 94.6 0.62 0.58 0.70
20g daily 96.8 95.2 94.4 0.62 0.62 0.68
40g EOD 94.7 96.5 95.1 0.61 0.67 0.71
Parameter i . phosphate AP
Week 0 3 6 0 3 6
Horse group
5g daily 1.12 1.11 0.97 383.3 327.8 329.4
lOg EOD 1.15 1.18 0.95 343.3 329.8 355.3
20g daily 1.19 1.16 0.88 370.1 349.6 336.5
40g EOD 1.11 0.93 1.04 344.3 354.7 323.2
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Table 3 (continued)
Parameter AST bilirubin
Week 0 3 6 0 3 6
Horse group
5g daily 296.4 299.3 270.0 8.9 14.0 9.7
lOg EOD 337.1 246.2 251.9 13.3 14.8 10.9
20g daily 300.3 320.3 282.3 8.6 12.1 10.3
40g EOD 265.0 328.4 300.9 9.2 9.6 11.9
Parameter TPP albumin
Week 0 3 6 0 3 6
Horse group
5g daily 70.2 78.0 74.4 31.6 31.9 29.8
lOg EOD 71.3 83.3 79.1 31.1 30.8 28.8
20g daily 69.6 76.3 69.8 31.1 30.0 29.8
40g EOD 77.8 78.3 72.1 29.8 31.6 33.3
Parameter globulins TG
Week 0 3 6 0 3 6
Horse group
5g daily 38.6 44.5 44.6 0.46 0.31 0.39
lOg EOD 40.3 52.5 50.3 0.41 0.32 0.42
20g daily 38.5 45.4 39.3 0.43 0.47 0.36
40g EOD 48.0 46.7 38.8 0.37 0.34 0.33
Parameter cholesterol
Week 0 3 6
Horse group
5g daily 2.41 2.50 2.33
lOg EOD 2.11 1.97 1.86
20g daily 2.33 2.40 2.22
40g EOD 1.97 2.14 2.40
A fu ll  set of biochemical results is found in Tables X I I I  to XXVII 
in Appendix I .  Normal ranges and units of measurement for 
biochemical parameters are given in Appendix IV.
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phosphate showed a d i f fe re n t  pattern to other groups once more: 
values rose, while they f e l l  fo r  other groups. Aspartate 
aminotransaminase values increased between week 0 and week 3, then 
f e l l  between weeks 3 and 6 fo r  the 5g, 20g, and 40g dose groups;
in contrast, the lOg group values f e l l  between week 0 and week 3, 
then rose between week 3 and week 6. Globulin values fo r  the 5g 
group remained s ta t ic  between week 3 and week 6, whereas values 
f e l l  between these time points fo r  the other groups. Cholesterol 
values f e l l  over time fo r  the lOg group, but increased over time 
fo r  the 40g group.
Differences were found between EFA treatment groups fo r  values o f 
urea and cho lestero l. Values fo r  the group receiving lOg were 
lower than fo r  other groups fo r  both parameters, as seen by the 
group means: fo r  lOg group the cholesterol value in mmol/1 was
1.979, compared to 2.415, 2.315 and 2.171 o f the 5g, 20g and 40g
treatment groups, respective ly. S im ila r ly , urea values were lower 
fo r  th is  group, with a group mean o f 5.25 mmol/1 as compared to 
5.63 fo r  the 5g group, 5.88 fo r  the 20g group, and 6.39 fo r  the 
40g group. These differences proved to be s ta t is t ic a l l y  
s ig n if ic a n t .
No s ig n if ic a n t  differences were seen fo r  chloride, b i l i r u b in ,  
albumin, or t r ig ly c e r id e  leve ls. S ign if ican t differences over time 
were seen fo r  a l l  groups fo r  the other parameters: sodium,
potassium, calcium, a lka line phosphatase, inorganic phosphate, 
to ta l  plasma proteins, g lobulins, urea and magnesium. For a l l  
groups to ta l protein values rose at week 3, then f e l l  back at week 
6. Inorganic phosphate values fo r  the 40g group dipped at week 3, 
and increased at week 6, whereas values fo r  other groups f e l l  over 
time. Although changes over time fo r  sodium, g lobulins and 
a lka line  phosphatase values were s ta t is t ic a l l y  s ig n if ic a n t ,  no 
spec if ic  trends were seen. The drop which was recorded in 
potassium values fo r  a l l  groups over time was s ta t is t ic a l l y  
s ig n if ic a n t .
Results o f s ta t is t ic a l  analyses of biochemical parameters are 
recorded in ANOVA tables in Appendix V.
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EFA Estimations
The d i f fe re n t  dose rates o f EFAs were not in f lu e n t ia l  on LA, AA or 
EPA values in c ircu la to ry  frac t ions . DGLA values, however, were 
s ig n i f ic a n t ly  lower when horses received lOg EFAs on a lternate 
days than when the dose was 5g or 20g d a i ly ,  or 40g on alternate 
days.
The mean values fo r  LA, DGLA, AA and EPA at weeks 0, 3 and 6, in 
red blood ce ll  phospholipids, plasma phospholipids, and plasma 
cholesteryl esters are given fo r  the d i f fe re n t  dose rate groups in 
Tables 4, 5 and 6, respective ly.
From the resu lts  o f EFA estimations o f red blood ce ll 
phospholipids, presented in Table 4, increases in values between 
week 0 and week 3, then again between week 3 and week 6, were 
found fo r  a l l  groups fo r  LA, DGLA, AA and EPA.
Assays o f plasma phospholipids in Table 5 reveal tha t there were 
increases fo r  LA between week 0 and week 6 fo r  a l l  groups. DGLA 
values increased over th is  time span fo r  the 5g, 20g and 40g
groups. Horses in the 5g, lOg and 20g groups showed increases in 
AA values between week 0 and week 6, but values fo r  the 40g group 
dropped over the s ix  weeks. A pattern of decrease over time was 
found fo r  EPA values fo r  horses receiving 5g and lOg EPO, but 
there was no d e f in i te  trend fo r  the 20g and 40g groups.
In plasma cholesteryl esters increases in LA values between were 
recorded fo r  a l l  the groups between week 0 and week 6, shown in 
Table 6. The groups o f horses which received lOg, 20g and 40g o f 
EFAs showed increases in DGLA levels between week 0 and week 6. 
Values fo r  AA fo r  the same groups also rose over th is  period. 
Elevation o f EPA values fo r the 5g, lOg and 40g groups were 
recorded between weeks 0 and 6.
S ta t is t ic a l  analyses of these resu lts  revealed, however, that 
none o f the differences which occurred in LA, AA or EPA values 
e ith e r between groups between week 0 and week 3, or between week 0 
and week 6, were s ig n if ica n t.  S im ila r ly , no s ig n if ica n t 
differences were found between groups fo r  the values fo r  DGLA
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Table 4. Mean values for linoleic  acid (LA), dihomogammalinolenic 
acid (DGLA), arachidonic acid (AA) and eicosapentanoic acid (EPA) 
in red blood cell phospholipids at weeks 0, 3 and 6, of four
group of 12 horses receiving different oral doses of n-3 and n-6 
EFAs
Parameter LA DGLA
Week 0 3 6 0 3 6
Horse group
5g daily 13.33 26.38 34.48 0.00 0.08 0.12
(10.80) (7.86) (3.86) (0.00) (0.08) (0.11)
lOg EOD 12.48 18.27 33.85 0.00 0.00 0.09
(8.58) (7.33) (5.57) (0.00) (0.00) (0.09)
20g daily 15.03 24.92 34.48 0.01 0.08 0.17
(11.41) (11.49) (4.65) (0.03) (0.07) (0.06)
40g EOD 19.29 25.88 35.93 0.00 0.05 0.10
(15.09) (11.30) (4.59) (0.00) (0.09) (0.13)
Parameter AA EPA
Week 0 3 6 0 3 6
Horse group
5g daily 0.73 0.94 1.30 0.36 0.39 0.97
(0.44) (0.25) (0.36) (0.43) (0.22) (1.27)
lOg EOD 0.73 0.79 1.33 0.35 0.30 0.43
(0.34) (0.31) (0.59) (0.25) (0.17) (0.34)
20g daily 0.81 0.99 1.45 0.43 0.37 0.64
(0.44) (0.30) (0.23) (0.27) (0.22) (0.14)
40g EOD 0.49 1.16 0.98 0.16 0.23 0.35
(0.58) (0.62) (0.74) (0.24) (0.29) (0.33)
Values are given as % of total EFAs 
Values in brackets are standard deviations
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Table 5. Mean values for linoleic  acid (LA), dihomogammalinolenic 
acid (DGLA), arachidonic acid (AA) and eicosapentanoic acid (EPA) 
in plasma phospholipids at weeks 0, 3 and 6, of four group of 12
horses receiving different oral doses of n-3 and n--6 EFAs
Parameter LA DGLA
Week 0 3 6 0 3 6
Horse group
5g daily 37.03 42.37 42.13 0.33 0.41 0.41
(2.72) (5.83) (6.23) (0.05) (0.06) (0.08)
lOg EOD 40.54 46.75 44.70 0.35 0.42 0.29
(4.92) (4.90) (7.35) (0.13) (0.06) (0.14)
20g EOD 46.24 53.75 52.47 0.35 0.45 0.42
(4.19) (3.92) (3.40) (0.07) (0.09) (0.14)
40g daily 41.17 45.64 45.16 0.32 0.46 0.47
(6.76) (5.88) (6.93) (0.12) (0.07) (0.07)
Parameter AA EPA
Week 0 3 6 0 3 6
Horse group
5g daily 1.43 1.57 1.57 0.54 0.51 0.44
(0.51) (0.71) (0.61) (0.09) (0.08) (0.11)
lOg EOD 1.86 1.86 1.91 0.64 0.60 0.58
(0.75) (0.52) (0.67) (0.16) (0.16) (0.10)
20g daily 1.56 1.67 1.69 0.75 0.76 0.75
(0.33) (0.47) (0.26) (0.13) (0.21) (0.15)
40g EOD 1.98 1.87 1.85 0.69 0.74 0.62
(0.60) (0.44) (0.42) (0.34) (0.14) (0.24)
Values are given as % of total 1EFAs
Values in brackets are standard deviations
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Table 6. Mean values for linoleic acid (LA), dihomogammalinolenic 
acid (DGLA), arachidonic acid (AA) and eicosapentanoic acid (EPA) 
in plasma cholesteryl esters at weeks 0, 3 and 6, of four group of 
12 horses receiving different oral doses of n-3 and n-6 EFAs
Parameter LA DGLA
Week 0 3 6 0 3 6
Horse group
5g daily 43.69 50.51 52.45 0.14 0.03 0.04
(9.05) (10.95) (13.01) (0.33) (0.07) (0.15)
lOg EOD 41.36 48.83 45.95 0.10 0.11 0.14
(10.00) (11.44) (10.55) (0.27) (0.27) (0.23)
20g daily 45.93 44.51 46.96 0.12 0.16 0.18
(9.72) (16.24) (8.06) (0.13) (0.21) (0.21)
40g EOD 44.64 52.30 53.95 0.05 0.14 0.20
(13.63) (10.18) (14.76) (0.12) (0.27) (0.33)
Parameter AA EPA
Week 0 3 6 0 3 6
Horse group
5g daily 6.62 6.42 6.55 0.18 0.10 0.25
(2.32) (3.65) (2.85) (0.17) (0.10) (0.55)
lOg EOD 7.48 8.29 7.77 0.00 0.00 0.03
(2.41) (2.61) (2.96) (0.00) (0.00) (0.10)
20g daily 4.73 3.96 5.60 0.08 0.04 0.02
(1.65) (2.05) (2.26) (0.08) (0.07) (0.06)
40g EOD 3.78 3.53 4.49 0.13 0.21 0.19
(3.60) (2.70) (7.13) (0.14) (0.10) (0.16)
Values are given as % of total EFAs
Values in brackets are standard deviations
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between weeks 0 and 3. M u lt ip le  range analysis revealed tha t 
between weeks 0 and 6, the DGLA values were s ig n i f ic a n t ly  lower 
fo r  the lOg group than fo r  the other groups.
Results o f s ta t is t ic a l  analyses o f EFA values are presented in 
Appendix V.
The basal leve ls o f LA, and i t s  metabolites DGLA and AA in plasma 
phospholipids in the horse are i l lu s t ra te d  in Figure 11. 
Comparative leve ls in the dog, the cat and in man are shown.
Discussion
Basal leve ls  o f EFAs were established fo r  the horse, and the
metabolism o f EFAs was found to be d i f fe re n t  in the horse to that
in other species. The percentage o f to ta l EFAs comprised by LA in
the horse is  more than twice the percentage in the dog, the cat
and in man. In contrast, the percentages o f to ta l EFAs o f LA 
metabolites, DGLA and AA, in the horse are very much lower than in 
other species. The percentage of to ta l EFAs formed by DGLA is 
approximately one f i f te e n th  of that in man; and the percentage o f 
to ta l EFAs comprised by AA is less than one tenth o f the 
percentage found in the dog.
The ra t io  of LA to i t s  metabolites was examined fo r  the horse, and 
was found to be very much lower than the ra t io  found in the dog, 
the cat, or in man. I t  was considered l ik e ly  that the low ra t io  in 
th is  species was due to slow 6-desaturation o f LA by the 
6-desaturase enzyme. The rate of the 6-desaturation reaction was 
slower, fo r  example, in the horse than in man; and the ra t io  in 
man is  closer to that o f herbivores such as the rabb it and guinea 
pig, than i t  is to that o f the ra t.  The conversion rate o f LA to 
i t s  b io lo g ic a l ly  active metabolites fo r  the horse was therefore 
found to be s im ila r to the conversion rate fo r  other herbivores.
Although the improvements recorded in the condition o f the coat, 
mane, t a i l  or hooves of the horses were s ta t is t ic a l l y  s ig n if ica n t 
with respect to time, no s ign if ica n t d ifference was found fo r  time
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Figure 11. Basal levels o f l in o le ic  acid (LA), and i t s  metabolites 
dihomogammalinolenic acid (DGLA) and arachidonic acid (AA) in the 
horse, with comparison to levels in other species. A ll values are 
given as % of to ta l EFAs.
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pattern between groups. As th is  was a t i t r a t io n  study, a control 
group was not used, and i t  could not therefore be assumed that 
these changes over time fo r  c l in ic a l  parameters were a tt r ibu tab le  
to the EFA treatments. Moreover, i t  is l i k e ly  that the improvement 
in these c l in ic a l  parameters was a ttr ibu ted  to the improving plane 
o f n u t r i t io n  o f the grazing between June and July when the study 
was performed, ra ther than to the EFA treatments.
Fluctuations over time were seen fo r  haematological and 
biochemical parameters w ith in  groups and between groups during the 
study. Despite the fac t that s ta t is t ic a l  analyses revealed several 
o f these changes to be s ig n if ic a n t ,  no d is t in c t  patterns were 
found which were considered relevant to, or a tt r ib u ta b le  to , the 
EFA treatments. Fluctuations in these parameters were thought to 
r e f le c t  n u tr i t io n a l factors . Thus, no harmful e f fe c t was evident 
on e ith e r haematological or biochemical parameters at any of the 
EFA dose rates studied.
S ta t is t ic a l  analyses o f resu lts  o f EFA estimations indicated that 
no p a r t ic u la r  dose regimen was s ig n i f ic a n t ly  more eff icac ious than 
another. In order to ensure maximum opportunity fo r  uptake, i t  was 
decided tha t the dose level o f 20 g o f Efamol Marine d a i ly  should 
be administered.
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The Use of Essential Fatty Acids (EFAs) 1n the Treatment of 
Dermatophilosis in Horses 
Introduction
The need fo r  an a lte rna tive  approach to the treatment o f 
dermatophilosis in the horse was emphasised in the in troductory 
chapters. Evening primrose o i l  (EPO) with added f ish  o i l  and 
vitamin E, formulated as Efamol Marine (Scotia Pharmaceuticals), 
was used to t r y  to t re a t dermatophilosis in horses. EPO is  a r ich  
source o f l in o le ic  acid (LA) and gamma-1inolenic acid (GLA), the 
EFAs which are v i ta l  to the maintenance o f the epidermal ba rr ie r 
to water. Fish o i l  contains n-3 eicosapentanoic acid (EPA), 
deriva tives o f which in h ib i t  inflammation; and vitamin E blocks 
conversion o f arachidonic acid (AA) to the pro-inflammatory 
leukotrienes.
Active EFA treatment was to be compared to placebo, which was 
hydrogenated coconut o i l  with added vitamin E. EFA and placebo 
treatments were to be administered at the period when prevalence 
o f dermatophilosis in fec tion  was found to be highest, in la te  
autumn and early w inter. This study followed the autumn period 
when the ra in fa l l  recorded in the West o f Scotland is 
t r a d i t io n a l ly  highest. The dose rate fo r  EFA supplementation to 
ensure maximum opportunity fo r  uptake was determined in a 
pharmacokinetic study, detailed in th is  section. Improvement in 
the severity  of lesions of dermatophilosis was sought, and lesion 
material was to examined microscopically to determine the a c t iv i ty  
o f such lesions. The condition of the haircoat, the mane, t a i l  and 
hooves and general body condition were to be monitored. There were 
reports o f improvement o f these parameters when EFAs were used to 
t re a t anhidrotic horses, described in the EFA review. I t  was hoped 
tha t these findings could be substantiated by the use o f EFAs in 
th is  study. Haematological and biochemical parameters were also to 
be monitored fo r  any systemic e ffec t or adverse event.
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Materials and Methods
Method o f Administration of EFAs 
The method o f administration o f treatments, and d e ta i ls  o f the EFA 
treatment capsules, Efamol Marine, are described in the Materials 
and Methods fo r  the pharmacokinetic study in th is  section o f the 
re su lts .  Placebo capsules contained hydrogenated coconut o i l  and 
vitamin E.
Experimental Design 
A group o f randomly selected horses received active, EFA 
supplementation, and were compared to placebo and control groups. 
Three groups o f 12 animals were randomly id e n t i f ie d .  One group 
received 20 g o f a combination o f n-3 and n-6 EFAs (Efamol Marine)
d a i ly ,  the dose rate which was found in the pharmacokinetic study
to allow maximum opportunity fo r  uptake; and a second group 
received 20g placebo d a i ly .  The th i rd  group, the control animals, 
received no treatment.
The supplementation period spanned 16 weeks, from early November 
to la te  February, during which the horses were housed, but were 
most l i k e ly  to be infected by D. congolensis , based on the
experience o f previous years on the two farms, and on the typ ica l 
disease pattern in the West o f Scotland. The t r i a l  was run
double-blind, the investigator was unaware o f which horses 
received which, i f  any, treatment.
Parameters Monitored
Dermatophilosis lesions 
The severity  and the extent of d is t r ib u t io n  o f the lesions of 
dermatophilosis were recorded at weeks 0, 2, 4, 6, 8, 10, 12, 14,
and 16 during the study. Details are provided in the general 
Materials and Methods section.
Bacteriology
Where present, paintbrush lesions and scab material from D. 
congolensis infected horses were subjected to bacterio logical 
examination at regular in te rva ls  during the study. Material was 
collected in to  s te r i le  bijoux, and where secondary bacteria l
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in fe c t ion  was evident, lesions were swabbed and material 
transferred in Ames transport medium (Transwab, The Medical Wire 
and Equipment Company) to the laboratory. Paintbrush lesions and 
scabs were soaked overnight in s te r i le  physiological saline to 
soften them and to allow release o f zoospores, and stored at 4°C 
to reduce the r is k  o f contamination. Thick impression smears were 
made from soaked scabs, then methanol fixed and stained by Giemsa. 
Material were cultured on sheep blood agar and MacConkey's agar, 
and on mannitol sa lt  agar to screen fo r  Staphylococc i . Culture was 
also made on medium selective fo r  D. congolensis , containing 
polymixin B sulphate at a concentration of 1000 IU/ml (160 mg/ml) 
in blood agar base No.2 (Oxoid), supplemented with 5% sheep blood, 
according to the method of Abu-Samra (1977). Cultures were 
incubated at 37°C fo r  48 h.
D. congolensis and any other s ig n if ic a n t bacteria were sought. 
Giemsa stained smears were examined under o i l  immersion at xlOO 
magnification fo r  the presence of Gram-positive cocci and 
filamentous hyphal growths showing the transverse and longitud inal 
d iv is ion s , the "ra ilroad  tracks" considered cha rac te r is t ic  o f D. 
congolensis.  Smears were graded in severity : + was mild in fec tion , 
++ was moderate, and +++ was severe in fec t ion , as judged by the 
density o f organisms seen. Cultures considered positive  fo r  D. 
congolensis were dry, beta-haemolytic, grey-yellow coloured, 
p inprick  sized colonies which were embedded in the agar. 
Bacterio logical examination was performed at week 0, before EFA 
supplementation was begun; at week 10, during supplementation, and 
at week 16, when supplementation was stopped.
C lin ica l monitoring system 
C lin ica l indices of condition of the coat, mane, t a i l  and hooves, 
and general body condition were recorded at weeks 0, 2, 4, 6, 8,
10, 12, 14 and 16 during the study. Details o f the measurement o f
these parameters are provided in the general Materials and Methods 
section.
Haematological and biochemical parameters were examined, and EFA 
estimations were performed, at weeks 0, 4, 8, 12 and 16. Details 
o f these measurements are provided in the general Materials and
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Methods section.
S ta t is t ic a l  analyses were undertaken on the c l in ic a l  indices, on 
haematological and biochemical parameters, and on EFA estimations 
using a repeated measures design, which is  described in the 
general Materials and Methods section.
Results
The E ffect o f EFAs on the Lesions o f Dermatophilosis 
Dermatophilosis lesions became less severe fo r  a l l  the groups, 
indicated by the drop in the dermatophilosis index in most cases; 
and the d is t r ib u t io n  of dorsum and hindlimb lesions became less 
widespread with time. Lesions were more severe and more widespread 
on horses in the placebo and EFA groups than fo r  the controls. 
Most o f the horses showed mild in fec tions, with low 
dermatophilosis indices, group means of less then 3, but each 
group did contain severely affected animals. In the control group 
one horse scored 8, and another 7 fo r  severity o f lesions; in the 
placebo group one scored 8 and another 7; and in the EFA group one 
horse scored 9, the most severe in fec tion  in the study. The most 
widespread d is t r ib u t io n  occurred fo r  the horse which had scored 9 
on the dermatophilosis index, Henry, in the EFA group: at week 0
lesions affected 60% of his body, and 60% of his hindlimbs. I t  is 
seen from the values presented in Table 7 that lesions affected a 
fa r  lesser area of the body and hindlimbs than th is  in most 
horses.
An example o f the typ ica l "paintbrush" dermatophilosis lesions, of 
matted exudate in the haircoat, is shown in Figure 12. These 
lesions were situated on the rump region o f th is  p a rt icu la r  
animal. Figure 13 i l lu s t ra te s  the painful scab lesions o f 
dermatophilosis on the dorsum o f one o f the study horses. 
Grey-green pus is seen on the undersides of the u p l i f te d  scabs, 
and there are u lc e r - l ik e  raw areas below the scabs. The scab 
lesions found on the lower hindlimbs of infected horses are seen 
in Figure 14. These "mud fever" lesions were id e n t i f ie d  on the 
dorsal pasterns, and around the fe t lock  and coronary band regions.
109
Table 7. Mean indices at weeks 0, 8 and 16 for the severity and 
the extent of distribution of dermatophilosis lesions on the 
dorsum and on the hindlimbs of three groups of horses in a 
treatment study. Eleven horses received no treatment, 12 received 
20g daily placebo of hydrogenated coconut o il and vitamin E, and 
12 animals received 20g of n-3 and n-6 EFAs daily.
C linical index dermatophilosis
index
Week 0 8 16
Horse group
Controls 3.2 1.3 1.1
PIacebo 4.2 2.1 1.7
EFAs 4.3 2.9 1.5
Clinical index 
Week
Horse group 
Controls 
Placebo 
EFAs
dorsum
distribution
0 8 16
18.1 7.1 2.5
19.8 9.4 5.5
20.5 8.6 6.8
hindlimb
distribution
0 8 16
17.5 2.1 2.5
25.0 4.2 8.5
19.0 5.3 2.8
A fu ll set of results of severity and distribution of lesions of 
dermatophilosis is found in Tables I to I I I  in Appendix I I .
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Figure 12. The typ ica l "paintbrush" lesions o f dermatophilosis 
seen on the dorsum of a horse during the EFA treatment study
Figure 13. Painful scab lesions o f dermatophilosis found on 
the dorsum o f a horse during the EFA treatment study
111
Figure 14. Dermatophilosis lesions involving the lower 
hindlimbs of a horse during the EFA treatment study
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The reduction in dermatophilosis lesion severity  and in the 
d is t r ib u t io n  o f dorsum and hindlimb lesions were s ta t is t ic a l l y  
s ig n if ic a n t .  These improvements occurred, however, fo r  a l l  groups: 
improvement was not s ta t is t ic a l l y  greater fo r  the treatment than 
fo r  placebo or fo r  untreated groups.
Bacteriology
Although D. congolensis organisms were isolated from over 60% of 
lesions examined, they were more d i f f i c u l t  to cu ltu re . Throughout 
the study the prevalence of dermatophilosis in fec tion , according 
to c l in ic a l  observation, Giemsa smears, and cultures, was not 
s ig n i f ic a n t ly  lower fo r  the animals which received EFA than fo r  
those which received placebo, or were untreated.
Of the 65 c l in ic a l  dorsum lesions sampled over the duration o f the 
study, 48 (73.8%) proved positive  on Giemsa smear, and 27 (41.5%) 
were confirmed pos it ive  on cu ltu re . Of 56 c l in ic a l  lesions o f the 
lower hindlimbs which were sampled, 36 (64.3%) were pos it ive  on 
Giemsa smear and 7 (12.5%) were posit ive  on cu ltu re . Where
secondary in fec t ion  and pus were present on dorsum lesions, swabs 
were taken. Seven o f the 10 (70%) of the lesions swabbed proved 
pos it ive  on cultu re fo r  D. congolensis. The results  of 
bacterio log ica l findings are summarised in Table 8. Each entry in 
the table fo r  each horse shows results  of detection of c l in ic a l  
lesions, and o f detection of D. congolensis on smear and on 
cu ltu re .
One horse from the control group and one from the EFA group, both 
o f which were negative fo r  c l in ic a l  lesions at the study onset, 
developed dorsum lesions which were confirmed posit ive  on cultu re 
during the t r i a l .  Three horses, one each from contro l, placebo 
and EFA groups, and having no lesions at the study onset, devel­
oped lower hindlimb lesions. Two of these were pos it ive  fo r  D. 
congolensis organisms by Giemsa smear, although none could be c u l­
tured.
Pathogenic Staphylococci were isolated from one o f the EFA group 
horses at the onset of the study, and from two animals in the 
placebo group at the end of the study. The organism was recovered
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from lesions involv ing the lower hindlimbs in each case.
These organisms were confirmed to be pathogenic by subculture from 
mannitol s a l t  agar to DNase medium. Other incidental f ind ings were 
tha t two animals had l ic e  in fes ta tions at the conclusion o f the 
t r i a l ,  one control and one EFA group animal. One o f the placebo 
group horses showed evidence o f a mite in fec tion  o f the fe tlocks 
during the t r i a l ,  but a species could not be id e n t i f ie d .  Owing to 
the fac t tha t the horses were run together in large groups, most 
animals showed minor skin trauma at some point during the t r i a l  
due to kicking and b it in g .
Chi-square analyses were undertaken on the prevalence of 
dermatophilosis in d i f fe re n t  treatment groups as determined 
according to observation on each of c l in ic a l  lesions, Giemsa 
smears and cu ltu res. Results are presented in Table 8. In each 
case analysis was undertaken on pre-treatment (Week 0), 
mid-treatment (Week 10) and post-treatment (Week 16) points in 
time. No s ig n if ic a n t differences between groups were detected, 
with the exception o f c l in ic a l  lower hindlimb lesions 
post-treatment. Only two out o f 10 horses in the control group had 
lesions, whereas s ix  out of eight and s ix out o f 10 in the placebo 
and EFA groups, respective ly, had lesions.
C lin ica l Indices
For most animals in a l l  the groups the indices fo r  coat, t a i l  and
hooves increased over time, i .e .  the condition improved. Although
body condition scores fluctuated, no d e f in i te  upward or downward
trends were id e n t i f ie d . Mean values, at weeks 0, 8, and 16, fo r
the c l in ic a l  indices of coat condition, mane condition, t a i l  
condition, hoof condition, and body condition are contained in 
Table 9.
From the resu lts , condition indices fo r  coat, mane, t a i l  and 
hooves around the middle of the scale, 5 or 6, average condition, 
were found at the study onset, w h ils t by the end of the study 
values were moving toward the upper end of the scale, at 7 or 8. 
Values showed p a r t icu la r ly  marked improvement fo r  a l l  groups fo r  
coat and t a i l  condition. Very small differences between group
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Table 8. Bacteriological results, comparing results of clin ical 
examination, Giemsa smears and cultures for detection of
Dermatophilus congolensis organisms.
Clinical dorsum lesions 
Before treatment 
present absent
Group
Controls 7 4
Placebo 7 4
EFAs 7 4
During treatment After treatment
present absent present absent
Total Chisquares: 0.00
Results NS NS NS
1.64
NS NS
0.75
NS
Clinical lower hindlimb lesions
Before treatment During treatment
present absent present absent
Group
Controls
Placebo
EFAs
After treatment 
present absent
Total Chisquares: 0.36
Results NS NS NS
4.78
NS NS
6.00
Sig
Giemsa Smear of Infective Material 
Dorsum lesions
Before During After
Lower hindlimb lesions
Before During After
Group
Controls
Placebo
EFAs
Group
Controls
Placebo
EFAs
10
8
6
Total Chi­
squares: 0.24 2.43
Results NS NS
NTP 0.73
NS
3.64
NS
0.68
NS
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Table 8 (continued)
Culture of Infective Material
Dorsum lesions
Before During After 
+  -  +  -  +  -
Group Group
Lower hindlimb lesions
Before During After
+ + +
Controls 0 11 2 9 4 6
Placebo 1 10 3 9 2 6
EFAs 2 9 3 8 3 7
Controls 1 10 0 11 1 9
Placebo 0 11 1 11 1 7
EFAs 0 11 2 9 1 9
Total Chi­
squares: 2.20 0.27 0.49
Results NS NS NS
NTP NTP NTP
Key
Before, during and after indicate before, during and after  
supplementation with active treatments.
+ indicates the presence of D. congolensis organisms 
- indicates the absence of D. congolensis organisms 
NTP indicates no test possible, as numbers were too small 
NS indicates result was not significant
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Table 9. Mean values at weeks 0, 8 and 16 for c lin ica l indices of 
condition of coat, mane, ta il  and hooves, and of general body 
condition of three groups of horses during a treatment study. 
Eleven horses received no treatment, 12 received 20g daily placebo 
of hydrogenated coconut oil and vitamin E, and 12 animals received 
20g of n-3 and n-6 EFAs daily
Clinical index coat mane
condition condition
Week 0 8 16 0 8 16
Horse group
Controls 5.3 6.9 7.3 5.6 6.9 7.7
Placebo 5.4 7.3 6.9 5.1 7.3 7.9
EFAs 5.5 7.0 7.2 5.5 6.8 7.7
Clinical index ta il hoof
condition condition
Week 0 8 16 0 8 16
Horse group
Controls 5.4 7.1 6.8 6.7 7.3 7.1
Placebo 5.3 7.3 7.9 6.4 7.3 7.1
EFAs 5.6 7.0 7.5 6.5 6.9 6.9
Clinical index body
condition
Week 0 8 16
Horse group
Controls 3.1 3.2 3.0
Placebo 3.0 3.3 3.1
EFAs 3.1 3.3 3.1
A fu ll set of clin ical results is found in Tables IV to V II I  in 
Appendix I I .
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means were seen fo r  coat, mane, t a i l  and hoof condition.
The improvements recorded fo r  coat, t a i l  and hoof condition were 
a l l  s t a t is t ic a l l y  s ig n if ic a n t .  These improvements occurred, 
however, fo r  a l l  groups: improvement was not s t a t is t ic a l l y  greater 
fo r  EFA treatment than fo r  placebo or fo r  untreated groups.
Haematology
The pattern fo r  animal groups fo r  haematological parameters in 
th is  treatment study resembled that of the groups in the 
pharmacokinetic study, in that values fluctuated over time. The 
values fo r  a l l  haematological parameters dropped fo r  the three 
groups over time, and the reductions were s ta t is t ic a l l y  
s ig n if ic a n t .
The administration o f EFA and placebo treatments was not 
in f lu e n t ia l  on the haematological parameters, and no adverse 
e f fe c t  was found. There were no s ta t is t ic a l l y  s ig n if ica n t 
differences fo r  time patterns fo r  the parameters between EFA, 
placebo and control groups.
The values fo r  haematological parameters fo r  each horse are given 
in Tables IX to XVI o f Appendix I I .  Values were w ith in  normal 
ranges fo r  haematological parameters with the exception o f several 
low p la te le t  counts, fo r  three horses in the placebo group and fo r  
two in the EFA group. Normal ranges fo r  hot and cold blooded 
animals, Thoroughbreds and ponies, and the units used in 
measurement o f each parameter are indicated in Appendix IV.
Biochemistry
As fo r  haematological parameters, differences in time patterns 
were recorded fo r  biochemical parameters which were found to be 
s t a t is t ic a l l y  s ig n if ic a n t.  Examination of these differences fa i le d  
to reveal spec if ic  trends fo r  parameters over time. Values were 
w ith in  normal ranges fo r  biochemical parameters. Although a 
s ta t is t ic a l l y  s ig n if ica n t difference between groups was recorded 
fo r  the time pattern fo r  magnesium values, no d e f in i te  upward or 
downward trends were found fo r  the values. For a l l  other 
biochemical parameters, there were no s ig n if ica n t differences fo r
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time patterns between groups.
EFA and placebo treatments caused no harmful e f fe c t  on biochemical 
parameters. Tables XVII to XXXII o f Appendix I I  show values fo r
biochemical parameters. Normal ranges and the units used in
measurement o f each parameter are indicated in Appendix IV.
EFA Estimations
No pattern o f increase over time fo r  any EFA measured in
c irc u la to ry  frac tions  was found fo r  the group o f horses which
received oral n-3 and n-6 EFAs compared to placebo or control
groups.
Group means at weeks 0, 8 and 16 fo r  n-6 series EFA, LA, and i t s
metabolites DGLA and AA; and n-3 series EPA in plasma
phospholipids, plasma cholesteryl esters and red ce ll
phospholipids are contained in Tables 10, 11 and 12, respective ly.
Results o f s ta t is t ic a l  analyses o f EFAs indicated s ig n if ica n t
d ifferences over time fo r  LA, AA and EPA values in red ce ll
phospholipids. For a l l  groups LA values dropped markedly between 
weeks 0 and 8, and were at the lower value at week 16. AA and EPA 
values increased over time fo r  a l l  groups.
In plasma phospholipids and in plasma cholesteryl esters there 
were s ta t is t ic a l l y  s ig n if ica n t differences over time fo r  LA, DGLA 
and AA values. No d e f in i te  trends could be detected, however, fo r  
changes in EFAs in plasma phospholipids over time. In plasma
cholesteryl esters no trend was detected fo r LA values over time,
but AA values increased over time fo r  a l l  groups. No s ig n if ica n t
d ifference was recorded fo r  EPA values in plasma cholesteryl
esters. S ta t is t ic a l  analyses revealed that mean EPA values in
plasma phospholipids fo r  the EFA group were s ig n if ic a n t ly  higher, 
with group mean of 0.721, than fo r  the control or placebo groups, 
o f group means 0.610 and 0.573,
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Table 10. Mean values at weeks 0, 8 and 16 for lin o le ic  acid (LA), 
dihomogammalinolenic acid (DGLA), arachidonic acid (AA) and 
eicosapentanoic acid (EPA) in red cell phospholipids of three 
groups of horses during a treatment study. Twelve animals received 
no treatment, 12 received 20g coconut o il and vitamin E placebo 
daily , and 11 received 20g n-3 and n-6 EFAs daily.
LA DGLA
Week 0 8 16 0 8 16
Horse group
Control 14.98 4.85 5.02 0 0.01 0
(7.03) (1.09) (1.34) (0) (0.02) 0
Placebo 12.83 5.12 5.26 0 0.03 0
(4.84) (2.07) (1.35) (0) (0.05) (0)
EFAs 12.65 5.11 5.13 0.43 0.05 0
(8.40) (1.14) (0.68) (0.96) (0.09) (0)
AA EPA
Week 0 8 16 0 8 16
Horse group
Control 0.40 1.09 1.33 0.16 0.68 0.73
(0.31) (0.45) (0.27) (0.33) (0.51) (0.32)
Placebo 0.52 1.11 1.41 0.25 0.54 1.20
(0.34) (0.53) (0.18) (0.29) (0.31) (0.94)
EFAs 0.65 0.97 1.27 0.26 0.65 0.86
(0.49) (0.49) (0.55) (0.24) (0.26) (0.55)
Values are given as % of total EFAs 
Values in brackets are standard deviations
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Table 11. Mean values at weeks 0, 8 and 16 for lin o le ic  acid (LA), 
dihomogammalinolenic acid (DGLA), arachidonic acid (AA) and 
eicosapentanoic acid (EPA) in plasma phospholipids of three groups 
of horses during a treatment study. Twelve animals received no 
treatment, 12 received 20g coconut oil and vitamin E placebo 
daily , and 11 received 20g n-3 and n-6 EFAs daily.
LA DGLA
Week 0 8 16 0 8 16
Horse group
Control 48.74 46.79 48.08 0.55 0.54 0.39
(13.90) (3.29) (5.43) (0.35) (0.13) (0.14)
PIacebo 51.74 48.46 51.15 0.38 0.60 0.44
(4.67) (3.03) (2.43) (0.25) (0.17) (0.09)
EFAs 54.05 48.45 50.94 0.31 0.70 0.59
(3.98) (2.40) (3.37) (0.30) (0.15) (0.12)
AA EPA
Week 0 8 16 0 8 16
Horse group
Control 2.25 2.08 1.94 0.83 0.54 0.57
(0.38) (0.35) (0.36) (0.32) (0.14) (0.21)
Placebo 2.24 2.02 1.80 0.86 0.53 0.54
(0.37) (0.40) (0.32) (0.33) (0.13) (0.12)
EFAs 1.94 2.08 1.97 0.78 0.71 0.69
(0.66) (0.24) (0.29) (0.40) (0.14) (0.18)
Values are given as % of total EFAs 
Values in brackets are standard deviations
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Table 12. Mean values at week 0, 8 and 16 for lin o le ic  acid (LA), 
dihomogammalinolenic acid (DGLA), arachidonic acid (AA) and 
eicosapentanoic acid (EPA) in plasma cholesteryl esters of three 
groups of horses during a treatment study. Twelve animals received 
no treatment, 12 received 20g coconut o il and vitamin E placebo 
daily , and 11 received 20g n-3 and n-6 EFAs daily.
LA DGLA
Week 0 8 16 0 8 16
Horse group
Control 68.28 68.14 59.39 0 0.01 0
(5.67) (5.37) (9.86) (0) (0.02) (0)
PIacebo 67.72 68.15 66.06 0 0.03 0
(4.10) (3.47) (4.29) (0) (0.05) (0)
EFAs 69.65 70.46 63.06 0.43 0.05 0
(5.33) (3.50) (5.76) (0.96) (0.09) (0)
AA EPA
Week 0 8 16 0 8 16
Horse group
Control 0.40 1.09 1.33 0.16 0.68 0.73
(0.31) (0.45) (0.27) (0.33) (0.51) (0.32)
PIacebo 0.52 1.11 1.41 0.25 0.54 1.20
(0.34) (0.53) (0.18) (0.29) (0.31) (0.94)
EFAs 0.65 0.97 1.27 0.26 0.65 0.86
(0.49) (0.49) (0.55) (0.24) (0.26) (0.55)
Values are given as % of total EFAs 
Values in brackets are standard deviations
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respective ly . No d ifference found between groups over time was 
s ta t is t i c a l l y  s ig n if ic a n t fo r  values fo r  any EFA in any blood 
f ra c t io n .
S ta t is t ic a l  Analyses 
The tables d e ta i l in g  s ta t is t ic a l  analyses by analysis o f variance 
(ANOVA) fo r  dermatophilosis indices, c l in ic a l  condition indices, 
haematological and biochemical parameters, and indiv idual EFAs in 
the d i f fe re n t  c ircu la to ry  fractions are given in Appendix VI.
Exclusions
The horse named Sandy Lad, (EFA treatment group) was removed from 
the t r i a l  before the midway po int, owing to generalised d e b i l i ty .  
Data were not included in s ta t is t ic a l  analysis. Natasha, (placebo 
group) l e f t  the farm at week 12. Horses named Temple, (con tro l) ;  
Jack, (placebo); Big Ben, (placebo); Rainbeam, (placebo); O ff ice r, 
(placebo) and Heidi, (EFA) were removed from the t r i a l  at week 14, 
fo r  commercial reasons. Data from these animals were included in 
s ta t is t ic a l  analyses.
Discussion
In th is  contro lled study the oral administration o f 20g d a i ly  o f 
n-3 and n-6 series EFAs had no c l in ic a l  or bacterio logica l e ffec t 
on the severity or on the d is t r ib u t io n  o f lesions of 
dermatophilosis. The progression of in fec tion  was not influenced 
by 80% EPO and 20% f ish  o i l  and vitamin E (Efamol Marine) or by 
hydrogenated coconut o i l  and vitamin E placebo, when comparison 
was made to untreated controls. At the same time, EFAs did not 
cause s ig n if ic a n t improvement in the condition of the haircoat, 
mane, t a i l  or hooves of the general body condition. Although 
values fo r  haematological and biochemical parameters fluctuated, 
these changes were a ttr ibu ted  to other factors, such as changing 
n u t r i t io n ,  and not to EFAs. No adverse e ffec t was recorded during 
the study, and EFAs were not therefore found to be harmful. The 
f a l l  over time fo r  haematological parameters over th is  period, 
ju s t  before winter housing of the horses, may re f le c t  the f a l l  in 
the n u tr i t io n a l value of grazing at th is  time. The PCV values are
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observed by the farm owner to drop every year at th is  time.
Oral supplementation o f n-3 or n-6 EFAs did not lead to 
s ig n if ic a n t  increases in levels o f these EFAs in c ircu la to ry  
frac t ions  when treated animals were compared to placebo and 
control groups.
The reason fo r  the fa i lu re  of EFAs to produce s ig n if ic a n t c l in ic a l  
e f fec ts , e ithe r on the severity and d is t r ib u t io n  of the lesions of 
dermatophilosis or on the condition o f the haircoat, mane, t a i l  or 
hooves was unclear. The EFA dose rate may have been incorrect, but 
the adopted 20g d a i ly  dose was selected on the resu lts  o f the 
pharmacokinetic study to allow maximum opportunity fo r  EFA uptake. 
Any higher a dose would not have been practica l from the point of 
view of administration or of cost.
I t  was considered that the fa i lu re  of EFAs in respect o f treatment 
o f dermatophilosis was possibly due in part to the fac t that 
dermatophilosis lesions were already established p r io r  to the 
in i t ia t io n  o f EFA supplementation. The epidermis would already 
have been disrupted, f a c i l i t a t in g  invasion by D. congolensis and 
the subsequent development o f lesions. The s ta r t  o f treatment may 
thus have been too la te .
124
The Use of Essential Fatty Acids (EFAs) in the Prophylaxis of 
Dermatophilosis in Horses 
Introduction
In the previous study, oral supplementation o f EFAs at the 20g 
d a i ly  dose rate determined in the pharmacokinetic study was not 
e ffe c t ive  in the treatment o f dermatophilosis in horses. No 
reduction in the severity nor in the extent o f d is t r ib u t io n  o f 
lesions o f dermatophilosis was afforded by the treatment regime 
used. The fa i lu re  o f s ig n if ic a n t e ffec t may have been due to the 
fac t tha t lesions were already established p r io r  to in i t ia t io n  o f 
EFA supplementation, and so the epidermis was already traumatised 
allowing invasion o f D. congolensis organisms and development o f 
lesions.
The aim o f th is  study was to supplement EFAs in a prophylactic 
approach to management of dermatophilosis in the horse. EFAs were 
administered in the same form, at the same 20g da ily  dose rate, 
and supplementation was started before the period o f highest 
in fec t ion  r is k .  In th is  way, i t  was hoped to combat in fec tion  
before any lesions were established, when the epidermis was s t i l l  
in ta c t .
In reviewing accepted treatments and control measures in 
dermatophilosis in horses in the introductory section i t  was 
evident that no e ffec t ive  prophylactic exists at present, as 
vaccination is  not commercially available. The use o f EFAs was 
thought to provide a possible new prophylactic fo r  the management 
o f equine dermatophilosis.
Materials and Methods
Method and Administration o f EFAs 
The method o f administration and the de ta ils  o f the EFA 
supplementation are provided in the Materials and Methods of the 
pharmacokinetic study in th is  section.
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Experimental Design 
Two groups o f 12 animals were randomly selected. One group 
received 20 g o f a combination o f n-3 and n-6 EFAs (Efamol Marine) 
d a i ly ,  and the control group received no treatment. 
Supplementation spanned 16 weeks when the horses were believed to 
be at highest r is k  o f dermatophilosis, beginning in September when 
the horses were s t i l l  at pasture, and continuing through to 
January, by which time they had been housed fo r  several months. 
The animals were monitored c l in ic a l ly ,  haematologically and 
biochemically fo r  8 weeks fo llowing supplementation, and EFA 
estimations were made 8 weeks a fte r  the end o f supplementation, in
an attempt to determine the persistence, i f  any, of the effects  of
EFAs in the horse beyond the end of supplementation.
Parameters Monitored 
The severity  and d is t r ib u t io n  of dermatophilosis lesions, were 
recorded repeatedly, at weeks 0, 3, 6, 9, 12, 15, 20 and 24 o f the 
study. The indices o f the condition o f the coat, the mane, the 
t a i l ,  the hooves, and general body condition were also monitored 
at these times. Haematological and biochemical parameters were 
recorded at weeks 0, 8 and 16 o f the study. EFA estimations were
made at weeks 0, 8, 16 and 24. Details o f measurement o f
parameters are detailed in the general Materials and Methods 
section. Values fo r  a l l  c l in ic a l ,  haematological and biochemical 
parameters, and EFAs, were s ta t is t ic a l l y  analysed using a 
repeated measures analysis of variance design, described in the 
general Materials and Methods section.
Results
C lin ica l Indices
The mean values fo r  dermatophilosis index, and the dorsal and 
hindlimb d is t r ib u t io n  indices fo r  lesions are very low, ind ica ting 
mild, localised in fec tions. Very few horses in e ithe r treatment or 
control groups were infected. The mean values fo r  indices denoting 
dermatophilosis lesion severity, and dorsal and hindlimb lesion 
d is tr ib u t io n s  at weeks 0, 9, 15 and 24 are presented in Table 13.
One horse in each group developed dorsal lesions during the study;
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Table 13. Mean values at weeks 0, 9, 15 and 24 weeks for the
severity and extent of distribution of dermatophilosis lesions on 
the dorsum and on the hindlimbs of two groups of horses in a 
prophylactic study; 12 animals received no treatment, and 11 
animals received 20g of n-3 and n-6 EFAs
Parameter dermatophilosis
index
Week 0 9 15 24
Horse group
Controls 0.1 0.2 0.1 0.1
EFAs 0.2 0.5 0.0 0.0
Parameter
Week
Horse group
Controls
EFAs
dorsum 
distribution  
0 9 15 24
0 0 1.3 1.3
0 0.2  0 0
hindlimb 
distribution  
0 9 15 24
0.2 0.3 0 0
1.0 0.7 0 0
A fu ll set of measurements of dermatophilosis indices is found in 
Tables I to I I I  in Appendix I I I .
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one horse in the control group had hindlimb lesions at week 0, and 
another two animals la te r  developed lesions. In the EFA group, 
hindlimb lesions were noticed on two horses at the beginning of 
the study and on a fu r the r four animals la te r  in the study. No 
s ig n if ic a n t  differences were detected between groups fo r  severity  
or d is t r ib u t io n  o f dermatophilosis lesions. Examination o f the 
data revealed no differences in the severity  or the extent of 
d is t r ib u t io n  o f dermatophilosis lesions between EFA and control 
groups.
The horses were in good body condition, and the coat, mane, t a i l  
and hoof conditions were above average. The indices were not 
s ig n i f ic a n t ly  higher, however, fo r  the EFA group than fo r  the 
con tro ls . The c l in ic a l  indices o f coat condition, mane condition, 
t a i l  condition, hoof condition, and body condition score, are 
presented in Table 14. For coat, mane, t a i l  and hoof condition, 
the m a jority  o f scores f e l l  w ith in  the upper h a lf  o f the 10 point 
index scale fo r  both groups, they were above 5, or above average 
condition. Most animals were awarded condition scores o f 3 or 
above, tha t is ,  most animals showed optimal condition score, or 
tended towards the fa t  end o f the scale.
There were s ta t is t ic a l l y  s ig n if ica n t time differences fo r  mane, 
t a i l  and body condition: f luc tuations were small, and values fo r
the mane and t a i l  condition improved over the la t te r  h a lf  o f the 
study. No d e f in i te  pattern was detected fo r  body condition score 
values.
Although differences in time pattern fo r  mane condition values 
between the two groups was s ig n if ic a n t ly  d i f fe re n t ,  no d e f in i te  
pattern was established fo r  e ither group. No s ta t is t ic a l l y  
s ig n if ic a n t  d ifference occurred between groups over time fo r  any 
o f the other parameters.
The tables o f s ta t is t ic a l  analyses by analysis o f variance are 
given in Appendix V II.
Haematology
With the exception of several low p la te le t  counts, three control
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Table 14. Mean values at weeks 0, 9, 15 and 24 weeks for clin ical 
parameters of condition of the coat, mane, ta il  and hooves, 
general body condition, dermatophilosis index, dorsal and hindlimb 
lesion distribution for two groups of horses in a prophylactic 
study; 12 animals received no treatment, and 11 animals received 
20g of n-3 and n-6 EFAs daily
Parameter
Week
Horse group
Controls
EFAs
coat 
condition 
0 9 15
7.0 6.8 7.0
6.8 6.4 7.0
24 0
7.0 6.8
6.9 7.1
mane 
condition 
9 15 24
7.0 7.1 7.8
6.6 7.2 6.9
Parameter
Week
Horse group
Controls
EFAs
ta il  
condition 
0 9 15
7.3 7.2 7.1
7.3 6.4 7.2
24 0
7.5 6.8
7.2 7.2
hoof 
condition 
9 15 24
6.9 7.0 7.1
7.0 7.3 7.2
Parameter body
condition
Week 0 9 15 24
Horse group
Controls 3.4 3.5 3.3 3.4
EFAs 3.3 3.4 3.1 3.2
A fu ll set of c lin ical results is found in Tables IV to V II I  in 
Appendix I I I .
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values, and seven values fo r  EFA treated horses, values fo r  
haematological parameters were w ith in  normal ranges. Tables IX to 
XVI o f Appendix I I I  show the values fo r  haematological parameters. 
Normal ranges fo r  hot and cold blooded animals, Thoroughbreds and 
ponies, and the units used in measurement o f each parameter are 
indicated in Appendix IV.
Although a s ta t is t ic a l l y  s ig n if ica n t difference between groups fo r  
time pattern was recorded fo r  mean ce ll haemoglobin values, trends 
were not marked. No s ta t is t ic a l l y  s ig n if ica n t differences in time 
patterns were found between groups fo r  the other haematological 
parameters. The tables o f s ta t is t ic a l  analyses by analysis o f 
variance are given in Appendix V II.
Biochemistry
Most values were w ith in  normal ranges fo r  biochemical parameters, 
although a large proportion o f animals in both groups showed AP 
values above the normal ranges at each time po int. AST values fo r 
two animals in each group were elevated. At the week 3 time point 
four control animals and three treated animals demonstrated 
reduced tr ig ly c e r id e  values. Elevated tr ig lyce r id e s  values were 
fo r  one control and three treated horses at week 0; fo r  two 
contro ls and one treated horse at week 8; and fo r  two controls and 
one treated horse at week 16.
Tables XVII to XXXII of Appendix I I I  show values fo r  biochemical 
parameters. Normal ranges and the units used in measurement of 
each parameter are indicated in Appendix IV.
No s ig n if ic a n t difference existed between groups over time fo r  any 
biochemical parameter. Although s ta t is t ic a l l y  s ig n if ic a n t 
d ifferences over time were recorded fo r  several parameters, both 
treated and untreated animals behaved in the same way, so these 
patterns o f change could not be a ttr ibu ted  to EFAs. Calcium, 
magnesium and AST values, increased over time fo r  both groups; and 
potassium and AP values f e l l  over time fo r  both groups. The tables 
o f s ta t is t ic a l  analyses by analysis of variance are given in 
Appendix V II.
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EFA Estimations
There were no s ig n if ic a n t increases in EFA values in c ircu la to ry  
frac t ions  over time fo r  horses which received n-3 and n-6 EFAs as 
compared to the con tro l, untreated animals. Means values at weeks 
0, 8, 16 and 24 fo r  n-6 EFAs LA, and i t s  metabolites DGLA and AA,
and n-3 EPA in red ce ll phospholipids and plasma phospholipids 
are contained in Tables 15 and 16, respective ly.
Although s ta t is t ic a l l y  s ig n if ica n t differences were seen over time 
fo r  LA, AA and EPA values in red ce ll phospholipids, d e f in i te  
trends fo r  values fo r  AA and EPA were not seen. LA values fo r  both 
groups showed a pattern of increase between week 0 and week 8, 
then f e l l  towards week 24. A s ta t is t ic a l l y  d if fe re n t  pattern over 
time was recorded between groups fo r  AA values, but trends were 
not marked fo r  e ithe r group. Values fo r  DGLA were too low fo r  
analyses to be performed.
No d e f in i te  trends over time were found fo r  LA, AA or EPA values 
in plasma phospholipids, although the difference was s ta t is t ic a l ly  
s ig n if ic a n t .  Examination of the time difference fo r  DGLA revealed 
tha t values increased fo r  both groups between weeks 0 and 16, then 
values dropped u n t i l  week 24. There was a s ta t is t ic a l l y  
s ig n if ic a n t  difference between groups over time fo r  AA values, but 
once again, no d e f in i te  trends were seen fo r  e ithe r group.
ANOVA tables used in s ta t is t ic a l  analyses are demonstrated in 
Appendix V II .
Discussion
EFAs were not found to be an e ffec t ive  prophylactic in equine 
dermatophilosis in th is  study. There was an unusually low 
incidence o f dermatophilosis in fection in the horse herd at the 
time o f the study owing to a very dry autumn p r io r  to the study. 
Nevetheless, the supplementation o f horses with 20g d a ily  o f 80% 
EPO and 20% fish  o i l  and vitamin E (Efamol Marine) did not 
prevent development of dermatophilosis lesions, nor did i t  reduce 
the severity or extent of d is tr ib u t io n  of lesions in th is
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Table 15. Mean values at weeks 0, 8, 16 and 24 fo r  l in o le ic  acid
(LA), dihomogammalinolenic acid (DGLA), arachidonic acid (AA) and 
eicosapentanoic acid (EPA) in red ce ll  phospholipids o f two groups 
o f horses during a study o f the prophylaxis o f EFAs in 
dermatophilosis. Twelve animals received no treatment and 11 
received 20g n-3 and n-6 EFAs d a i ly
LA
Week 0 8 16 24
Control 9.09 10.17 6.61 6.29
(2.16) (1.89) (2.06) (4.45)
EFAs 10.06 10.45 6.19 5.54
(1.20) (2.17) (1.49) (1.27)
DGLA
Week 0 8 16 24
Control 0.01 0 0 0.01
(0) (0) (0) (0.03)
EFAs 0 0 0 0
(0) (0) (0) (0)
AA
Week 0 8 16 24
Control 0.62 0.64 0.63 0.52
(0.25) (0.25) (0.27) (0.33)
EFAs 0.62 0.44 0.82 0.67
(0.26) (0.41) (0.12) (0.14)
EPA
Week 0 8 16 24
Control 0.09 0.02 0.02 0.03
(0.11) (0.06) (0.06) (0.06)
EFAs 0.14 0 0.02 0
(0.01) (0) 0.05 (0)
Values are given as % o f to ta l EFAs 
Values in brackets are standard deviations
132
Table 16. Mean values at weeks 0, 8, 16 and 24 fo r  l in o le ic  acid
(LA), dihomogammalinolenic acid (DGLA), arachidonic acid (AA) and 
eicosapentanoic acid (EPA) in plasma phospholipids o f two groups 
o f horses during a study o f prophylaxis o f  EFAs in 
dermatophilosis. Twelve animals received no treatment and 11 
received 20g n-3 and n-6 EFAs d a i ly
LA
Week 0 8 16 24
Control 47.79 47.55 45.71 46.42
(4.93) (4.71) (2.86) (4.30)
EFAs 49.45 49.20 44.71 47.64
(3.39) (2.37) (3.48) (4.64)
DGLA
Week 0 8 16 24
Control 0.56 0.82 0.87 0.67
(0.14) (0.10) (0.10) (0.06)
EFAs 0.55 0.64 0.78 0.55
(0.08) (0.06) (0.07) (0.10)
AA
Week 0 8 16 24
Control 1.61 1.89 1.95 1.88
(0.30) (0.32) (0.29) (0.30)
EFAs 1.81 2.04 1.93 1.72
(0.31) (0.37) (0.36) (0.32)
EPA
Week 0 8 16 24
Control 0.49 0.60 0.60 0.52
(0.19) (0.13) (0.31) (0.16)
EFAs 0.56 0.60 0.55 0.56
(0.15) (0.17) (0.21) (0.15)
Values are given as % o f to ta l EFAs 
Values in brackets are standard deviations
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contro lled  study. EFAs were administered over a time period when 
the r is k  o f dermatophilosis in fec tion  was highest, p r io r  to the 
wet autumn months in the West o f Scotland. As in the previous 
studies, no s ig n if ic a n t improvement in the condition o f the 
ha ircoat, mane, t a i l  or hooves was recorded fo r  horses which 
received n-3 and n-6 EFAs as compared to untreated contro ls. 
Changes in haematological or biochemical parameters were 
a tt r ib u te d  to factors such as n u tr i t io n  rather than to EFA 
treatment. EFAs were not harmful to these parameters.
EFA values in c ircu la to ry  frac tions o f animals which received EFA 
supplementation did not increase s ig n if ic a n t ly  more during the 
study than those values fo r  animals which received no treatment. 
S ta t is t ic a l ly  s ig n if ic a n t differences were recorded over time and 
between groups fo r  EFAs in red ce ll phospholipids and in plasma 
phospholipids. Examination o f these differences, however, revealed 
no spe c if ic  trends fo r  EFA values between treated and control 
groups.
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SECTION 2. THE CHARACTERISTICS OF DERMATOPHILUS CONGOLENSIS IN 
RELATION TO SITE AND SEVERITY OF LESIONS, LEADING TO INVESTIGATION
OF AN EXTRACELLULAR PROTEASE
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Introduction
The l i fe c y c le  o f Dermatophilus congolensis begins when a motile 
zoospore which germinates, se tt les , loses m o t i l i t y ,  then swells to 
form several germ tubes which in turn elongate to form hyphae 
(Roberts, 1961). As elongation progresses, transverse d iv is ions 
are established in the oldest part of the hyphae, and there is  
branching growth. Consequently, areas are divided by new septae, 
then hyphae d iv ide in to cubic arrangements of cocci, often eight 
cocci wide, by development of longitudinal septae in ve r t ica l and 
horizontal d irec tions . The cocci are thought to move o f f  from the 
hyphae to form new hyphae or zoospores.
Scanning electron microscopy (SEM) studies of individual colonies 
o f D. congolensis isolated from d i f fe re n t animal species revealed 
tha t more than one form of the organism could be present in any 
one colony a f te r  48h culture (Abu-Samra, 1977). Germinating 
zoospores were developed w ith in certa in hyphae and were 
subsequently released, w h ils t coccoid forms were produced by 
budding action from a d i f fe re n t type o f hyphae. Variation in 
temperature, n u t r i t io n  or a i r  supply did not influence germination 
o f coccoid forms, contrary to e a r l ie r  be lie fs . No evidence was 
found that the coccoid form i t s e l f  could germinate.
L i t t l e  is curren tly  known regarding the characte ris tics  o f D. 
congolensis which are relevant to the production and severity of 
skin lesion in the horse or in other species. A close re la tionship  
was found to ex is t fo r  example amongst equine and bovine isolates 
with regard to culture characte ris t ics , morphology and 
fermentation reactions; but experimental lesions induced in 
rabbits were found to d i f fe r  (Stableforth, 1937). Dermatophilus 
lesions in the horse have been considered merely to be o f acute or 
chronic type and of varying severity (Scarnell, 1961).
Serological c la ss if ica t io n ,  a n t ib io t ic  p ro f i le  and biochemical 
typing of bovine isolates has proven d i f f i c u l t  or impractical 
(El-Nageh, 1971). Biochemical characters o f bovine and donkey 
stra ins and th e ir  a n t ib io t ic  s e n s it iv i t ie s  showed l i t t l e  or no 
var ia tion  (El-Nageh, 1971; Lloyd and Ojo, 1975); and between
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f i f t y - t h r e e  s tra ins , isolated from lesions in c a t t le ,  sheep, goats 
and horses, only t r i v i a l  varia tions were discovered, and these 
were confined to fermentation tests (Abu-Samra, 1977). In another 
study, v a r ia b i l i t y  existed in colonial morphology, and w ith in  a 
s tra in  varia tions were evident which were independent o f the 
o r ig ina l host (Gordon, 1964). Antigenic re la tionsh ip  has been 
proven in bovine stra ins by d ire c t tube agglutination and by 
fluorescent antibody tes t (El-Nageh, 1971) and clear antigenic 
differences were recorded between stra ins in fec ting  the domestic 
donkey: f iv e  d i f fe re n t  serological groups were id e n t i f ie d  (Lloyd
and Ojo, 1975). The most obvious varia tions between D. congolensis 
s tra ins  have been claimed to occur in pigmentation of colonies and 
in p ro te o ly t ic  a b i l i t y ,  but these differences could not be 
correlated with host species and were sometimes noted among 
variants o f a given iso la te  (Gordon, 1964).
The subtyping o f stra ins using molecular techniques such as 
investiga tion  o f protein p ro f i les  by sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE) has not, as fa r  as 
can be determined, been attempted fo r  D. congolensis. I t  was 
thought tha t such techniques might allow discrim ination between 
s tra ins  isolated from separate lesions on the same or d if fe re n t  
animals. By application of these methods, corre la tion was thought 
possible between subgroups of D. congolensis with size, type, 
severity , d is t r ib u t io n  and persistence of lesions in the horse.
The bacteria l characteris tics of D. congolensis re la t ing  to 
virulence are not currently  understood, and the factors underlying 
severity  of in fec tion  in certain regions are p a r t ic u la r ly  obscure 
(Davis, 1984).
S im ila r ly ,  the properties of D. congolensis responsible fo r  
invasion o f the epidermis are not known. Penetration o f the 
stratum corneum and epidermal invasion by the organism induces an 
acute inflammatory response, considered by some to be nonspecific 
(Roberts, 1965), with neutrophil accumulation, accelerated 
kera tin isa tion  and epidermal p ro l i fe ra t io n  immediately below the 
inflamed region. Dermatophilus is not considered l ik e ly  to 
penetrate the ba rr ie r formed by neutrophils but, in the early
137
stages o f in fec tion  the newly formed epidermis is  colonised by 
extension from adjacent infected s ites . Repetition o f the process 
resu lts  in the formation of a laminated scab composed of 
a lte rna te  layers of infected epidermis and c e l lu la r  exudate 
(Roberts, 1965; Oduye, 1976). Invasion stops and healing commences 
over a varying time span, which is dependent on previous exposure 
to Dermatophilus (Roberts, 1966). I t  has been hypothesised that 
D. congolensis can be eliminated from normal skin but i f  the 
e lim ination processes are inh ib ited , then the lesion becomes 
chronic (Davis and Ph ilpo tt,  1980). Elimination of D. congolensis 
from skin may, fo r  example, be inh ib ited  at the s ite  of a delayed 
type hypersens it iv ity  reaction, induced by hapten e ithe r 
introduced in arthropod saliva at the s ite  of an insect or t ic k  
b ite  or by experimental application of contact sensitiz ing agents. 
Moisture and skin in ju r ie s  have been proposed to predispose to 
dermatophilosis (Roberts, 1967a), but the severe, generalised 
f ie ld  condition has not been produced experimentally, even by 
introducing large inocula and causing simultaneous mechanical skin 
damage. This is  thought by some authors to indicate the secondary 
importance of transmission and inoculation factors (Lloyd, 1984), 
and to h igh ligh t the importance of factors that reduce skin 
resistance or augment in fec t ive  challenge in pathogenesis o f the 
disease (Davis, 1984).
Few microorganisms are able to penetrate the in tac t epidermal 
b a rr ie r .  The virulence of those that are capable of invading the 
skin, the dermatophyte fungi, is influenced by the production of 
p ro te o ly t ic  enzymes, keratinase, collagenase and elastase 
(B iberste in, 1990). Most D. congolensis isolates from c a t t le  were 
found to be strongly p ro teo ly t ic  in v i t r o , with p ro teo ly t ic  
properties varying between stra ins (Gordon, 1964). Intense 
necrosis of the skin, induced when rabbits were experimentally
infected with D. congolensis (Makinde, 1979), suggested the
presence of a responsible factor contained in t ra c e l lu la r ly  and/or 
w ith in  crude whole ce ll fractions of the organism. The presence of 
such a fac to r, i f  i t  ex ists , would contest previous b e l ie f  that D. 
congolensis produces no toxin (Roberts, 1967a), and that the
inflammatory response was a consequence of products o f c e l lu la r  
damage d if fus ing  from the infected epidermis (Roberts, 1967a).
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The production o f such a fac to r, tox in or enzyme would be o f great 
importance to the understanding o f pathogenesis o f the disease. 
P u r i f ica t io n  o f the various antigenic components o f D. congolensis 
was described as the method most l i k e ly  to extend knowledge o f 
immune responses to the crude D. congolensis antigens and would 
contribute to the understanding of the pathogenesis and control o f 
the disease in horses and in other species. I t  might also 
h ig h lig h t the most appropriate d irec tion  fo r  diagnostic serology 
fo r  herds and fo r  vaccination (Makinde and Wilkie, 1979). Failure 
to demonstrate such a fac to r would be an equally s ig n if ica n t 
f ind ing , as i t  would suggest that the disease is  seen as a resu lt 
o f host reaction, such as hypersensit iv ity  or inflammation, to the 
presence of the bacterium i t s e l f .
In the present study, D. congolensis lesions in the horse were 
examined c l in ic a l l y  and bac te r io log ica lly . The characteris tics o f 
the lesions were recorded, together with bacterio logical 
characters o f the s tra in  isolated. Bacteria were examined using 
SDS-PAGE. The resu lts  of c l in ic a l  examination were correlated with 
the analy tica l data in an e f fo r t  to determine whether d if fe re n t 
s tra ins  were responsible fo r  d if fe re n t types of lesion.
In addition to d i f fe re n t ia t io n  o f D. congolensis iso la tes, the 
other aim o f the study was to examine D. congolensis fo r  
production o f keratinase and other protease a c t iv i ty  which may be 
involved in the determination o f virulence of the organism.
Materials and Methods
Iso la t ion  and Growth o f Bacteria 
Scab material from c l in ic a l  lesions o f D. congolensis was soaked 
in physiological saline overnight at 4°C and inoculated on to 
se lective medium, composed of blood agar base No.2 (Oxoid) with 7% 
horse blood and 1,000 IU/ml polymixin B sulphate added, according 
to the method of Abu-Samra (1977), and incubated aerobically fo r 
48h at 37°C. Individual colonies of isolates were subcultured from 
selective agar onto 5% sheep blood agar and incubated aerobically
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fo r  48h at 37°C. Isolates were preserved by freeze-drying, by 
inoculation onto Dorset Egg slopes, and by weekly subculture on 
sheep blood agar. Confirmation of the organism's presence was by 
examination o f smears of soaked scab or paintbrush lesions stained 
by Giemsa. Subcultured colonies were suspended in saline and 
stained by the method of Gram fo r examination.
Preparation o f Culture Supernatant
A single colony o f D. congolensis was inoculated from sheep blood 
agar in to  5 ml Brain Heart Infusion (BHI) broth (Oxoid) in a 
cu ltu re  tube. Broths were slope incubated aerob ica lly  at 37°C in a 
Gallenkamp O rb ita l Incubator at 150 r.p.m. fo r  48h, centrifuged in 
a microfuge (3 x 10 sec spins) at high speed, ro ta ting  between 
spins to ensure complete p e l le t isa t io n ,  and supernatant drawn o f f .
Determination and corre la tion o f c l in ic a l  and bacteriological 
cha rac te r is t ics  o f D. congolensis iso lates obtained from f ie ld  
material
Scab and paintbrush lesion material was collected from f ie ld  cases 
o f D. congolensis  in fec t ion . Where lesions were swabbed, material 
was collected in Ames Transport medium. D. congolensis organisms 
were isolated as described above. A c l in ic a l  index was assigned 
to each infected animal on a 0 to 10 scale, detailed in the 
general Materials and Methods section. The index described the 
severity  o f the dermatophilosis lesions. A score o f 0 indicated 
the absence of in fection and a score o f 10 indicated the most 
severe in fe c t io n . Bacteriological characte r is t ics  of growth of 
iso lates on polymixin B sulphate selective medium, sheep blood 
(5%) agar, horse blood (5%) agar, chocolate agar and in BHI broth, 
including presence of haemolysis and p i t t in g  o f agar by colonies, 
were recorded a f te r  standard incubation fo r  48h at 37°C.
Enzyme Assays Using Protein Substrates
Keratinase
Keratin degradation was assayed i n i t i a l l y  by the method of Das and 
Banerjee (1982). The reaction mixture contained 0.056 M phosphate 
bu ffe r, pH 7.2, 2 .6 m l;  ha ir fragments, 10 mg; and culture
f i l t r a t e ,  0.4 ml. I t  was incubated at 37°C fo r  lh and the reaction 
terminated by the addition of 3 ml o f 0.612 M tr ich lo roa ce t ic  acid
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(TCA) and immediate c h i l l in g  to 0°C fo r  30 mins. The solution was 
then f i l t e r e d  using Whatman f i l t e r  paper (size 3, 9 cm). The
optica l density o f the c lear f i l t r a t e  was measured at 280 nm, 
against water as the co lo rim etr ic  blank, on a Beckman DU-64 
spectrophotometer. For the reaction blank, TCA was added before 
the enzyme source. The assay was run in duplicate, and each 
absorbance measurement was the average o f three readings.
Keratin degradation was then assayed by an a lte rna tive  method 
(Apodaca and McKerrow, 1990) using keratin azure (Sigma), a dyed 
wool product, as substrate. 900 /il pu r if ied  culture supernatant 
[prepared by polyethylene glycol (PEG) (20,000 Carbowax) 
concentration followed by ion exchange chromatography as described 
below] were incubated with 5 mg o f keratin azure in 100 /il o f 1 M 
glycine-NaOH, pH 7.0, 10 mM CaCl2 buffer fo r  48 h at 37°C. Final 
reaction volume was 1 ml. A duplicate set of samples were 
prepared, with 5 mM mercaptoethanol added as a reducing agent. 
Following incubation the reaction was spun in a microfuge fo r  5 
minutes. The degradation of keratin azure by enzyme present in 
cu ltu re  supernatant was measured by determining, by 
spectrophotometer, the change in A595 of the supernatant pre- and 
post-incubation. Results were compared to controls, containing 
uninoculated broth.
Collagenase, Elastase, Gelatinase and Caseinase 
Assays were performed by the method of Conlan, Baskerville and 
Ashworth (1986). Collagenase and elastase a c t iv i t ie s  were assayed 
by incubation at 37°C of 100 /i 1 tes t solution with 20 mg o f the 
appropriate dye-impregnated substrate in 5 ml 0.05 M-phosphate 
bu ffer pH 7.0. Azocoll (Sigma) was used as substrate fo r  
collagenase and Elastin-Congo Red (Sigma) was used fo r  elastase 
a c t iv i t y .  Gelatinase a c t iv i ty  was detected using ge la tin  
incorporated in to agar [0.25% (w/v) ge latin  (D ifco), 1.0% (w/v)
agar, 0.001% NaN3 in 0.2 M-Tris/HCl pH 7.2]. Molten gelatin-agar 
was poured in to 12 cm Petri dishes, tes t materials (50 /xl volumes) 
were placed in wells (7 mm diameter) cut in the s o l id i f ie d  medium 
and the dishes were incubated fo r  16 h at 37°C. The gels were then 
treated with a solution of 15% (w/v) HgCl2 in 2 M-HC1, causing the 
gelatin-agar to become milky white except fo r  clear zones where
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proteo lys is  had occurred. Caseinate-precipitating a c t iv i ty  
(caseinase) was measured by a s im ila r  method using a medium 
containing 1.0% sodium caseinate (D ifco), 1.0% agar and 0.001% 
NaN3 in 50 mM-phosphate buffer pH 6.2. 40 p 1 o f culture
supernatant was inoculated in to each tes t w e ll.  A fte r incubation 
caseinase a c t iv i t y ,  evident as a zone o f p rec ip ita te  around 
pos it ive  wells without any treatment o f the medium, was quantif ied 
by measuring the p rec ip ita t ion  zone area in mm2.
S ta b i l i t y  o f Protease to Heat and Cold 
A liquots o f 0. congolensis broth culture supernatants, 0.5ml 
volume, were held at 56°C in a waterbath, at 100°C in a steamer, 
and at 0°C on ice fo r  15 mins. 0.5ml aliquots of broth culture 
supernatants were stored at 4°C fo r  one month and at -20°C fo r  3 
months.
Neutra lisation o f Protease A c t iv i ty  
Broth cu ltu re  supernatants from 0. congolensis isolates were 
incubated with one tenth volume of tes t serum (180 /xl supernatant 
and 20 /xl serum) and held on ice at 0°C fo r  lh . Test sera were 
obtained from a c a l f  showing very severe, generalised 
dermatophilosis of dermatophilosis index (DI) of 10; and from two 
Dermatophilus infected horses, DI of 4. Sera were d ilu ted by 
two-fo ld seria l d i lu t io n  to 1:256. Caseinase a c t iv i ty  was examined 
immediately a fte r  incubation and compared to control neonatal c a l f  
serum.
The IgG frac tion  of serum from Dermatophilus infected animals was 
separated by the method of Harlow and Lane (1988). One volume of 
serum was d ilu ted  in 2 volumes 0.06M sodium acetate buffer, pH
4.0, and mixed vigorously. 7.5ml N-octanoic acid (BDH 41021) were 
added per 100ml serum volume slowly and le f t  to mix fo r  30 mins at 
room temperature, then f i l te re d  through grade 4 f i l t e r  paper and 
dialysed overnight against 0.154M NaCl.
Sodium dodecyl sulphate (SDS) polyacrylamide gel 
electrophoresis (PAGE)
Preparation of Samples 
One ml aliquots of broth culture were centrifuged to provide
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pe lle ts .  Ten mg lysozyme were mixed with 1 ml 100 mM Tris-HCl 
bu ffe r, pH 8.0, and a 1:10 d i lu t io n  made. 2.5 /xl o f th is  solution 
was mixed with p e l le t  resuspended in 100 /j1 100 mM Tris-HCl
bu ffe r, pH 8.0, and incubated at room temperature fo r  15 mins. One 
h a lf  volume sample bu ffer was added and the mixture was heated to 
100°C fo r  15 mins p r io r  to examination by SDS-PAGE.
SDS-PAGE
SDS-Page was performed using the BRL V16 Vertica l Gel
Electrophoresis Apparatus fo r  discontinuous buffer system, by the 
method of Rycroft and Taylor (1987). The separating gel consisted 
o f 12.5% (w/v) acrylamide (acrylamide/bisacrylamide ra t io ,  75:1) 
in 0.37 M Tris  hydrochloride (pH 8.7), 0.1% w/v SDS. The stacking 
gel consisted o f 5% w/v acrylamide (acrylamide/bisacrylamide
ra t io ,  36:1) in 125 mM Tris  hydrochloride (pH 6.9), 0.1% SDS.
Supernatant was added to one ha lf  volume sample bu ffer, which was 
60 mM Tris hydrochloride, 10% v/v g lycerol, 2% w/v SDS, 5% v/v 
mercaptoethanol and electrophoresed at 25 mA fo r  approx. 200 mins 
in 25 mM Tris-192 mM glycine (pH 8.3). 35 /il samples o f culture
supernatant were loaded per well.
Proteins were visualised by f ix in g  and stain ing with 0.25% w/v
Coomassie B r i l l i a n t  Blue stain (Sigma) in 50% water-40% methanol- 
10% acetic acid overnight at 37°C followed by destaining in the
same solvent fo r  24h at 37°C, or overnight, agitated, at 4°C.
Molecular Weight Markers 
High molecular weight markers (Sigma) were dissolved in 192 mM
Tris  Glycine bu ffe r, pH 8.3, according to the manufacturer's 
ins truc tions . One ul lysozyme (5 mg/ml) and 4 /il tryps in  in h ib i to r  
(5 mg/ml) were added to 5 /xl markers to increase the range o f the 
markers. The marker mixture was then dissolved in sample buffer to 
30 ji l volume.
SDS-Gelatin PAGE
Preparation o f Samples 
One ml aliquots o f D.congolensis broth cu ltu re f lu id  were 
centrifuged to provide pe lle ts , which were subjected to 3
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freeze-thaw cycles at -70°C, and mixed with 100 /il sample buffer 
[1.8 ml 1 M Tris-HCl buffer pH 6.8; 3 ml 20% SDS; 3 ml g lycero l;
1.5 ml mercaptoethanol; 0.001% BP; 0.7 ml water]. Culture
supernatants were mixed with h a lf  volume (200 /il supernatant: 100
/xl sample buffer) sample buffer.
SDS-PAGE
For separation and analysis of gelatinase a c t iv i ty  two systems 
were used, the BioRad Minigel Electrophoresis Apparatus and BRL
V16 Vertica l Gel Electrophoresis Apparatus fo r  discontinuous 
bu ffe r system.
Minigel Apparatus 
Electrophoresis when using the Minigel apparatus was performed by 
the method o f Hames (1981). Stacking gel consisted o f 2.5% (w/v) 
acrylamide, (acrylamide-bisacrylamide ra t io ,  30:0.8) in 0.5 M 
Tris-HCl buffer, pH 6.8, 5 ml stacking gel buffer stock; 0.2 ml
10% SDS; 1 ml 1.5% ammonium persulphate; 11.3 ml d is t i l le d  water; 
0.015 ml TEMED. Separating gel consisted of 7.5% (w/v) acrylamide, 
(acrylamide-bisacrylamide ra t io ,  30:0.8) in 3 M Tris-HCl buffer, 
pH 8.8, 3.75 ml resolving gel buffer stock; 0.3 ml 10% SDS; 1.5
ml 1.5% ammonium persulphate; 13.95 ml d is t i l le d  water; 3 ml 2% 
ge la t in  solution and 0.015 ml TEMED. Culture supernatant was added 
to one h a lf  volume sample buffer and electrophoresis was performed 
at 150 V fo r  45 mins in 0.25 M Tr is , 1.92 M glycine buffer, pH
8.3, with 1% SDS added.
V16 Vertical Gel Electrophoresis Apparatus 
When using BRL V16 apparatus SDS-PAGE was performed as described
above with modification in the form of 10% separating gel with
incorporation of 2% ge la tin .
A fte r  SDS-gelatin PAGE, gels were washed in 2.5% Triton X-100
solu tion in 0.1M Tris-HCl buffer, pH 7.0, fo r  lh at 37°C in a
waterbath, then incubated fo r  lh at 37°C in 0.1M sodium acetate 
bu ffe r, pH 6.0. Proteins were visualised by stain ing as previously 
described.
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SDS-PAGE Analysis o f Caseinase A c t iv i ty  
Culture supernatant o f D. congolensis iso la te , Del, was 
concentrated, by d ia lys is  against polyethylene glycol (PEG) 
(20,000 Carbowax) fo r  6h at 4°C, and pu r if ied  by DEAE-Sepharose 
ion exchange chromatography (detailed below). Eluted 
caseinase-active frac tions were separated by SDS-gelatin PAGE and 
compared to unconcentrated samples o f cu lture supernatant o f the 
same iso la te . Samples were not heated p r io r  to SDS-PAGE. The 
resu ltan t gel was washed in 0.1M phosphate buffer, pH 6.0, fo r  30 
mins, agitated, and overlaid with 100ml o f tes t caseinate agar and 
incubated overnight at 37°C.
Western or Immunoblotting 
Immunoblotting was carried out by the method o f Rycroft and Taylor 
(1987). Gels were washed in 25 mM T ris , 192 mM glycine, pH 8.3, 
fo r  20 mins at room temperature. Proteins were transferred to 
n itroce llu lo se  membrane in a Trans Blot apparatus (Bio-Rad) in 25 
mM T r is ,  192 mM glycine overnight at 0.15A, 22V at 4°C. Membrane 
was then agitated gently in 10% skimmed milk powder and 0.02%
sodium azide in TNT buffer: lOmM Tris-HCl; 0.15M NaCl; 0.05% Tween
20, pH 8.0, fo r  lh at 4°C. Washing ( 3 x 5  mins) in TNT buffer was
carried out before detection of antigen by incubation with 1:200
d i lu t io n  of serum from a Dermatophilus infected c a l f  in TNT buffer 
with 5% skimmed milk powder overnight at 4°C. The membrane was 
then washed ( 3 x 5  mins in TNT buffer) before antigen was detected 
by enzyme linked immunosorbent assay (ELISA) involving incubation 
fo r  lh at 4°C with 1:2000 solution of rabbit anti-bovine IgG 
horseradish peroxidase conjugate (HRP), (Sigma), in TNT buffer 
with 5% skimmed milk powder added. Washing (5 mins in TNT buffer, 
then 2 x 5  mins in TNT buffer without Tween 20) preceded 
lo ca liza t io n  and v isua liza tion  of bound conjugate using 0.05% w/v 
4 -ch lo ro -l-naphtho l, 4.4 mM H2O2 in 16% methanol, 10 mM Tris
hydrochloride (pH 8.0), 150 mM NaCl.
The procedure was repeated using a 1:100 d i lu t io n  of serum from a 
Dermatophilus infected horse and detection of antigen was by a 
1:100 solution of rabbit anti-horse IgG horseradish peroxidase 
(Sigma). The gel was blotted at 100V fo r 90 mins at 4°C.
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Protease In h ib i t io n  Experiments 
The fo llow ing in h ib ito rs  were used at concentrations given below.
Antipain (Sigma); stock solution 10 mM in water; e ffec t ive  
concentration 100 /zM.
Bestatin (Sigma); stock solution 1 mM in methanol; e ffec t ive  
concentration 10 /zM.
Chymostatin (Sigma); stock solution 10 mM in dimethyl sulphoxide 
(DMSO); e ffe c t ive  concentration 100 /zM.
3,4-dichloroisocoumarin (3,4-DCI), (Sigma); stock solution 10 mM 
in DMSO; e ffec t ive  concentration 100 /zM.
Ethylenediaminetetraacetic acid (EDTA); stock solution 0.5 M in 
water, e ffec t ive  concentration 10 mM solution made up in 0.1 M 
phosphate buffer, pH 7.0.
Iodoacetic Acid (IAA) (Sigma); Stock solution 10 mM in water; 
e f fe c t ive  concentration 100 uM in 0.1 M phosphate buffer, pH 7.0.
Leupeptin (Sigma); Stock solution 10 mM in water; e ffec t ive  
concentration 100 /zM in 0.1 M phosphate buffer, pH 7.0.
Pepstatin A (Sigma); stock solution 1 mM in methanol; e f fec t ive  
concentration 1 ^M solution made up in 0.1 M phosphate buffer, pH
7.0.
1,10-Phenanthroline (Sigma); stock solution 200 mM in methanol; 
e f fe c t ive  concentration 10 mM.
Phenylmethanesulphony1 f luo ride  (PMSF), (Sigma); stock solution 
200 mM in methanol; e ffec tive  concentration 1 mM.
Tosyl lysy l chloromethyl ketone (TLCK), (Sigma); stock solution 10 
mM in 1 mM HC1, pH 3.0. Effective concentration 100 /zM.
Tosyl phenylalany1 chloromethyl ketone (TPCK), (Sigma); stock
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solu tion 10 mM in methanol, e ffe c t ive  concentration 100 nM.
Control was equivalent volume of the respective solvent, e.g. 
water, methanol or DMSO, without in h ib i to r  added. Stock solutions 
were made up according to the method o f Beynon and Salvesen 
(1989).
SDS-gelatin PAGE was rou tine ly  performed using the Minigel 
apparatus. A pooled sample of D. congolensis iso la te  culture
pe lle ts  was examined. The gel was washed in 2.5% Triton X-100
solu tion in 0.1 M T r is -g lyc ine  buffer, pH 7.0, fo r  lh , then cut 
in to  f iv e  identica l sections, each incubated with a specific  
protease in h ib i to r  fo r  4h in a waterbath at 37°C alongside a 
con tro l, containing no in h ib i to r .  Gel sections were stained and 
destained as previously described. Gel sections treated with 
in h ib i to rs  were compared to the untreated contro l. Positive 
in h ib i t io n  was indicated by loss o f the negative ly-sta in ing band
o f gelatinase a c t iv i ty  as compared to the untreated contro l. 
D i th io th re ito l  (DTT), a reducing agent which activates cysteine 
proteases, was added to in h ib ito rs  at ImM concentration in one
experiment.
In h ib ito rs  above were added to culture supernatants o f D. 
congolensis at working concentrations according to 
Beynon and Salvesen (1989). Duplicate experiments were performed, 
one where the supernatant-inh ib itor solution was loaded in to  wells 
in caseinase tes t agar incubated to 37°C, and a second where the 
agar was at room temperature. 40 /il of sample were loaded in to 
each w ell. Controls contained equivalent volume o f appropriate 
in h ib i to r  solvent, with no in h ib i to r  present.
Molecular Exclusion Chromatography 
D. congolensis culture f lu id  was centrifuged at 12,000 rpm fo r  20 
mins using a JA 20 ro tor, and supernatant f i l te r e d  (0.45 fim 
f i l t e r ,  Sartorius). Approx. 75 ml culture f i l t r a t e  was transferred 
in to  visking tubing and dialysed against PEG. A Sephacryl S300 
column (16mm internal diameter, 40 cm long) was poured and 
equil ib ra ted with T r is :NaCl: EDTA buffer, (10:150:0.1), pH 7.2. One 
ml concentrated supernatant was loaded onto the column and eluted
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with the same bu ffe r, and one ml frac tions were collected.
Ion Exchange Chromatography 
A DEAE-Sepharose CL6B (Pharmacia) column (16mm interna l diameter, 
20cm long) was poured and equil ib ra ted with Tris-EDTA buffer 
(lOmMilmM), pH 7.2. The sample was loaded on to the column in 
Tris-EDTA buffer and was eluted with 40 ml o f a 0 to 500 mM NaCl 
l in e a r  gradient using a BRL Gradient Former GA 1080.
Results and Discussion
Iso la t ion  o f Bacteria 
D. congolensis iso lates were id e n t i f ie d  on selective polymixin B 
sulphate medium a fte r  48h aerobic incubation at 37°C as 
beta-haemolytic, approximately 2 mm diameter, grey-white to 
yellowish colonies which often embedded deeply in to the agar. 
Colonial morphology varied between iso lates, as described by other 
authors (Gordon, 1964; El-Nageh, 1971; Lloyd and Ojo, 1975; 
Abu-Samra, 1977). The appearance of successive colonies altered. 
A fte r repeated subculture on solid  medium the colonies became 
smoother and smoother, confirming previous work (Gordon, 1964). 
Diverse forms of the organism had also been reported on d if fe re n t 
media, under varying conditions, and from one time to another, and 
even on the same agar plate (Gordon, 1964). Growth was evident 
a f te r  inoculation from selective medium on to sheep blood agar as 
beta-haemolytic grey-fawn coloured colonies approx. 2mm diameter, 
a f te r  48h aerobic incubation at 37°C. In contrast to resu lts  of 
Abu-Samra (1977), greater expression of haemolysis was seen on 
sheep blood agar than on horse blood agar, so th is  medium was 
adopted fo r  subcultures.
Optimisation of Growth Conditions 
Optimal l iq u id  medium fo r growth; optimal incubation type, s ta t ic  
or o rb it in g ,  which provided aeration; and optimal length of 
incubation were sought fo r  D. congolensis iso la tes. The isolates 
examined in th is  area part of the study and th e ir  sources are
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described in Table 15. Isolates examined were iso la te  2, which 
orig inated from a swab o f a dorsal les ion; iso la te  15, which 
orig inated from a dorsal scab lesion; and iso la te  Dur, recovered 
from a paintbrush lesion o f the lower hindlimbs. Three months 
a f te r  iso la te  15 was found, iso la te  Dur was id e n t i f ie d  from a 
lesion at a d i f fe re n t  s i te  on the same horse.
Growth characters of isolates were recorded in broths o f varying 
n u t r i t io n ,  which in general order of increasing n u tr i t io n a l value 
were L-broth (SOB); Nutrient Broth (MIB); Tryptone Soya Broth 
(TSB); Blood Agar Broth (BAB) and Brain Heart Infusion (BHI) 
Broth. Characters were recorded at d i f fe re n t stages in the growth 
cycle, at 3.5h, 20h and 44h.
No v is ib le  growth, tu rb id i ty  of the broth or enlargement o f 
inoculated colonies, were found fo r  any iso la te  a fte r  3.5 h s ta t ic  
or o rb it in g  incubation in any medium. Growth was evident a fte r  20 
h fo r  iso la te  15 but was sparse fo r  iso la te  Dur and iso la te  2. 
Most profuse growth was seen fo r  each iso la te  a f te r  44h, and 
growth was not affected by aeration.
The type o f medium affected growth of iso lates. Poor growth fo r  
a l l  iso lates on nu tr ien t broth, was discovered in contrast to 
f ind ings o f Abu-Samra (1977), but confirmed those o f Roberts 
(1961). The la t te r  author believed that in n u t r i t io n a l ly  poor 
medium zoospores did not germinate or that mycelia fa i le d  to 
complete the lengthy, complex growth cycle, and died before new 
zoospores were produced. No growth of any iso la te  was seen on TSB 
at 20 h, and colonies which grew by 44 h were hard and leathery, 
as found by Abu-Samra (1977). Growth was more p r o l i f i c  in SOB and 
BAB, and was optimal in BHI broth. Isolate 15 grew more profusely 
than other iso la tes, while growth of iso la te  2 was sparse, and 
adherent to the inoculated colony.
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D ifferentia l Characteristics of D. congolensis Isolates 
Obtained From Field Material
In fec t ive  material was collected from f ie ld  cases of D. 
congolensis in fe c tion . The severity o f in fec tion  varied from 
animal to animal, and several cases were sampled from d if fe re n t  
s ites  on the body. Correlation of bacterio logical and c l in ic a l  
cha rac te ris t ics  o f isolates with s ite  and pathogenicity o f lesions 
was attempted; a bovine iso la te  was compared to 14 equine 
iso la tes. Relationships between protein p ro f i le s  o f iso la tes, 
obtained by SDS-PAGE, were sought.
The presence of D. congolensis isolates in in fec t ive  material was 
confirmed by f ix in g  smears of saline-soaked scab or paintbrush 
material and sta in ing by Giemsa. Characteristic "ra ilroad  tracks" 
were seen in posit ive  smears, budding hyphal forms and packets of 
Gram-positive cocci, often 4 to 6 wide, d iv id ing  transversely and 
lo n g itu d in a l ly .  Subcultured colonies were confirmed positive  by
the presence o f budding hyphae and transversely- and 
lo n g itu d in a l ly -d iv id in g  groups of cocci, visualised by Gram stain. 
Correlation between c l in ic a l  dermatophilosis indices and 
d i f fe re n t ia l  bacterio logical growth characters of isolates was 
attempted. I t  was seen from the results presented in Table 15 that 
no two f ie ld  isolates showed identica l bacterio logical
cha rac te r is t ics , although c l in ic a l  lesions were s im ila r .
D if fe re n t ia l  bacteria l growth characters of isolates were not 
species-specific. C lin ica l severity of in fection could not be
correlated with bacterio logical growth characte ris t ics .
Protein p ro f i le s  of D. congolensis whole so lubilised bacteria by 
SDS-PAGE were found to be very diverse, Figure 15. Although 
re la tionsh ips could be detected between iso lates, d e f in i te  
corre la tions could not be made.
Search fo r  Protease A c t iv i ty  in D. congolensis Isolates 
D. congolensis stra ins examined by Gordon (1964) were found to be 
strongly p ro teo ly t ic  in v i t r o , and p ro teo ly t ic  properties varied 
among stra ins and could not be correlated with host species. In 
th is  study protease a c t iv i ty ,  in the forms of keratinase, 
collagenase, elastase, caseinase and gelatinase, was sought.
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Figure 15. Whole ce ll protein p ro fi les  of D. congolensis by 
SDS-PAGE. From l e f t  to r ig h t ,  isolates 1, 8, 24, 29, 30, 34,
110058 (bovine is o la te ) ,  110578, SI and S2 (molecular weight 
standards)
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Culture supernatants o f iso lates Dur and Dc2 were examined fo r  
a b i l i t y  to degrade keratin , using ha ir fragments as substrate. 
Keratinase a c t iv i t y  was measured by recording absorbance at 280 nm 
before and a f te r  incubation of cu lture supernatant with ha ir. 
Background absorbance at 280 nm, which was i n i t i a l l y  too high to 
allow in te rp re ta t ion  o f resu lts , orig inated from 280 nm absorbing 
components in the BHI broth.
In an attempt to reduce th is  background absorbance, isolates were 
inoculated onto synthetic medium, M9, with casamino acids 
incorporated, but fa i le d  to grow. Cell free culture supernatants 
o f iso la tes were then concentrated by d ia lys is  against PEG, and by 
Lyphogel (Gelman), (polyacrylamide beads used to concentrate high 
molecular weight components o f solutions) to remove low molecular 
weight 280 nm absorbing materia l. Supernatants were then 
fractionated by Sephadex chromatography. Eluted frac tions were 
examined fo r  caseinase a c t iv i ty  and caseinase-positive fractions 
were assayed fo r  keratinase a c t iv i ty ;  results  are presented in 
Table 16. Although reduction in background absorbance at 280 nm 
was achieved, allowing d is t in c t io n  of samples from contro ls, 
absorbance readings did not increase measureably a fte r  incubation 
with substrate.
Hair substrate was washed six times in acetone p r io r  to the assay 
in order to remove l ip id s .  Washing in detergent, and a combination 
o f washing in detergent followed by washing in acetone was also 
t r ie d ,  but the method of treatment of hair did not influence 
resu lts .
D iffe ren t buffers were t r ie d  fo r  the assay, 75 mM sodium acetate 
bu ffe r, pH 4.0; and 50 mM Tris buffer, pH 7.2, were substituted 
fo r  phosphate buffer, but buffer type did not influence resu lts .
When th is  i n i t i a l  assay and attempted modifications fa i le d  to 
detect keratinase a c t iv i ty ,  isolates Dur and Del were examined by 
an a lte rna tive  method, using keratin azure as substrate. The 
e ffe c t of the presence of the reducing agent mercaptoethanol, 
included to fa c i l i t a te  hydrolysis of disulphide bonds, was also
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Table 16. Change in absorbance values at 280 nm of culture 
supernatants of D. congolensis isolates after incubation with 
hair substrate in a search for keratinase ac tiv ity .
Absorbance at 280 nm
Stage o f experiment t o t 60 t jC A Change
Sample
Iso la te  Dur PEG 0.129 0.132 0.130 0.001
Lyphogel 0.099 0.112 0.147 0.048
Iso la te  Dc2 PEG 0.171 0.179 0.171 0
Lyphogel 0.110 0.108 0.139 0.029
Control 0.068 0.069 0.079 0.011
Key:
to = preincubation
t6o = a f te r  lh incubation with substrate
tjcA = termination o f experiment by t r ich lo roa ce t ic  acid
PEG = Culture supernatant concentrated by polyethylene glycol
Lyphogel = Culture supernatant concentrated by Lyphogel
Control contained no enzyme source
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investigated. Results o f absorbance readings, at 595nm, o f 
reaction mixtures, pre- and post-incubation, are presented in 
Table 17.
Post incubation absorbance values were not s ig n if ic a n t ly  higher 
than pre-incubation values fo r  e ithe r iso la te  when compared with 
control which contained no enzyme source. The presence of 
mercaptoethanol did not influence resu lts .
When keratinase a c t iv i ty  was not detected, a lte rna tive  protease 
assays were attempted. No collagenase or elastase a c t iv i ty  was 
detected fo r  the isolates examined.
The rate o f ge la tin  lique faction  varied among iso lates, as found 
in previous work by Gordon (1964). Liquefaction was seen a fte r  2 
days fo r  iso la te  F2, a fte r  5 days fo r  isolates 15, Del, Dc2, FI 
and F2, a f te r  7 days fo r isolates Dur and 7915; and ge la tin  was 
not l ique f ied  by iso la te  5175.
Expression o f caseinase and gelatinase a c t iv i ty  was investigated 
a f te r  growth of isolates in d if fe re n t media. The caseinate- 
p re c ip ita t in g  a c t iv i ty  detected by the tes t caseinate agar was 
equated w ith, and is therefore described as, caseinase in th is  
work. Caseinase a c t iv i ty  was greater when isolates were grown in 
BHI broth, than when grown in BAB or SOB; and no caseinase 
a c t iv i t y  was detected a fte r growth in TSB. A c t iv i ty  was greater 
a f te r  44 h than a fte r 20 h. S tatic  and o rb it ing  (aerated) 
incubation o f isolates led to production of s im ila r amounts of 
caseinase a c t iv i ty .  No caseinase a c t iv i ty  was detected fo r  iso la te  
2, and no gelatinase a c t iv i ty  was detected fo r  any iso la te . The 
caseinase assay is shown in Figure 16.
D. congolensis iso late cultures were monitored over a period o f 8 
days as they were incubating. Culture f lu id  was repeatedly 
examined microscopically, and at each time point was tested fo r 
caseinase production. Similar patterns of growth were found fo r 
the isolates examined. Growth of isolates was f i r s t  detected in 
cu ltu re f lu id  a fte r 4 h incubation, as ensheathed cocci, and 
caseinase a c t iv i ty  was f i r s t  detected from isolates a fte r  hyphal
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Table 17. Change in absorbance values at 595nm of culture 
supernatants of D. congolensis isolates after incubation with 
keratin azure substrate in a search for keratinase ac tiv ity .
Absorbance at 595 nm
Stage o f experiment to t24h change
Sample
Dur 0.176 0.887 0.711
Del 0.266 0.545 0.284
Control 0.110 0.574 0.464
Dur + M 0.188 0.548 0.360
Del + M 0.194 0.408 0.214
Control + M 0.080 0.749 0.669
Key:
to = preincubation
t 24h = post 24-hour incubation with substrate 
Control = uninoculated BHI broth, buffer and substrate 
M = 5 mM mercaptoethanol present in sample
Samples contained 900 /il culture supernatant, 100 /il 1 M 
glycine-NaOH buffer, pH 9.0, and 10 mM CaCh, and 5 mg keratin 
azure substrate
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Figure 16. The caseinase assay, with demonstration of positive 
a c t iv i t y ,  a milky zone of caseinate p rec ip ita t ion  around the tes t 
w e ll ,  e .g .,  well C, upper r ig h t  of centre.
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elements were seen in the cu ltu re  f lu id ,  at 22 h. Caseinase 
production did not in te ns ify  beyond 46h fo r  iso la te  Dur or beyond 
day 4 fo r  iso la te  15.
In a previous study (Lloyd and Ojo, 1975), an equine D. 
congolensis iso la te , f ive  bovine iso la tes, an ovine iso la te , and 
seven donkey iso la tes, a l l  from Nigeria, decomposed casein, when 
tested on casein agar. Gordon (1964) examined 17 stra ins o f D. 
congolensis o r ig ina t ing  in skin lesions of c a t t le ,  sheep, horses, 
deer and man, and found that only two stra ins fa i le d  to hydrolyze 
casein, a l l  others cleared casein agar.
No corre la t ion  existed between lesion severity and the amount o f 
caseinase a c t iv i ty  produced by the causative organism, as the 
resu lts  in Table 18 demonstrate. Isolates recovered from animals 
with the highest dermatophilosis indices, i . e . ,  the most severe 
in fec t ions , did not produce the greatest caseinate p rec ip ita t ion  
zone areas. Isolates Dc2 and 15, fo r  example, produced identica l 
p re c ip ita t io n  zones, but c l in ic a l  dermatophilosis indices o f the 
animals o f o r ig in  were very d i f fe re n t,  1 and 4, respectively.
Characterisation of Caseinase A c t iv i ty  o f D. congolensis 
Culture Supernatants
Quantification of Protease in Culture Supernatant 
Culture supernatants of D. congolensis isolates were d ilu ted  using 
two-fo ld seria l d i lu t io ns  and caseinase a c t iv i ty  of the d i lu t io n s  
was measured. An inverse re la tionsh ip  was found to ex is t between 
caseinase a c t iv i ty  (measured by area of the zone o f caseinase 
p re c ip ita t io n  in the tes t agar) and d i lu t io n  of supernatant. This 
allowed re la t ion  of p rec ip ita t ion  zone size to the quantity o f the 
protease enzyme.
S ta b i l i t y  of the Protease to Heat and Cold 
The s ta b i l i t y  of caseinase a c t iv i ty  of D. congolensis isolates 
was investigated under conditions of extreme heat and cold. 
Determination of the protease s ta b i l i t y  was thought necessary to 
ensure that enzyme a c t iv i ty  was not lo s t under laboratory 
conditions.
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Table 18. Comparison of c lin ica l dermatophilosis index with 
a b ility  of the causative isolate to produce caseinase ac tiv ity  in
v i t r o
Iso la te  Date o f C lin ica l description Derm Caseinase
iso la t io n  of lesion o f o r ig in  Index A c t iv i ty
Lower hindlimb lesions
Del 5.9.88 Paintbrush lesions 2 67
Dc2 5.9.88 Paintbrush lesions 1 149
Dorsum lesions
2 23.2.89 Swab o f dorsum lesion 2
Scabs, pus
15 23.2.89 Scab from dorsum lesion 4 149
Scabs, pus, pain 
Dur 15.5.89 Scab from dorsum lesion 1 67
Paintbrush lesions 
FI 20.11.89 Scab from dorsum lesion 3 105
Scab, paintbrushes, pain 
F2 20.11.89 Scab from dorsum lesion 3 105
Scab, paintbrushes, pain
Key:
Derm Index = C lin ica l Dermatophilosis Index, on a 0 to 10 scale, 
based on assessment of the severity and extent o f d is t r ib u t io n  o f 
lesions o f dermatophilosis. 0 denotes absence of in fec t ion , and 10 
is  the most severe in fection
Caseinase a c t iv i ty  is given as the area, in mm2, o f caseinate 
p re c ip ita t io n
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Results shown in Table 19 show tha t the protease was stable to 
heating o f culture supernatant to 56°C fo r  15 mins, but was 
destroyed by heating cu ltu re  supernatant to 100°C fo r  15 mins.
Excepting iso la te  F2, where a c t iv i t y  was reduced, a c t iv i t y  was
preserved a f te r  storage o f cu ltu re  supernatant at 4°C fo r  one 
month. A ll isolates except iso la te  15 appeared to show increased 
caseinase a c t iv i ty  a fte r  storage at -20°C fo r  3 months.
Search fo r Antibody to  Protease A c t iv i ty  in Serum from D. 
congolensis Infected Animals
Serum from D. congolensis infected animals was examined fo r  the 
presence of antibody to the caseinase a c t iv i ty  found in several D. 
congolensis culture supernatants. Neutralisation of caseinase 
a c t iv i t y  was attempted by incubation of serum from a Dermatophilus 
infected c a l f  and from two infected horses with D. congolensis 
cu ltu re  supernatant, and comparison o f caseinase a c t iv i ty  to a
con tro l,  serum from a newborn c a l f  (Gibco BRL), not exposed to D. 
congolensis in fection . Sera from the infected animals reduced the
caseinase a c t iv i ty  of cu ltu re supernatant, but th is  e ffe c t was
also seen fo r  the contro l.
As neutra lisa tion  o f caseinase a c t iv i ty  may have been due to 
non-specific effects o f serum, the experiment was repeated,
incubating culture supernatant with IgG fraction  of serum from a 
Dermatophilus infected c a l f ,  and results were compared to a 
control which was incubated with neonatal c a l f  serum. Although 
incubation with the IgG serum frac tion  did reduce caseinase
a c t iv i t y ,  whole serum and control neonatal serum also had the same 
e f fe c t .
Inac tiva tion  o f serum from Dermatophilus infected animals, by heat 
treatment of culture supernatant to 56°C fo r 15 mins, did not 
a l te r  the a b i l i t y  of serum to reduce caseinase production.
Serum was thus found to have a neutra lis ing e ffec t on the 
caseinase a c t iv i ty ,  but th is  e ffec t was not confined to serum from 
D. congolensis infected animals. These findings were supported by 
la te r  work in th is  study, when immunoblotting using serum from 
Dermatophilus infected animals fa i le d  to detect specific
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antibodies to the protease.
Investiga tion o f Gelatinase A c t iv i ty  o f D. congolensis by 
SDS Gel atin-PAGE
In th is  study, f ie ld  equine D. congolensis isolates 2, 15, Dur,
Del, Dc2, FI and F2 previously showed caseinase a c t iv i ty  in v i t r o .  
Isolates 2, and NCTC laboratory isolates 5175 (equine) and 7915 
(ovine), had repeatedly fa i le d  to demonstrate th is  a c t iv i ty .  
Supernatant and so lub il ised whole ce ll fractions o f isolates were 
examined fo r  gelatinase a c t iv i ty  using SDS gelatin-PAGE, and bands 
o f gelatinase a c t iv i t y  o f whole ce ll and supernatant fractions 
were visualised as negative ly-sta in ing areas on the gel, 
i l lu s t ra te d  in Figures 17 and 18.
Gelatinase a c t iv i t y  was developed at varying pH: 0.1M sodium
acetate bu ffer o f pH 4.0 and of pH 6.0, and 0.1M Tris-HCl buffer 
o f pH 8.0 were used with equally good resu lts . The pH o f 
development bu ffer was not therefore in f lu e n t ia l  on protein 
v isu a lisa t io n , and 0.1M sodium acetate buffer of pH 6.0 was 
adopted fo r  fu r the r work.
In Figures 17 and 18 no gelatinase band was seen fo r  iso la te  2 or 
fo r  NCTC equine iso la te , 5175, or ovine iso la te , 7915. Several 
bands were seen in whole ce ll frac tions , but the most d is t in c t  one 
corresponded to that of the supernatant fra c t ion . Where the band 
was detected, i t s  position was identica l fo r  each iso la te , at 
approximately 110 kD when compared to molecular weight markers on 
a standard SDS-PAGE gel.
P u r i f ica t io n , Separation and Id e n t i f ica t io n  o f the Protease 
D. congolensis culture supernatants were concentrated by PEG 
d ia lys is  and fractionated by Sephacryl chromatography. Eluted 
frac tions  were tested fo r  caseinase a c t iv i ty ,  and active fractions 
were examined by SDS-PAGE, and compared to molecular weight 
markers. There was inadequate resolution of proteins by 
electrophoresis and no specific  polypeptide band could be 
correlated to caseinase a c t iv i ty .
Ion exchange chromatography was used in a fu rthe r attempt to
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Figure 17. SDS gelatin-PAGE of cu ltu re supernatant fractions o f D. 
congolensis. From le f t  to r ig h t ,  cu lture supernatants of isolates 
2, 15, Dur, Del, Dc2, FI, and F2.
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Figure 18. SDS gelatin-PAGE of supernatant and whole ce ll 
f rac t ions  o f D. congolensis. From l e f t  to r ig h t ,  isolate Dur(W), 
Dur(S), Dcl(W), Del(S), 5175(W), 5175(S), Dc2(W), Dc2(S), F1(W), 
F1(S), F2(W), F2(S), 7915(W), 7915(S). (W) denotes whole ce ll 
f ra c t io n ,  and (S) denotes supernatant fra c t io n .
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frac t iona te  and id e n t i fy  the protease. Iso la te Dur culture 
supernatant was again separated by molecular exclusion 
chromatography, and caseinase-producing frac tions were pooled and 
concentrated p r io r  to ion exchange chromatography. Eluted 
frac tions  were assayed fo r  caseinase a c t iv i ty ,  which was found in 
frac t ions  20, 21, 22, 23 and 24, with a peak (measured by the
area o f caseinate p rec ip ita t ion  zone) seen in fra c t ion  22. 
Fractions 20 to 24 were then examined by SDS-PAGE, and compared to 
the pooled, concentrated sample p r io r  to ion exchange 
fra c t io n a t io n . Results are shown in Figure 19.
In Figure 19 two d is t in c t ,  but very fa in t ly -s ta in in g  polypeptide 
bands were separated by ion exchange chromatography: one at
approximately 55 kD, in fractions 18, 19, 20, 21, 22, 23, 24 and
25; and the other at around 28 kD, evident in fractions 21, 22 and
23.
The same caseinase-active fractions were also examined fo r  
gelatinase a c t iv i ty  by SDS gelatin-PAGE, shown in Figure 20. A 
pooled sample o f a l l  caseinase-active chromatography frac tions was 
run alongside the individual frac tions.
Figure 20 shows the single, d is t in c t  band o f gelatinase a c t iv i ty
present in fractions 20, 21, 22, 23 and 24, and in the pooled
sample. The peak of gelatinase a c t iv i ty ,  the brightest band on the 
ge l, in frac t ion  22, corresponded with peak caseinase a c t iv i ty .  No 
protein o f 110 kD could be found in the ion exchange frac t ions .
Protease In h ib it io n  Experiments 
Protease a c t iv i ty  had been detected fo r several D. congolensis 
iso la tes. In order to equate gelatinase and caseinase a c t iv i t ie s ,  
the gelatinase band of approximately 110 kD was cut out o f the gel 
and implanted into caseinate tes t agar. Caseinase a c t iv i t y  was 
detected.
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Figure 1 9 .  S D S - P A G E  of caseinase-active frac tions  obtained by ion 
exchange frac t iona tion  o f D. congolensis cu ltu re supernatant. 
F r o m  l e f t  t o  r i g h t ,  c o n c e n t r a t e d  s u p e r n a t a n t  p r i o r  t o  i o n  e x c h a n g e  
c h r o m a t o g r a p h y ,  ( C ) ;  f r a c t i o n  n u m b e r  1 8 ;  1 9 ;  2 0 ;  2 1 ;  2 2 ;  2 3 ;  2 4 ;
2 5 ;  2 6 ;  2 7 ;  2 8 ;  2 9 ;  3 0 ;  m o l e c u l a r  w e i g h t  m a r k e r ,  ( M ) .
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Figure 20. SDS gelatin-PAGE of caseinase-active fractions
obtained by ion exchange frac tiona tion  o f D. congolensis 
cu ltu re  supernatant. F r o m  l e f t  t o  r i g h t ,  f r a c t i o n  n u m b e r  1 8 ;  1 9 ;
2 0 ;  2 1 ;  2 2 ;  2 3 ;  2 4 ;  2 5 ;  2 6 ;  a n d  a p o o l e d ,  c o n c e n t r a t e d  s a m p l e  o f
c a s e i n a s e - a c t i v e  f r a c t i o n s ,  ( P ) .
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In general, c la s s i f ic a t io n  o f protease a c t iv i t y  is  made on the 
basis o f the amino acid type involved in the active s i te  o f the 
enzyme. Proteases f a l l  in to four mechanistic fam ilies : the serine, 
cysteine, aspartic and metallo proteases (Neurath, 1989). 
C la ss if ica t io n  has been based on s u s c e p t ib i l i ty  to a group of 
in h ib i to rs ;  and a recommended set fo r  the i n i t i a l  c la s s if ic a t io n  
o f a newly discovered protease (Dunn, 1989) was employed to t r y  to 
categorise the protease a c t iv i ty  of D. congolensis.
In h ib i t io n  o f Gelatinase A c t iv i ty  on Polyacrylamide Gels 
I n i t i a l l y ,  Pepstatin A which in h ib its  aspartic proteases; EDTA, 
which in h ib i ts  metallo proteases; iodoacetic acid (cysteine 
proteases) and leupeptin (spec if ic  fo r  serine and cysteine 
proteases), were each incubated with a pooled sample o f whole, 
so lub il ised  bacteria. No in h ib it io n  of gelatinase occurred with 
in h ib i to rs  at standard concentrations.
The experiment was repeated using sonicated culture f lu id  (3 x 20 
sec periods o f ultrasound) to fu rthe r so lub il ise  protein m ateria l, 
and reducing agent d i th io th re i to l  (DTT), an activa to r o f cysteine 
proteases, was added to reaction mixtures. S t i l l  no in h ib i t io n  
occurred.
In h ib i t io n  o f Caseinase A c t iv i ty  
Protease in h ib ito rs ,  EDTA, iodoacetic acid, leupeptin and 
Pepstatin A, and antipain, specific  fo r  t ry p s in - l ik e  serine and 
some cysteine proteases; bestatin, specific  fo r  aminopeptidases; 
chymostatin, specific  fo r chymotrypsin-1ike serine proteases and 
some cysteine proteases; 3,4-dichloroisocoumarin (3,4-DCI) (serine 
proteases); 1 ,10-Phenanthroline (metallo-proteases,
metal-activated proteases); phenylmethanesulphonyl f luo r ide  (PMSF) 
(a l l  serine proteases); tosyl lysyl chloromethyl ketone (TLCK) 
( t r y p s in - l ik e  serine proteases) and tosyl phenylalanyl 
chloromethyl ketone (TPCK) (chymotrypsin-1ike serine proteases) 
were incubated with supernatants of isolates Dur, 15 and Del. The 
influence of temperature on the reaction was investigated. Results 
presented in Table 20 show that no in h ib i t io n  o f protease 
occurred fo r  any iso la te  with antipain, bestatin, chymostatin,
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Table 20. Inhibition of caseinase production by D. congolensis 
isolates using specific protease inhibitors
% o f control area o f caseinate p rec ip ita t ion
Isola te Dur Isolate 15 Isola te Del
In h ib i to r
RT 37°C RT 37°C RT 37°C
Antipain 100 100 100 100 100 100
Bestatin 100 100 100 100 100 100
Chymostatin 100 100 100 100 100 100
3,4-DCI 0 0 81 67 60 0
EDTA 100 100 100 100 100 100
IAA 100 100 100 100 100 100
Leupeptin 100 100 100 100 100 100
Pepstatin 100 100 100 100 100 100
1,10 Phe 100 100 100 100 100 100
PMSF 0 0 40 53 0 0
TLCK 100 100 100 100 100 100
TPCK 100 100 100 100 100 100
Key:
3 ,4 -DC I = 3,4-dichloroisocoumarin
EDTA = Ethylenediaminetetraacetic acid
IAA = Iodoacetic acid
1,10-Phe = 1,10-Phenanthroline
PMSF = Phenylmethanesulphonyl f luo ride
TLCK = Tosyl lysy l chloromethyl ketone
TPCK = Tosyl phenylalanyl chloromethyl ketone
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EDTA, IAA, leupeptin, pepstatin A, 1,10-Phenanthroline, TLCK or 
TPCK. 3,4-DCI inh ib ited  protease a c t iv i ty  of iso la te  Dur at both 
temperatures, and o f iso la te  Del at 37°C only. Reduction o f 
caseinase a c t iv i t y  o f iso la te  Del by 3,4-DCI occurred at room 
temperature, and iso la te  15 a c t iv i ty  was reduced though not 
abolished at both temperatures. A c t iv i ty  of isolates Dur and Del 
were inh ib ited  by PMSF; and a c t iv i ty  of iso la te  15 was reduced. 
Temperature did not influence results s ig n if ic a n t ly .
I t  was concluded from these results that the protease a c t iv i t y  was 
o f the serine c la s s i f ic a t io n .  The serine proteases form covalent 
enzyme complexes, and are the most thoroughly studied class o f 
protease enzymes (Dunn, 1989). Examples include pancreatic 
t ryp s in , chymotrypsin, elastase and k a l l ik re in  (Neurath, 1989).
SDS-PAGE Analysis of Caseinase A c t iv i ty  
PEG concentrated, unheated, culture supernatant of D. congolensis 
iso la te ,  Del, was fractionated by ion exchange chromatography. The 
caseinase-active fractions obtained were examined by SDS-PAGE 
alongside unconcentrated culture supernatant. The SDS-PAGE gel was 
run and overla id with tes t caseinate agar. Two d is t in c t  zones of 
caseinase protease a c t iv i ty  were found on the gel. The la rger, 
predominant zone of a c t iv i ty  was seen between approximately 70 and 
120 kD. The second, less active zone was easily detected between 
20 and 40 kD fo r  the concentrated sample, and was ju s t  v is ib le  in 
th is  position fo r  the unconcentrated sample. These zones o f 
caseinase p rec ip ita t ion  are demonstrated on the gel in Figure 21.
Two proteases which showed caseinase a c t iv i ty  were thus thought 
to be produced by D. congolensis. One protease, of approximately 
110 kD, also demonstrated gelatinase a c t iv i ty .  The second 
caseinase producing protease was of lower molecular weight.
The find ing  of two zones of caseinase p rec ip ita t ion  by SDS-PAGE 
was thought to inva lidate the e a r l ie r  protease in h ib i t io n  resu lts , 
because i f  two proteases were present, one could mask spec if ic  
in h ib i t io n  o f the other.
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Figure 21. SDS-PAGE analysis of caseinase a c t iv i t y  of D.
congolensis . On the le f t  hand side, concentrated culture 
supernatant o f iso la te  Del, (Del Cone); on the r ig h t  hand side, 
unconcentrated cu ltu re  supernatant of iso la te  Del, (Del).
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Immunoblotting Using Serum From D.congolensis Infected 
Animals
Equine f ie ld  isolates 2, 15, Dur, Del, Dc2, FI and F2 and
laboratory isolates 5175 (equine) and 7915 (ovine) were 
immunoblotted using serum from a c a l f  suffering from a very 
severe, generalised dermatophilosis in fec tion , o f dermatophilosis 
index 10. Neonatal c a l f  serum was used as a con tro l. The 
isolates examined produced s im ila r patterns, with numerous protein 
bands detected fo r  whole so lubilised bacteria and supernatant 
frac t ions . B lo tt ing  with serum from infected animals fa i le d  to 
h igh ligh t p a rt icu la r  bands of a c t iv i ty  fo r  fractions o f isolates 
examined.
The experiment was modified by PEG concentration and ion exchange 
frac tiona tion  of supernatants of overnight culture of isolates
Dur and Del p r io r  to b lo t t in g .  Eluted fractions were examined fo r
caseinase a c t iv i ty ,  and the peak frac tion  fo r  each iso la te  was 
selected fo r  immunoblotting: frac tion  25 fo r  Dur and frac t ion  30
fo r  Del. The fractions were divided into two a liquots, one was 
heated to 100°C fo r  5 minutes, and the other was untreated. 
Overnight broth culture supernatants were used as posit ive  
contro ls. The gel was loaded in duplicate, and each identica l h a lf  
was b lo tted using serum from a Dermatophilus infected horse. The 
horses were both suffering from moderate dermatophilosis 
in fec tions, o f dermatophilosis index of 4 in each case. Results of 
b lo t t in g  were s im ila r fo r  the isolates examined, no p a r t icu la r  
band o f a c t iv i ty  was visualised by the addition of the serum from 
the infected horses. One of these immunoblots is shown in Figure 
2 2 .
Antibody to the protease was not detected in serum from e ither
infected horse in th is  study. This resu lt was in agreement with 
e a r l ie r  work in th is  study, where i t  was found that although serum 
had a neutra lis ing  e ffec t on the protease a c t iv i ty ,  th is  e ffec t
was not spec if ic  fo r  serum from Dermatophilus infected animals.
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Figure 22. Immunoblot of concentrated supernatant from D. 
congolensis iso lates using serum from a Dermatophilus infected 
horse. From l e f t  to r ig h t ,  isolate Del [heated to 100°C fo r 5 mins 
before load ing,(H )] ,  Del 30 (H), Del 30, Dur (H), Dur 25 (H), Dur 
25.
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Conclusion
No two D. congolensis isolates examined showed identica l 
bacterio log ica l characteris tics although lesions induced by a l l  
isolates were s im ila r . C lin ica l severity o f lesions could not be 
correlated with bacterio logical growth characteris tics o f the 
causative iso la te . S im ila r i t ie s  were detected between SDS-PAGE 
protein p ro f i le s  of seven equine isolates and one bovine iso la te , 
but d e f in i te  correlations could not be made.
Several but not a l l  of the equine D. congolensis iso lates examined 
produced ex trace llu la r  protease a c t iv i ty .  One protein estimated to 
be approximately 110 kD by SDS-PAGE produced caseinase and 
gelatinase a c t iv i t ie s ,  and a second, of lower molecular weight, 
showed caseinase a c t iv i ty .  The caseinase a c t iv i ty  was stable to 
cold. The a c t iv i ty  was non-specifica lly  inh ib ited , by serum from 
Dermatophilus infected horses, and by serum from an infected c a l f .  
Immunoblotting studies fa i le d  to demonstrate antibody to any 
protein species in serum from infected animals.
No keratinase a c t iv i ty  was detected using hair or keratin azure as 
substrate, and no collagenase or elastase production was 
discovered.
In summary, although s im ila r ites  existed between the D. 
congolensis isolates examined in th is  thesis, with regard to 
d i f fe re n t ia l  bacterio logical growth characteris tics  and SDS-PAGE 
protein p ro f i le s ,  the isolates were a l l  d i f fe re n t .  Protease 
a c t iv i ty  was produced by some but not a l l  o f the iso la tes, but 
could not be used as a marker o f virulence.
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SECTION 3. THE CLINICAL AND HAEMATOLOGICAL CONSEQUENCES OF 
BLEEDING HORSES AT REGULAR INTERVALS
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Introduction
The consequences of bleeding horses in terms of frequency and 
quantity are a major animal welfare consideration. A s itua tion  
which o ffe rs  the opportunity to address th is  question is  where 
horses are managed fo r  production of blood products. Such an 
opportunity arose on a farm in the West o f Scotland where 200 
mature horses of d if fe re n t breeds were maintained and bled at 
recorded regular in terva ls  thus creating a major database fo r  
evaluating the management of th is  operation in terms of c l in ic a l  
condition, as well as haematological consequences.
The practice of regular, repeated blood harvest arises in horses 
managed fo r  blood production in a commercial s itua t ion . I t  is 
therefore not surpris ing that examination of current and h is to r ic  
l i te ra tu re  reveals that de ta ils  of current practices, and figures 
regarding incidence and extent to which horses are managed fo r  
regular, repeated blood harvest fo r blood products in the U.K. and 
elsewhere are d i f f i c u l t  to obtain. Blood harvesting has probably 
been undertaken " in  house" in research in s t i tu te s  and in 
Veterinary Investigation Centres and U nivers it ies, fo r  
microbiological culture material fo r  th e ir  own use (Home Office 
Veterinary Inspector, personal communication). P rior to the new 
Animals (S c ie n t i f ic  Procedures) Act of 1986 there was no national 
requirement to disclose such a c t iv i t ie s .
As fa r  as can be determined, substantiated guidelines fo r  harvest 
procedures do not ex is t,  and so the area was considered worthy of 
detailed monitoring studies. C lin ica l and haematological data were 
collected and analysed in an attempt to provide background fo r  
guidelines fo r  Home Office regulations on regular, repeated blood 
co llec t ion  in horses.
An i n i t i a l  study was designed to obtain an overview o f the 
c l in ic a l  and haematological effects of repeated, regular blood 
harvest on a group of animals in the herd, under the existing 
management regime. This was to be followed by a shorter, more 
detailed haematological investigation using a smaller number of 
the horse group. Blood samples were to be collected between two
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harvest points in order to fo llow  more closely the recovery 
pattern o f the haematological parameters o f these animals. 
Influence o f sex, breed and the length o f time in blood production 
on the recovery pattern were to be monitored.
Materials and Methods 
Horses
For the purpose of the i n i t i a l  study a group o f 48 horses was 
monitored. The group comprised 21 mares and 27 geldings. Eighteen 
animals were Thoroughbreds, 13 were cobs or heavy types, and 17 
were crosses o f the two, i . e . ,  30 animals were non-Thoroughbreds.
The age o f the group ranged from six to 22 years old. Twelve 
animals were younger than 10 years, 27 were between 10 and 15 
years old, and nine were over 15 years of age. Height o f animals 
varied from 15 to 17 hands. Twenty horses were between 15 and 15.3 
hands, 21 were between 16 and 16.3 hands, and two animals stood 17 
hands t a l l .
For the subsequent study, 10 of the horses were randomly selected 
from the group above. Four mares and six geldings were involved, 
and three animals were Thoroughbreds. Age ranged from nine to 20 
years o f age. Two animals were younger then 10 years, s ix  were 
between 10 and 15 years, and two were older than 20 years.
Details o f the management of the group, including the harvesting 
procedure, are provided in the general Materials and Methods 
section.
Experimental Designs 
Experiment 1
In the i n i t i a l  study regular c l in ic a l  and haematological 
monitoring was carried out over a period of 16 weeks, which 
spanned f ive  harvest cycles. C l in ic a l ly ,  body condition was 
assessed, as detailed in general Materials and Methods, at monthly 
in te rva ls  in the f i r s t  study. Blood was collected and 
haematological examinations were performed according to the 
de ta ils  given in the general Materials and Methods section. Total
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estimation and electrophoresis o f proteins was performed at these 
times using a Beckman Appraise Junior Densitometer in the Medicine 
Laboratory o f the University of Glasgow Veterinary School. Full 
haematological examination was carried out at weekly in te rva ls  fo r  
each horse during the f i r s t  study. On harvest days, samples were 
collected immediately p r io r  to harvest.
Experiment 2
Haematological monitoring was performed in th is  study over a 21 
day period, between two harvest points. Blood samples were 
collected and f u l l  haematological examination was performed as 
described in the general Materials and Methods section on samples 
collected immediately p r io r  to harvest, tO, and at 30 mins, 60 
mins, 90 mins, 2 h, 6h, 12h and 24h a fte r  harvest. Thereafter, 
samples were collected da ily  u n t i l  day 21 of the cycle, before the 
next harvest took place. The aim was to investigate the recovery 
pattern fo r  the haematological parameters between harvests.
S ta t is t ic a l  analyses were undertaken in both studies, to examine 
influence o f sex, breed and the length of time in blood 
production, on the haematological parameters of packed ce ll volume 
(PCV), red ce ll count (RCC) and haemoglobin (Hb). Influence o f 
body condition was also evaluated in the i n i t i a l  overview study. 
Details o f s ta t is t ic a l  analyses are provided in the general 
Materials and Methods section.
Results
Experiment 1. Monitoring over Five Harvest Cycles
Body Condition
There was no evidence that body condition was affected by the f ive  
harvest cycles. Body condition scores are presented in Figure 23. 
Animals were scored on a 1 to 5 point scale, with 0.5 point 
increments. The horses were in good body condition at each o f the 
monthly measurements, most animals scored 2.5 or above, ind icating 
moderate to good condition. Changes in body condition scores are 
demonstrated in Figure 24. In the period April to May 87.5% of the
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horses e ithe r maintained or gained condition. In the period May to 
June th is  percentage increased to 89.4% o f the horses. Over the 
duration o f the study, between April and June, 39 o f the 48 horses 
(81.3%) maintained or gained condition.
Haematology
Figures 25, 26, and 27 i l lu s t ra te  the values fo r  group mean PCV,
RCC and Hb values, respectively. Normal ranges and units used in 
measurement o f haematological parameters in the horse are given in 
Appendix IV.
A cyc l ic  pattern was found fo r  the group mean PCV values, shown in 
Figure 25. Values f e l l  to th e ir  lowest point the f i r s t  week post 
harvest, with gradual restoration over the second and th i rd  weeks 
post harvest. This pattern was repeated uniformly fo r  the f ive  
harvest cycles studied. Values were w ith in normal ranges at a l l  
points recorded.
Group mean RCC values, demonstrated in Figure 26, showed a s im ila r  
cyc l ic  pattern to PCV in Figure 25. Values were lowest one week 
post harvest, and showed gradual increase over the second and 
th i rd  weeks, and peaked temporarily before the next harvest. As 
with PCV, mean values fo r RCC were w ith in normal ranges throughout 
the 16 week study.
The group mean Hb pattern of Figure 27 followed closely the 
cyc lica l trends fo r  PCV and RCC. Values lay w ith in  normal ranges 
throughout.
Protein Profiles
Protein p ro f i le s ,  i l lu s t ra te d  in Figure 28, include values fo r  
mean to ta l plasma proteins, which were w ith in normal range at the 
three time points monitored. Mean albumin to g lobulin  ra t ios  were 
above the normal value o f 1 at each time point studied. P rofiles 
demonstrate the re la t ive  percentages of albumin, alpha 1-, alpha 
2-, beta- and gamma- globulins.
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S ta t is t ic a l  Analyses
In the s ta t is t ic a l  analyses the performance o f geldings was 
compared to mares, Thoroughbreds to non-Thoroughbreds (halfbreds 
and heavier types), and the performance o f animals used fo r  less 
than 5 years was compared to those used fo r  longer than 5 years. 
Thin animals (condition score of 2.5 points or less) were compared 
to those o f moderate condition (condition score o f 3 to 3.5 
points) and those which were fa t  (condition score o f 4 points or 
more). Analyses of group mean PCV, RCC and Hb are presented in 
Table 21.
Results indicated no s ig n if ica n t influence o f condition score, sex 
or length o f time in blood production on any o f the parameters. 
S ign if ican t differences existed between breeds fo r  PCV, RCC and 
Hb. Values were always higher fo r  Thoroughbreds than fo r  
non-Thoroughbreds.
Experiment 2. Monitoring Between Two Harvest Points
Values fo r  the haematological parameters were maintained w ith in  
normal ranges fo r  the 21 day period between the two harvest
points. Normal ranges and units used in measurement of
haematological parameters are given in Appendix IV.
For the mean values fo r  PCV, i l lu s tra te d  in Figure 29, a sharp 
drop in values was evident 30 mins post harvest, then the value 
rose again at 1 h post harvest and remained re la t iv e ly  constant 
between 90 mins and 12 h post harvest. PCV was lowest at 4 days 
post harvest, a fte r  which time there was an increase over the 
remainder o f the cycle, but i t  did not, however, a tta in  the 
preharvest value.
The pattern fo r  mean red ce ll count, Figure 30, followed the PCV
pattern: a sharp f a l l  was seen 30 mins post harvest, with a
fu r the r drop fo r  1 h more then the value rose s l ig h t ly  and 
remained constant t i l l  12 h post harvest, when there was a decline
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Table 21. Influence of body condition, sex, breed and the length 
of time regular bleeding has occurred, on the group mean values 
for packed cell volume (PCV), red cell count (RCC) and haemoglobin 
(Hb) of horses bled regularly, in a study which monitored five  
harvest cycles
Body Condition
Poor Good Fat
(score<3) (score 3-3.5) (score:
Mean PCV 0.427 0.409 0.387
Mean RCC 8.25 7.99 7.21
Mean Hb 14.58 14.31 13.64
Number of horses 6 31 11
Sex
Geldings Mares
Mean PCV 0.392 0.418
Mean RCC 7.70 8.03
Mean Hb 13.93 14.53
Number of horses 27 21
Breed
Thoroughbreds Non-Thoroughbreds 
Mean PCV 0.431 0.374 *
Mean RCC 8.49 7.03 *
Mean Hb 14.88 13.07 *
Number of horses 13 13
Length of time regular bleeding has occurred
>5 years <5 years
Mean PCV 0.387 0.399
Mean RCC 7.39 7.57
Mean Hb 13.60 13.90
Number of horses 12 12
* indicates a s ign if ica n t difference
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to a trough at 4 days post harvest. RCC climbed over the remainder 
o f the cycle but, as fo r  PCV, i t  never reached the preharvest 
f igu re .
The pattern fo r  mean haemoglobin values, Figure 31, echoed closely 
those o f PCV and RCC. The value preharvest was not attained during 
the cycle.
Minimal f luc tua tions were seen in the results  fo r  group mean fo r  
mean ce ll  volume, Figure 32. The value remained s ta t ic  towards the 
upper l im i t  o f normal range. Very l i t t l e  change was evident in 
mean ce ll  haemoglobin values u n t i l  a f te r  day 7. MCH had risen 
again by day 21. Figure 33 i l lu s t ra te s  that mean values never 
regained the preharvest f igu re . As fo r  MCV, values tended towards 
the upper l im i t  o f normal range. This pattern was followed by 
group mean values fo r  mean cell haemoglobin concentration, shown 
in Figure 34.
The pattern which was seen fo r values of group mean fo r  p la te le t  
counts in Figure 35 resembles the pattern shown in Figures 29 to 
31: a sharp fa l l  by 30 mins post harvest, temporary recovery then
decline by 2 h, a second temporary recovery then fu r the r decline 
by 4 days post harvest. The preharvest value was gradually reached 
by day 21 post harvest.
Group means fo r  WCC in Figure 36 showed a s l ig h t  decline fo r  90 
mins a f te r  harvest, then an increase was seen u n t i l  12 h post 
harvest, a f te r  which values returned to the preharvest level by 4 
days, and remained s ta t ic  thereafter.
S ta t is t ic a l  analysis of PCV, RCC and Hb, presented in Table 22, 
indicated no s ign if ica n t difference between the groups fo r  sex, 
breed or the length of time in blood production.
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Table 22. Influence of sex, breed and the length of time regular 
bleeding has occurred on the pattern of recovery between two 
harvest points of group means for packed cell volume (PCV), red 
cell count (RCC) and haemoglobin (Hb) of horses bled regularly
Sex
Geldings Mares
Mean PCV 0.363 0.371
Mean RCC 6.77 6.81
Mean Hb 12.48 12.73
Number of horses 7 3
Breed
Thoroughbreds Non-Thoroughbreds
Mean PCV 0.383 0.363
Mean RCC 7.12 6.64
Mean Hb 13.08 12.34
Number of horses 3 7
Length of time regular bleeding has occurred
> 5 years < 5 years
Mean PCV 0.312 0.370
Mean RCC 6.69 6.85
Mean Hb 12.55 12.57
Number of horses 6 4
No s ig n if ica n t difference was recorded fo r  any parameter
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Discussion
The observation that body condition scores were generally good, 
most horses maintained or gained condition over the period o f 
study, probably re flected the improving plane of n u t r i t io n  o f the 
horses with seasonal improvement of pasture during the studies, 
between A pril and June. The good d ie tary management and parasite 
control programme in operation under the current management on 
th is  farm support the consistently good body condition scores in 
the horses.
Total plasma protein values, which were a l l  w ith in  normal ranges 
here, re f le c t  plasma water balance more accurately than do PCV, as 
the normal TPP range is narrower than that of PCV and is  not 
influenced by pain, fear or excitement (Becht, 1986). The fac t 
tha t these values are w ith in  normal ranges indicates adequate 
hydration and assures that regular, repeated bleeding in th is  herd 
does not induce chronic protein loss. This is not surpris ing i f  
one considers that i t  has been calculated, using radioisotope 
studies, that in a normal 500kg horse of the type in th is  herd, 
one l i t r e  o f plasma is los t into the gut da ily  (Love, 1990).
The haematological parameters studied remained w ith in  the normal 
ranges during the f ive  harvest cycles studied. The herd comprises 
predominantly Thoroughbreds and Thoroughbred types, which 
s ta t is t ic s  indicate to have s ig n if ic a n t ly  higher 
erythrocyte-related parameters than heavier, halfbred types. These 
Thoroughbred types are less influenced by the current harvesting 
regime than are non-Thoroughbreds. This is not unexpected i f  one 
considers the published data which show Thoroughbreds to have 
higher blood volumes ( 88-110 ml/kg ) than cold blooded or
heavier, cob and pony type ( 6 2 - 6 6  ml/kg ) animals (Schalm, 
1986).
Several o f the unique aspects of blood volume and erythropoiesis 
o f horses are exemplified in the studies. Up to h a lf  o f the red 
ce ll volume in the horse may be stored in the spleen; an important 
adaptive process fo r exercise which results in a very unstable 
c ircu la t in g  blood volume (Becht, 1986; J e f fc o t t ,  1977). Splenic
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contraction is a normal haematological response, spec if ic  to the 
horse, which is stimulated w ith in seconds in response to 
haemorrhage, as well as to exercise or exc ita t ion . In these 
studies th is  response was observed repeatedly, as red ce ll  counts 
did not f a l l  dramatically even a fte r repeated, sizeable 
haemorrhage. In healthy Thoroughbreds, splenic contraction can 
increase PCV by up to 50% above resting levels (J e f fc o t t ,  1977).
According to Torten and Schalm (1964), PCV and other red ce ll 
parameters may r ise  owing to splenic contraction, making 
determination of the magnitude of blood loss during the f i r s t  4 or 
5 h a fte r haemorrhage almost impossible. The degree o f blood loss 
may not become c l in ic a l l y  evident un t i l  up to 48 h a f te r  the 
in i t ia t io n  of haemorrhage, owing to sh if ts  o f f lu id  and the 
capacity of the spleen (Lumsden, V a ll i  and McSherry, 1975). The 
results  of th is  study supported th is :  lowest values fo r  PCV, RCC
and Hb were not recorded u n t i l  7 days a fte r harvest. J e f fc o t t  
(1977) believes that reduction in red cell parameters or anaemia 
is appreciated by 12 to 24 hours a fte r acute blood loss.
Acute haemorrhage, of up to one-third of c ircu la t in g  blood volume 
(around 12 l i t r e s  in a 500kg animal), can be withstood by the 
horse without exh ib it ion  of serious distress (J e f fc o t t ,  1977). 
Under th is  management system approximately 8 l i t r e s  o f blood were 
collected at any one harvest from animals of around 500kg. This
blood co llec t ion  is equivalent to less than one f i f t h  o f to ta l
blood volume fo r horses of the Thoroughbred type involved in th is  
herd. Under the current management system, horses on occasion
simply appear drowsy fo r  the f i r s t  hour or so a fte r  harvest.
Approximately four days are reported to be required a f te r  the 
onset of haemorrhage fo r  the bone marrow to release increased 
numbers of mature red blood ce lls  into the c ircu la t io n  in the 
horse and other animals (V a l l i ,  Lumsden, Carter and McSherry, 
1975, cited by Becht, 1986). Results obtained in th is  study 
revealed that fo r  these horses a fte r day 4 post harvest group 
means fo r PCV, RCC and Hb and, to a lesser extent, p la te le ts  and 
WCC showed gradual increases towards the o r ig in a l,  preharvest 
values.
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Eight out o f the 10 horses monitored during the interharvest study 
never regained preharvest values fo r PCV, RCC or Hb p r io r  to the 
subsequent harvest. Values fo r these parameters were, however, 
maintained w ith in  normal ranges. I t  was thought tha t the PCV and 
RCC values would probably be elevated fo r  these horses at the
harvest point owing to splenic contraction as a resu lt of 
excitement and apprehension. PCV is the parameter currently  
monitored at harvest under the routine management system. I t  must 
be borne in mind that any excitement p r io r  to or during blood
harvest w i l l  influence red blood ce ll parameters, and low values 
could eas ily  be masked. Ideally, therefore, a f u l l  haematological 
examination would be carried out, but at present only PCV is
measured, as th is  can be quickly performed in the farm laboratory. 
Adequate haematological monitoring is being provided by PCV
assessment under the current management.
I t  has been reported that between 30 and 60 days are often
required a f te r  severe anaemia from blood loss fo r  red ce ll
parameters to return to normal in the horse (Becht, 1986). For 
these horses the degree of blood loss which occurs regularly  does 
not appear to induce anaemia. Fluctuations were small fo r  the red 
blood ce ll indices: MCV, MCH and MCHC over the 21 days, but these 
are claimed to be of l i t t l e  value in equine c l in ic a l  medicine 
(Becht, 1986). Values fo r MCV lay towards the upper range of
normal values, suggesting immaturity o f red blood ce lls ,  
although these values did not give grounds fo r  concern.
Sex, breed and length of time in blood production did not 
influence patterns o f recovery between the two harvest points fo r 
PCV, RCC or Hb.
In summary, the studies have been reassuring in that the c l in ic a l  
condition o f these animals, which are managed fo r  regular, 
repeated blood harvest, is consistently good. The haematological 
p ro f i le s  show regular, cyc lic  changes between harvest points, but 
these f luc tua tions  are safely w ith in normal ranges fo r  a l l  
haematological parameters when one considers the range of types of 
horse w ith in  the herd. The co llection of 8 l i t r e s  of blood from 
these horses on a regular three week cycle did not therefore
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adversely a ffec t th e ir  welfare, c l in ic a l ly  or haematologically. I t  
was evident from s ta t is t ic a l  analyses o f values fo r  PCV, RCC and 
Hb over a period of f ive  harvest cycles, however, tha t values were 
consistently  higher fo r  the Thoroughbred animals in the herd than 
fo r  non-Thoroughbreds.
The recovery patterns found fo r  PCV, RCC and Hb over f iv e  harvest 
cycles, and the s ta t is t ic a l ly  s ign if ica n t influence o f breed on 
these patterns, provided valuable guidelines fo r  commercial blood 
production. I t  was thought that 8 l i t r e s  of blood could probably 
be removed on a more frequent basis from the Thoroughbred animals 
without adverse c l in ic a l  or haematological e ffe c t,  perhaps every 
two weeks rather than every three weeks. Taking in to  account the 
PCV, RCC and Hb recovery patterns, and the l i te ra tu re  on 
differences in blood volume between breeds, the p o s s ib i l i ty  of 
increased frequency of regular blood harvest was not considered 
fo r  the non-Thoroughbred horses. The results  o f the studies 
therefore also supported the b e l ie f  of the farm owner tha t, in 
general, the Thoroughbred animal is more suited to commercial 
blood production than are the heavier types o f horses in the herd.
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SECTION 4. THE CREATION OF A MANAGEMENT EQUINE DATABASE
Introduction
The Requirement fo r a Database 
This group o f horses is surely unusual fo r  several reasons. I t  is  
uncommon in the U.K., and especially in Scotland, to encounter a 
herd o f th is  size; and less common s t i l l  to discover horses 
managed as a group throughout grazing and housing periods, as are 
these animals. The feeding and the stabling regimes are atypical 
of the way horses and ponies are generally kept in B r i ta in ,  they 
more resemble the routines employed fo r  ca t t le .  Equally, the 
purpose fo r  which these animals are managed, that is  fo r  the 
production of blood products, is not a common industry. We are 
unaware of any other commercial blood producers in Scotland, and 
there are but a few in the U.K. as a whole (personal communication 
from the owner of the herd).
The management o f a horse group of th is  size is a daunting task, 
from the point of view of the herd size, but perhaps even more so 
from a welfare point of view. The business of production o f blood 
products is  re l ia n t  on a source of horses fo r  purchase, but also 
re l ie s  on the loaning of horses from the public. The people 
involved, the owner and the s ta f f  on the farms, are aware o f the 
necessity of e f f ic ie n t  management to protect the health and 
wellbeing of the horses. The premises are licensed by the Home 
Office and are regularly v is ited  by appointed Veterinary 
Inspectors.
The volume of data which requires to be collected to monitor a 
group o f animals of th is  size is enormous. Approximately 45 to 50 
horses are harvested every week, and so large amounts of 
information are generated very quickly. Reference to h is to r ic  data 
can be very time-consuming under these circumstances, and space 
fo r  storage may become problematic.
In order to monitor the e ff ic iency of blood production there must 
be regular accurate recording of information fo r  ind iv idua ls . This 
is essential, to build up a picture fo r  the herd as a whole. 
E ffective co llec t ion  and storage of such information aids the 
selection of animals fo r the herd, and i t  id e n t i f ie s  which animals
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are performing best. I t  also id e n t i f ie s  early those horses which 
are not suited to the group system of management and to the 
practice o f regular, repeated blood harvest.
The owner o f the herd required a simple, e f f ic ie n t  system fo r  
storage o f data and one which would allow analyses o f information 
to fu r the r improve the existing management system. The aim was 
thus to create an equine management database, which was to be 
ta i lo re d  to the needs of the herd and the owner, and which took 
in to  account the unique features of the existing operations.
I t  was intended to reach a point where, by co llec t ing  spec if ic  
information fo r  each horse regularly , data fo r  that ind iv idual 
could then be extracted and analysed to provide a performance 
p ro f i le  which could be compared to p ro f i les  of others in the herd. 
Groupings fo r  performance could then be made, and management 
ta i lo re d  accordingly.
Analyses were then planned on collected data to investigate 
influence, of breed or type, sex, age and length o f time in blood 
production, fo r  examples, on the performance figures. Seasonal and
d ie tary  influences were to be examined; as well as the farm on
which the horse was grazed, and where i t  was harvested were to be 
compared.
Established Databases 
A database is a computerized record-keeping system, the purpose o f 
which is  to maintain information and to make i t  available on 
request (Date, 1986). Databases may be designed to provide 
in-depth examination of data, and to fa c i l i t a te  updating when more 
information is collected (Kock, Clark and Jessup, 1989). The 
system user may add new data to, or re tr ieve data from, ex is ting 
f i l e s ;  and data may be updated or deleted in existing f i l e s .  New 
f i le s  can be added to the system and existing f i le s  may be
permanently removed. The components of a database system are the
data, the hardware, the software and the users. Advantages of such 
a system are compactness, speed, reduction in drudgery, and 
currency (Date, 1986). The operation of databases by menu allows 
rapid access to data without the need fo r  extensive computer
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knowledge or experience (Kock, Clark and Jessup, 1989). 
Microcomputer spreadsheet packages can be u t i l is e d  to allow 
analysis and graphics programs allow visual display o f data (Kock, 
Clark and Jessup, 1989).
Databases are employed in several aspects o f veterinary medicine. 
They have been used, fo r  instance, to develop animal disease data 
banks (Jamaluddin, Chang, Johar and Yaacob, 1988). The CONSULTANT 
database, fo r  example, contains information on over 6,000 diseases 
of dogs, cats, horses, c a t t le ,  sheep, goats and swine; and is  used 
by hundreds o f veterinary practices and in s t i tu t io n s  across North 
America (White, 1988).
Databases also allow in te rp re ta t ion  of b io logica l data from 
w i ld l i f e  (Kock, Clark and Jessup, 1989). Provision o f sources of 
information in the f ie ld s  of animal health and production have 
been achieved (Giovannetti and Meissonnier, 1987). Systematic data 
storage and re tr ieva l programmes were developed fo r  tox ico log ica l 
and hazardous material case information (Hyde, S ch lo tfe ld t, 
Schmidt and Stahr, 1983); and a food-animal residue avoidance 
databank (FARAD) was created by research workers at f iv e  U.S. 
veterinary schools in 1986.
BOVID, Bovine Information and Diagnosis System, is a veterinary 
computer program which is designed to help the practis ing 
veterinary surgeon in the diagnosis of diseases of c a t t le  (Blood, 
B righ tl ing  and Larcombe, 1989). A co llec t ion  of possible diagnoses 
are produced in response to the input by the vet o f c l in ic a l  
f ind ings, epidemiological patterns and c lin ico-patho log ica l 
findings in ind iv iduals or in groups of c a tt le .  The diagnoses are 
l is te d  in order of diagnostic p robab il i ty , with a numerical 
p roba b il i ty  estimated fo r each. The primary advantages are that 
the information provided is current and comprehensive, based on 
Australian data, but there are future plans to include inputs from 
the United Kingdom and North America (Blood, B righ tl ing  and 
Larcombe, 1989).
The BENCHMARK database system was developed as the resu lt  of a 
three year study designed to monitor the health and production of
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the beef cow industry in Ontario, as a component o f e f f ic ie n t  food 
production in Canada (Martin, Lissemore and Kelton, 1990). The 
system involved cooperation of farmers, private veterinarians, 
government personnel and un ivers ity  veterinarians. The Veterinary 
Services o f the United States Department of A gr icu ltu re 's  Animal 
and Plant Health Inspection Service (APHIS) created the National 
Animal Health Monitoring System (NAHMS). This database is  founded 
on the co llec t ion  of data and bio logical specimens, from a 
s ta t is t ic a l  sample o f United States herds and animals, by 
government veterinarians and animal health technicians (Pointon 
and Hueston, 1990). The aim of the system is to protect and 
improve animal and human health, while guaranteeing q u a lity  and 
quantity o f animal-derived food and f ib re ,  and making the U.S. 
ag ricu ltu re  more competitive (Pointon and Hueston, 1990).
A c l in ic a l  database was constructed as a consequence o f a 
nationwide survey carried out by the B r it ish  Cattle Veterinary 
Association (BCVA) to investigate the circumstances under which 
Caesarian sections were performed on ca tt le  (Gettinby, Thorpe and 
Anderson, 1989). The database was developed from two sections o f a 
questionnaire, one section involved basic animal de ta ils  and 
d e ta ils  o f the operation, including outcome; while the second 
concerned subsequent f e r t i l i t y .  Analyses are underway on the 
information contained in th is  database (Gettinby, Thorpe and 
Anderson, 1989).
Examples of management databases include COSREEL (Computer system 
fo r  Recording Events affecting Economically important Livestock) 
in the U.K., which has been designed fo r the management o f ca t t le ,  
sheep and pigs at the Agricu ltura l Research Council In s t i tu te  fo r  
Research on Animal Diseases (Russell and Rowlands, 1983). In 
A fr ica , the International Livestock Centre fo r  A fr ica  (ILCA) 
developed, between 1984 and 1986, the ILCA Data Entry and Analysis 
System (IDEAS) to record and analyse a l l  the important performance 
t r a i t s  fo r  a wide range of livestock species, and store 
information on health, n u tr i t io n ,  climate and management aspects 
(Wissocq, Durkin, T ra i l ,  Gettinby, Bell, Berhane and Light, 1989). 
Equine management databases in the l i te ra tu re  are concerned with 
stud work. The use of a microcomputer was tested fo r  improving the
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stud management and ra is ing conception rates by Rohn and Reinhard 
(1985). The microcomputer evaluated the management and calculated 
target dates fo r  mating or insemination, fo r  teasing and 
gynaecological examination. Plans overviewed the s ta l l io n s  and 
mares with th e ir  re la tions, and dates o f each mare, plan o f 
foa ling , overview of pregnant mares and plans fo r  various 
vaccinations. Conception rate increased by 28% over two years o f 
operation o f the database system (Rohn and Reinhard, 1985).
The Benefits o f Management Databases 
The benefits o f using management databases are diverse. 
Relationships between variables that a ffec t performance and 
resu lts  are id e n t i f ie d ,  and variables can be made and monitored on 
a continuous basis (Bywater and Goodger, 1985). The use o f such 
systems may make the manager into a data user, rather than a data 
recorder, and the focus of management could be changed. In terest 
in re la t ing  control variables to production w i l l  probably 
increase; and the f a c i l i t y  fo r  calcu lation may provide q u a l i ta t ive  
answers to performance questions, rather than generalisations. A 
m u lt id isc ip l in a ry  approach to management and decision-making may 
be promoted by the use of a database (Bywater and Goodger, 1985).
Materials and Methods
Herd Details
The horses are part of a large herd, o f between 150 and 200 
animals, which is managed fo r  blood products in the West o f 
Scotland. The animals are harvested on a regular cycle, o f three 
weeks duration. The de ta ils  of the horses and th e ir  management 
system are given in the general Materials and Methods section.
Data Currently Recorded 
At present on the farm there is a microcomputer, situated at 
Burnhouse Farm. Data recorded fo r general management include the 
name and id e n t i f ic a t io n  number of each horse, i t s  age, breed, sex, 
and height. The source of acquisition of the animals are stored on 
f i l e ,  along with record of whether the horse is on loan from a 
member of the horse owning public, or whether i t  has been
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purchased by the owner o f the farms. Any other relevant de ta i ls  o f 
health or temperament o f horses are noted.
With respect to management fo r  blood products, at each harvest 
point the PCV fo r  each individual is  recorded, in addition to the 
volume o f blood collected, the percentage lo s t  in c lo t t in g  
(waste), and the volume dispensed from each harvest. The average 
packed ce ll  volume (PCV) fo r  the herd fo r  the week is  recorded to 
allow monthly and annual production figures to be calculated. The 
date on which the next harvest is due fo r  each horse is  projected.
Recording System and Analyses Performed 
The de ta i ls  fo r  each horse were stored in the microcomputer using 
a simple database system. Several simple calcu lations were 
undertaken longhand by the owner, fo r  example weekly and monthly 
blood volumes fo r  the herd as a whole; and retrospective 
comparisons were made o f these to ta ls  to to ta ls  fo r  previous 
years.
Details taken at the time of blood harvests were collected in a 
notebook, and preprinted da ily  sheets were used to record 
information once the blood was transferred to the dispensing 
laboratory.
Databases
A database is  a structured co llec t ion  of data, stored in a 
consistent fashion w ith in records which have a common format 
(Gettinby, Thorpe and Anderson, 1989). In a re la tiona l database 
the data are contained in two-dimensional tables, in which entries 
are not repeated and must a l l  be of the same form, with every 
column and row in the table being unique (Thrusfie ld, 1986). 
Relationships between the records are not determined u n t i l  they 
become operational, and so they may be constantly altered, which 
makes th is  type of database very simple and f le x ib le  (Thrusfie ld, 
1986).
Several important features are afforded by an e lectron ic  database, 
namely the f a c i l i t i e s  of range checks, lookup, query and 
transaction (Gettinby, Thorpe and Anderson, 1989). Normal ranges
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fo r  values fo r  PCV were b u i l t  in to  th is  database, to emphasise any 
abnormality to the manager, and to ensure accuracy o f information.
The lookup f a c i l i t y  ensures that the data entry is  va lid  by 
comparing i t  to a l im ited  co llec t ion  o f legal en tr ies . Mistakes 
and errors in typing, which could resu lt  in the fa i lu re  o f 
accurate extraction o f information, are thus prevented. Lookup was 
used in the s ta t ic  records w ith in th is  database, fo r  example, in 
the f ie ld  fo r  gender, where only f ,  or female, and g, or gelding, 
were lega l; and in the breed f ie ld ,  where cob, TB (Thoroughbred) 
and mid (crosses between cobs and Thoroughbreds) were acceptable 
en tr ies.
The query f a c i l i t y  allows rapid, accurate extraction o f data using 
a query language, and is the most valuable asset o f the database. 
The query command [gender] = f  and [height] > 16.0 hands could be 
entered, fo r  example, in th is  database to id e n t i fy  a l l  the female 
horses over 16.0 hands in height.
D iffe ren t databases may share information w ith in  a re la t iona l 
database, and the transaction f a c i l i t y  permits linkage of 
information by a common f ie ld .  In th is  database the common f ie ld  
was the animal id e n t i f ic a t io n  number, which allowed the manager to 
move between the three databases, the s ta t ic  records, the 
bloodroom records and the laboratory records.
Software Tools
There are several proprietary software packages available which 
provide data management options to s im plify  the construction and 
analysis o f e lectron ic databases (Gettinby, Thorpe and Anderson, 
1989). The software package used fo r the database in th is  thesis 
was the Smart system, Version 3.1 from Informix Software, which 
was selected because i t  is integrated to allow the use o f 
spreadsheet, wordprocessing and graphics f a c i l i t i e s .  The e a r l ie s t  
packages, such as dBASE by Ashton Tate, fo r  example, do not o f fe r  
th is  in tegra tion.
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Results
Overall Structure o f the Equine Management Database 
The equine management database was designed so that information 
was i n i t i a l l y  entered in to one o f three databases. Horse 
id e n t i f ic a t io n  de ta ils  were entered in to the S ta tic  Record in the 
f i r s t  database. Each horse was treated as a separate record, and 
each record consisted of nine f ie ld s .  These f ie ld s  were horse 
number and name; i t s  gender (female/gelding); i t s  age, in years; 
i t s  type, which was subdivided in to cob, Thoroughbred, or crosses 
between the two (cob/TB/mid); whether i t  was on loan or purchased 
(0/P); i t s  colour; i t s  height, in hands (< 15h/ 15 - 15.3h /
>16h), and the date on which i t  was acquired.
The second database contained information from the blood harvest 
room, with eight f ie ld s ,  with one each fo r  the animal number and 
name; on which farm blood was harvested from the animal (Burnhouse 
or Gartmorn H i l l  Farms; B/G); the date of blood harvest; the 
volume taken; the flow of the blood during harvest (good/poor); 
and the frac t ion  of blood to be dispensed (defibrinated blood, D, 
or serum, S). There was also a f ie ld  fo r  comments, such as the 
appearance o f the blood, or the temperament of the horse during 
the harvest.
Information from the farm laboratory was collected in the th ird  
database. The eight f ie ld s  contained w ith in th is  database took 
account o f the laboratory batch number; animal number and name; 
the volume o f blood collected (in l i t r e s ) ;  the volume o f blood 
dispensed ( in  l i t r e s ) ;  the PCV of the blood (as %); and the date 
of the end of the week of the blood co llec t ion . The amount o f 
blood which was los t during c lo t t in g  (% waste) fo r  each animal was 
automatically calculated by the computer, from the f ie ld s  fo r  
volume o f blood collected and the volume dispensed.
The screen layouts, containing sample data, fo r  the s ta t ic  record, 
bloodroom and laboratory databases are shown in Figures 37, 38 and 
39, respectively.
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STATIC RECORD
Animal Number : 194 Name : Crest
Description
Gender : f  Age : 15 Breed : Cob On loan or purchased : 0
Colour : Palomino Height : 15.0
Date of acquisition : 01.01.84
V_________________J
Figure 37. Screen layout for the static record database
BLOODROOM RECORD
Animal number : 194 Name : Crest
Bleeding Details  
Bled at G on 13.09.89
Volume taken : 7.6 litre s  Flow : Good Blood for : D
Comments : Horse excitable
Vs.
Figure 38. The screen layout for the bloodroom record
database
204
r
LABORATORY RECORD
Batch number : 1389 Animal number : 194 Name : Crest
Volume of blood collected : 7.6 l i t re s  
Volume of blood dispensed : 6.6 l i t re s  
With a PCV of 41 % Waste : 13 %
Collected during the week ending 15.09.89
Figure 39. The screen layout for the laboratory record
database
The database was operated by a menu system which allowed rapid 
access to the information without great knowledge or experience o f 
the computer. When the database program was loaded, the operator 
used the "EXECUTE" command, then was given the options o f "ENTER", 
to add, modify or delete records; or "ANALYSE", which allowed 
analysis o f the information contained w ith in  the databases. The 
th i rd  option was the "FINISH" command, which was used to escape 
from the program.
On selection o f e ither the "ENTER" or "ANALYSE" commands, the user 
was then asked to select which of the three databases were 
required: "STATIC" fo r the animal d e ta i ls ;  "BLOODROOM" fo r  the
bloodroom record database; or "LABORATORY", to access the
laboratory record database.
There were two options available w ith in  the analysis f a c i l i t y  of 
th is  database. In the menu the operator was offered the option of
analysing "STOCK", the data fo r the herd as a whole, or analysing
"ANIMAL", the analysis of data fo r  a p a r t icu la r  animal which was 
selected by the input of i t s  animal number. The information
displayed on the screen in response to the "STOCK" and "ANIMAL" 
commands are demonstrated in Figures 40 and 41, respectively.
The stock balance analysis record produces three f ie ld s  of data 
output fo r  the horse herd as a whole, namely the to ta l volume of 
blood collected to date, the to ta l volume dispensed to date, and 
the average waste.
The f ie ld s  fo r  to ta l volume of blood collected, to ta l volume 
dispensed, and average waste are also produced in response to the 
"ANIMAL" analysis command, and in addition, the number o f blood 
co llec t ions  made and the number o f qu a li ty  control fa i lu res  are 
calculated fo r  the individual horse.
The overall structure of the equine management database is 
presented diagrammatically in Figure 42.
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ASTOCK BALANCE SHEET TO DATE
Volume Collected : 9190.1 li t re s  
Volume Dispensed : 7736.4 li t re s  
Average Waste : 15.8 %
Figure 40. The screen display obtained by selecting the "STOCK" 
command in analysis within the equine management database
SUMMARY FOR ANIMAL NUMBER 194
Volume Collected : 53 litre s  
Volume Dispensed : 45.8 l itre s  
Average Waste : 13.5 %
This was from 7 collections 
There were 0 Quality Control Failures
V____________________ J
Figure 41. The screen display obtained in response to selection of 
the "ANIMAL" command in analysis within the 
equine management database
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Load SMART package
I
Load DATABASE program
I
Select "EXECUTE" command
"ENTER" "ANALYSE" "FINISH"
/ \"STATIC” "BLOODROOM" "LABORATORY"
"STOCK" "ANIMAL"
/
Stock Balance Sheet
Select Animal Number
\
Animal Summary Sheet
Figure 42. The overall structure of the equine management database
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Status Implemented
At the time o f w r it ing  th is  thesis, the database contains 1272 
records. The data from a l l  blood harvests on the two farms between 
July, 1989, when the farm laboratory was set up, and A pril 1990, 
are recorded.
A fte r entering information in to the database fo r  several months, 
and as a resu lt  of discussion with the manager o f the farms during 
th is  time, a requirement fo r  several working modifications was 
id e n t i f ie d .  The aim was to keep the system as simple as possible, 
and i t  was thought that the bloodroom and laboratory records could 
be combined. The modified database was to contain the f ie ld s  of 
the laboratory record, namely laboratory batch number, animal name 
and number, volume of blood collected, volume dispensed, PCV, and 
waste; and f ie ld s  fo r  the location of blood harvest, flow o f blood 
at harvest, and blood frac tion  dispensed, were to be added. The 
format of the date of harvest was to be altered, from the day,
month and year layout currently  adopted to the week number, from
one to 52, with week one as the f i r s t  week in January. This 
modification was aimed to make the comparison of performance 
figures w ith in  the database to those of previous years easier fo r  
the manager. Weeks had been numbered in th is  fashion, from one to 
52, to record information collected in previous years.
The lookup f a c i l i t y  had been introduced fo r the breed and height 
f ie ld s  on the s ta t ic  records as a modification o f an e a r l ie r
database, to s im plify  entry of these data. S im ila r ly , the addition 
o f a f ie ld  fo r  animal name as well as fo r animal number was the 
resu lt  o f modification of an e a r l ie r  record. The change was
instigated because the farm s ta f f  found id e n t i f ic a t io n  o f the 
animal in the blood harvest room easier by horse name than by 
number. In the orig ina l s ta t ic  record there were f ie ld s  fo r  horse 
weight, and fo r  the source and reason fo r  acquis it ion . The weight 
f ie ld  was considered unnecessary and was therefore abandoned. The 
manager prefers to record the information on acquis it ion of 
animals in a separate logbook, because the information is  often 
required at locations where there is no microcomputer terminal. 
These f ie ld s  were also deleted.
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The recording o f information fo r  the database by the manager is  
consistent now that the records have been ta i lo red  to her needs, 
and any ir re levan t f ie ld s  on records have been removed. The data 
recording is  thus kept b r ie f  and simple, which is  essential in 
th is  farm s itua t ion , as d if fe re n t  members o f s ta f f  w i l l  be 
involved in recording and in the input o f information to the 
database.
Discussion
The database as developed is a management to o l.  I t  was not 
designed s p e c if ic a l ly  fo r  s c ie n t i f ic  investigation although 
suitable information is contained w ith in the database. A fte r 
consideration o f analysis i t  has become clear tha t there is  a need 
fo r  a new way o f l in k ing  or transacting the records. In analysis 
o f performance data, the f ie ld s  of breed, blood volumes collected 
and dispensed, and PCV, should be recorded w ith in the same record 
to allow s ta t is t ic a l  corre lation using the spreadsheet w ith in  the 
Smart software package. At the moment, while the animal number is  
the only f ie ld  which permits transaction, th is  is not possible. 
The f ie ld  fo r  breed must be incorporated in to the combined 
bloodroom/1aboratory record, also become a l ink ing  f ie ld  fo r  these 
analyses to become possible.
The manager of the horses has id e n t if ied  several areas fo r  future 
development of the database. An additional "o u t-o f-c ircu la t io n  
temporarily" record is requested. This would contain data fo r  
young or brood animals, animals which are used fo r  r id in g  or 
d r iv ing , and horses which are temporarily on loan from the farm 
fo r  any reason. Information from these horses, which would be 
removed temporarily from the blood producing herd, could then be 
kept separate from that fo r  the blood horses.
A f a c i l i t y  fo r  s lo t t in g  individual animals in to established seven, 
14 or 21 day patterns fo r bleeding is required by the manager.
Idea lly , summary herd s ta t is t ic s  and summary animal s ta t is t ic s  
would be able to be called up in d if fe re n t ways fo r  analyses. At
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present, summary herd data analyses are calculated using every 
entry in the database. Subsequently there is no f a c i l i t y  to 
extract and analyse data fo r  a p a rt icu la r  week, or fo r  a 
p a rt icu la r  month fo r  the herd. I f  information could be analysed 
according to week number, then comparisons could be drawn between 
herd performance in successive weeks, months, or between housing 
and grazing. Performance might be assessed on volume o f blood 
collected and dispensed, or on the percentage average waste 
recorded. Targets might then be introduced fo r  these parameters, 
to attempt to improve herd production.
I f  data could be extracted and analysed fo r  ind iv iduals according 
to key f ie ld s ,  then widespread s ta t is t ic a l  examinations would be 
possible w ith in  the herd. The influence of breed, sex, age, and 
length o f time in blood production on performance could be 
investigated, fo r  instance. I t  would be in te resting  to compare 
blood volumes collected over a period of two months, or over six 
co llec t ions , from geldings and from mares. The percentage waste 
from animals which had been bled fo r less than f ive  years might be 
analysed, in contrast to waste from those which had been used fo r  
commercial blood production fo r longer than f ive  years. Volumes of 
blood collected from horses grazing at Burnhouse Farm over the 
summer months might be analysed to see i f  they were more or less 
productive than those which were at grass at Gartmorn H i l l  Farm. 
The permutations fo r  analyses would be numerous.
I t  might be possible to use results of summary animal data to 
modify herd management. The herd could perhaps be divided in to 
smaller groups, according to level of performance. Bracketing 
average blood co llec t ion  volumes as high, medium or low would 
permit subgrouping of the herd; and the feeding regime, fo r  
example, might be altered to supplement those animals fo r  which 
poor co llec t ion  volumes were recorded.
Horses which are consistently performing poorly under th is  
management system might be readily  id e n t if ie d  using the range 
check f a c i l i t y  w ith in th is  database system. Limits fo r  action 
could be decided by the manager and in b u i l t  in to the system fo r  
parameters such as volume of blood collected, or PCV value. I f
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values fo r  an individual fo r  these parameters were repeatedly 
below th is  l im i t ,  then corrective action would be required. The 
horse might have to be removed from the harvest group and rested 
fo r  several weeks, fo r  example.
In th is  respect the database system could be regarded as a tool to 
address any queries regarding the welfare o f th is  herd, in 
addition to being a management to o l.
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GENERAL DISCUSSION AND CONCLUSIONS
Skin disease, and in p a rt icu la r  bacteria l skin disease, was 
highlighted in th is  thesis as an area which has received l i t t l e  
attention in recent years. As such, i t  gives grounds fo r  concern 
with respect to the welfare of horses in the U.K.. Bacterial skin 
disease is  often misdiagnosed and d i f f i c u l t  to manage, resu lt ing  
in undue animal suffering and the prevention of useful work. 
A ttention was focused on dermatophilosis, which is  one o f the 
commoner bacteria l skin conditions of horses and ponies in the 
West o f Scotland. I t  is a condition to which outwintered animals, 
therefore the m ajority of the equine population in Scotland, are 
p a r t ic u la r ly  vulnerable. Prolonged exposure to excessive wetting 
predisposes to in fec t ion , which may then be manifest in recurrent 
annual outbreaks and which may be transmitted to other animals and 
to man. These circumstances warranted investigation o f an 
a lte rna tive  approach to management of dermatophilosis in horses.
Essential fa t ty  acids (EFAs) were investigated in th is  respect. 
The ro le  o f EFAs, in the form of evening primrose o i l  (EPO) which 
contains n-6 series l in o le ic  acid (LA) and gamma-1inolenic acid 
(GLA), with added f ish  o i l  containing n-3 series eicosapentanoic 
acid (EPA) and vitamin E, and the success of th e ir  use in the 
management of skin disorders in man and in companion animals were 
reviewed in th is  thesis. LA and GLA are known to be essential in 
the maintenance of the in te g r i ty  of the impermeability ba rr ie r 
formed by the skin to water. EFAs also modulate the immune
response, and the supplementation of LA and GLA increases
formation of anti-inflammatory metabolites while in h ib i t in g  the 
formation o f pro-inflammatory metabolites. EFAs have been shown to 
be free from adverse events, and are non-carcinogenic. The 
pharmacokinetics of EFAs were studied in the horse fo r  the f i r s t  
time, and the possible role of EFAs in the management of equine 
dermatophilosis was investigated.
Baseline information on the metabolism of EFAs in horses was 
obtained in a pharmacokinetic study. LA must be converted to i t s  
metabolites to exert the fu l l  range of bio logical actions o f EFAs
(Horrobin, 1990b). The conversion of LA to GLA is the f i r s t  and
the rate l im it in g  step in the EFA metabolic cascade, and is 
controlled by the 6-desaturase enzyme. Considerable species
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var ia t ion  is  known to ex is t in the rate o f th is  conversion, as 
indicated by the ra tion of LA to i t s  metabolites. The reaction 
rate is  known to be fastest in the ra t ,  and slowest in the rabb it 
and the guinea pig (Horrobin, 1990b). I t  was found in the horse to 
be very slow, comparable to that in other herbivores such as the 
rabb it or guinea pig, and was very much slower than the reaction 
in dogs, cats or in man. This was a ttr ibu ted  to slow 
6-desaturation of the LA by the 6-desaturase enzyme.
A d a i ly  dose regime of 20g of 80% EPO and 20% f ish  o i l  and vitamin 
E (Efamol Marine), providing n-6 and n-3 series EFAs, was adopted 
from the resu lts  of the pharmacokinetic study, to allow maximum 
opportunity fo r  EFA uptake. This dose was used in consequent 
contro lled studies to investigate the use o f EFAs in the 
treatment, then in the prophylaxis, of dermatophilosis in horses.
During the pharmacokinetic study no influence was recorded on the 
condition o f the coat, mane, t a i l  or hooves, or on general body 
condition which could be a ttr ibu ted to EFA treatments. No adverse 
influence was recorded on haematological and biochemical 
parameters by the various doses of n-6 and n-3 EFAs administered 
to the horses.
In a placebo-controlled, double blind treatment study no
s ig n if ic a n t e ffec t was seen on the severity or on the extent of
d is t r ib u t io n  of lesions of dermatophilosis when horses received 
20g oral n-3 and n-6 EFAs da ily . No s ig n if ica n t improvement was 
afforded by EFAs on the condition of the coat, mane, t a i l  or
hooves, nor on general body condition. No influence, adverse or
bene f ic ia l,  was exerted by EFAs on haematological or biochemical 
parameters.
When the use of EFAs in treatment of dermatophilosis in horses was 
found to be unsuccessful, a controlled experiment was designed to 
investigate the ro le of EFAs in the prophylaxis o f the disease. 
The study spanned the period of high ra in fa l l  in the autumn and 
winter months when the r is k  of developing the disease is highest 
in horses in the U.K.. The period of supplementation of EFAs was 
begun before the horses were exposed to the prolonged wetting
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which is thought to damage the epidermis, predisposing to 
dermatophilosis. The treatment was thus provided before 
dermatophilosis lesions developed, while the epidermis was in ta c t .  
EFAs did not prevent the development of lesions, nor did they 
reduce the incidence of in fe c t ion . As in the pharmacokinetic and 
treatment studies, no improvement in the condition o f the coat, 
mane, t a i l  and hooves or general body condition was seen; and no 
s ig n if ic a n t  influence was exerted on haematological or biochemical 
parameters by EFAs.
Two p o s s ib i l i t ie s  were considered to account fo r  the fa i lu re  o f 
EFAs in the management of equine dermatophilosis, and the fa i lu re  
to improve c l in ic a l  condition in the horse. F irs t ly ,  the dose rate 
may not have been s u f f ic ie n t .  A higher dose rate, however, would 
be impractical to administer o ra l ly  and would prove a very 
expensive treatment. The horses which are at greatest r is k  from 
dermatophilosis in fection are usually those which are poorly 
managed, and where l i t t l e  f inanc ia l consideration is given to the 
animals. Under these circumstances expensive treatment is  un like ly  
to be viable.
A lte rn a t ive ly ,  EFAs may not be as important in the horse as they 
have been shown to be in other species. I t  may be that th is  is 
re flec ted  by the slow 6-desaturase reaction rate found in th is
species.
EFAs were not found to be harmful in the horse. No adverse e ffe c t 
was recorded on any parameter fo r  any horse by EFA or placebo
treatments administered during the studies. Although no influence 
was believed to be exerted on haematological or biochemical 
parameters by EFAs during the studies, the monitoring o f such
parameters has provided a useful database of haematological and
biochemical information fo r  healthy horses.
The characteris tics of D. congolensis were examined in re la t ion  to 
the s i td  and severity of lesions of dermatophilosis. No 
corre la t ion  was found in th is  respect. Although s im i la r i t ie s  
between isolates were id e n t i f ie d ,  by examination of d i f fe re n t ia l  
bacterio log ica l growth characteris tics and by sodium dodecyl
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sulphate polyacrylamide gel electrophoresis (SDS-PAGE), a l l  the 
iso lates o f D. congolensis investigated were d if fe re n t .
P ro teo ly tic  enzyme production by D. congolensis was investigated 
with regard to the virulence of the organism. No keratinase, 
collagenase or elastase a c t iv i t ie s  were detected. Several isolates 
did, however, demonstrate ex trace llu la r protease a c t iv i t y .  The 
resu lts  o f the study suggested that two proteases were produced. 
One, estimated to be of 110 kD, demonstrated caseinase a c t iv i t y  
which was evidenced as p rec ip ita t ion  o f caseinate on agar, and 
gelatinase a c t iv i ty ,  detected using SDS gelatin-PAGE. The other, a 
protease o f lower molecular weight, demonstrated caseinase 
a c t iv i t y .  In th is  work, the production of protease a c t iv i ty  could 
not be used as a marker of virulence because i t  was not produced 
by every iso la te  which induced c l in ic a l  lesions of 
dermatophilosis. Further investigation is required in to  the 
possible implication o f protease a c t iv i ty  in the disease process 
of dermatophilosis.
The horses under study in th is  thesis were kept fo r  commercial 
blood production and as such were subjected to regular, repeated 
blood harvest. The c l in ic a l  and haematological consequences o f the 
practice o f bleeding horses regularly have been p a r t ic u la r ly  
neglected and th is  herd provided an unique opportunity to monitor 
the welfare of animals which are involved in such practices. The 
c l in ic a l ,  protein and haematological p ro f i les  o f a group o f 
animals w ith in  the herd were followed over f ive  harvest cycles, 
leading to a more detailed analysis of haematological data 
obtained from a smaller number of horses between two harvest 
points. Cyclic patterns of recovery were established fo r  
haematological parameters, but values remained w ith in  normal 
ranges at a l l  times. The animals were ca re fu lly  attended and well 
fed, and consequently the horses were in excellent body condition. 
No adverse e ffec t was recorded on c l in ic a l ,  protein or 
haematological p ro f i les  when 8 l i t r e s  of blood were removed from 
the horses every three weeks. Reassurance was thus provided that 
there were no adverse c l in ic a l  and haematological consequences of 
regular, repeated bleeding in these horses under th e ir  current 
management system.
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S ta t is t ic a l  analyses revealed that Thoroughbred animals, which 
have higher blood volumes, supported repeated bleeding be tter than 
non-Thoroughbred animals: red ce ll parameters were always
s ig n i f ic a n t ly  higher. Based on th is  information, and the recovery 
patterns fo r  the haematological parameters, i t  was thought tha t 8 
l i t r e s  o f blood could be removed from Thoroughbreds more 
frequently without adverse e ffec t.  A harvest frequency o f two 
weeks was therefore suggested fo r the Thoroughbreds under th is  
management system, but not fo r the other animals in the herd.
A re la t iona l management database system was created fo r  a 
microcomputer, as a management tool fo r  the manager o f the horse 
herd. An integrated computer software package provided the 
f a c i l i t i e s  of spreadsheet, wordprocessor and graphics.
The overall structure o f the system comprised three databases 
which contained information on horse de ta i ls , bloodroom records 
and laboratory records, respectively. The manager was afforded 
f l e x i b i l i t y  to move between these databases, which were linked by 
the animal id e n t i f ic a t io n  number. Information contained w ith in  the 
f ie ld s  o f these records could be constantly updated, and there was 
provision fo r  analyses of data, e ither fo r the horse herd as a 
group, or fo r  an individual animal.
At the time of w r it ing  the database contained 1272 records, and 
analyses of these data had begun. In working with the system, 
areas which required modification were id e n t i f ie d  and relevant 
a lte ra tions  were made. The database as developed is a management 
to o l.  I t  was not designed fo r s c ie n t i f ic  investigation although 
w ith in  i t  suitable information is contained fo r such examinations.
The potentia l merits of the database as a management tool are 
highlighted fo r  th is  horse herd. The widespread benefits afforded 
by such a system could be appreciated by others, as the database 
may be adapted to numerous aspects of the management of groups of 
horses. From the welfare aspect, the database could be adapted to 
detect quickly any animals which were performing poorly and any 
which became anaemic. This would allow corrective action to be 
instigated promptly, thus avoiding any undue animal suffering .
218
While a cure was not found fo r  dermatophilosis, i t  is  hoped that 
by h igh ligh t ing  the problem and developing management too ls  fo r  
monitoring equine health and wellbeing that th is  thesis has 
contributed to the welfare o f horses in the U.K..
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APPENDIX I
TABLES OF RESULTS OF THE STUDY ON THE PHARMACOKINETICS OF EFAs IN
HORSES
C lin ica l Indices, Haematological and Biochemical Parameters
1
Table I
Coat condition scores
Scored on a 1 to 10 scale, 1 is  poorest, 10 i 
Horse
5g EPO d a i ly  
Annabelle 
Donald 
Myrtle 
Calumn 
G ira ffe  
Gunsmoke 
Sovereign 
Orlando 
Jack „ 
Nicholas 
Suzie 
Hermione
Mean
S.D.
Week
0 3 6
7 7 7
4 6 6
4 6 6
6 8 8
7 4 6
3 4 7
4 4 75 6 7
6 8 8
4 5 8
4 4 6
6 7 8
5.0 5.8 7.0
1.3 1.5 0.9
Group
mean
5.9
lOg EPO alternate day
Charlotte
Marigold 
Jasperrx * L  n
PIS? Dongora 
Chocolate 
Goldie 
Durando 
BeBe 
Samuel 
Jordan 
Dick
Mean
S.D.
5 5 5
6 6 6
5 5 5
6 6 6
4 4 4
5 5 5
4 4 4
6 6 6
6 6 6
5 5 5
5 6 6
6 8 8
5.3 5.5 5.5
0.8 1.1 1.1
Group
mean
5.4
20g EPO d a i ly
5aflace 
Gold Loch 
Bonny 
Skippy
Rocky
Cnariie
G$no
Biggies
SmiTer
Aird
Mean
S.D.
3 5 6
5 5 8
5 5 6
4 5 6
6 7 7
5 4 6
5 7 7
6 7 6
5 7 7
5 5 7
4 5 6
6 7 7
4.9 5.8 6.6
0.9 1.1 0.7
Group
mean
5.8
40g EPO alternate day
Karl ops
Big Ben
Walter
Pollux
Armpit
Sandy Lad
Sabrian
Qllie
Poppett
imit
Darkie
Mean
S.D.
4
5 
5
5 
4 
4
6
4 
3
5 
5 
3
4.4
0.9
7 75 6
5 5
6 7
7 8 
6.4 6.9
1.1 1.0
Group
mean
5.9
optimal
2
Table I I
Mane condition scores
Scored on a 1 to 10 scale, 1 is  poorest, 10 i 
Horse
5g EPO d a i ly  
Annabelle 
Donald 
Myrtle 
Calumn 
G ira ffe  
Gunsmoke 
Sovereign 
Orlando
Nicholas 
Suzie 
Hermione
Mean
S.D.
Week
0 3 6
6 6 c
5 7 6
5 7 64 7 7
4 4 5
4 6 6
4 6 6
5 6 6
5 6 7
5 6 6
4 4 4
5 6 7
4.7 5.9 6.0
0.7 1.0 0.9
Group
mean
5.5
lOg EPO alternate day 
Charlotte
Marigold
Jasper
Ding Dong
Flora
Chocolate
Goldie
Durando
BeBe
Samuel
Jordan
Dick
Mean
S.D.
5 6 7
6 6 7
5 6 6
6 7 6
4 4 6
5 6 6
5 6 6
5 6 6
6 7 6
5 6 7
5 6 6
5 7 8
5.2 6.1 6.4
0.6 0.8 0.7
Group
mean
5.9
20g EPO d a i ly
C S fface
Gold Loch
Bonny
Skippy
Flynn
Rocky
Cnarlie
G?no
Biggies
SmiTer
Aird
Mean
S.D.
5 6 6
3 5 7
5 5 6
3 6 7
5 7 6
5 5 7
5 6 6
5 7 6
5 7 6
5 5 5
5 6 7
6 6 6
4.8 5.9 6.3
0.9 0.8 0.6
Group
mean
5.6
40g EPO alternate day 
Karl ops 
Big Ben 
Walter 
Pollux 
Armpit 
Sandy Lad 
Sabrian 
Oil ie 
Poppett 
Tessa 
Alfred 
Darkie
Mean
S.D.
5
5
5
4
4 
3
5 
5
3 
5 
5
4
4.4
0.8
5.7 6.4
1.2 0 .8
Group
meag
optimal
3
Table I I I
Tail condition scores
Scored on a 1 to 10 scale, 1 is  poorest, 10 i 
Horse
5g EPO d a i ly
Annabelle 
Donald 
Myrtle 
Calumn 
G ira ffe 
Gunsmoke 
Sovereign 
Orlando 
Jack 
icnolNi h as 
Suzi? 
Hermione
Mean
S.D.
Week
0 3 6
6 6 7
5 6 6
5 7 7
5 7 7
4 4 6
4 6 7
4 4 7
5 6 7
5 7 75 6 7
4 5 5
5 6 7
4.8 5.8 6.7
0.6 1.0 0.7
Group
mean
5.8
lOg p o .a l te rn a te  day
  o tte
Marigold
Jasper
Ding Dong
Flora
Chocolate
Goldie
Durando
BeBe
Samuel
Jordan
Dick
Mean
S.D.
5 6 7
6 6 7
5 6 6
6 7 6
4 6 7
5 6 7
5 6 7
5 6 7
6 7 7
5 6 7
5 6 6
5 7 8
5.2 6.3 6.8
0.6 0.5 0.6
Group
mean
6.1
20g EPO d a i ly
Wallace 
Gold Loch 
Bonny 
Skippy 
Flynn 
Rocky 
Chariie 
Geno 
Biggies 
SrpiTer 
Aird
Mean
S.D.
5
3
5
3
5
5
5
5
5
5
5
6
4.8
0.9
7
8 
6 
7 
7 
7 
6 
7 
7
5 6
§ 76 6 
5.9 6.8 
0.8  0.6
Group
mean
5.8
40g EPO alternate day
Karl ops
Big Ben
Walter
Pollux
Armpit
Sanay Lad
I w i ™
Poppett
IW r ld
Darkie
Mean
S.D.
5
5
5
5
4 
3
5 
5
3 
5 
5
4
4.5
0.8
5 ?7 7
6.2 6.9
1.3 0.9
Group
mean
5.9
optimal
4
Table IV
Hoof condition scores
Scored on a 1 to 10 scale, 1 is  poorest, 10 i 
Horse
5g EPO d a i ly  
Annabelle 
Donald 
Myrtle 
Calumn 
G ira ffe 
Gunsmoke 
Sovereign 
Orlando
Nicholas
Suzi?
Hermione
Mean
S.D.
Week
0
5 6 6
4 6 6
3 5 6
5 6 8
5 5 7
5 7 7
5 5 7
4 4 6
6 7 8
4 4 7
5 5 5
4 5 7
4.6 5.4 6.7
0.8 1.0 0.9
Group
mean
5.6
lOg EPO alternate day 
Charlotte
Marigold
Jasper
Ding Dong
Flora
Chocolate
Goldie
Durando
BeBe
Samuel
Jordan
Dick
Mean
S.D.
4 6 7
6 7 7
5 7 8
6 7 6
4 6 8
5 6 8
5 6 6
4 6 8
4 5 6
5 6 7
4 6 6
5 8 8
4.8 6.3 7.1
0.8 0.8 0.9
Group
mean
6.1
20g EPO d a i ly
JSaflface
Gold Loch
Bonny
Skippy
Flynn
Rocky
Charlie
S fS S le .
f f i r
Mean
S.D.
4 6 5
4 5 7
4 5 6
2 4 6
5 5 6
4 4 8
5 6 7
5 7 8
5 6 7
4 5 6
5 5 6
6 7 7
4.4 5.4 6.6
1.0 1.0 0.9
Group
mean
5.5
40g EPO alternate day 
Karl ops 
Big Ben 
Walter 
Pollux 
Armpit 
~ idy Lad 
>nan 
ie 
>oppett
i m i  d
Darkie
Mean
S.D.
6 7 8
4 6 7
5 6 7
3 6 6
5 4 6
4 6 6
6 7 7
5 7 7
5 5 6
5 5 7
4 5 6
4 5 7
4.7 5.8 6.7
0.9 1.0 0.7
Group
T 9
optimal
5
Table V
Red ce ll  counts
Horse Week 0
5g EPO d a i ly  
Annabelle 
Donald 
' t ie
Values x lO ^ / l
Week 3 Week 6
Myr1
O .Gunsmoke
Sovereign
Orlando
Jack
Nicholas
Suzie
Hermione
Mean
S.D.
lOg EPO al
Charlotte 
Marigold 
Jasper 
Ding Dong 
Flora 
Chocolate 
Goldie 
Durando 
BeBe 
Samuel 
Jord
Dick
Mean
S.D.
an
7.6 7.2 7.1
6.6 6.6 M6.4 6.8 6.7
5.9 6.2 6.7
6.7 6.0 7.5
6.7 7.2 7.3
5.3 5.6 7.3
7.8 6.1 8.1
8.2 6.0 8.8
6.1 6.6 7.5
7.6 6.8 8.0
6.9 6.0 7.1
6.82 6.43 7.46
0.85 0.52 0.60
day
7.2 5.4 8.5
7.2 6.4 8.0
6.8 5.4 8.6
6.8 5.3 6.3
7.7 8.3 9.9
8.6 7.5 8.6
7.7 6.2 8.4
6.6 5.1 7.3
5.5 5.4 6.8
7.0 7.9 8.2
7.4 5.9 6.3
8.9 8.8 9.9
7.28 6.47 8.07
0.90 1.31 1.21
6.90
7.27
20g EPO d a i ly
Foxy
Wallace
Gold Loch
Bonny
Skippy
Flynn
Rocky
Chari ie
Geno
Biggies
SmiTer
Aird
Mean
S.D.
40g EPO alternate day 
Karl ops 7.2
Big Ben  ^ *
Walter 
Pollux 
Armpit 
Sandy Lad 
Sabrian 
Q ll ie  
Poppett
M t d
Darkie 
Megn
7.5 6.6 8.4
7.0 6.4 7.9
7.3 6.5 7.5
7.0 6.4 7.7
7.0 6.6 7.4
6.0 5.9 5.9
6.5 6.1 7.9
6.8 6.3 6.8
6.3 5.3 7.6
7.3 5.9 7.9
8.5 7.5 8.5
6.2 7.3 7.5
6.95 6.40 7.58
0.68 0.60 0.70
i v
8.1 8.7
6.4 6.1 7.1
5.4 6.5 7.3
5.1 5.5 7.5
6.9 6.9 7.9
5.7 8.3 9.0
4.5 6.3 7.5
6.6 6.6 Z-47.4 8.1 9.2
6.2 6.1 6.6
6.2 5.9 8.0
5.7 6.8 7.0
6.11 6.77 7.77
0.87 0.93 0.82
6.98
6.88
6
Table VI
Haemoglobin values
Horse Week 0
5g EPO d a i ly  
Anna be lle
Values in  g /d l
Week 3 Week 6
Dona'
Myrt
Gira _
Gunsmoke
Sovereign
Orlando
Jack
Nicholas
Suzie
Hermione
Mean
S.D.
lOg EPO al
Charlotte
Marigold
Jasper
Ding Dong
Flora
Chocolate
Goldie
Durando
BeBe
Samuel
Jordan
Dick
Mean
S.D.
5.3
3.0
2.7
1.7
2.5
2.3 
0.0
4.8
4.9 
1.7
3.5
2 . 0
14.0 
12.8
13.3
12.5
11.3
13.5
11.0 
11.1 
10.9
12.6
12.3 
10.6
12.7
13.1
11.7
12.3
12.4 
12.3
12.8  
13.6
14.1
13.2 
12.8
11.2
12.87 12.16 12.68
1.55 1.15 0.79
;e day
13.3 9.3 13.8
12.7 12.1 13.3
11.2 8.9 12.3
12.4 10.0 10.4
13.5 13.9 15.1
14.7 12.9 13.2
15.1 11.8 13.9
12.0 9.4 12.0
10.6 10.5 12.0
13.0 14.2 13.5
14.6 11.5 11.0
16.6 16.6 16.9
13.31 11.76 13.12
1.72 2.33 1.77
20g EPO d a i ly
Foxv
Wallace
Gold Loch
Boijny
Skippy
G ®Chan ie
Geno
Biggies
SmiTer
Aird
Mean
S.D.
12.5 11.8 [3.1
13.5 12.3 [3.7
13.4 11.8 [2.2
14.4 12.9 [4.5
12.0 10.9 LI.5
11.3 11.2 [0.3
12.4 11.7 L3.4
12.6 11.5 [1.6
12.2 10.1 [3.0
13.5 10.8 [2.9
14.6 12.8 1.6
10.6 12.8 12.0
12.75 11.72 12.48
1.19 0.88 1.16
40g EPO
Karl ops 
Big Ben 
Walter 
Pollux 
Armpit 
Sandy Lad 
Sabrian 
01 l i e  
Poppett
i m i d
Dark;ie
Mean
S.D.
alternate day 
12.6  
12.8
10.3 
9.6
12.3 
10.6
8.4 
12.8
13.1
11.9
12.1
10.9
11.45
1.48
14.3 
12.0
11.9 
10.8 
12.5
14.9
11.4
1U
11.7
11.2
13.0
12.52
1.30
14.0
13.1
12.3
13.1 
12.8
14.3 
12.0
11:111.5 
13.9
11.6
13.00
1.00
Group
mean
12.57
Group
mean
12.73
Group
mean
12.32
Group
mean
12.32
7
Table VII
Packed ce ll  volumes
Horse Week 0
f tnna
Dona'
Gira . 
Gunsmoke 
Sovereign 
Orlando 
Jack 
Nicholas 
Suzie 
Hermione
Mean
S.D.
(jiaily
Values in  1/1
Week 3 Week 6
0.440
0.379
0.367
0.336
0.371
0.364
0.297
0.434
0.430
0.343
0.401
0.358
0.3767
0.0432
0.408
0.376
0.388
0.360
0.327
0.390
0.317
0.336
0.313
0.368
0.356
0.314
0.3544
0.0327
0.373
0.383
0.358
0.360
0.377
0.361
0.375
0.412
0.428
0.425
0.379 Group 
0.341 mean
0.3810
0.0273
0.3707
10g fPO^alternate dajj
Charlotte
Marigold
Jasper
Ding Dong
Flora
Chocolate
Goldie
Durando
BeBe
Samuel
Jordan
Dick
Mean
S.D.
20g EPO d a i ly
Foxy
Wall ace
Gold Loch
Bonny
Skippy
Flynn
Rocky
Chari ie
Geno
Biggies
SmiTer
Aird
Mean
S.D.
Karl ops
Big Ben
Walter
Pollux
Armpit
Sandy Lad
Sabrian
Oil ie
Poppett
Tessa
Alfred
Darkie
Mean
S.D.
0.376
0.339
0.369
0.397
0.445
0.434
0.353
0.314
0.374
0.425
0.491
0.289
0.348
0.258
0.287
0.413
0.377
0.343
0.269
0.301
0.411
0.331
0.477
0.432
0.404
0.383
0.305
0.466
0.406
0.431
0.360
0.365
0.393
0.329 Group 
0.537 mean
0.3923 0.3420 0.4009
0.0496 0.0670 0.0621
0.362 0.333 0.391
0.391 0.355 0.397
0.393 0.344 0.364
0.429 0.381 0.447
0.347 0.323 0.363
0.329 0.323 0.307
0.363 0.339 0.400
0.375 0.343 0.357
0.354 0.296 0.398
0.392 0.316 0.398
0.435 0.384 0.362
0.325 0.382 0.359
0.3746 0.3433 0.3786
0.0351 0.0280 0.0345
ite day 
0.369 0.415 0.425
0.370 0.354 0.387
0.296 0.346 0.360
0.288 0.304 0.391
0.372 0.365 0.388
0.309 0.441 0.447
0.244 0.332 0.367
0.367 0.364 0.421
0.394 0.418 0.453
0.353 0.341 0.328
0.353 0.330 0.410
0.322 0.373 0.352
0.3364 0.3653 0.3941
0.0445 0.0407 0.0385
0.3784
0.3655
0.3653
8
Table V I I I
Horse
5g EPO d a i ly
Annabelle
Dona'
KT*
Gira _ 
Gunsmoke 
Sovereign 
Orlando 
Jack 
Nicholas 
Suzie 
Hermione
Mean
S.D.
lOg EPO al
Charlotte
Marigold
Jasper
Ding Dong
Flora
Chocolate
Goldie
Durando
BeBe
Samuel
Jordan
Dick
Mean
S.D.
! values, in f l
; 0 Week 3 Week 6
57.9 56.7 52.5
57.4 56.9 52.1
57.4 57.1 53.8
56.9 58.0 53.6
55.3 54.5 50.1
54.3 54.2 49.2
56.0 56.6 51.2
55.6 55.1 51.2
52.4 52.1 48.6
56.2 55.7 56.1
52.8 52.4 47.5
51.9 52.3 48.1
55.34 55.13 51.17
2.06 2.05 2.60
:e day
54.2 53.6 51.0
52.6 54.4 50.8
49.8 47.8 44.6
54.3 54.2 48.6
51.6 49.8 47.0
51.8 50.2 47.3
56.3 55.3 51.6
53.5 52.7 49.0
57.1 55.7 53.5
53.4 52.0 48.2
57.5 56.1 52.2
55.2 54.2 53.8
53.94 53.00 49.80
2.33 2.59 2.81
53.88
52.25
20g EPO d a i ly
Foxy 
i l l ;
Gold Loch
Wa lace
Bonny 
Skippy
Char1ie
Geno
Biggies
SmiTer
Aird
Mean
S.D.
40g EPO alternate day 
Karlops 51.3
Big Ben ”
WaTter 
Pollux 
Armpit 
Sandy Lad 
Sabrian 
Oil ie 
Poppett
i m i  d
Darkie
Mean
S.D.
48.4 50.5 46.4
55.9 55.5 50.3
53.8 52.9 43.8
61.3 59.6 57.8
49.6 49.0 48.9
54.8 54.7 52.0
55.9 55.6 50.8
55.2 54.5 52.6
56.2 55.8 52.2
53.7 53.5 50.5
51.2 51.2 48.5
52.4 52.3 48.1
54.03 53.76 50.16
3.42 2.84 3.51
e
. 51.2 48.9
57.8 58.1 54.7
54.8 53.3 49.2
56.4 55.2 51.9
53.9 52.9 49.4
54.2 53.1 49.8
54.3 52.7 48.9
55.7 55.2 52.9
53.2 51.6 49.2
57.0 55.9 49.6
56.9 55.9 51.6
56.5 54.9 50.1
55.17 54.17 50.52
1.89 2.03 1.85
52.65
53.28
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Table IX
Mean cell haemoglobin values, in pg
Horse Week 0 Week 3 Week 6
59 M ilyAnna.
Dona
a r
lira  . 
Gunsmoke 
Sovereign 
Orlando 
Jack 
Nicholas 
Suzie 
Hermione
Mean
S.D.
18.92
0.85
20.1 L9.4
19.7 L9.4
19.8 L9.6
19.8 20.2
18.7 18.8
18.4 18.8
18.9 19.6
19.0 L8.2
18.2 18.2
19.2 [9.1
17.8 [8.1
17.4 [7.7
18.93
0.76
7.9
7.8 
7.6
8.3
6.5
6.8
7.5 
6.9 
6.0
7.4
6.0 Group 
5.8 mean
17.04
0.83
18.29
lOg EPO al
Charlotte
Marigold
Jasper
Ding Dong
Flora
Chocolate
Goldie
Durando
BeBe
Samuel
Jordan
Dick
Mean
S.D.
e day
18.5 17.2 [6.3
17.8 18.9 [6.7
16.5 16.5 [4.3
18.2 18.9 L6.6
17.5 16.7 [5.2
17.1 17.2 L5.4
19.6 19.0 [6.6
18.2 18.4 [6.3
19.3 19.4 [7.6
18.6 18.0 [6.5
19.7 19.5 [7.5
18.7 18.9 [6.9
18.31 18.22 16.33
0.98 1.06 0.95
17.62
20g EPO d a i ly
Waflace
Gold Loch
Bonny
Skippy
Flynn
Rocky
Chariie
Geno
Biggies
SmiTer
Aird
Mean
S.D.
16.8 17.9 [5.6
19.3 19.2 [7.3
18.4 18.2 6.2
20.6 20.2 [8.8
17.1 16.5 5.5
18.8 19.0 L7.5
19.1 19.2 L7.0
18.5 18.3 [7.1
19.4 19.1 [7.1
18.5 18.3 [6.4
17.2 17.1 5.5
17.1 17.5 [6.1
18.40 18.38 16.68
1.16 1.03 0.98
17.82
40g EPO alternate day 
Karlops 17.5
-  2 0 . 0
19.1 
18.8
17.8 
18.6
18.7
Big Ben 
Walter 
Pollyx 
Armpit 
Sandy Lad 
Sabrian 
01 l i e  
Poppett 
Tessa 
Alfred 
Darkie
Mean
S.D.
19.4
17.7
19.2
19.5
19.1
18.78
0.77
17.7
19.7
18.3 
19.6 
18.1 
18.0 
18.1 
18.9
17.3 
19.2
19.0
19.1
18.58
0.77
16.1
18.5
16.8
17.4
16.3
15.9 
16.0
16.5
15.5
17.4
17.5 Group
16.5 mean
16.70
0.85
18.02
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Table X
Mean ce ll  haemoglobin concentration values, in  g/dl
Horse Week 0 Week 3 Week 6
5g EPO d a i ly  
Annabelle 
Donald 
Myrtle
(5ira??e
Gunsmoke 
Sovereign 
Orlando 
Jack 
Nicholas 
Suzie 
Hermione
Mean 34.15 34.33 33.32 33.93
S.D.
34.8 34.3 34.0
34.3 34.1 34.2
34.6 34.3 32.7
34.9 34.8 34.2
33.7 34.6 32.9
33.8 34.6 34.1
33.7 34.7 34.1
34.1 33.0 33.0
34.7 34.9 32.9
34.1 34.3 31.1
33.6 34.5 33.8
33.5 33.8 32.8
0.50 0.52 0.93
10g fPO^alternate^day
Charlotte
Marigold
Jasper
Ding Dong
Flora
Chocolate
Goldie
Durando
BeBe
Samuel
Jordan
Dick
Mean
S.D.
20g EPO d a i ly
Foxy 
Gold Loch
Wallace
Bonny 
Skippy
E'ycnRocky
Char I ie
Geno
Biggies
SmiTer
Aird
Mean
S.D.
Big Ben
Walter
Pol Tux
Armpit
Sandy Lad
Sabrian
Oil ie
Poppett
Tessa
Alfred
Darkie
Mean
S.D.
33.9
33.1
33.6
34.0
33.0
34.8
34.0
33.8
34.8 
34.3
33.8
32.1
34.8
34.5
34.8
33.6
34.3
34.4 
35.0
34.9
34.6
34.7
34.8
31.9
32.9
32.1
34.1
32.4
32.5
32.3
33.3
32.9
34.4
33.4 Group
31.5 mean
33.98 34.38 32.81
0.60 0.81 0.87
34.5 35.4 33.5
34.5 34.6 34.5
34.1 34.3 33.5
33.6 33.8 32.8
34.6 33.7 31.7
34.4 34.7 33.6
34.1 34.5 33.5
33.6 33.5 32.5
34.5 34.2 32.7
34.4 34.2 32.4
33.5 33.3 32.0
32.6 33.5 33.4
34.03 34.14 33.01
0.60 0.61 0.79
:e day
34.1 34.5 32.9
34.6 33.9 33.9
34.8 34.3 34.2
33.4 35.6
33.1 34.2 33.0
34.3 33.8 32.0
34.4 34.3 32.7
34.8 34.3 31.1
33.3 33.5 31.6
33.7 34.3 35.1
34.3 34.0 33.9
33.8 34.8 33.0
34.05 34.29 33.08
0.58 0.53 1.14
33.72
33.73
33.81
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Table XI
P la te le t values
Horse Weel
5g EPO d a i ly  
Annabelle 
Donald 
Myrtle
Gunsmoke
Sovereign
Orlando
Jack
Nicholas
Suzie
Hermione
Mean
S.D.
Values x l0 9/ l
0 Week 3 Week 6
180 210 183
180 130 113
100 60 40
170 140 169
198 130 233
240 190 219
130 170 129
130 130 118
150 220 174
170 190 160
130 150 205
170 170 240
162.3 157.5 165.3
37.3 43.9 58.0
lOg EPO al
Charlotte
Marigold
Jasper
Ding Dong
Flora
Chocolate
Goldie
Durando
BeBe
Samuel
Jordan
Dick
Mean
S.D.
e day
210 180 222
200 160 240
160 180 97
210 170 [98
180 200 L03
200 120 167
120 210 [83
210 210 204
170 220 164
120 190 114
150 120 117
188 150 96
176.5 175.8 158.8
33.1 33.4 51.8
20g EPO d a i ly
Foxy 185 190 181
Wallace 250 110 138
Gold Loch 150 210 162
Bonny 219 160 124
Skippy 140 120 123
Flynn 160 190 157
Rocky 160 180 94
Charlie 170 140 105
Geno 180 190 208
Biggies 180 200 180
SmiTer 160 130 131
Aird 120 110 54
Mean 172.8 160.8 138.1
S.D. 34.7 37.0 42.6
40g EPO alternate day 
Karlops 210
Big Ben 
Walter 
Pollux 
Armpit 
Sandv Lad
baorian
Oil ie
Poppett
Tessa
Alfred
Darkie
170
210
180
150
150
210
150
140
140
170
112
220
180
160
200
160
110
260
140
120
170
200
150
207
190 
128 
117 
162
84
182
142
107
191 
155 
126
Mean
S.D.
166.0
31.7
172.5
42.7
149.3
38.3
Group
mean
161.7
Group
mean
170.4
Group
mean
157.3
Group
mean
162.6
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Table XII 
White ce l l  counts
Horse Weel
5g EPO d a i ly  
Annabelle 
Donald 
Myrtle
Values x l0 9/ l
i i ra r te
Gunsmoke
Sovereign
Orlando
Jack
Nicholas
Suzie
Hermione
Mean
S.D.
Charfotte 
Marigold 
Jasper
PO alternate da
uing
Flor
Dong
a 
Chocolate 
Goldie 
Durando 
BeBe 
Samuel 
Jordan 
Dick
Mean
S.D.
, 0 Week 3 Week 6
12.2 14.3 9.2
11.0 10.2 11.6
8.5 8.5 7.9
6.9 7.3 8.4
6.8 5.5 7.3
7.5 8.6 6.6
6.9 5.6 6.2
6.9 8.1 7.8
8.2 14.9 9.7
9.3 9.2 9.3
8.4 12.5 11.0
8.6 11.1 6.4
8.43 9.65 8.45
1.71 3.07 1.76
v
8.2 15.3 11.3
10.5 8.8 12.3
9.0 19.3 14.2
8.0 11.8 8.5
18.3 14.5 8.6
8.7 10.4 8.7
9.3 17.9 15.1
6.9 11.2 6.8
8.0 9.2 7.8
17.1 14.1 9.1
8.7 8.0 6.8
15.1 11.8 9.1
10.65 12.69 9.86
3.89 3.58 2.75
8.84
11.07
20g EPO d a i ly
Foxv 9.0 9.3 8.8
Wallace 10.2 7.6 13.0
Gold Loch 5.9 12.9 6.4
Bonny 13.3 9.0 8.7
Skippy 8.9 7.4 9.5
Flynn 9.0 8.2 8.5
Rocky 7.1 6.9 13.3
Charlie 9.3 6.9 13.3
Geno 8.2 9.4 8.2
Biggies 9.8 14.2 12.4
SmiTer 12.7 9.5 8.5 Group
Aird 9.4 8.5 7.4 mean
Mean 9.40 9.15 9.83 9.46
S.D. 2.06 2.27 2.47
40g EPO alternate day 
Karlops 9.0nL„  - TOBig Ben 
Walter 
Pol Tux 
Armpit 
Sandy Lad 
Sabrian 
Q ll ie  
Poppett
i m t *
Darkie
Mean
S.D.
7.3 
16.1
8.3 
7.0
11.8
13.9
7.6
8.7
7.8
9.4
7.5
9.53
2.89
11.1
7.8
12.5
9.9
7.7
13.5 
10.0
i ! : 87.0
9.7 
14.3
10.28
2.41
8.8
7.4
7.6
7.5
9.9 
10.1
9.7 
7.4 
8.1 
7.3
8.1 Group
8.9 mean
8.40 
1.05
9.40
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Table X I I I
Urea values Values in  mmol/1
Horse Week 0 Week 3 Week 6
Anna 
Dona,
"  ' t l  
;a~ 
l i ra  
Gunsmoke 
Sovereign 
Orlando 
Jack 
Nicholas 
Suzie 
Hermione
Mean
S.D.
lOg EPO a'
Charlotte 
Marigold 
Jasper
H o r
Dong
a 
Chocolate 
Goldie 
Durando 
BeBe 
Samuel 
Jordan 
Dick
Mean
S.D.
6.8 6.2 6.7
5.1 4.0 4.2
5.7 5.5 5.7
7.2 6.0 7.1
6.5 2.3 2.9
6.7 6.2 5.9
6.9 6.1 6.5
6.3 4.1 6.8
5.7 2.5 5.1
6.8 5.5 7.2
6.1 3.5 6.3
6.5 4.3 5.7
6.36 4.68 5.84
0.61 1.43 1.27
i day
7.3 2.9 5.5
7.1 6.2 6.3
6.5 2.8 3.4
4.7 2.2 3.9
4.2 5.0 7.8
6.8 2.3 5.9
7.0 3.1 6.0
7.2 2.8 5.0
4.2 4.5 5.9
3.8 4.9 6.7
5.9 5.5 6.4
6.0 6.1 7.3
5.89 4.03 5.84
1.32 1.49 1.27
5.63
5.25
20g EPO d a i ly
Foxy
Wallace
Gold Loch
Bpnny
Skippy
Chariie
Geno
Biggies
SmiTer
Aird
Mean
S.D.
karlops
Big Ben
Walter
Pollux
Armpit
Sandy Lad
Sabrian
QTlie
Poppett
IW r ld
Darkie
Mean
S.D.
7.5 3.6 7.4
5.1 4.0 4.5
5.8 2.6 6.0
5.6 5.9 8.2
6.3 5.5 7.1
6.6 6.0 6.7
6.2 4.8 5.0
6.8 4.8 5.7
6.8 4.5 6.7
6.8 2.9 6.1
8.7 5.8 6.2
6.6 5.9 6.8
6.57 4.69 6.37
0.93 1.20 1.02
i dav
7.2 6.2 7.9
7.6 6.2 6.8
4.2 5.7 6.5
7.6 6.9 8.1
6.3 5.0 5.8
5.7 6.5 8.1
4.0 6.1 6.7
7.1 6.8
5.5 4.7 6.2
7.6 7.2 8.5
5.7 5.0 7.7
5.5 4.7 6.1
6.17 5.91 7.10
1.28 0.88 0.91
5.88
6.39
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Table XIV
Sodium values
Horse Week 0
5g EPO d a i ly  
Annabel!e 
Donald 
Myrtle
E mGunsmoke 
Sovereign 
Orlando 
Jack 
Nicholas 
Suzie 
Hermione
Mean 
S.D.
Values in  mmol/I
Week 3 Week 6
140 [38 L36
136 138 L36
136 138 134
138 L35 138
137 127 135
136 137 137
137 138 L36
135 129 L34
136 135 L35
138 140 L40
135 130 L34
137 138 [36
6.8 135.3 135.9
1.4 4.2 1.8
lOg EPO al
Charlotte
Marigold
Jasper
Ding Dong
Flora
Chocolate
Goldie
Durando
BeBe
Samuel
Jordan
Dick
Mean
S.D.
day
138 L32 [36
135 [39 [33
138 L28 [34
136 [34 [33
132 [37 L35
137 [28 L31
136 [31 [33
136 [33 [32
134 L37 [34
133 L37 L36
139 L39 L34
136 [37 [35
5.8 134.3 133.8
2.1 3.9 1.5
20g EPO d a i ly
Foxy 
Wallace 
Gold Loch 
Bonny 
Skippy
l ia s
Chariie
Geno
Biggies
SmiTer
Aird
Mean
S.D.
136 133 [31
135 138 [37
136 130 [34
138 136 [34
138 139 L36
133 138 L34
135 137 L35
135 137 L36
136 134 [33
136 132 [32
136 138 [29
133 133 [32
135.6 135.4 133.6
1.6 2.9 2.3
40g EPO alternate day 
Karlops 138
Big Ben 
Walter
Pollux 
Armpit 
Sandy Lad 
Sabrian 
Oil ie 
Poppett
IW r l *
Darkie
Mean
S.D.
37
30
34
35
36
31
38 
36 
36 
34
133
134.8
2.6
137 133
[37 135
[28 135
[38 133
[39 134
[36 133
[52 128
[35 136
[35 134
[38 133
[34 135
[37 133
137.2 133.5
5.5 2.0
Group
mean
136.0
Group
mean
134.7
Group
mean
134.9
Group
mean
135.2
15
Table XV
Potassium values
Horse Week 0
5g EPO d a i ly  
Annabelle 
Dona, d
Values in  mmol/1
Week 3 Week 6
&  
Gunsmoke 
Sovereign 
Orlando
Nicholas
Suzie
Hermione
Mean
S.D.
lOg EPO al
Charlotte
Marigold
Jasper
Ding Dong
Flora
Chocolate
Goldie
Durando
BeBe
Samuel
Jordan
Dick
Mean
S.D.
4.7 
4.9
4.8
5.3 
5.1
4.6
4.6
5.0
4.0
4.3
5.0
4.3
4.0
4.2
4.0
4.0
3.9
3.8
3.8
4.2
3.9
3.9 
3.8 
3.6
3.5
3.7
3.6
3.8
3.2
3.8
3.8
4.2
3.7
3.4
3.5 Group
3.9 mean
4.72 3.93 3.68
0.38 0.17 0.26
n 2.7 3.8
6.0 3.8 3.7
4.0 4.2 3.5
4.7 4.4 3.4
4.2 4.2 3.4
4.2 3.5 3.8
4.8 3.5 4.0
4.5 3.6 3.4
3.8 4.5 3.7
4.3 4.5 3.6
4.0 4.1 3.2
4.7 4.9 3.6
4.48 3.99 3.59
0.57 0.60 0.22
4.11
4.02
20g EPO d a i ly
Foxy 4.1 3.8 3.5
Wallace L 4.2 4.2 4.2
Gold Loch 4.7 4.0 4.5
Bpnny 4.2 4.0 3.5
Skippy 5.2 4.7 3.3
Flynn 5.4 4.6 4.7
Rocky 4.8 4.4 3.5
Charlie 5.2 4.8 3.8
Geno 4.5 4.4 3.6
Biggies 4.9 3.9 3.5
SmiTer 5.5 4.1 3.2 Group
Aird 3.8 3.8 3.3 mean
Mean 4.71 4.23 3.72 4.22
S.D. 0.56 0.35 0.49
40g EPO alternate day 
Karlops 3.b
Big Ben 
Walter 
Pollux 
Armpit 
Sandy Lad 
Sabrian 
Q ll ie  
Poppett 
;sa
Darkie
Mean
S.D.
4.6
4.4
4.2
4.7
4.7
4.8
5.2
4.4
4.5 
5.1 
4.4
4.55
0.42
3.9
4.7 
4.1
4.5
4.7
U
4.5
3.7
3.6
3.7 
4.0
4.14
0.39
3.8 
4.0
3.2
3.9
4.2
4.2
3.4
4.3
3.5 
3 8
318 Group
3.6 mean
3.81 
0.34
4.17
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Table XVI
Calcium values
Horse Week 0
a?,
Anna_
Dona 
Myrt
Gir  _ 
Gunsmoke 
Sovereign 
Orlando 
Jack 
Nicholas 
Suzie 
Hermione
Mean
S.D.
Values in  mmol/1
Week 3 Week 6
2.94
2.96
3.03
3.03 
2.85
3.02 
2.93 
2.98 
3.09
3.02 
3.07
3.02
2.995
0.067
2.71
2.96 
2.89 
2.86 
2.63 
3.15 
2.88  
2.98 
2.82 
2.87 
2.77
2.97
2.874
0.136
3.08
2.92 
2.76 
2.87 
2.86 
3.29 
2.83 
2.99 
3.04
2.92
2.81 Group
2.93 mean
2.942
0.144
2.937
Charfotte 
Marigold 
Jasper 
Ding Dong 
Flora 
Chocolate 
Goldie 
Durando 
BeBe 
Samuel 
Jordan 
Dick
Mean
S.D.
PO alternate day
3.05 2.86 2.94
2.96 2.98 3.01
3.08 3.07 3.06
2.96 2.77 2.84
3.04 2.87 2.99
3.00 2.75 2.92
3.05 2.88 3.08
3.10 2.69 2.96
2.72 2.84 2.96
2.69 2.88 3.07
2.89 2.90 2.73 Group
2.87 3.08 3.30 mean
20g EP0 d a i ly
fiS ffaceGold Loch
Bpnny
Skippy
pyc1Rocky
Chari ie
Geno
Biggies
SmiTer
Aird
Mean
S.D.
40g EP0 a lternate day 
Karl ops °
Big Ben 
Walter 
Pollux 
Armpit 
Sandy Lad 
Sabrian
01 Tie
Poppett 
Tessa 
A lfred 
Darkie
Megn
2.951 2.881 2.988
0.135 0.118 0.140
3.10 2.82 2.92
3.05 3.05 3.05
3.03 2.77 2.74
2.63 2.79 3.14
2.91 2.81 3.08
2.84 2.83 2.82
3.03 2.97 2.92
3.06 3.07 3.02
2.93 2.76 2.77
2.96 2.99 3.03
2.99 2.90 2.81
2.90 3.01 3.03
2.953 2.898 2.944
0.127 0.115 0.133
2.93 3.10
2.77 2.84 2.92
2.76 2.55 2.97
3.09 3.04 3.14
3.08 3.07 3.07
3.02 2.90 3.12
2.81 2.58 2.91
3.00 3.07 3.14
2.94 2.96 2.99
3.00 2.86 3.06
2.99 2.89 3.20
2.90 2.97 2.99
2.927 2.888 3.051
0.124 0.169 0.094
2.940
2.931
2.955
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Table XVII
C hloride values
Horse Week 0
5g EPO d a i ly  
Annabelle 
Donald 
Myrtle
E O feGunsmoke 
Sovereign 
Orlando 
Jack 
Nicholas 
Suzie 
Hermione
Mean 
S.D.
Values in  mmol/1
Week 3 Week 6
100 97 96
97 96 96
95 101 97
96 94 96
100 91 96
98 94 99
99 100 97
98 97 95
96 92 95
98 99 98
94 92 95
96 95 95
97.3 95.7 96.3
1.9 3.3 1.3
lOg EPO alternate day 
Charlotte
Marigold
Jasper
Ding Dong
Flora
Chocolate
Goldie
Durando
BeBe
Samuel
Jordan
Dick
Mean
S.D.
20g EPO d a i ly
Foxy
Wallace
Gold Loch
Bonny
Skippy
Chariie
Geno
Biggies
SmiTer
Aird
Mean
S.D.
40g EPO alternate
Karl ops
Big Ben
Walter
Pollyx
Armpit
Sandy Lad
Sabrian
Oil ie
Poppett
IW r la
Darkie
Mean
S.D.
98
95 
94
98 
91
99
96
97
94
95 
97 
99
95
96 
84 
93
96
93 
90 
92
94
97 
99
95
97
95
94 
93
96
95 
92
91
97
96
92
97
96.1 93.7 94.6
2.4 3.9 2.2
95 94 92
96 91 94
97 88 98
97 97 95
99 99 92
95 99 101
98 94 97
98 97 94
96 98 96
102 94 93
97 98 95
92 93 86
96.8 95.2 94.4
2.4 3.4 3.7
97 93
93 103 94
91 92 95
96 97
92 99 95
100 95 92
94 89 95
99 96 96
94 97 95
95 97 97
94 99 95
94 97 97
94.7 96.5 95.1
2.6 3.5 1.6
Group
mean
96.4
Group
mean
94.8
Group
mean
95.5
Group
mean
95.4
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Table X V III
Magnesium values
Horse Week 0
5g EPO d a i ly  
Annabelle 
Donald 
Myrtle 
Calumn 
G ira ffe 
Gunsmoke 
Sovereign 
Orlando 
Jack 
Nicholas 
Suzie 
Hermione
Mean 
S.D.
Values in  mmol/1
Week 3 Week 6
0.63 0.63 0.73
0.55 0.56 0.59
0.69 0.72 0.75
0.66 0.64 0.76
0.63 0.49 0.60
0.60 0.60 0.60
0.66 0.61 0.66
0.63 0.65 0.66
0.62 0.50 0.71
0.65 0.65 0.71
0.63 0.53 0.64
0.60 0.60 0.61
0.629 0.598 0.668
0.036 0.068 0.062
0.632
10g ECharlotte
Marigold
Jasper
Ding Dong
Flora
Chocolate
Goldie
Durando
BeBe
Samuel
Jordan
Dick
Mean
S.D.
PO alternate day
0.65 0.50 0.68
0.63 0.67 0.71
0.64 0.66 0.68
0.65 0.55 0.65
0.50 0.62 0.74
0.68 0.49 0.69
0.59 0.42 0.66
0.67 0.44 0.73
0.59 0.66 0.73
0.52 0.63 0.75
0.68 0.65 0.65 Group
0.62 0.61 0.77 mean
20g EPO d a i ly
Foxv
Wallace
Gold Loch
Bonny
Skippy
Flynn
R o c k y
Chariie
Geno
Biggies
SmiTer
Aird
Mean
S.D.
40g EPO alternate day 
Karl ops 0.6b
Big Ben A ,‘ r
Walter 
Pollux 
Armpit 
Sandy Lad 
Sabrian 
Q ll ie  
Poppett
Darkie
Mean
S.D.
0.619 0.575 0.703
0.059 0.091 0.041
0.66 0.58 0.72
0.23 0.23 0.23
0.64 0.55 0.67
0.56 0.63 0.77
0.74 0.69 0.69
0.67 0.70 0.74
0.68 0.70 0.71
0.64 0.69 0.81
0.65 0.61 0.77
0.66 0.68 0.70
0.70 0.69 0.68
0.63 0.67 0.65
0.622 0.618 0.678
0.131 0.132 0.149
;
0.66 0.72 0.79
0.65 0.67 0.69
0.50 0.57 0.68
0.62 0.69 0.72
0.61 0.64 0.68
0.60 0.74 0.68
0.53 0.62 0.69
0.63 0.68 0.73
0.63 0.65 0.66
0.65 0.67 0.72
0.59 0.71 0.70
0.63 0.72 0.78
0.608 0.674 0.710
0.049 0.048 0.040
0.633
0.639
0.664
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Table XIX
Inorganic phosphate values, in mmol/I 
Horse W
5g EPO d a i ly
Annabelle 
Donald 
Myrtle
E m
Gunsmoke 
Sovereign 
Orlando 
Jack 
Nicholas 
Suzie 
Hermione
Mean 
S.D.
lOg EPO al
Charlotte
Marigold
Jasper
Ding Dong
Flora
Chocolate
Goldie
Durando
BeBe
Samuel
Jordan
Dick
Mean
S.D.
0 Week 3 Week 6
. 16 0.72 0.95
. 10 1.47 0.94
L .30 1.41 1.06
i.14 0.88 0.97
i.02 1.32 0.75
0.84 0.68 0.88
1.17 1.18 0.88
1.21 1.18 1.11
1.26 1.33 0.87
1.07 1.09 0.95
1.13 1.17 1.09
1.00 0.91 1.16
1 117 1.112 0.968
0 124 0.262 0.118
ei d§£ 1.03 0.84
1.11 1.11 0.65
1.60 1.62 1.55
1.13 1.23 0.80
1.05 1.12 1.01
1.10 1.30 0.82
1.31 1.09 0.91
1.09 0.91 0.99
0.81 1.27 0.91
1.17 1.20 0.88
1.17 1.13 1.19
1.14 1.11 0.88
1 145 1.177 0.953
0 184 0.175 0.229
1.065
1.091
20g EPO d a i ly
Foxy 1.33 1.41 0.84
Wallace 1.20 1.24 1.22
Gold Loch 1.17 1.38 0.85
Bonny 1.18 1.17 0.85
Skippy 1.03 1.08 0.77
Flynn 1.07 1.22 0.87
Rocky 1.37 1.22 0.85
Charlie 1.12 1.20 0.86
Geno 1.23 1.10 0.88
Biggies 1.04 1.12 0.76
SmiTer 1.06 0.94 0.86 Group
Aird 1.45 0.82 0.98 mean
Mean 1.188 1.158 0.883
S.D. 0.137 0.166 0.120
1.076
40g EPO alternate day , _  ,
Karl ops 1.51 1.04 1.18
Big Ben 1.33 1.22 0.81
Walter 0.98 0.78 1.04
Pollux 1.00 0.77 0.81
Armpit 1.03 1.43 0.90
Sandy Lad 1.05 0.86 0.95
Sabrian 1.18 0.91 0.86
01 Tie 0.99 0.70 0.94
Poppett 1.05 0.80 1.13
Tessa 0.95 0.78 1.70 „
A lfred 0.89 0.80 1.22 Group
Darkie 1.31 1.08 0.93 mean
Mean 1.106 0.931 1.039
S.D. 0.187 0.220 0.249
1.025
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Table XX
Alka line phosphatase values, in  I.U.
Horse Week 0 Week 3 Week 6
5g EPO d a i ly  
Annabelle 
Dona, d 
Myrtle
»
Gunsmoke 
Sovereign 
Orlando 
Jack 
Nicholas 
Suzie 
Hermione
Mean 
S.D.
418 484 359
456 375 488
312 284 263
359 337 303
500 349 346
316 384 328
345 242 249
361 345 419
558 346 368
379 319 328
343 231 283
253 238 219
383.3 327.8 329.4
86.0 72.4 74.9
346.9
lOg EPO al
Charlotte
Marigold
Jasper
Ding Dong
Flora
Chocolate
Goldie
Durando
BeBe
Samuel
Jordan
Dick
Mean
S.D.
e day
303 302 302
241 230 194
525 341 486
353 266 377
297 421 346
362 310 354
471 351 500
211 168 255
419 349 341
352 469 392
289 430 396
297 320 321
343.3 329.8 355.3
91.7 85.4 86.3
342.8
20g EPO d a i ly
Foxy 352 230
Wallace 268 268
Gold Loch 283 218
Bonny 454 409
Skippy 274 294
Flynn 463 350
Rocky 381 361
Charlie 389 392
Geno 298 343
Biggies 362 240
SmiTer 499 641
Aird 418 449
Mean 370.1 349.6
S.D. 78.6 118.2
274
268
310
408
283
340
287
387
268
340
515 Group 
358 mean
336.5
73.4
352.1
40g EPO alternate day 
Karl ops 343n  • _ n L _  n o nBig Ben 
WaTter 
Pollux 
Armpit 
Sandy Lad 
Sabrian 
Q ll ie  
Poppett
im td
Darkie
Mean
S.D.
328 
246 
409 
444 
273 
264 
383 
386
329 
423 
303
344.3
65.3
406
406
350
322
428
314
256
346
397
308
396
327
354.7
51.9
330
322
314
329
362
270
279
310
360
299
374 Group 
329 mean
323.2
31.9
340.7
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Table XXI
Aspartate aminotransaminase values, in I.U.
Horse W
5g EPO d a i ly  
Annabelle 
Dona d 
Myrtle 
Calumn 
G ira ffe 
Gunsmoke 
Sovereign 
Orlando 
Jack 
Nicholas 
Suzie 
Hermione
Mean 
S.D.
0 Week 3 Week 6
265 389 336
383 373 399
263 310 278
341 367 313
267 171 106
301 313 301
385 362 334
278 310 271
299 186 237
248 285 301
274 253 166
253 273 198
296.4 299.3 270.0
48.1 70.5 81.4
288.6
lOg EPO alternate day 
Charlotte 257
Marigold
Jasper
Ding Dong
Flora
Chocolate
Goldie
Durando
BeBe
Samuel
Jordan
Dick
Mean
S.D.
20g EPO d a i ly
Foxy
Wallace
Gold Loch
Bonny
Skippy
Flynn
Rocky
Charlie
Geno
Biggies
SmiTer
Aird
Mean
S.D.
40g EPO a'
Karl ops
Big Ben
WaTter
Pollux
Armpit
Sandy Lad
Sabrian
OlTie
Poppett
Tessa
Alfred
Darkie
Mean
S.D.
207
283 
307 
369 
265 
331 
280 
907 
314 
241
284
212
249
191
255
235
182
261
242
321
241
292
273
235
183
220
197
325
232
248
195
349
239
319 Group 
281 mean
337.1 246.2 251.9
184.4 39.6 54.8
305 235 254
285 319 302
276 228 212
379 325 314
348 367 324
321 356 317
262 307 197
315 379 335
267 282 266
289 352 248
337 379 312
220 314 306
300.3 320.3 282.3
43.1 51.2 45.7
;e day 
263 384 324
412 384 342
115 225 278
266 325 280
286 384 224
186 234 245
124 213 260
420 358 329
206 258 286
337 476 347
396 434 423
169 266 273
265.0 328.4 300.9
108.6 87.8 54.5
278.4
300.9
298.1
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Table XXII 
B i l i ru b in  values
Horse Week 0
5g EPO d a i ly  
Annabelle
Dona!
8 S k
Gunsmoke
Sovereign
Orlando
Jack
Nicholas
Suzie
Hermione
Mean
S.D.
5
20
10
5
13
9
8
7
8 
9 
7
6
lOg EPO alternate day 
Charlotte 7
Marigold
Jasper
Ding Dong
Flora
Chocolate
Goldie
Durando
BeBe
Samuel
Jordan
Dick
Mean
S.D.
Values in  umol/1
Week 3 Week 6
6 9
2 9
11 12
8 9
52 12
11 10
6 10
11 8
19 10
6 13
26 7
10 7
8.9 14.0 9.7
4.1 13.6 1.9
19 13
10 10 12
8 22 10
8 32 12
44 8 16
7 23 8
7 19 8
6 15 9
19 7 11
25 8 11
4 8 8
14 6 13
13.3 14.8 10.9
11.4 8.3 2.5
Group
mean
10.9
13.0
20g EPO d a i ly
6 2 fT .c eGold Loch
Bonny
Skippy
E&K
Chari ie
Geno
Biggies
SmiTer
Aird
Mean
S.D.
40g EPO alternate
Karl ops
Big Ben
WaTter
Pollux
Armpit
Sandy Lad
Sabrian
Oil ie
Poppett
i m i d
Darkie
Mean
S.D.
10 15 13
9 9 9
10 25 11
15 6 12
6 8 8
6 7 9
8 10 12
5 4 8
7 9 10
8 38 9
12 7 10
7 7 13
8.6 12.1 10.3
2.8 9.8 1.8
dt « 10 9
9 10 10
8 5 7
6 7 IQ11 14 14
9 9 11
15 7 10
9 7 128 16 10
5 6 8
6 7 9
14 17 26
9.2 9.6 11.9
3.0 4.0 5.4
10.3
Group
10.2
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Table X X III
Total plasma protein values
Horse Week 0 Week 3
Values in g/1 
Week 6
Do
E
nna, 
na 
' t
Gunsmoke
Sovereign
Orlando
Jack
Nicholas
Suzie
Hermione
Mean
S.D.
75 76 69
74 74 70
70 66 61
70 74 70
68 102 98
76 74 70
63 60 63
70 76 70
70 91 73
69 85 70
74 90 102
63 68 77
70.2 78.0 74.4
4.2 11.9 12.7
74.2
Marigold
Jasper
Ding Dong
Flora
Chocolate
Goldie
Durando
BeBe
Samuel
Jordan
Dick
Mean
S.D.
85 75
74 74 87
71 89 95
66 84 82
77 93 76
63 96 79
73 90 89
65 75 81
79 81 76
81 76 67
68 75 65
73 81 77
71.3 83.3 79.1
5.8 7.5 8.6
77.9
20g EPO d a i ly
Foxv 71 91
Wallace 69 68
Gold Loch 67 98
Bonny 81 86
sKip^y 76 77
Flynn 66 64
Rocky 67 64
Charlie 64 65
Geno 65 73
§ig?les 7nSmiTer 70 73
Aird 69 70
Mean 69.6 76.3
S.D. 4.8 11.4
69 
68
70
76 
74 
62 
79
65 
69
77
63 Group
66 mean
69.8
5.6
71.9
40g EPO alternate 
Karl ops 
"-‘ I  Ben 
te r  
. . lux 
Armpit 
Sandy Lad 
Sabrian 
Q ll ie  
Poppett
i m u
Darkie
Mean
S.D.
65 
103
66 
68
71 
100
74
87
79
72 
84
77.8
13.2
74
74 
78
69 
66
i??
] \
70
75 
80
78.3
13.7
72
72
76
65
80i
72
72 Group 
70 mean
72.1
3.8
76.1
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Table XXIV
Albumin values
Horse Week 0
5g EPO d a i ly  
Annabelle 
Dona d 
Myrtle
»Gunsmoke 
Sovereign 
Orlando 
Jack 
Nicholas 
Suzie 
Hermione
Mean 
S.D.
Values in  g/1
Week 3 Week 6
31 33 32
34 33 35
31 34 19
30 27 31
31 25 31
29 33 36
28 29 29
33 35 30
35 35 27
30 29 30
34 36 22
33 34 36
31.6 31.9 29.8
2.2 3.5 5.2
31.1
lOg EPO alternate day 
Charlotte 31
Marigold 
Jasper
Ding Dong
Flora
Chocolate
Goldie
Durando
BeBe
Samuel
Jordan
Dick
Mean
S.D.
20g EPO d a i ly
Foxv
Wallace .
Gold Loch
Bonny
Skippy
Chari ie
Geno
Biggies
SmiTer
Aird
Mean
S.D.
Big Ben
Walter
Pollux
Armpit ,
Sandy Lad
Sabrian
Oil ie
Poppett
Tessa
A1fred
Darkie
30
31 
33
32
33 
33 
33 
31 
31
27
28
33
33 
35
34 
23 
31 
29 
28
31
32 
32 
28
32
29 
28 
25 
31 
22 
25
30 
29
31
32 Group 
31 mean
Mean
S.D.
31.1 30.8 28.8
2.0 3.3 3.2
32 24 28
36 37 36
33 29 31
31 26 30
29 26 31
31 36 28
33 36 28
31 30 33
31 22 27
30 33 23
29 34 30
27 27 32
31.1 30.0 29.8
2.3 5.1 3.3
!dB 37 3629 37 34
24 25 32
33 33 35
33 38 32
30 27 33
26 22 30
35 38 36
30 35 35
31 29 33
32 27 35
27 31 29
29.8 31.6 33.3
3.2 5.6 2.3
30.2
30.3
31.6
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Table XXV
Globulin values
Horse Week 0
5g EPO d a l ly
Annabelle 
Donald 
Myrt Ie 
Calumn 
G ira ffe 
Gunsmoke 
Sovereign 
Orlando 
Jack 
Nicholas 
Suzie 
Hermione
Mean
S.D.
Values in  g/1
Week 3 Week 6
44 44 37
40 41 35
39 32 42
40 47 39
37 77 67
47 31 34
35 31 34
37 31 40
35 56 46
39 56 40
40 54 80
30 34 41
38.6 44.5 44.6
4.4 14.3 14.2
42.6
lOg EPO alternate day 
Charlotte 35
Marigold
Jasper
Ding Dong
Flora
Chocolate
Goldie
Durando
BeBe
Samuel
Jordan
Dick
Mean
S.D.
20g EPO d a i ly
44 
40 
33
45 
30
40 
32 
48 
50
41 
45
Foxy 
i l l ;
Gold Loch
Wa lace
Bonny 
Skippy
i& rc
Char I ie
Geno
Biggies
SmiTer
Aird
Mean
S.D.
40g EPO alternate
Karl ops
Big Ben
WaTter
Pollux
Armpit
Sandy Lad
Sabrian
Oil ie
Poppett
Xfffid
Darkie
Mean
S.D.
52 
41 
54 
50 
70 
65 
61 
47 
50 
44 
43
53
43
58
67
57
45 
57 
64 
51 
47 
36
33 Group
46 mean
40.3 52.5 50.3
6.5 8.9 10.6
39 67 41
33 31 32
34 69 39
50 60 46
47 51 43
35 28 34
34 28 51
33 25 22
34 51 42
40 53 54
41 39 33
42 43 34
38.5 45.4 39.3
5.7 15.5 8.9
37 36
36 37 38
79 53 44
33 36 30
35 28 48
41 63 40
74 95 44
39 33 35
57 40 33
48 41 39
40 48 37
57 49 41
48.0 46.7 38.8
15.5 18.0 5.1
47.7
41.1
44.5
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Table XXVI
Horse V
5g EPO d a i ly
Annabelle
Donald
Myrtle
Calumn
G ira ffe
Gunsmoke
Sovereign
Orlando
Jack
Nicholas
Suzie
Hermione
Mean
S.D.
ues Values in mmol/I
; 0 Week 3 Week 6
0.68 0.45 0.37
0.15 0.59 0.65
0.47 0.34 0.32
0.56 0.20 0.25
0.33 0.29 0.17
0.51 0.37 0.41
0.48 0.27 0.36
0.41 0.36 0.38
0.54 0.19 0.38
0.53 0.30 0.56
0.53 0.16 0.24
0.34 0.23 0.56
0.461 0.313 0.388
0.137 0.122 0.142
0.387
lOg EPO a*
Charlotte
Marigold
Jasper
Ding Dong
Flora
Chocolate
Goldie
Durando
BeBe
Samuel
Jordan
Dick
Mean
S.D.
e day 
0.49 0.21 0.50
0.51 0.30 0.42
0.47 0.33 0.31
0.31 0.19 0.17
0.19 0.53 0.43
0.38 0.20 0.28
0.57 0.23 0.58
0.39 0.25 0.35
0.24 0.29 0.41
0.44 0.33 0.47
0.55 0.60 0.61
0.38 0.32 0.51
0.410 0.315 0.420
0.119 0.128 0.127
0.382
20g EPO d a i ly  _  ^
Foxy 0.53 0.21 0.39
Wallace 0.44 0.46 0.45
Gold Loch 0.50 0.26 0.33
Bonny 0.33 0.23 0.26
Skippy 0.37 0.34 0.29
Flynn 0.53 0.35 0.38
Rocky 0.34 0.32 0.25
Charlie 0.53 1.77 0.47
Geno 0.37 0.34 0.48
Biggies 0.56 0.25 0.40
SmiTer 0.18 0.32 0.30 Group
Aird 0.51 0.73 0.32 mean
Mean 0.433 8 -^ 5  0.360
S.D. 0.115 0.434 0.080
0.419
40g EPO alternate day 
Karl ops 0.24
Big Ben 
Walter 
Pollux 
Armpit 
Sandy Lad 
Sabrian 
Oil ie 
Poppett
m u
Darkie
Mean
S.D.
0.25
0.40
0.34
0.28
0.46
0.46
0.50
0.37
0.29
0.51
0.32
0.368
0.097
0.48
0.28
0.25
0.38
0.32
0.41
0.49
0.35
0.29
0.14
0.38
0.31
0.340
0.098
0.37
0.55
0.24
0.23
0.44
0.37
0.34
0.29
0.29
0.27
0.31 Group 
0.30 mean
0.333
0.090
0.347
27
Table XXVII
Cholesterol values
Horse Week 0
5g EPO d a i ly  
Annabelle 
Donald 
f e
Values in  mmol/1
Week 3 Week 6
i umn G ira ffe 
Gunsmoke 
Sovereign 
Orlando 
Jack 
Nicholas 
Suzie 
Hermione
Mean
S.D.
lOg EPO al
Charlotte
Marigold
Jasper
Ding Dong
Flora
Chocolate
Goldie
Durando
BeBe
Samuel
Jordan
Dick
Mean
S.D.
3.03 3.25 3.24
1.61 2.93 3.06
2.57 2.64 2.40
2.77 2.66 2.68
2.03 2.26 1.57
1.84 1.91 2.43
2.62 2.40 2.32
2.73 2.56 2.49
2.71 2.42 2.35
2.21 2.13 2.19
2.16 2.46 1.63
2.68 2.40 1.61
2.413 2.502 2.331
0.433 0.352 0.533
e day 
2.27 2.19 1.39
2.29 2.28 1.78
2.12 2.26 1.47
1.96 1.86 1.56
2.04 1.65 2.17
2.04 2.19 1.58
2.81 2.12 1.93
2.28 1.94 1.43
1.99 1.55 2.04
2.14 1.76 2.41
1.72 2.08 2.39
1.64 1.72 2.18
2.108 1.967 1.861
0.301 0.254 0.376
2.415
1.979
20g EPO d a i ly
Foxy
Wallace
Gold Loch
Bonny
Skippy
Chan ie
Geno
Biggies
SmiTer
Aird
Mean
S.D.
40g EPO alternate day 
Karl ops 1.42
Big Ben °
WaTter 
Pollux 
Armpit 
Sandy Lad 
Sabrian 
01 l i e  
Poppett
l m i d
Darkie
Mean
S.D.
2.56 2.34 1.95
2.79 2.83 2.81
2.19 2.31 1.73
1.85 1.79 2.07
2.59 2.70 2.88
2.64 2.74 2.36
2.07 1.91 1.43
2.47 2.34 2.38
2.52 2.39 2.15
2.64 2.73 1.74
2.12 2.36 2.30
1.56 2.31 2.78
2.333 2.396 2.215
0.373 0.321 0.462
e
1.42 2.04 2.05
2.49 2.04 3.24
1.41 1.54 2.45
2.46 2.56 2.69
2.14 2.17 1.67
1.59 1.77 2.12
1.91 1.85 2.18
2.24 2.38 2.60
1.86 2.13 2.61
2.27 2.57 2.19
2.27 2.44 2.69
1.62 2.18 2.33
1.973 2.139 2.402
0.392 0.318 0.404
2.315
2.171
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APPENDIX I I
TABLES OF RESULTS OF THE STUDY ON THE USE OF EFAs IN THE TREATMENT
OF DERMATOPHILOSIS IN HORSES 
C lin ica l Indices, Haematological and Biochemical Parameters
29
C lin ica l Indices
Table I
Indices o f  dermatophilosis lesion severity
Scored on a 1 to 10 scale, 0 is  absence o f in fe c t ion , 10
severe in fec tion
Horse Week 
0 2 8 10 12 14 16
Controls
s?r
Fred
Temple
Delta
PlfVa
Sprig
Durando
Natasha
Mean
S.D.
1 0 0 0 0 0 0 0 1
8 6 6 5 3 4 3 2 2
1 0 2 1 0 0 1 0 0
1 3 2 1 0 0 1 1 1
2 0 0 1 0 0 1 1 1
3 4 1 0 0 0 0 0 0
5 4 4 2 2 2 2 1 1
1 0 0 1 0 0 0 0 1
0 0 0 0 0 0 0 0 0
5 4 4 3 3 3 2 3 1
4 3 4 3 3 4 5 3 4
7 6 4 3 4 3 3 1 1
3.2 2.5 2.3 1.7 1.3 1.3 1.5 1.0 1.
2.6 2.4 2.1 1.6 1.6 1.7 1.6 1.1 1.
 Group 
mean
PIacebo
Charlotte 
Charlie 
Jack 
Rose
North Star 
Lord Muckle
8]geBen
Rainbeam 
Choppy
0?Ficer 6 6 6 6 4 4 5 2 2  Group
mean
Mean 4.2 3.3 2.9 2.0 2.1 1.8 1.8 1.6 1.7 2.4S.D. - - - - -
3 2 3 2 2 1 2 1 1
0 0 0 0 0 0 0 0 0
2 0 0 1 1 0 0 2 1
4 4 2 1 2 2 1 1 1
7 6 6 4 4 3 3 2 5
8 8 8 4 4 5 4 2 2
5 0 0 0 0 0 0 2 2
6 4 4 2 3 2 2 3 1
4 2 2 2 2 2 1 2 2
6 8 4 2 3 3 3 2 2
0 0 0 0 0 0 0 0 1
6 6 6 4 4 5 2 2
2.6 3.1 2.7 1.9 1.6 1.7 1.7 0.9 1.;
EFAs
"erpnica
o i ly
Danny
Prudence
Jeeves
K t h
Anne
5 6 6 6 4 2 4 3 2
1 2 4 1 1 1 0 1 0
5 6 4 2 3 3 2 2 2
1 1 0 1 1 0 0 0 0
6 6 5 3 4 3 2 3 1
3 3 3 2 2 2 1 1 1
6 4 5 3 1 0 2 1 1
4 2 2 3 2 1 1 1 1
4 8 6 5 3 4 4 2
3 6 4 2 3 3 2 2
9 10 9 7 7 5 6 5 5
4.3 4.6 4.7 3.5 2.9 2.1 2.3 2.1 1.
2.3 2.6 2.6 2.1 1.9 1.5 1.8 1.5 1.
Henry   7 7 5 6 5 5  Group
mean
Mean 4.3 4.6 4.7 3.5 2.9 2.1 2.3 2.1 1.5 3.1
S.D. ‘  ‘  .............................
is  most
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Table I I
Extent o f d is t r ib u t io n  o f dorsal dermatophilosis lesions 
Scored by % o f body surface area affected
Horse Week
0 2 4 6 8 10 12 14 16
Controls
5 flfnFred 
Temple 
Delta 
Beau 
Fella
Dick 
Noddy 
Durando 
Natasha
mean
Mean 18.1 13.5 10.4 9.2 7.1 5.0 4.8 3.6 2.5 8.2
S.D.
2 . .5 0 , . 0 0 , . 0 0 . . 0 0 . . 0 0 , . 0 0 , . 0 0 , . 0 1 , . 0
55,. 0
Lf>
CM
. 0
oCO
. 0 2 0 , . 0 1 0 , . 0 1 0 , . 0 1 , . 0 1 , . 0 2 , .5
5,. 0 0 . . 0 0 , . 0 0 , . 0 0 . . 0 0 , . 0 0 , . 0 0 . . 0 0 , . 0
0 , . 0 2 , .5 0 , . 0 0 , . 0 0 . , 0 0 . . 0 1 , . 0 3,.6 2 , .5
5.. 0 0 . . 0 0 , . 0 0 . . 0 0 . . 0 0 , . 0 0 . . 0 0 . . 0 0 , . 0
2 0 . . 0 5,, 0 0 , . 0 0 , . 0 0 , . 0 0 , . 0 0 , . 0 0 , . 0 0 , . 0
30, . 0 40. . 0
oCO . 0 ro o . 0 25.. 0 15.. 0
oCM . 0
oCM
. 0 1 0 , . 0
0 . . 0 0 . . 0 0 , . 0 0 . . 0 0 , . 0 0 . . 0 0 . . 0 0 . . 0 0 . . 0
0 . . 0 0 . . 0 0 , . 0 0 . . 0 0 . , 0 0 . . 0 0 , . 0 0 . . 0 0 . . 0
45. . 0 25. . 0 25.. 0 30. . 0 10.,0 1 0 . . 0 1 0 . . 0 1 0 . . 0 1 0 . . 0
15.. 0 2 0 . . 0 2 0 , . 0 15,. 0 10.. 0 1 0 , . 0 5.. 0 5.. 0 1 , . 0
40. . 0 45. . 0 2 0 . . 0 25. . 0 30. , 0 15.. 0 2 0 . . 0 3..6 2 , .5
.. .. .. ., , ., 0 ., ., . .
19,.7 16..8 13,.2 11..8 10..5 6,.4 7..7 6.. 0 3,.7
Placebo
Charlotte 
Chariie 
Jack 
Rose
North Star 
Lord Muckle 
Big Ben 
Mi Re
Rainbeam 
Choppy
S f F lS i r mean
Mean 19.8 19.2 15.4 11.8 9.4 10.4 9.2 7.3 5.5 12.0
S.D. '  ‘
0,.0 0..0 0,.0 0,.0 0..0 0,.0 0,.0 0..0 0..0
0..0 0..0 0,.0 0,.0 0..0 0..0 0..0 0..0 0..0
2..5 0..0 0..0 1..0 2..5 0..0 0..0 7..3 5..5
0,.0 0,.0 0,.0 0,.0 0..0 0,.0 0,.0 0,.0 0,.0
30..0 35,.0 25,.0 30..0 10..0 20,.0 15,.0 15,.0 15..0
50..0 55..0 40..0 20..0 20..0 20..0 20..0 5,.0 5..0
25..0 0.,0 0..0 0..0 0.,0 0..0 0..0 10..0 6.,9
45,.0 45,.0 35..0 30,.0 25,.0 25,.0 20,.0 20,.0 15..0
15,.0 20..0 20,.0 15..0 20.,0 10..0 10..0 10,.0 6..9
40,.0 30.,0 30..0 20..0 10.,0 20..0 20..0 10..0 5 ,.0
0,.0 0..0 0..0 0.,0 0.,0 0..0 0..0 0..0 0.,0
30,.0 45..0 35,.0 25..0 25,.0 30,.0 25,.0 10,.0 6..9
,. .. ,. ,. , ,. . ,. ,
19..3 21.,7 16..8 12.,8 10.,5 11.,8 10.,2 6..5 5.,3
EFAs
eipjmica
lanny 
Prudence 
Jeeves 
Heidi 
Elspeth 
Anne
20,.0 20..0 20,.0 15,.0 10,.0 10,.0 20..0 20,.0 2..5
5,.0 2,.5 2,.5 2,.5 0..0 1,.0 0..0 0,.0 0..0
30,.0 35,,0 25..0 20,.0 20..0 15,.0 10..0 10..0 5,•90,.0 0..0 0..0 0,.0 0,.0 0..0 0..0 0..0 0..0
30..0 25..0 20,.0 20,.0 5,.0 10,.0 5,.0 1,.0 1,.0
0..0 2..5 0,.0 0,.0 0.,0 0..0 0..0 5..2 5..2
25,.0 10.,0 5..0 2,.5 0..0 0..0 1..0 1..0 1..0
5,,0 0.,0 0..0 0,.0 0.,0 0..0 0,.0 0..0 0..0
.0 30..0 15.•Q 15,.0 10..0 10,.0 15,.0 10..0 19-■825 .0 35,.0 30..0 30..0 20..0 25..0 25,.0 25,.0 35..0
6o:.0 55.,0 45..0 40,.0 30.,0 25.,0 30..0 20..0 15.,0
20.,5 19.,5 14.,8 13.,2 8.,6 8.,7 9.,6 8.,4 6.,8
17..7 18.,2 14..9 13..6 10..5 9.,7 11..2 9.,4 10..5
Henry 0.  .  .  .  .  .  .  .  .  Group
mean
Mean .  .  .  .    .    12.2
S.D. "  “ .......................................................
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Table I I I
Extent of distribution of hindlimb dermatophilosis lesions
Scored by % 
Horse
of body surface area affected 
Week
0 2 4 6 8 10 12 14 16
Controls
S?lfn 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.040.0 40.0 50.0 15.0 10.0 10.0 1.0 1.0 2.5
f e l l e
Delta
0.0 0.0 5.0 1.0 0.0 0.0 1.0 0.0 0.0
20.0 20.0 10.0 1.0 0.0 0.0 0.0 0.4 2.7
20.0 0.0 0.0 1.0 0.0 0.0 1.0 1.0 1.0
Beau 20.0 20.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0
Fella 20.0 10.0 15.0 1.0 0.0 0.0 0.0 0.0 10.0
Sprig 15.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.0
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
50.0 20.0 35.0 20.0 2.5 2.5 1.0 1.0 0.0
Durando 5.0 5.0 0.0 2.5 2.5 2.5 2.5 1.0 10.0
Natasha 20.0 20.0 10.0 2.5 10.0 0.0 2.5 0.4 2.7
Mean 17.50 11.25 10.63 3.88 2.08 1.25 0.75 0.40 2.49
S.D. 15.59 12.81 16.03 6.52 3.82 2.92 0.94
Group
0.47
mean 5
3.67
58
Placebo
Charlotte 10.0 25.0 20.0 10.0 5.0 5.0 10.0 5.0 1.0
Chariie 
Jack
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
5.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 8.5
Rose 60.0 15.0 10.0 10.0 20.0 20.0 20.0 20.0 20.0
North Star 30.0 20.0 30.0 0.0 0.0 0.0 0.0 0.0 1.0
Lord Muckle 60.0 60.0 60.0 50.0 20.0 40.0 50.0 30.0 30.0
Big Ben 
Mike
30.5 0.0 0.0 0.0 0.0 0.0 0.0 6.8 9.6
25.0 20.0 0.0 0.0 2.5 0.0 0.0 2.5 0.0
Rainbeam 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6
Choppy 30.0 20.0 20.0 2.5 2.5 2.5 2.5 1.0 2.5
Soring
O ff ice r
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0
40.0 30.0 40.0 30.0 0.0 2.5 2.5 6.8 9.6
Mean 25.04 15.83 15.00 8.54 4.17 5.83 7.08 6.56 8.48
S.D. 21.01 17.94 19.77 15.76 7.56 12.17 14.80
Group
9.30 9.01 
mean 10.73
EFAs
Ve^nica 20.0 20.0 10.0 20.0 10.0 0.0 5.0 5.0 2.5
0.0 0.0 10.0 0.0 2.5 0.0 0.0 1.0 0.0
)anny
Prudence
20.0 30.0 20.0 0.0 2.5 0.0 0.0 1.0 0.0
10.0 5.0 0.0 2.5 2.5 0.0 0.0 0.0 0.0
Je$v?s 20.0 20.0 20.0 1.0 2.5 0.0 5.0 5.0 0.0
Heidi
Elspeth
40.0 40.0 40.0 30.0 25.0 20.0 20.0 1.7 0.9
20.0 5.0 2.5 2.5 2.5 0.0 1.0 0.0 0.0
Anne 30.0 25.0 20.0 5.0 2.5 2.5 2.5 2.5 2.5m 30.0 30.0 20.0 10.0 2.5 2.5 2.5 5.0 20.00.0 20.0 15.0 2.5 0.0 2.5 2.5 0.0 2.5Henry 60.0 50.0 30.0 10.0 10.0 20.0 20.0 5.0 2.5
Mean 19.00 19.50 15.75 7.35 5.25 2.75 3.85 2.12 2.84
S.D. 17.37 15.23 11.56 9.54 7.17 7.83 7.47 2.21 5.82
Group mean 8.70
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Table IV
Coat condition scores
Scored on a 1 to  10 sca le, 1 is  poorest, 10 is  optimal
Horse Week 
0 2 8 10 12 14 16
Controls
5fltn
Temple
Delta
Beau
Fella
Sprig
Dick
Noddy
Durando
Natasha
Mean
S.D.
5 5 7 7 8 8 8 8 8
5 4 5 6 5 6 6 7 7
4 5 7 8 8 8 8 8 8
6 5 7 8 8 8 8 8 7
6 4 4 7 7 6 7 8 8
7 6 6 8 8 8 8 8 8
5 4 5 6 6 6 7 7 6
6 4 4 6 7 6 7 7 7
6 7 7 8 8 8 8 8 8
4 5 4 6 6 7 7 7 7
5 4 5 6 7 7 8 8 6
5 4 4 6 5 5 5 8 7
5.3 4.8 5.4 6.8 6.9 6.9 7.3 7.6 7.:
0.9 1.0 1.3 0.9 1.2 1.1 1.0 0.5 0.
 Group 
mean
Placebo
Charlotte 
Chariie 
Jack 
Rose
North Star 
Lord Muckle 
Big Ben 
Mike
Rainbeam 
Choppy
0? flcer 8 3 3 6 7 6 6 7 7  Group
mean
Mean 5.4 4.8 5.3 6.8 7.3 7.0 7.5 7.2 6.9 6.5
S.D. ‘ '
6 6 7 8 8 8 8 7 8
6 6 6 7 8 8 8 8 8
5 7 7 8 8 8 8 7 7
5 4 5 6 8 7 7 6 6
6 5 5 6 7 5 7 8 6
3 2 3 7 5 5 7 7 5
5 6 6 7 7 8 8 7 7
5 4 4 8 8 7 8 7 7
4 5 7 7 8 8 8 7 7
5 5 4 7 7 7 7 8 9
6 4 6 5 7 7 8 7 7
3 3 6 7 6 6 7 7
'
1.2 1.4 1.5 0.9 0.9 1.1 0.7 0.6 1.
EFAs
Veronica 5 4 4
Dolly 6 6 6
S>ru3ence I § Iatar I t i
pspeth 5 5
Anne 6 6
biky l  \  . . . . . .  .
lenry 4 3 6 7 6 6 6 7 7  Group
mean
Mean 5.5 4.8 5.2 6.6 7.1 7.0 7.2 7.4 7.2 6.4
S.D. 0.7 1.1 0.9 0.7 0.7 0.6 0.8 0.7 0.6
6 7 7 8 7 7
7 8 7 7 8 8
7 7 6 8 8 7
7 8 7 7 7 7
8 7 8 7 8 8
6 7 7 8 8 8
6 8 8 7 8 8
7 7 7 7 8 7
6 6 7 6 7 6
6 7 7 8 6 7
7 6 6 6 7 7
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Table V
Mane condition scores
Scored on a 1 to  10 scale, 1 is  poorest, 10 is  optimal
Horse Week 
0 2 8 10 12 14 16
Controls
5?lfn
Fred,
Temple
Delta
Beau
Fella
Sprig
Dick
Noddy
Durando
Natasha
Mean
S.D.
6 5 6 6 8 8 8 8 8
5 5 5 7 7 8 8 8 7
7 6 6 7 8 8 8 8 8
6 6 6 7 7 8 8 8 8
6 6 6 7 7 7 7 8 8
7 5 6 8 8 8 8 8 8
5 4 6 6 6 7 7 8 6
5 6 6 6 7 7 8 8 8
6 7 7 7 8 8 8 8 8
4 5 4 7 5 8 8 8 8
6 5 6 7 7 8 8 8 8
4 4 5 6 5 6 7 8 8
5.6 5.3 5.8 6.8 6.9 7.6 7.8 8.0 7.
1.0 0.9 0.8 0.6 1.1 0.7 0.5 0.0 0.1
mean
Placebo
Charlotte 
Chariie 
Jack 
Rose
North Star 
Lord Muckle 
Big Ben 
Mike
Rainbeam 
Choppy 
Spring 
O ff ice r
mean
Mean 5.1 5.3 5.6 6.8 7.3 7.3 7.8 7.9 7.9 6.8
S.D.
5 5 6 8 7 8 8 8 8
6 6 6 7 8 8 8 8 8
5 7 6 8 7 8 8 8 8
5 5 6 6 7 7 7 7 8
6 6 5 6 7 7 8 8 8
5 4 5 7 7 6 7 8 7
5 5 6 7 7 8 8 8 8
4 5 6 7 8 7 8 8 8
4 4 6 6 7 7 8 8 8
5 6 6 7 8 8 8 8 9
6 6 6 6 8 8 8 8 8
5 4 3 6 7 6 7 8 8
!
0.7 1.0 0.9 0.8 0.5 0.8 0.5 0.3 o.<
EFAs
Veronica 
Dolly 
Danny 
Prudence 
Jeeves 
Heidi 
Elspeth 
Anne
Wily
Henry mean
Mean 5.5 5.6 5.5 6.9 6.8 7.1 7.5 7.7 7.7 6.7
S.D. ..................................................................
5 6 4 7 7 7 8 7 7
6 6 6 7 8 7 7 8 8
6 6 6 7 7 7 8 8 8
6 6 6 7 8 8 7 8 8
5 5 5 8 6 7 8 8 8
6 5 6 6 7 8 8 8 8
5 6 5 7 7 8 7 8 7
6 6 6 7 6 6 7 7 7
6 5 5 7 7 6 7 8 8
5 5 5 6 6 7 8 7 8
5 6 6 7 6 7 8 8 8
0 5 0.5 0 7 0.5 0.8 0.7 0.5 0.5 0.!
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Table VI
T a il con d itio n  scores
Scored on a 1 to  10 scale, 1 is  poorest, 10 is  optimal
Horse Week
0 2 4 6 8 10 12 14 16
Controls
5?lfn
Fred,
Temple
Delta
Beau
Fel]a
Durando
Natasha
Mean
S.D.
6 5 6 7 8 8 8 8 8
5 5 5 7 7 8 8 8 7
5 6 6 7 8 8 8 8 8
6 6 6 7 8 8 8 8 7
6 6 6 7 7 7 7 8 8
7 5 6 8 7 7 8 8 7
5 4 6 7 6 7 7 7 7
5 6 6 6 7 7 8 7 7
6 7 7 8 8 8 8 8 0
4 5 6 7 6 7 7 8 8
6 6 6 7 7 8 8 8 8
4 5 6 6 6 7 7 8 7
5.4 5.5 6.0 7.0 7.1 7.5 7.7 7.8 6.1
0.9 0.8 0.4 0.6 0.8 0.5 0.5 0.4 2.;
Group 
mean 
J 6.8
Placebo
Charlotte 
Chariie 
Jack 
Rose
North Star 
Lord Muckle
l ^ e Ben
Rainbeam 
Choppy
mean
Mean 5.3 5.6 5.9 7.0 7.3 7.4 7.7 7.9 7.9 6.9
S.D.
6 5 6 8 7 8 8 8 8
7 6 6 7 8 8 8 8 8
5 7 7 7 7 8 8 8 8
5 5 6 6 8 7 8 7 8
6 6 6 6 7 7 7 8 8
5 4 6 7 7 6 7 8 7
5 6 6 8 7 8 8 8 8
4 5 4 8 7 7 8 8 8
5 6 6 7 7 8 8 8 8
5 6 6 8 8 8 8 8 9
5 6 6 6 7 7 7 8 7
6 5 6 6 7 7 7 8 8
'
0.8 0.8 0.7 0.9 0.5 0.7 0.5 0.3 0.!
EFAs
6 6 4 7 7 7 8 8 86 6 6 7 8 7 7 8 7
6 6 6 7 7 7 8 8 7
6 6 6 7 8 8 7 8 8
5 5 6 8 7 7 8 8 7
7 5 6 7 7 7 8 8 8
5 6 5 7 7 8 7 8 8
6 6 6 7 7 7 7 8 8
4 5 7 6 6 7 8 7
6 5 6 6 7 8 7 8
5 6 6 7 7 7 8 8 7
5.6 5.6 5.5 7.0 7.0 7.1 7.5 7.9 7.!
0.8 0.5 0.7 0.4 0.6 0.5 0.5 0.3 0.!
W CaDanny 
Prudence 
Jeeves 
Heidi 
Elspeth 
Anne
Wily . . . . . . . . .Henry 5 7 7 7 8 8 7  Group
mean
Mean         5 6.8
S.D. .. .............. .........................
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Table VII
Hoof condition scores
Scored on a 1 to  10 scale, 1 is  poorest, 10 is  optimal
Horse
Controls
5?lfu
Fred
Temple
Delta
Beau
Fella
Dick
Noddy
Durando
Natasha
Mean
S.D.
Week
0 2 4 6 8 10 12 14 1
7 6 7 8 8 8 7 75 6 7 7 7 7 7 7
7 7 7 8 8 8 7 77 6 7 7 7 7 7 7
6 6 7 7 7 7 7 6
8 7 7 7 8 8
6 6 7 7 7 7 6 7
6 6 7 7 7 7 7
8 7 7 8 8
6 6 7 7 7 7 7 7
6 7 6 7 7 7 7 7
7 7 7 8 7 8 7 7
6.6 6.4 6.8 7.3 7.3 7.4 7.1 7.
0.9 0.5 0.4 0.5 0.5 0.5 0.5 0.
Group 
mean 
1 7.0
Placebo
, a r lo t te  
Chariie 
Jack 
Rose
North Star 
Lord Muckle 
Big Ben 
Mike
Rainbeam
Choppy
S M r
Mean
S.D.
7 7 7 7 8 7 8 7 7
7 7 7 6 7 7 7 7 7
7 8 7 7 8 8 7 7
6 6 6 5 7 7 7 6 6
6 6 6 7 7 7 7 8 7
5 6 6 6 7 7 6 6 7
6 6 6 6 7 7 7 7 7
6 6 7 7 7 7 8 6 8
6 6 7 7 8 7 8 7 7
7 7 6 7 7 8 8 8
7 7 6 6 8 7 8 7 7
7 7 6 6 7 7 7 7 7
6.4 6.6 6.4 6.4 7.3 7.2 7.4 6.9 7.
0.7 0.7 0.5 0.7 0.5 0.4 0.7 0.7 0.
Group 
mean 
[ 6.9
EFAs
Veronica
Dolly
Danny
Prudence
Jeeves
Heidi
Elspeth
Anne
[jonyHenry
Mean
S.D.
6 4 6 7 7 7 8 7 7
5 5 6 6 7 6 6 6 6
7 7 6 7 7 7 7 7 7
7 6 7 7 7 7 7 7 7
7 6 7 6 7 7 7 7
7 6 6 7 7 7 7 7
6 6 6 7 7 7 7 7 7
7 7 6 7 8 7 8 7
7 7 7 7 7 7 75 6 6 6 7 6 7 7
7 6 6 7 7 7 7 7 7
6.5 5.9 6.2 6.7 6.9 7.0 6.9 7.0 6.
0.7 0.8 0.4 0.5 0.5 0.4 0.5 0.4 0.
Group 
mean 
) 6.7
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Table VIII
Body condition scores
Scored on a 1 to  5 scale , 1 is  emaciated, 5 is  obese.
Horse
Controls
F e l f i t
Week
red
5 l T ? i e
PlfVa
& T
Noddy
Durando
Natasha
Mean
S.D.
0 2 4 6 8 10 12 14 16
3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0
3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0
3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0
3.5 3.0 3.0 3.0 3.5 3.5 3.5 3.5 3.5
3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0
3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0
3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0
3.5 3.5 3.5 3.0 4.0 3.0 3.5 3.5 3.0
3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0
3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0
3.0 3.0 3.0 3.5 3.5 3.0 3.0 3.0 3.0
3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0
3.08 3.04 3.04 3.04 3.17 3.04 3.08 3.08 3.04
0.19 0.14 0.14 0.14 0.33 0.14 0.19 0.19 0.14
Placebo
Charlotte 
Chariie 
Jack 
Rose
L.Muckle 
Big Ben 
Mike
Rainbeam
Choppy
SeeingO ffice r
Mean
S.D.
3.0 3.0 3.0 3.5 3.5 3.5 3.5 4.0 4.0
4.0 3.5 4.0 3.5 4.0 4.0 4.0 4.0 4.0
3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0
3.0 3.5 3.0 3.5 3.5 3.0 3.5 3.5 3.0
■ 3.0 3.0 3.0 3.0 2.5 3.0 3.0 3.0 3.0
2.0 1.5 2.0 2.5 2.5 2.5 2.5 2.5 1.5
3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5
3.0 3.0 3.0 2.5 3.0 2.5 3.0 3.0 3.0
3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0
3.0 3.0 3.0 3.0 3.0 3.5 3.5 3.0 3.0
3.0 3.0 3.0 3.5 3.5 3.5 3.5 3.0 3.5
3.0 3.5 3.0 3.0 3.0 3.0 3.0 3.0 3.0
3.04 3.04 3.04 3.13 3.17 3.17 3.25 3.21 3.13
0.45 0.54 0.45 0.38 0.44 0.44 0.40 0.45 0.64
Group
EFAs
Veronica
Dolly
Danny
Prudence
Jeeves
T O t hAnne
mHenry
Mean
S.D.
3.0 3.0 3.0 2.5 3.0 3.0 3.0 3.0 3.0
3.5 3.5 3.5 3.5 4.0 3.5 4.0 3.5 4.0
3.0 3.0 3.0 3.5 3.5 3.0 3.0 3.0 3.0
3.5 3.5 4.0 4.0 4.0 4.0 4.0 4.0 4.0
3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0
3.0 3.0 3.5 3.0 3.5 3.5 3.5 3.5 3.0
3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0
3.0 3.0 3.0 3.0 3.5 3.0 3.0 3.0 3.0
3.0 3.0 3.0 3.0 3.5 3.5 3.0 3.0 3.0
3.5 3.5 3.5 3.5 3.0 3.5 3.0 3.0 3.0
2.5 1.5 2.0 2.5 2.5 2.5 2.5 2.0 2.5
3.09 3.00 3.14 3.14 3.32 3.23 3.18 3.09 3.14
0.30 0.55 0.50 0.45 0.46 0.41 0.46 0.49 0.45
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Haematological Parameters
Table IX
Red ce l l  counts Values x IO iy i 
Horse Week 
0 4 8 12 16
Controls
F e l f i t
J i l l
Fred
Temple
Delta
P ltV a
Noddy
Durando
Natasha
Mean
S.D.
9.0 7.5 8.6 7.1 6.0
7.7 7.3 6.5 6.8 6.2
5.5 6.3 5.2 5.5 5.3
6.9 6.3 6.5 6.0 6.3
6.3 5.4 6.2 5.6 5.4
7.0 7.1 7.2 7.2 7.1
7.4 8.1 6.7 7.2 7.4
7.4 7.1 6.8 7.1 8.1
6.8 6.9 6.4 6.0 5.8
6.4 5.9 5.9 6.5 5.9
6.1 6.7 7.8 5.7 6.1
6.6 7.6 7.0 6.2 6.3
6.93 6.85 6.73 6.41 6.33
0.90 0.77 0.88 0.66 0.82
Group
mean
6.65
Placebo
Charlotte 
Chariie 
Jack 
Rose
iorth Star . . 
.ord Muckle 7.2 
Jig Ben 
l ike
Rainbeam 
Choppy 
Spring 
O ff ice r
Mean 
S.D.
7.4 6.7 7.0 6.8 6.3
6.5 6.0 6.0 6.3 5.8
8.0 7.1 7.2 7.0 6.6
7.1 5.9 5.6 5.9 6.9
6.6 6.5 6.4 7.5 6.9
8.2 6.1 7.8 7.3
6.7 6.2 5.2 5.7 6.5
6.6 6.5 6.6 6.4 5.7
6.6 7.2 6.2 6.7 6.5
7.8 8.2 8.8 8.6 8.4
6.1 6.4 6.1 6.7 6.0
7.0 7.2 6.4 7.0 6.5
6.97 6.84 6.47 6.87 6.62
0.56 0.77 0.91 0.81 0.73
Group
mean
6.75
EFAs
Veronica 
Dolly 
Danny 
Prudence 
Jeeves
e ? $ th
Anne
b illy
Henry 7.6 6.6 6.8 6.6 6.6 Group
mean
Mean 6.80 6.51 6.36 6.41 6.39 6.49
S.D.
6.4 5.8 6.4 6.4 7.4
6.7 5.6 6.6 8.0 6.2
7.7 7.8 9.9 6.6 7.1
5.2 6.0 5.1 5.0 5.2
6.4 6.2 6.2 6.6 6.1
7.3 6.5 5.2 6.8 6.5
6.9 5.2 5.7 5.5 5.7
8.5 6.7 §•2 6.9
i i 2 6.2 6.1 o.6 5.6
7.7 7.2 5.3 6.2 Z-97.6 6.6 6.8 6.6 6.6
6.80 6.51 6.36 6.41 6.39
0.76 0.98 1.32 0.76 0.70
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Table X
Haemoglobin values Values given in  g /d l
Horse Week
0 8 12 16
Controls
j i ] f n
Fred
siTel6
PlfY a
B?&9
Noddy
Durando
Natasha
Mean
S.D.
16 .0 12 .9 15.5 12.5 [0.2
13 .5 12 .3 11.0 11.7 0.5
12 .7 11 .6 9.2 10.1 <).4
12 .7 11 .4 11.7 10.9 LI.2
12 .7 10 .4 12.1 11.0 [0.5
12 .3 12 .2 12.4 12.3 [2.0
12 .8 14 .1 11.3 12.3 L2.6
13 .9 13 .3 12.6 12.9 [5.0
12 .2 12 .4 11.4 10.6 [0.2
12 .3 10 .7 11.0 12.0 [0.9
10 .5 12 .0 13.5 9.7 [0.3
12 .7 14 .2 12.7 11.3 [1.2
12 .86 12 .29 12.03 11.44 11.17
1. 28 1. 20 1.55 1.01 1.48
Group
mean
Placebo
Charlotte 
Chariie 
Jack 
Rose
North Star 
Lord Muckle 12.1 
Big Ben 
Mike
Rainbeam 
Choppy
Seeing O ff ice r
Mean 
S.D.
13 .3 11 .7 12 .5 12 .3 11 .4
11 .9 10 .9 11 .1 11 .2 10 .3
14 .2 12 .2 12 .6 12 .6 11 .6
13 .5 10 .9 10 .1 10 .5 12 .4
11 .8 11 .2 10.9 12 .8 11 .7
13 .4 10 .6 12 .5 12 .0
12 .2 12 .2 10 .1 11 .0 11 .6
12 .2 11 .7 12 .1 11 .7 10.3
12 .0 12 .7 11 .1 11 .8 11 .6
13 .4 14 .0 15 .3 14 .6 14.1
10.8 11 .5 11 .1 11 .8 10.8
12 .1 12 .4 11 .0 12 .1 11 .6
12 .46 12 .07 11 .54 12 .08 11 .62
0.'94 0.'96 l.<44 l . i05 l . i01
Group
mean
EFAs
Veronica
Jo l ly
Danny
Prudence
Jeeves
^ dPk hty?Polly
Henry
Mean
S.D.
2.7
2.8
3.9 
0.0
1.9
3.8
2.8  
2.3
1.7
4.8
3.9
12.78
1.32
0.8
0 . 2
3.8
2 . 2
0.8
_2.4
9.3
15.4
11.7 
13.2
11.7
12.0
12.0
17.8
9.8 
11.4
9.8 
0.7 
1.8  
1.4
9.7
11.9
1.8
4.9
1.6
0 . 2
2.3 
2.7 0.5 
0.9
2.3
1.5
1.6
4.2 
1.0
2.4 
0 . 2
1.2 
1.8 
0.5
2.4 
0.7 
3.0 
1.6 Group 
mean
11.95 11.66 11.85 11.73 11.99 
1.73 2.23 1.27 1.20
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Table XI
Packed c e ll volumes Values given as 1/1
Horse Week
0 8 12 16
Controls
F e l f i t
J i l l
Fred
Temple
Delta
PlfV a
Noddy
Durando
Natasha
Mean
S.D.
0.472 0,.392 0,.460 0..371 0.309
0.405 0,.371 0,.332 0,.346 0.316
0.304 0,.352 0..283 0..299 0.281
0.383 0,.348 0..352 0..323 0.334
0.356 0..312 0..363 0..324 0.313
0 .360 0,.367 0,.373 0..369 0.361
0.377 0..411 0,.339 0,.364 0.374
0.405 0..388 0,.370 0,.381 0.434
0.364 0,.376 0,.347 0,.322 0.309
0.358 0.,332 0,.329 0,.360 0.329
0.308 0.,346 0..399 0..294 0.312
0.360 0,.414 0,.386 0,.337 0.334
o.:3710 0,.3674 0,.3611 0,.3418 0.3338
0.13446 0..0310 0..0435 0..0289 0.0401
Group
mean
Placebo
Charlotte 
Chariie 
Jack 
tose
lorth Star 
_ord Muckle 
3ig Ben 
^ike
Rainbeam
L i ly
Sgnng
O ffice r
Mean (
S.D. (
0.393
0.355
0.418
0.393
0.345
0.359
0.361
0.363
0.349
0.351
0.324
0.368
0.358 0.382 0.370 0.343
0.334 0.331 0 .343 0.310
0.377 0.378 0.365 0.000
0.323 0.305 0.315 0.371
0.338 0.330 0.381 0.351
0.400 0.296 0.372 0.358
0.362 0.301 0.326 0.345
0.361 0.370 0.354 0.316
0.383 0.334 0.352 0.345
0.353 0.353 0.368 0.314
0.344 0.328 0.362 0.323
0.375 0.337 0.364 0.345
o.:3590 o.:3371 o.:3560 o.:3101
0.13223 0.13290 0.13195 0.10994
Group
mean
0.3454
EFAs
Veronica 
Dolly 
Danny 
Prudence 
Jeeves 
Heidi 
Elspeth 
Anne
Pony 0.430 0.397 0.286 0.335 0.374
Henry 0.407 0.357 0.365 0.352 0.351 Group
mean
Mean 0.3746 0.3602 0.3500 0.3508 0.3484 0.3568
S.D. ‘ .. .........................................
0 .360 0,.328 0.356 0.353 0.411
0.379 0,.314 0.364 0.438 0.340
0.407 0,.415 0.524 0.345 0.370
0.297 0,.349 0.298 0.286 0.301
0.353 0,.341 0 .345 0.368 0.339
0.402 0..364 0 .288 0.377 0.351
0.377 0,.289 0 .319 0 .310 0.317
0.358 0,.455 0,.352 0,.327 0.364
0.351 0,.353 0,.353 0 .368 0.314
0.430 , 0 5 .
0 .407 , , 0,. 2 0.351
0.3746 . 0. 500 0.3508 o.:
0 .367 0..471 0,.651 0,.395 0.314
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Table X II
Mean c e ll volumes Values given in  f l
Horse Week 
0 4 8 12 16
Controls
5 ? ] f n
Fred
Temple
Delta
Beau
Fella
Spr i gDick
Noddy
Durando
Natasha
Mean
S.D.
52 .4 52 .3 53 .5 52 .3 51 .5
52 .6 50 .8 51 .1 50 .9 50 .9
55 .3 55 .8 54 .5 54 .3 53 .0
55 .5 55 .3 54 .2 53 .8 52 .9
56 .5 57 .8 58 .6 57 .8 58 .0
51 .4 51 .7 51 .8 51 .2 50 .9
50 .9 50 .7 50 .6 50 .6 50 .6
54 .7 54 .7 54 .4 53 .7 53 .6
53 .5 54 .5 54 .2 53 .7 53 .2
56 .0 56 .2 55 .8 55 .4 55 .7
50 .5 51 .7 51 .1 51 .5 51 .2
54 .5 54 .5 55 .2 54 .3 52 .9
53 .65 53 .83 53 .75 53 .29 52 .87
2.136 2.:33 2.:32 2. 11 2. 19
Group
mean
Placebo
Charlotte 
Chariie 
Jack 
Rose
North Star 
Lord Muckle 
Big Ben 
Mike
Rainbeam
Choppy
SpringO ff ice r
Mean
S.D.
53 .1 53 .4 54 .5 54 .4 54 .4
54 .6 55 .7 55 .2 54 .5 53 .4
52 .3 53 .1 52 .5 52 .2 52 .7
55 .4 54 .8 54 .4 53 .4 53 .7
52 .3 52 .0 51 .6 50 .8 50 .9
49 .9 48 .8 48 .5 47 .7 49 .0
58 .4 57 .8 57 .2 59 .0 53 .4
55 .0 55 .6 56 .0 55 .3 55 .4
52 .9 53 .2 54 .2 52 .5 53 .4
51 .0 51 .6 50 .0 50 .4 48 .9
53 .1 53 .7 53 .8 54 .1 53 .8
52 .5 52 .1 52 .7 52 .0 53 .4
53 .59 53 .48 53 .38 53 .03 52 .70
2.;20 2.:33 2.'18 2.84 2.04
Group
mean
EFAs
Veronica
Dolly
DannyPrudence
Jeeves
Heidi
Elspeth
Anne
p ,
Henry
Megn
56.3
56.5
52.9 
57.2 
55.1 
55.0 
54.7
53.5
56.6
55.9
53.6
1.43
56 .6 55,.6 55 .2 55 .5
56 .1 55,.1 54 .7 54 .9
53 .2 52,.9 52 .3 52 .1
58 .2 58,.4 57 .3 57 .8
55 .0 55,.7 55 .8 55 .6
56 .0 55,.4 55 .4 54 .0
55 .6 55,.9 56 .3 55 .7
53 .5 52,.5 52 .7 52 .8
56 .9 57,.9 55 .8 56 .1
55 .1 54,.0 54 .0 53 .4
54 .1 53,.7 53 .3 53 .2
55 .48 55,.19 54 .80 54 .65
1.!51 1.86 1.!57 1.70
Group
mean
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Table X I I I
Mean c e ll haemoglobin values in  pg
Horse Week
0 8 12 16
Controls
j i l f n
Fred
Temple
Delta
PltV a
&
Noddy
Durando
Natasha
Mean
S.D.
17.8 17.2 [8.0 [7.6 [7.0
17.5 16.8 [6.9 [7.2 L6.9
18.4 18.4 L7.7 [8.4 L7.7
18.4 18.1 L8.0 [8.2 L7.6
20.2 19.3 L9.5 [9.6 L9.4
17.6 17.2 [7.2 [7.1 [6.9
17.3 17.4 [6.9 L7.1 [7.0
18.8 18.7 [8.5 [8.2 L8.5
17.9 18.0 [7.8 [7.7 [7.6
19.2 18.1 [8.6 [8.5 L8.5
17.2 17.9 L7.3 [7.0 [6.9
19.2 18.7 L8.1 [8.2 L7.6
18.29 17.98 17.88 17.90 17.63
0.92 0.73 0.76 0.77 0.80
Group
mean
Placebo
Charlotte 
Chariie 
Jack 
Rose
North Star 
Lord Muckle 16.8 
Big Ben 
Mike
Rainbeam 
Choppy 
Spring 
O ff ice r
Mean 
S.D.
18 .0 17 .5 17 .9 18.1 18 .1
18 .3 18 .2 18 .5 17 .8 17 .8
17 .8 17 .2 17 .5 18 .0 17 .6
19 .0 18 .5 18 .0 17 .8 18.0
17 .9 17 .2 17 .0 17 .1 17 .0
16 .3 17 .4 16 .0 16 .4
18 .2 19 .7 19 .4 19 .3 17 .9
18 .5 18 .0 18 .3 18 .3 18 .1
18 .2 17 .6 18.1 17 .6 17 .9
17 .2 17 .1 17 .4 17 .0 16.8
17 .7 18 .0 18.2 17 .6 18.0
17 .3 17 .2 17 .2 17 .3 17 .9
17 .91 17 .71 17 .91 17 .66 17 .63
0.61 0.86 0.67 0.80 0.!57
Group
mean
EFAs
Veronica
Dolly
Danny
Prudence
Jeeves
Heidi
Elspeth
Aijne
Fjony
Henry
Mean
S.D.
9.8
9.1
8.1
9.2 
8.6
8.9 
8.6 
8.4
8.9
9.2
8.3
18.6
18.2
17.7
20.3
7.4
9.1
7.9
8.1
8.9 
8.3 
7.7
18.8
18.2
18.0
19.2
18.4 
18.8 
18.8
17.6
18.7
18.3
17.5
18.4 
18.6
17.6
20.4
18.6 
18.7 
19.1
17.6
18.6
18.5
17.6
9.2
7.7
7.5
9.6
8.4 
8.1
8.4 
8.0 
9.1
8.6 
7.6 Group
18.83 18.38 
0.49 0.82
18.39 18.52 18.38 18 
0.54 0.80 0.69
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Table XIV
Mean c e ll haemoglobin concentration values (g /d l)
Horse Week
0 8 12 16
Controls
F e l f i t
J i l l
Fred
Temple
Delta
P i t t a
Noddy
Durando
Natasha
Mean
S.D.
33.9 32.9 33.7 33.7 33.0
33.3 33.2 33.1 33.8 33.3
33.2 33.0 32.5 33.8 33.5
33.2 32.7 33.2 33.8 33.4
35.7 33.3 33.3 34.0 33.5
34.2 33.2 33.2 33.4 33.2
34.0 34.3 33.3 33.8 33.7
34.3 34.2 34.1 33.8 34.5
33.5 33.0 32.9 32.9 33.1
34.3 32.3 33.4 33.3 33.2
34.1 34.6 33.9 33.0 33.0
35.3 34.3 32.9 33.6 33.4
34.08 33.42 33.29 33.58 33.40
0.78 0.74 0.45 0.35 0.41
Group
mean
Placebo
Charlotte 
Chariie 
Jack 
Rose
North Star 
Lord Muckle 33.7 
Big Ben 
Mike
Rainbeam 
Choppy 
Spring 
O ff ice r
Mean 
S.D.
33 .8 32 .7 32 .8 33 .3 33 .3
33 .5 32 .6 33 .5 32 .6 33 .3
33 .9 32 .4 33 .3 34 .5 33 .4
34 .3 33 .7 33 .2 33 .3 33 .5
34 .2 33 .1 33 .0 33 .6 33 .3
33 .5 35 .8 33 .6 33 .5
33 .9 33 .7 33 .6 33 .7 33 .5
33 .6 32 .4 32 .7 33 .1 32 .6
34 .4 33 .2 33 .3 33 .5 33 .5
33 .7 33 .1 34 .8 33 .7 34 .3
33 .3 33 .5 33 .8 32 .6 33 .5
32 .9 33 .1 32 .6 33 .2 33 .5
33 .77 33 .08 33 .53 33 .39 33 .43
0.<42 0.<47 0.!93 0.!51 o.:37
Group
mean
EFAs
Veronica 
Dol ly  
Danny 
Prudence 
Jeeves
P f $ t n
Anne
L i ly
RoilyHenry
Mean
S.D.
35.2
33.8
34.1
33.6
33.7 
34.4
33.9
34.3
33.3
34.4
34.1
32.9 
32.5 
33.3
34.9
31.7
34.1
32.2
33.9
33.2
33.3
32.8
0.51 0.90
33.7 33.4 34.6
33.0 34.0 32.3
34.0 33.6 33.5
32.9 35.6 33.9
33.0 33.4 33.0
34.0 33.7 33.6
33.6 33.9 33.1
33.5 33.4 34.0
32.3 33.4 34.1
33.9 34.3 34.8
32.6 33.0 33.0
33.32 33.79 33.63
0.59 0.70 0.75
Group
l a§9
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Table XV
Platelet counts 
Horse Week
0
Values x l0 9/ l
4 8 12 16
Controls
F e l f i t
J i l l
Fred
S iT S l6
PlfV a
8?!IP
Noddy
Durando
Natasha
Mean
S.D.
150
130
160
110
220
160
190
160
140
170
180
210
130
110
140
100
160
150
110
130
130
130
180
200
140
150
150
130
230
120
150
170
160
140
140
220
150
130
150
100
160
120
170
160
140
150
160
190
30
70
40
45
200
140
160
150
120
110
130
145
165.0 139.2 
31.8 29.4
Group 
mean
158.3 148.3 145.0 151.2 
33.8 23.7 23.8
Placebo
Charlotte 170 130 140 170 140
Chariie 146 122 130 100 142
Jack 180 180 170 170 146
Rose 190 180 150 180 240
North Star 110 30 60 30 142
Lord Muckle 200 180 170 200 140
Big Ben 146 140 150 140 142
Mike 60 80 80 60 142
Rainbeam 130 80 130 50 142
Choppy 130 110 120 120 120
SeeingO ff ice r
150 130 130 110 110
170 140 140 180 142
Mean 148.5 125.2 130.8
32.6
125.8 145.7
31.6S.D. 38.5 45.6 57.0
Group
mean
EFAs
Veronica 
Dolly 
Danny 
Prudence 
Jeeves 
Heidi 
Elspeth 
Anne 
L i ly
Henry 160 140 170 130 130 Group
. mean.
Mean 
S.D.
160 120 120 100 100
120 140 160 120 80
170 140 140 170 160
220 200 200 180 140
160 120 120 120 110
10 152 158 100 141
230 210 210 210 180
170 140 150 150 170
130 120 130 120 130
220 150 170 M 170
159.1 148.4 157.1 141.8 137.4
61.1 30.3 29.7 35.2 31.7
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Table XVI
White cell counts 
Horse
Controls
F e l f i t
J i l l
Fred
Temple
Delta
PlfYa
Noddy
Durando
Natasha
Mean
S.D.
Week 
0 4
Values x l0 9/ l
8 12 16
5.9 4.9 5.2 6.0 5.3
7.8 7.1 6.1 9.0 7.1
5.5 5.4 5.2 4.7 5.6
6.7 5.4 4.7 6.9 5.8
7.9 7.1 8.0 7.1 6.6
9.4 6.2 6.7 6.0 6.0
7.2 5.5 4.6 4.6 5.2
6.7 6.8 6.1 6.7 6.4
7.0 6.3 5.8 5.7 5.6
8.0 5.9 6.2 5.5 6.0
5.0 4.5 5.2 4.5 4.4
10.6 8.1 9.5 8.3 5.8
7.31 6.10 6.11 6.25 5.82
1.59 1.04 1.42 1.42 0.70
Group
mean
6.32
Placebo
Charlotte 
Chariie 
Jack 
lose
\lorth Star . . .  
_ord Muckle 8.0 
l ig  Ben 
liKe
lainbeam 
Choppy 
Sgring 
O ff ice r
Mean 
S.D.
6.8 6.4 7.1 6.9 7.1
6.3 5.6 6.6 5.4 5.5
6.0 7.9 5.4 6.1 6.4
7.4 6.4 4.9 5.0 6.3
9.0 5.0 7.0 8.7 7.9
8.6 16.0 7.8 9.1
7.1 5.5 5.7 4.7 6.5
6.6 5.2 6.1 5.0 4.7
5.4 6.5 6.9 5.5 6.5
6.2 6.5 7.4 8.5 7.1
4.0 4.9 4.7 4.7 3.6
7.3 5.7 5.5 7.2 6.5
6.68 6.18 6.94 6.29 6.43
1.28 1.13 2.99 1.48 1.42
Group
mean
6.51
EFAs
Veronica 
Dolly 
Danny 
Prudence 
Jeeves 
Heidi 
Elspeth 
Anne
Pony 8.2 6.0 5.2 4.6 5.7 „
Henry 6.4 6.0 5.2 7.2 5.6 Group
mean
Mean 7.85 6.68 6.31 6.85 6.53 6.84
S.D. ‘ “ .................................
11.4 7.3 8.4 7.6 9.9
5.9 5.7 6.2 5.3 5.8
9.0 9.4 8.4 7.5 7.6
6.8 6.3 5.6 6.3
7.1 5.3 5.9 7.1 5.7
6.9 5.7 5.4 6.3 6.5
8.3 5.7 5.8 9.3 6.3
9.5 10.1 7.3 I -9 8.26.8 6.0 6.0 7.1 5.6
8.2 6. .
6.4 6. . 7.2
7.85 . . 6.85 6.53
1.63 1 61 1.19 1.24 1.47
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Biochemical Parameters
Table XVII
Urea values
Horse
Horse
Week 
0 4
Values in mmol/1 
8 12 16
Controls
j i l f n
Fred
Temple
Delta
Beau
Fella
Dick
Noddy
Durando
Natasha
Mean
S.D.
5.6 5.5 4.7 4.7 4.4
5.7 5.0 3.9 4.6 4.6
6.6 6.8 5.8 5.6 5.5
4.6 4.1 4.1 3.8 5.4
6.4 5.7 4.4 4.4 5.4
5.2 4.9 4.5 4.9 5.1
5.5 5.3 4.4 5.0 5.7
4.7 5.0 3.8 4.1 5.0
5.8 5.6 4.8 5.7 5.4
4.8 5.9 4.7 5.2 5.4
4.3 4.9 4.1 4.5 4.4
5.3 5.0 4.5 5.6 5.4
5.38 5.31 4.48 4.84 5.14
0.71 0.67 0.53 0.61 0.45
Group
mean
5.03
Placebo
Charlotte 
Chariie 
Jack 
Rose
North Star 
Lord Muckl< 
Big Ben 
Mike
Rainbeam
Choppy
Sm ogO ff ice r
Mean
S.D.
5.9 5.4 4.2 4.3 5.4
4.3 4.9 4.0 4.3 4.4
5.3 5.4 4.5 4.4 4.7
4.6 5.2 4.5 4.9 5.3
5.3 5.6 5.2 5.2 4.8
7.7 5.4 4.4 6.7 7.0
5.2 6.9 5.4 5.5 5.1
5.4 5.4 4.7 5.2 4.7
4.3 4.9 4.2 4.9 5.1
4.9 5.4 4.5 5.9 4.2
3.9 3.6 3.2 3.0 3.9
4.2 4.5 4.4 4.2 5.1
5.08 5.22 4.43 4.88 4.98
1.02 0.77 0.56 0.95 0.78
Group
mean
4.92
EFAs
Ve^nica
lanny 
Prudence 
Jeeves 
Heidi 
Elspeth 
Anne
_______
Henry 5.5 4.8 5.3 5.3 5.0 Group
mean
Mean 5.49 5.40 4.73 5.05 5.05 5.14
S.D. .............................
6.2 5.9 6.3 6.1 5.8
4.9 4.7 4.2 4.2 4.8
5.7 4.8 4.6 5.3 5.5
5.7 5.6 5.0 5.4 4.7
5.6 5.5 4.2 5.0 5.0
4.9 5.0 4.8 4.5 4.9
4.9 4.6 3.5 4.4 3.9
6.4 6.5 4.8 5.5 5.8
5.4 5.9 4.6 5.2 5.4
5.2 6.1 4.7 4.6 4.7
5.5 4.8 5.3 5.3 5.0
5.49 5.40 4.73 5.05 5.05
0.51 0.65 0 71 0.57 0.56
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Table X V III
Sodium values Values in  mmol/I
Horse Meek 
0 4 8 12 16
Controls
F e l f i t
J i l l
Fred
Temple
Delta
PlfV a
Noddy
Durando
Natasha
Mean
S.D.
137 140 139 [35 138
136 136 133 136 137
136 136 135 138 134
137 139 138 136 135
137 135 135 138 132
139 135 136 138 135
136 136 136 [32 133
132 136 132 [33 136
139 137 138 [30 133
139 137 136 L38 133
141 143 136 L30 134
139 137 132 [36 135
137.3 137.3 135.5 135.0 134.6
2.3 2.3 2.3 3.0 1.8
Group
mean
Placebo
Charlotte 
Chariie 
Rose
North Star _
Lord Muck Ie 134 
Big Ben 
Mike
Rainbeam 
Choppy
Soring __
O ffice r 137 134 135 135 135 Group
mean
Mean 
S.D.
136 139 135 133 134
141 144 133 138 133
138 137 133 138 138
139 137 135 136 135
137 131 138 131
138 139 137 129 135
138 138 135 135 138
139 135 136 132 135
141 138 137 135 136
136 136 134 134 133
137.9 137.6 134.6 134.8 134.8
2.1 2.6 1.8 2.8 2.1
EFAs
Veronica
Dolly
DannyPrudence
Jeeves
Heidi
Elspeth
Anne
WITy
Henry
Megn
34
34 
38 
36 
36
35 
34 
33
36 
32
38 Group 
mean
138.6 139.6 136.3 134.3 135.1 136.8 
1.9 2.9 1.9 3.0 1.9
136 L36 [36 [33
136 139 L36 [41
138 143 [37 [37
141 [40 L39 L34
141 [40 L39 [34
138 L36 136 L33
141 L40 [38 [34
138 [39 [36 [31
138 [38 [34 [36
140 [39 L33 [30
138 [46 [35 [34
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Table XIX
Potassium values Values in  mmol/I
Horse Week 
0 4 8 12 16
Controls
F e l f i t
J i T ? l e
P I f V a
W
Noddy
Durando
Natasha
Mean
S.D.
4.2 4.5 2.7 3.9 3.9
4.2 4.8 4.3 4.6 3.5
4.6 4.5 4.3 4.0 3.7
4.6 4.4 2.7 4.0 3.8
4.4 4.4 4.5 4.2 3.3
3.8 2.6 4.1 3.9 4.3
3.4 3.6 4.6 3.7 4.2
5.0 4.5 3.6 4.0 2.5
5.2 4.7 4.4 3.9 4.0
3.7 3.1 3.8 3.7 4.2
4.3 3.0 3.8 3.9 4.2
4.2 4.7 4.5 4.3 3.8
4.30 4.07 3.94 4.01 3.78
0.52 0.77 0.66 0.25 0.51
Group
mean
4.02
Placebo
Charlotte 
Chariie 
Jack 
Rose
\lorth Star 
_ord Muckle 4.0 
Jig Ben 
^ike
Rainbeam 
Choppy 
Sgnng O ff ice r
Mean 
S.D.
5.9 3.7 4.2 4.3 5.4
4.7 4.2 4.0 3.7 3.9
4.1 3.7 2.8 4.1 3.0
3.8 3.3 4.3 4.1 4.3
4.3 3.2 4.3 3.0 4.5
4.4 3.0 4.1 4.3
3.8 3.8 3.5 3.7 4.0
4.0 3.9 4.5 4.0 3.8
3.0 4.2 4.5 4.2 4.0
3.7 3.7 4.0 4.4 3.9
3.6 4.2 4.1 4.2 3.6
3.7 2.5 4.2 3.1 4.4
4.05 3.73 3.95 3.91 4.09
0.71 0.53 0.56 0.45 0.58
Group
mean
3.95
EFAs
Veronica
Dolly
Danny
Prudence
Jeeves
E ? $ th
Anne
; i i ,
Henry
Mean
S.D.
3.2 3.9 3.3 3.1 4.0
5.5 3.8 3.9 3.9 4.0
5.0 3.4 4.7 4.0 4.1
3.7 3.1 2.6 5.7 3.4
4.5 3.4 4.1 2.6 3.7
3.9 4.8 3.8 3.9 2*23.7 3.2 3.6 3.7 3.5
4.1 4.3 2.1 3-9 4.14.2 4.0 3.4 3.3 3.6
5.2 3.7 3.8 3.6 4.0
3.5 4.6 3.5 3.2 3.9
4.23 3.84 3.53 3.72 3.84
0.74 0.56 0.70 0.79 0.25
Group
mean
3.83
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Table XX
Calcium values 
Horse
Controls
F e l f i t
red
Temple
Delta
P ltV a
i r d 9
Noddy
Durando
Natasha
Mean
S.D.
Week
0
Values in  mmol/1
4 8 12 16
3.18 3.35 2.66 2.92 2.74
2.97 3.11 2.96 3.10 2.92
3.20 3.17 2.93 2.96 2.96
3.04 3.17 2.59 2.74 2.93
3.10 2.84 2.97 2.93 2.89
3.18 3.00 3.02 3.13 3.05
3.19 3.05 3.03 3.11 2.94
2.95 3.12 2.78 3.10 2.96
3.12 3.21 2.90 3.01 2.88
3.11 2.93 3.25 2.97 2.97
2.91 3.08 2.90 3.01 3.00
3.24 3.12 2.98 2.97 2.93 Group
mean
3.099 3.096 2.914 2.996 2.931 3.007
0.109 0.133 0.175 0.109 0.076
Placebo
Charlotte 
Chariie 
Jack 
Rose
North Star 
Lord Muckle 3.14 
Big Ben 
Mike
Rainbeam 
Choppy 
Spring 
O ff ice r
Mean 
S.D.
3..15 3..10 2,.97 3..04 2..89
3..16 3..22 2,.84 2..75 2,.99
3,.08 3,.10 3,.02 2,.93 3,.00
2..90 3..15 2,.82 2,.89 3,.00
3..13 2..81 2,.92 2,.95 2,.93
,. 3..12 2,.82 2,.99 3..03
3..09 3..09 2,.55 3,.06 2..97
3,.10 3..12 2,.95 2,.97 3,.04
3..20 3..10 2,.89 2,.97 2,.97
2..88 3..06 2,.78 3,.00 2..96
3,.17 3..07 3,.00 3,.14 2,.98
3..00 2..96 2..88 3,.04 2,.97
3,.083 3.,075 2,.870 2,.978 2,.978
0,.104 0..103 0,.126 0,.097 0..041
Group
mean
EFAs
Veronica
Dolly
Danny
Prudence
Jeeves
Anne
Mean
S.D.
2,.92 3..04 2.95 2,.88 2.70
3,.08 3,.01 2 ,.80 2,.50 3.10
3,.13 3,.16 3,.02 3,.04 2.99
2..88 3..10 2,.89 2..94 2.82
3..12 3,.09 3,.01 3..01 3 .05
3,.08 3..36 2,.82 3..03 3.00
3,.08 2..99 3,.08 3..00 3.07
3..16 3..17 2,.71 2..89 3.10
3..21 3.,06 3,.00 3.,14 3 .08
2..99 2..97 2,.81 3.,17 3 .05
3..10 3..08 3,.08 3.,09 3.02
3..068 3..094 2,.925 2.,972 2.998
0..100 0.,109 0,.126 0.,182 0.126
L i ly
Genry i l0  i  :  1  .  Group
mean
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Table XXI
C hloride values Values in  mmol/1
Horse Week
0 4 8 12 16
Controls
F e l f i t
J i l l
Fred
Temple
Delta
P iflfa
Noddy
Durando
Natasha
Mean
S.D.
103 102 92 99 96
98 97 94 95 95
[03 98 97 98 95
L02 100 94 100 98
L04 98 98 96 97
L02 97 93 97 92
100 97 94 100 94
96 99 97 97 96
105 99 96 98 96
99 101 93 99 97
97 101 96 102 97
101 101 95 100 96
100.8 99.2 94.9 98.4 95.8
2.9 1.8 1.9 2.0 1.6
mean
Placebo
Charlotte 102 99 97 99 95
Chariie 102 100 95 101 96
Jack 101 99 95 95 95
Rose 101 100 98 102 97
North Star 97 95 97 101 97
Lord Muckle 101 98 93 99 92
Big Ben 100 98 97 99 96
Mike 99 99 96 97 100
Rainbeam 100 97 95 97 96
Choppy 100 100 93 101 96f* Ml*/Sgnng
O ffice r
102 98 97 100 97
99 100 98 103 96
Mean 100.3 98.6 95.9 99.5 96.1
S.D. 1.5 1.5 1.7 2.3 1.8
mean
EFAs
Veronica
ack 
Danny 
Prudence 
Jeeves 
Heidi 
Jilspeth
fi
oVfy
enry
Mean
S.D.
95 96 93 98 93
102 101 94 97 97
101 99 95 95 95
100 97 93 97 95
100 102 99 101 97
102 100 98 102 97
102 99 94 100 95
108 99 99 102 94
103 97 93 99 92
97 98 95 97 93
101 96 95 99 93
101.0 98.5 95.3 98.8 94.6
3.3 2.0 2.3 2.3 1.8
m
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Table XXII
Magnesium values Values in  mmol/1
Horse Week
0 8 12 16
Controls
s i rFred
S i T ? l e
P lfY a
Noddy
Durando
Natasha
Mean
S.D.
0.71 0.61 0.63 0.80 0.74
0.70 0.67 0.78 0.90 0.88
0.81 0.93 0.82 0.95 0.84
0.78 0.79 0.63 0.78 0.76
0.72 0.62 0.84 0.84 0.84
0.68 0.82 0.71 0.83 0.70
0.74 0.50 0.72 0.90 0.69
0.70 0.56 0.76 0.78 0.75
0.73 0.56 0.70 0.78 0.72
0.65 0.79 0.71 0.85 0.66
0.66 0.54 0.75 0.83 0.74
0.73 0.49 0.72 0.72 0.76
0. 718 0.1557 0.731 0.830 0.757
0.1046 0. 143 0.065 0.064 0.066
mean
Placebo
Charlotte 
Chariie 
Jack 
lose
lorth Star 
_ord Muckle 
Dig Ben 
1i Re
lainbeam
Choppy
Spring
O ffice r
Mean
S.D.
0..71 0.76 0.74 0.84 0.70
0..84 0.64 0.79 0.83 0.84
0..67 0.76 0.75 0.94 0.71
0..82 0 .64 0.76 0.80 0.71
0..64 0.70 0.77 0.89 0.74
0,.59 0.92 0.60 0.80 0.80
0,.71 0.69 0.75 0.84 0.74
0.,72 0.86 0.70 0.94 0.68
0.,70 0.71 0.70 0.81 0.74
0..65 0.83 0.68 0.72 0.56
0,.73 0 .72 0.83 0.84 0.73
0..60 0.80 0.65 0.72 0.74
0,.70 0. 753 0.'727 0.831 0.'724
0..08 0J087 0.1364 0.1370 0.1367
mean
EFAs
Veronica
Jo l ly
Danny
Prudence
Jeves
Heidi ,
Elspeth
Anne
Pony
Henry
Mean
S.D.
0.67 0.61 0.67 0.61 0.60
0.81 0.61 0.76 0.67 0.88
0.66 0.64 0.66 0.66 0.78
0.54 0.78 0.74 0.78 0.68
0.79 0.83 0.77 0.90 0.68
0.72 0.57 0.65 0.75 0.71
0.75 0.57 0.83 0.75 0.74
0.81 0.64 0.68 0.74 0.71
0.71 0.68 0.84 0.87 0.76
0.66 0.56 0.74 0.69 0.66
0.80 0.61 0.79 0.77 0.80
0.720 0.645 0.739 0.745 0.727
0.084 0.087 0.067 0.087 0.076
Group
mean.
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Table X X III
Inorgan ic phosphate values Values in  mmol/1
Horse Week
0 4 8 12 16
Controls
ri tF e lf
J i l l .
Mean
S.D.
0..92 0..78 1..12 1..05 0..82
1..01 1..38 1,.08 1..04 0..80
0,.78 0,.68 0,.69 1..04 0..64
0..82 0,.80 0,.71 0..96 1..14
1,.02 0,.88 1,.07 1,.31 0..73
0.,97 1..27 0,.90 0.,99 1.,10
0..68 1..23 0,.95 0..72 0.,68
0..83 0,.78 0,.78 0..79 0.,59
0,.95 0,.68 0,.89 0,,86 0.,77
0,.83 1,.09 0,.98 0..74 0.,88
0..75 0,.88 0,.76 0,.93 1..04
0..99 1,.25 1,.03 0,.97 0,.84
0,.879 0..975 0,.913 0..950 0..836
0..112 0..253 0,.150 0..162 0.,177
Fred 
Temple 
Delta
PifY a
Noddy
Durando ___
Natasha .  .  .  .  .  Group
mean
Placebo
Charlotte 
Chariie 
Jack 
lose
torth Star 
_ord Muckl( 
l ig  Ben 
iike
lainbeam 
<h°ppy
O ff ice r o ;91 i ! l 5  0.60 0.73 0.88 Group
Mean
S.D.
EFAs
0..92 0.,97 0,.92 1..04 0..72
0.,77 0..67 0,.87 0,.98 1..01
0..91 0.,97 0..89 1,.03 0.,98
0,.96 0,,63 0,.98 0..80 0..78
0,.75 1..18 1,.04 1,.05 0,.76
0..82 0.,73 0,.54 0..88 0..70
0.,88 0..86 0,.77 0..73 0..88
0..93 0..94 0,.84 0..82 1..04
0..99 0..70 1..20 1,.04 0..88
1..19 1,.15 1,.00 1,.04 0,.92
0,.94 0..87 0..91 1,.22 0,.92
0.. 1.,15 .. .. ..
0..914 0..902 0..880 0..947 0..873
0,.114 0..194 0,.182 0..152 0..112
mean
Veronica 
Dolly 
Danny 
Prudence 
Jeeves
0,.88 0,.96 0..68 1,.05 0.79
0,.86 0,.91 0,.99 1,.31 0.74
0,.96 0,.92 1,.36 0..90 0.90
0,.79 0,.96 0,.96 1,.07 1.21
1..01 1,.17 0,.91 0,.95 1.08
1,.04 0..88 0..78 0..81 0.98
0..76 0..92 0..99 1..08 1.33
0,.88 0,.70 0,.87 0..88 0.84
0,.82 1,.26 0,.77 0..86 0.99
0,.89 1,.12 1,.02 1,.33 1.07
0,.87 0,.68 1..06 0..86 0.95
0..887 0..953 0,.945 1..009 0.989
0,.087 0..178 0,.182 0..179 0.177
PfldPkh
Anne
Pony 0.89 1. 2  1.33 1. 7 ^
Henry 0.87 0   0.86 0. 5 Group
mean
Mean 0.887  .9  1.009 .  0.957
S.D. .......................................
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Table XXIV
Alkaline phosphatase values, in I.U . 
Horse Week
0 8 12 16
Controls
F e l f i t
J i l l
Fred
Temple
Delta
PlfVa
Noddy
Durando
Natasha
Mean
S.D.
141 134 133 117 145
374 236 223 236 256
216 206 191 263 262
241 182 153 173 196
209 165 162 154 159
312 240 213 211 200
283 188 163 187 160
321 252 289 267 320
205 244 175 151 155
307 201 189 218 176
153 137 179 129 131
262 215 200 191 196
252.0 200.0 189.2 191.4 196.3
70.7 40.2 40.4 49.3 56.3
Group
mean
PIacebo
Charlotte 
Chariie 
Jack 
tose
torth Star 
_ord Muckle 274 
Jig Ben 
iike
n ?ppyRainbeam 
SDring 
O ff ice r
Mean
S.D.
211 213 194 179 187
183 216 239 195 234
217 213 192 180 202
265 195 179 211 245
312 234 222 221 245
251 219 198 209
263 193 192 189 201
279 233 195 184 181
253 225 232 286 241
238 238 207 239 201
160 159 137 143 149
331 226 181 222 201
248.8 216.3 199.1 203.9 208.0
50.0 24.8 27.6 36.0 29.1
Group
mean
EFAs
Veronica 259
Dolly 202
Danny 369
Prudence 242
Jeeves 311
Heidi , 251
Elspeth 225
Anne 230
L i ly  241
Renry 352 25i 189 179 194 Group
mean
Mean 278.5 209.4 200.4 193.7 194.3 215.2
S.D. 63.3..... .........................................
205 192 185 203
165 179 203 158
214 249 211 216
242 233 204 202
198 177 177 174
209 157 182 202
223 189 163 185
245
158
244
167
222
165
245
145
193 228 240 213
1
209.4 200.4 193.7 194.3
30 5 32 3 24.3 28.0
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Table XXV
Aspartate aminotransaminase values, in I.U . 
Horse Week
0 8 12 16
Controls
F e l f i t
J i l l
Fred
Temple
Delta
P itV a
W
faddy
Durando
Natasha
Mean
S.D.
297 314 261 236 287
295 327 279 291 360
284 379 266 298 353
275 333 241 254 310
373 342 319 356 389
254 292 250 260 337
265 322 324 304 317
222 265 222 237 240
252 273 221 245 256
225 299 303 293 288
235 273 231 223 274
359 373 320 336 310
278.0 316.0 269.8 277.8 310.1
48.1 37.5 38.8 42.0 44.2
Group
mean
Placebo
Charlotte 
Chariie 
Jack 
Rose
North Star _ 
Lord Muckle 370 
Big Ben 
Mike
Rainbeam 
Choppy 
Spring 
O ff ice r
Mean 
S.D.
299 336 226 240 234
285 345 316 279 308
213 336 251 267 336
249 247 189 214 237
258 316 284 313 331
355 276 279 265
322 319 287 316 311
307 362 318 327 322
433 413 403 383 311
342 396 344 398 780
400 386 300 336 367
284 345 283 296 311
313.5 346.25 289.8 304.0 342. 8
64.0 43.2 55.1 53.7 143. 2
Group
mean
EFAs
Veronica
Dolly
lanny
Prudence
Jeeves
Heidi ,
Elspeth
Anne
RonyHenry
Mean
S.D.
306
359
287
322
258
319
283
279
272
332
376
308.5
37.2
324 304 291 332
356 294 373 302
314 319 328 335
353 310 285 307
303 255 274 259
341 266 317 336
308 272 285 305
341 276 271 252
286 251 264 270
313 266 253 250
393 368 361 369
330.2 289.2 300.2 301.5
30.2 34.6 39.6 39.7
Group
mean
305.9
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Table XXVI
B i l i r u b in  values, in  umol/1
Horse Week 
0 4 8 12 16
Controls
F e l f i t
J i l l
Fred
Temple
Delta
P ltV a
Noddy
Durando
Natasha
Mean
S.D.
14 13 27 15 12
16 16 30 20 19
19 11 16 18 16
14 15 14 16 16
17 7 9 15 10
11 13 14 15 14
17 19 18 17 12
17 18 20 19 18
17 19 16 25 22
17 24 28 25 23
16 10 21 17 9
17 11 21 16 16
16.0 14.7 19.5 18.2 15.6
2.1 4.8 6.3 3.6 4.4
Group
mean
Placebo
Charlotte 
Chariie 
Jack 
Rose
North Star 
Lord Muckle 
Big Ben 
Mike
Rainbeam
Choppy
Spring
O ff ice r
Mean
S.D.
17 17 17 17 17
10 11 13 15 11
21 20 18 15 22
7 12 10 10 12
18 24 15 24 26
29 15 69 31 24
16 14 16 15 17
10 14 13 16 13
16 20 36 23 17
20 19 30 60 40
23 8 18 16 12
9 15 16 17 17
16.3 15.8 22.6 21.6 19.0
6.5 4.5 16.4 13.3 8.2
Group
mean
19.1
EFAs
Veronica
Dolly
Danny
Prudence
Jeeves
y ? $ th
L i ly
Anne
Roily
Henry
Mean
S.D.
13 13 13 13 13
18 15 14 14 11
17 19 19 14 15
12 5 9 10 8
12 15 17 16 14
13 9 11 13 22
22 14 18 16 14
15 18 24 29 1623 11 17 23 12
11 78 13 U 1 6324 22 31 32 22
16.4 19. 9 16.9 25.6 19
4.8 19. 8 6.3 29.0 15
Group
mean
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Table XXVII
Total plasma protein values, in g/1 
Horse Week 
0 4 8 12 16
Controls
F e l f i t
J i l l
Fred
S iT S l6
PlfV a
M 9
Noddy
Durando
Natasha
Mean
S.D.
61 63 58 54 55
69 65 65 65 65
60 78 59 63 63
66 63 57 56 61
63 58 60 57 58
61 60 57 60 59
65 66 57 61 55
74 72 67 67 73
60 71 60 62 61
67 60 61 63 57
68 74 61 60 62
64 69 65 62 61
64.8 66.6 60.6 60.8 60.8
4.2 6.2 3.4 3.7 4.9
Group
mean
Placebo
Charlotte 
Chariie 
Jack 
tose
'Jorth Star 
_ord Muckle 61 
Big Ben 
4ike
lainbeam 
Choppy 
Soring 
O ff ice r
Mean 
S.D.
68 68 66 65 62
67 68 63 57 60
67 68 58 59 63
65 68 57 61 65
72 69 67 67 65
68 67 67 67
64 60 60 61 63
60 64 65 65 63
56 66 58 59 63
72 67 65 71 69
64 62 60 62 57
66 65 59 63 63
65.2 66.1 62.1 63.1 63.3
4.7 2.8 3.8 4.1 3.1
Group
mean
64.0
EFAs
Veronica 
Dolly 
Danny 
Prudence 
Jeeves
m u  th
Anne 
L i ly
fienry 67 78 67 65 68 Group
mean
Mean 66.5 68.0 62.5 63.4 62.8 64.7S.D. - - - - ...................... -
65 64 63 61 62
65 62 58 66 61
71 75 70 62 68
71 69 62 61 61
63 60 56 58 52
68 71 57 65 6364 71 67 66 67
67 71 61 63 68
61 65 64 66 59
70 62 63 §} 5267 o
66.5 68.0 62.5 63.4 62.8
3.3 5.8 4.4 2.6 4.9
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Table XXVIII
Albumin values, in  g/1
Horse Week
0 4 12 16
Controls
F e l f i t
J i l l
Fred
Temple
Delta
PlfYa
Noddy
Durando
Natasha
Mean
S.D.
37 29 35 32 34
34 33 33 32 34
33 34 28 30 31
37 36 31 30 33
33 37 31 30 31
37 34 34 35 34
34 38 33 33 30
35 38 33 34 36
33 38 32 32 36
33 33 32 32 33
31 33 32 32 32
36 40 31 31 33
34.4 35.3 32.1 31.9 33.1
2.0 3.1 1.8 1.6 1.9
Group
mean
Placebo
Charlotte 35 35 30 34 31
Chariie 39 35 31 31 38
Jack 36 35 34 39 33
lose 33 35 27 28 27
lorth Star 32 35 32 34 33
_ord Muckle 36 34 34 32 31
Sig Ben 35 31 30 32 33
like 35 35 35 35 34Dfficer 34 34 30 33 33
lainbeam 31 29 31 31 33
Soring 39 36 35 35 33
O ff ice r 34 34 30 33 33
Mean 34.9 34.0 31.6 33.1 32.7
S.D. 2.4 2.0 2.5 2.7 2.5
Group
mean
EFAs
Veronica 
Dolly 
Danny 
Prudence 
Jeeves 
Heidi 
Elspeth 
Anne
Polly 33 29 32 33 31 „
Henry 39 35 37 35 35 Group
mean
Mean 
S.D.
32 34 34 33 31
36 36 33 35 31
39 35 37 33 32
32 35 34 32 35
36 36 33 35 35
39 32 31 34 33
34 39 35 33 34
36 39 34 34 3435 34 35 36 32
3 29 3 31
39 35 35
35.5 34.9 34.1 33.9 33.0
2.7 2.8 1.9 1.2 1.7
57
Table XXIX
Globulin values, In g/1
Horse Week
0 4 8 12 16
Controls
F e l f i t
s a
Temple 
Delta
PlfV a
Noddy 
Durando
Natasha 28 29 34 31 28 Group
mean
Mean 
S.D.
24 34 23 22 21
35 32 32 33 31
27 44 31 33 32
29 27 26 26 28
30 21 29 27 27
24 26 23 25 25
31 28 24 28 25
39 34 34 33 37
27 33 28 30 25
34 27 29 31 24
37 41 29 28 30
30.4 31.3 28.5 28.9 27.8
4.9 6.5 3.9 3.5 4.3
Placebo
Charlotte 33 33 36 31 31
Chariie 28 33 32 26 22
Jack 31 33 24 20 27
lose 32 33 30 33 38
lorth  Star 40 34 35 33 32
_ord Muckle 25 34 33 35 36
Jig Ben 29 29 30 29 30
4ike 25 29 30 30 29
lainbeam 25 37 27 28 30
Shoppy 38 33 30 33 35
Spring
O ff ice r
25 26 25 27 24
32 31 29 30 30
Mean 30.3
5.1
32.1 30.1 29.6
4.1
30.3
4.7S.D. 2.9 3.6
Group
mean
EFAs
Veronica 33 30 29 28 31
Dolly 29 26 25 31 30
Danny 32 40 33 29 36
Prudence 39 34 28 29 26
Jeeves 27 24 23 23 17
Heidi 29 39 26 31 27
Elspeth 30 32 32 33 33
^ p e  31 32 27 29 34
L i ly  26 31 29 30 27
Polly 37 33 31 31 31 „
Henry 28 43 30 30 33 Group
mean
Mean 31.0 33.1 28.5 29.5 29.5 30.3
S.D. 4.0 5.8 3.0 2.5 5.2
58
Table XXX
Gamma glutamyl transpeptidase values, in  I .U . / l
Horse Week
0 4 8 12 16
Controls
F e l f i t 19 18 16 11 22
J i l l 28 13 23 18 16
Fred 15 25 16 11 10
Temple
Delta
17 23 21 15 19
22 19 11 15 14
P i t t . 23 18 26 15 1927 18 18 17 19
Sprig 27 26 20 22 26
Dick 34 11 30 31 33
Noddy 24 18 14 15 22
Durando 15 17 11 16 9
Natasha 24 39 30 16 19
Mean 22.9 20.4 19.7 16.8 19.0
S.D. 5.7 7.3 6.6 5.3 6.6
Group
mean
Placebo
Charlotte 
Chariie 
Jack 
Rose
North Star 
_ord Muckle 
Big Ben 
MiKe
Rainbeam
Choppy
SpangO ff ice r
Mean
S.D.
23
20
26
20
32
23
25
21
25
28
27
31
23
28
23
20
25 
28
19 
27
20 
29 
33
26
29
34
16
14
16
25
16
29 
14
30 
23 
18
28
21
18
19
15
15
21
23
24 
26 
31 
30
16
25
8
1
7
8 
7
23
17
35
20
17 Group 
mean
25.1 25.1 22.0 22.6 19.5 22.9 
4.0 4.2 7.2 5.4 6.0
EFAs
Veronica
Dolly
Danny
Prudence
Jeeves
Heidi ,
Elspeth
Anne
p J n yHenry
Mean
S.D.
14 17 16 23 7
24 30 29 23 15
23 18 18 16 17
24 27 29 16 22
24 18 20 22 17
30 9 11 13 18
17 16 16 18 11
26 35 30 J9 1624 19 17 24 8
35 26 16 28 12
33 27 21 22 20
24.9 22.0 20.3 20.4 14
6.2 7.5 6.4 4.4 4.
Group
28 a g
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Table XXXI
T r ig ly c e r id e  values, in  mmol/I
Horse Week
0 8 12 16
Controls
F e l f i tnil
Temple 
DeltaPity.
Noddy
Durando ___ ___ ___
Natasha 0.14 0.18 0.35 0.21 Group
mean
Mean 
S.D.
0.,29 0..08 0.,13 0,.11
0..32 0..48 0..40 0..33
0..18 0.,48 0..27 0..14
0.,27 0,.38 0.,39 0.,00
0.,11 0..45 0.,12 0.,12
0..50 0..30 0..32 0..24
0.,19 0.,13 0..21 0..19
0.,47 0.,53 0.,30 0.,29
0.,17 0..26 0.,45 0.,32
0.,33 0..02 0.,17 0..17
0..19 0..44 0.,25 0..35
. , . .
0..263 0.,311 0..280 0..206
0.,125 0..175 0.,108 0..105
Placebo
Charlotte 
Chariie 
Jack 
Rose
torth Star ___
_ord Muckle 0.30 
l ig  Ben 
like
Rainbeam 
Choppy
Spring ___
O ff ice r 0.14 0.43 0.41 0.28 Group
mean
Mean 
S.D.
0..32 0.,48 0..28 0..28
0,.33 0..23 0..26 0..43
0..23 0..44 0..23 0..23
0..35 0..66 0..37 0..48
0..35 0.,43 0..13 0.,10
. 0..45 0..23 0..24
0..25 0..48 0.,42 0..28
0..12 0.,29 0..24 0..18
0,.21 0..44 0..16 0..28
0,.13 0.,20 0..11 0..10
0,.28 0..52 0..35 0..31
.. . . .
0,.251 0,.421 0.,266 0..266
0..085 0.,127 0..104 0..113
EFAs
Veronica
Dolly
Danny
Prudence
Jeeves
& ? $ « .
Anne
go lfy
enry 0.39 0.44 0.2/ 0.22 Group
mean
Mean 0.317 0.382 0.270 0.266 0.309
S.D. ................
0..14 0..34 0.,16 0. 22
0..08 0.,23 0..24 0. 30
0..31 0.,54 0.,38 0. 22
0..47 0.,46 0.,55 0. 59
0..51 0.,49 0.,32 0. 24
0..43 0..10 0.,24 0. 23
0..33 0..44 0.,18 0. 18
0..38 0..23 0.,24 2- 260..16 0.,51 0.,27 0. 33
0. 0..42 0.■12 0. 140. 0., 4 0..27 0. 2
0..317 0.,382 0.,270 0. 2 6
0.,140 0.,140 0.,118 0. 119
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Table XXXII
Cholestero l va lues, in  mmol/I
Horse Week
0 8 12 16
F e l f i t
u \  
>le 
;a
Controls 
el
ir
PlfVa
M 9
Noddy 
Durando
Natasha 1.91 2.44 1.87 2.22 Group
mean
Mean 
S.D.
1,.90 2,.39 2,.26 2..07
2,.10 2,.65 2..58 2,.09
1,.42 1,.77 1..99 1..76
2,.44 2,.79 2..72 2,.22
2,.03 2,.40 1,.92 1,.89
2..07 2,.65 2,.90 2,.75
3,.19 3,.74 3..70 3,.29
2,.08 2,.23 2,.10 2,.15
1,.61 2,.14 2..03 1,.96
1..84 2..43 2..60 2,.25
1,.72 1,.76 2..17 1,.98
.. ,. ,. ,.
2,.026 2,.449 2,.403 2,.219
0,.451 0,.518 0..530 0,.417
Placebo
Charlotte 
Chariie 
Jack 
Rose
North Star ___
Lord Muckle 2.10 
Big Ben 
Mike
Rainbeam 
Choppy
Spring   . ___  ___
O ffice r 2.21 2.41 3.00 2.19 Group
mean
Mean 
S.D.
1,.76 2,.17 2,.24 2..04
2,.13 2,.59 2,.20 2,.59
2,.33 2,.71 2,.75 2..46
2,.05 1,.92 2..38 2,.38
1,.60 1,.87 1..83 2..01
,. 2,.07 1..78 1..53
1,.77 2,.78 3..12 2..19
1..21 2..18 2..51 2..09
0,.44 2,.52 2,.49 2..19
0,.85 2,.22 2..37 1..82
2,.10 2..94 3,.11 2..64
,. ,. . .
1..713 2..365 2..482 2..178
0,.592 0..347 0..449 0.,317
EFAs
Veronica 
Dolly 
Danny 
Prudence 
Jeeves
e ? $ th
m s
fienry 2116 2.71 1.71 2.22 Group
mean
Mean 2.043 2.534 2.565 2.480 2.405
S.D. .................. .. ~
1,.89 2,.40 1,.92 2.46
2..10 2..81 3,.40 3.02
2..27 2..62 2,.61 2.33
2.,52 3..57 3,.70 3.46
1,.69 2,.46 2,.64 2.29
2,.11 1,.95 1,.30 2.46
2,.21 2..15 2,.81 2.79
1,.86 2.,47 2,.43 1.96
1..56 2,.13 2..10 1.83
2,.10 2..54 2,.58 2.46
2.. 2 .77 2 .72 2.22
.,043 .,534 .565 .480
0,.273 0..435 0..658 0.466
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APPENDIX I I I
TABLES OF RESULTS OF THE STUDY ON THE USE OF EFAs IN THE 
PROPHYLAXIS OF DERMATOPHILOSIS IN HORSES 
C lin ica l Indices, Haematological and Biochemical Parameters
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Table I .  Indices o f derm atophilosis les io n  s e v e r ity
Scored on a 1 to  10 scale, 1 is  m ilde s t, 10 is  most severe
Horse
f f i 01s
L l l /Sprig
B8W
Jeeves
Chariie
Smiler
Elspeth
Sean
Bliss
LP
Mean
S.D.
EFAs
Fel l a
Spring
Beau
Mike
Dick
Durando
3 ffly
Fred
R. Bridge 
John
Mean
S.D.
Week
0 3 6 9 12 15 20 24
0.0 0,.0 0,.0 0..0 1.0 1.0 1.0 1.0
1.0 1,.0 1..0 1,.0 1.0 0.0 0.0 0.0
0.0 0,.0 0,.0 0,.0 0.0 0.0 0.0 0.0
0.0 0,.0 0..0 0,.0 0.0 0.0 0.0 0.0
0.0 0..0 0,.0 0,.0 0.0 0.0 0.0 0.0
0.0 0,.0 0,.0 0..0 0.0 0.0 0.0 0.0
0.0 0,.0 0..0 0,.0 0.0 0.0 0.0 0.0
0.0 0,.0 0,.0 0,.0 0.0 0.0 0.0 0.0
0.0 1,.0 0,.0 0,.0 0.0 0.0 0.0 0.0
0.0 0..0 1,.0 1,.0 0.0 0.0 0.0 0.0
0.0 0..0 0,.0 0,.0 0.0 0.0 0.0 0.0
0.0 0,.0 0,.0 0,,0 0.0 0.0 0.0 0.0
0.1 0..2 0,.2 0..2 0.2 0.1 0.1 0.1
0.3 0,.4 0..4 0..4 0.4 0.3 0.3 0.3
0.0 0,.0 0..0 0,.0 0.0 0.0 0.0 0.0
0.0 0,.0 0..0 0..0 0.0 0.0 0.0 0.0
0.0 0..0 0,.0 0..0 0.0 0.0 0.0 0.0
1.0 0..0 0,.0 0..0 0.0 0.0 0.0 0.0
0.0 0,.0 0,.0 1,.0 0.0 0.0 0.0 0.0
0.0 0..0 0,.0 0,.0 0.0 0.0 0.0 0.0
1.0 0,.0 1,.0 1,.0 1.0 0.0 0.0 0.0
0.0 0,.0 1,.0 1,.0 0.0 0.0 0.0 0.0
0.0 1,.0 0,.0 0,.0 0.0 0.0 0.0 0.0
0.0 0,.0 1,.0 0..0 0.0 0.0 0.0 0.0
0.0 0,.0 0,.0 2,.0 0.0 0.0 0.0 0.0
0.2 0..1 0,.3 0..5 0.1 0.0 0.0 0.0
0.4 0,.3 0,.5 0..7 0.3 0.0 0.0 0.0
Table I I .  Extent o f d is tr ib u t io n  of dorsal dermatophilosis lesions 
% of dorsal body surface area affected by dermatophilosis lesions
Horse
Controls
Polly
L i lySprig
B8TO
Jeeves
Chariie
Smiler
Elspeth
Sean
Bliss
LP
Mean
S.D.
EFAs
Fel fa 
Spring 
leau 
like
ftrando
W
Fred
R. Bridge 
John
Mean
S.D.
Week
0 3 6 9 12 15 20 24
0..0 0,.0 0..0 0,.0 25 .0 15 .0 15.0 15.0
0..0 0,.0 0..0 0,.0 0.0 0.0 0.0 0.0
0..0 0,.0 0..0 0,.0 0.0 0.0 0.0 0.0
0..0 0,.0 0..0 0,.0 0.0 0.0 0.0 0.0
0..0 0..0 0..0 0..0 0.0 0.0 0.0 0.0
0,.0 0..0 0,.0 0,.0 0.0 0.0 0.0 0.0
0..0 0..0 0..0 0..0 0.0 0.0 0.0 0.0
0,.0 0,.0 0..0 0,.0 0.0 0.0 0.0 0.0
0..0 0..0 0,.0 0,.0 0.0 0.0 0.0 0.0
0..0 0,.0 0,.0 0,.0 0.0 0.0 0.0 0.0
0..0 0,.0 0,.0 0,.0 0.0 0.0 0.0 0.0
0,.0 0,.0 0..0 0,.0 0.0 0.0 0.0 0.0
0..0 0..0 0..0 0,.0 2.1 1.3 1.3 1.3
0..0 0,.0 0..0 0,.0 7.2 4.3 4.3 4.3
0..0 0,.0 0.,0 0,.0 0.0 0.0 0.0 0.0
0..0 0,.0 0.,0 0..0 0 .0 0.0 0.0 0.0
0,.0 0,.0 0..0 0,.0 0.0 0 .0 0.0 0.0
0..0 0..0 0..0 0..0 0.0 0.0 0.0 0.0
Q..0 0..0 0..0 0,.0 0 .0 0 .0 0.0 0.00..0 0,.0 0.,0 0,.0 0.0 0 .0 0.0 0.0
0..0 0..0 0.,0 0,,0 0 .0 0 .0 0.0 0.0
0..0 0,.0 0..0 0,,0 0.0 0.0 0.0 0.0
0.,0 0..0 0.,0 0,.0 0 .0 0 .0 0.0 0.0
0.,0 0,.0 0.,0 0..0 0 .0 0 .0 0.0 0.0
0..0 0..0 0.,0 2..5 0 .0 0 .0 0.0 0.0
0.,0 0..0 0.,0 0.,2 0 .0 0 .0 0.0 0.0
0.,0 0,.0 0..0 0..8 0 .0 0.0 0.0 0.0
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Table I I I .  Extent o f d is t r ib u t io n  o f hindlimb dermatophilosis 
lesions
% o f dorsal pastern surface area affected 
Horse Week
Controls
WSprig
B8YTCJeeves 
Chariie 
Smiler 
Elspeth 
Sean 
j31 iss
Mean 
S.D.
FeYfa
Spring 
Beau 
Mike 
Dick 
Durando 
Henry 
J i l l  
Fred
R. Bridge 
John
Mean 
S.D.
Table IV. Coat condition scores
Scored on a 1 to 10 scale, 1 is poorest, 10 is optimal 
Horse
Controls
Po Ty 
L i ly  
Sprig
8 i m
Jeeves 
Chariie 
Smiler,
Elspeth 
Sean 
Bliss 
LP
Mean 
S.D.
EFAs
Fella 
Spring 
Beau 
Mike
Burando
jHm y
Fred
R. Bridge 
John
Mean 
S.D.
0 3 6 9 12 15 20 24
0,,0 0.,0 0.,0 0,,0 0.0 0.0 0.0 0.0
2..5 2..5 1.,0 1..0 1.0 0.0 0.0 0.0
0..0 0..0 0.,0 0..0 0.0 0.0 0.0 0.0
0..0 0..0 0.,0 0..0 0.0 0.0 0.0 0.0
0..0 0.,0 0..0 0..0 0.0 0.0 0.0 0.0
0,,0 0..0 0.,0 0..0 0.0 0.0 0.0 0.0
0,.0 0,.0 0,.0 0,.0 0.0 0.0 0.0 0.0
0,.0 0,.0 0,.0 0,.0 0.0 0.0 0.0 0.0
0..0 2,.5 0,.0 0,.0 0.0 0.0 0.0 0.0
0,.0 0,.0 1,.0 2,.5 0.0 0.0 0.0 0.0
0,.0 0,.0 0.,0 0,.0 0.0 0.0 0.0 0.0 Group
0..0 0,.0 0.,0 0,.0 0.0 0.0 0.0 0.0 mean
0..2 0,.4 0.,2 0,.3 0.1 0.0 0.0 0.0 0.1
0.,7 1,.0 0.,4 0,.8 0.3 0.0 0.0 0.0
0..0 0,.0 0,,0 0,,0 0.0 0.0 0.0 0.0
0,.0 0,.0 0,.0 0,.0 0.0 0.0 0.0 0.0
0,.0 0,.0 0,.0 0,.0 0.0 0.0 0.0 0.0
1..0 0,.0 0,.0 0,.0 0.0 0.0 0.0 0.0
0..0 0,.0 0,.0 2,.5 0.0 0.0 0.0 0.0
0,.0 0,.0 0,.0 0,.0 0.0 0.0 0.0 0.0
10,.0 2,.5 2,.5 2,.5 2.5 0.0 0.0 0.0
0,.0 0,.0 2,.5 2,.5 0.0 0.0 0.0 0.0
0,.0 1,.0 0,.0 0,.0 0.0 0.0 0.0 0.0
0..0 0,.0 1..0 0,.0 0.0 0.0 0.0 0.0 Group
0,.0 0,.0 0..0 0,.0 0.0 0.0 0.0 0.0 mean
1,.0 0,.3 0.,5 0.,7 0.2 0.0 0.0 0.0 0.3
3..0 0,.8 1.,0 1.,2 0.8 0.0 0.0 0.0
Week
0 3 6 9 12 15 20 24
6.0 6.0 6.0 8.0 7.0 7.0 6.0 8.0
7.0 7.0 6.0 6.0 7.0 7.0 7.0 7.0
7.0 7.0 8.0 6.0 7.0 7.0 7.0 7.0
7.0 7.0 7.0 7.0 7.0 7.0 7.0 7.0
7.0 7.0 7.0 6.0 7.0 8.0 8.0 7.0
6.0 7.0 7.0 6.0 6.0 7.0 8.0 7.0
7.0 7.0 8.0 7.0 7.0 7.0 7.0 7.0
7.0 7.0 7.0 7.0 6.0 6.0 6.0 7.0
7.0 6.0 8.0 7.0 8.0 7.0 7.0 7.0
9.0 9.0 9.0 8.0 7.0 7.0 6.0 6.0
7.0 7.0 7.0 7.0 7.0 7.0 7.0 8.0 Group
7.0 7.0 7.0 6.0 6.0 7.0 6.0 6.0 mean
7.00 7.00 7.25 6.75 6.83 7.00 6.83 7.00 6.96
0.74 0.74 0.87 0.75 0.58 0.43 0.72 0.60
7.0 7.0 6.0 7.0 7.0 7.0 6.0 6.5
7.0 7.0 7.0 6.0 7.0 7.0 7.0 8.0
8.0 8.0 7.0 7.0 7.0 8.0 8.0 8.0
7.0 7.0 7.0 7.0 8.0 8.0 7.0 7.0
7.0 7.0 8.0 7.0 7.0 8.0 7.0 8.0
8.0 7.0 8.0 7.0 7.0 7.0 7.0 7.0
6.0 7.0 6.0 6.0 6.0 6.0 7.0 6.5
6.0 7.0 6.0 6.0 6.0 6.0 7.0 6.0
7.0 7.0 7.0 6.0 7.0 7.0 7.0 7.0
6.0 6.0 6.0 6.0 6.0 6.0 6.0 6.0 Group
6.0 7.0 6.0 5.0 7.0 7.0 7.0 6.0 mean
6.82 7.00 6.73 6.36 6.82 7.00 6.91 6.91 6.82
0.75 0.45 0.79 0.67 0.60 0.77 0.54 0.80
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Table V. Mane cond ition  scores
Scored on a 1 to  10 scale, 1 is  poorest, 10 is  optimal
Horse 
Controli
Sprig
BSTTC
Jeeves 
Chariie 
i l e r
Week
Sean 
Bliss 
LP
Mean
S.D.
EFAs
Fella
Spring
Beau
Mike
Dick
Durando
9 ffly
Fred
R. Bridge 
John
Mean
S.D.
0 3 6 9 12 15 20 24
6.0 7.0 6.0 8.0 7.0 7.0 7.0 8.0
6.0 7.0 7.0 6.0 7.0 7.0 8.0 8.0
6.0 7.0 7.0 7.0 7.0 7.0 7.0 8.0
7.0 7.0 8.0 7.0 6.0 7.0 7.0 7.0
7.0 7.0 8.0 6.0 7.0 7.0 8.0 7.0
6.0 7.0 7.0 7.0 7.0 7.0 8.0 8.0
6.0 7.0 7.0 7.0 7.0 7.0 8.0 8.0
8.0 6.0 7.0 7.0 6.0 7.0 8.0 8.0
8.0 7.0 7.0 7.0 8.0 7.0 8.0 8.0
8.0 9.0 9.0 8.0 8.0 7.0 8.0 8.0
7.0 7.0 7.0 7.0 7.0 8.0 8.0 8.0
7.0 7.0 8.0 7.0 6.0 7.0 8.0 8.0
6.83 7.08 7.33 7.00 6.92 7.08 7.75 7.83
0.83 0.67 0.78 0.60 0.67 0.29 0.45 0.39
6.0 7.0 5.0 6.0 7.0 6.0 6.0 6.0
7.0 8.0 8.0 7.0 7.0 7.0 7.0 8.0
8.0 8.0 7.0 7.0 7.0 8.0 8.0 8.0
7.0 7.0 8.0 8.0 8.0 8.0 7.0 7.0
8.0 7.0 8.0 7.0 8.0 8.0 7.0 8.0
8.0 7.0 8.0 7.0 8.0 7.0 7.0 7.0
7.0 7.0 6.0 7.0 6.0 7.0 7.0 7.0
7.0 6.0 6.0 6.0 6.0 7.0 7.0 6.0
7.0 7.0 7.0 6.0 7.0 7.0 7.0 7.0
7.0 6.0 6.0 6.0 6.0 6.0 6.0 6.0
6.0 5.0 6.0 6.0 7.0 8.0 7.0 6.0
7.09 6.82 6.82 6.64 7.00 7.18 6.91 6.91
0.70 0.87 1.08 0.67 0.77 0.75 0.54 0.83
7.23
6.92
Table VI. Tail condition scores
Scored on a 1 to 10 scale, 1 is poorest, 10 is optimal
Horse
Controls 
Pol ly  
L i l /  Sprig
t e r nJeeves 
Chariie 
Smiler
Week
Elspeth
Sean
Bliss
LP
Mean
S.D.
EFAs
Fella
Spring
Beau
Mike
Burando
w
Fred
R. Bridge 
John
Mean
S.D.
0 3 6 9 12 15 20 24
7.0 7.0 6.0 8.0 7.0 7.0 7.0 8.0
6.0 8.0 7.0 7.0 7.0 7.0 8.0 7.0
6.0 7.0 8.0 7.0 7.0 7.0 7.0 8.0
7.0 7.0 8.0 7.0 6.0 7.0 7.0 7.0
7.0 7.0 7.0 7.0 6.0 7.0 7.0 7.0
6.0 7.0 7.0 7.0 7.0 7.0 7.0 7-Q8.0 7.0 8.0 7.0 7.0 7.0 7.0 8.0
8.0 7.0 7.0 7.0 6.0 7.0 8.0 8.0
8.0 7.0 8.0 7.0 8.0 8.0 8.0 7.0
9.0 9.0 9.0 8.0 8.0 7.0 7.0 8.0
8.0 7.0 7.0 7.0 7.0 7.0 7.0 8.0
8.0 8.0 7.0 7.0 7.0 7.0 7.0 7.0
7.33 7.33 7.42 7.17 6.92 7.08 7.27 7.50
0.98 0.65 0.79 0.39 0.67 0.29 0.47 0.52
7.0 7.0 6.0 6.0 7.0 7.0 7.0 7.0
7.0 8.0 8.0 6.0 6.0 7.0 6.0 7.0
8.0 7.0 7.0 6.0 7.0 7.0 8.0 8.0
7.0 7.0 7.0 7.0 8.0 8.0 8.0 7.0
8.0 7.0 8.0 7.0 8.0 8.0 7.0 8.0
8.0 7.0 7.0 7.0 8.0 7.0 8.0 8.0
7.0 7.0 7.0 7.0 6.0 7.0 7.0 7.0
7.0 7.0 6.0 6.0 6.0 7.0 7.0 6.0
7.0 8.0 7.0 6.0 7.0 7.0 7.0 7.0
7.0 7.0 6.0 6.0 6.0 6.0 7.0 7.0
7.0 7.0 7.0 6.0 7.0 8.0 7.0 7.0
7.27 7.18 6.91 6.36 6.91 7.18 7.18 7.18
0.47 0.40 0.70 0.50 0.83 0.60 0.60 0.60
7.25
7.02
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Table V I I .  Hoof cond ition  scores
Horse 
Controls
WSprig
Bsm
Jeeves
Chariie
Smiler
Elspeth
Sean
Bliss
LP
Mean
S.D.
EFAs
Fella
Spring
Beau
Mike
Dick
Durando
3 ffly
Fred
R. Bridge 
John
Mean
S.D.
Horse
Controls
Polly
LilySprig
is ra
a 1 to 10 scale, 1 is  poorest, 10 is optimal
Week
0 3 6 9 12 15 20 24
6.0 7.0 7.0 7.0 7.0 7.0 7.0 7.0
7.0 7.0 7.0 7.0 7.0 7.0 7.0 7.0
7.0 7.0 7.0 7.0 7.0 7.0 7.0 7.0
7.0 7.0 7.0 7.0 7.0 7.0 7.0 7.0
6.0 7.0 6.0 7.0 7.0 7.0 7.0 7.0
6.0 7.0 7.0 7.0 7.0 7.0 7.0 7.0
8.0 8.0 7.0 7.0 6.0 7.0 7.0 7.0
6.0 7.0 7.0 7.0 7.0 7.0 7.0 7.0
7.0 7.0 7.0 7.0 7.0 7.0 7.0 7.0
8.0 8.0 9.0 7.0 7.0 7.0 8.0 7.0
8.0 7.0 7.0 7.0 7.0 7.0 7.0 8.0
6.0 6.0 7.0 6.0 7.0 7.0 7.0 7.0
6.83 7.08 7.08 6.92 6.92 7.00 7.08 7.08
0.83 0.51 0.67 0.29 0.29 0.00 0.29 0.29
7.0 7.0 7.0 7.0 7.0 7.0 7.0 7.0
8.0 8.0 7.0 7.0 7.0 7.0 7.0 7.0
7.0 7.0 7.0 7.0 7.0 7.0 8.0 8.0
7.0 7.0 7.0 7.0 7.0 8.0 7.0 7.0
8.0 7.0 7.0 7.0 7.0 8.0 8.0 8.0
7.0 7.0 7.0 7.0 7.0 7.0 7.0 7.0
7.0 7.0 7.0 7.0 7.0 7.0 7.0 7.0
7.0 7.0 7.0 7.0 6.0 7.0 7.0 7.0
7.0 7.0 7.0 7.0 7.0 7.0 7.0 7.0
7.0 7.0 7.0 7.0 6.0 7.0 7.0 7.0
7.0 7.0 7.0 7.0 7.0 8.0 7.0 7.0
7.18 7.09 7.00 7.00 6.82 7.27 7.18 7.18
0.40 0.30 0.00 0.00 0.40 0.47 0.40 0.40
!. Body condition scores
a 1 to 5 scale, 1 is emaciated, 5 is obese,
Week
0 3 6 9 12 15 20 24
7.00
7.09
Jeeves
Chariie
Smiler
Elspeth
Sean
Bliss
LP
Mean
S.D.
EFAs
Fella
Spring
Beau
Mike
Dick
Durando
3?TTy
Fred
R. Bridge 
John
Mean
S.D.
3.5
3.5
3.5
3.5
4.0
3.5
4.0
2.5
3.5
3.0
3.0
3.0
3.38
0.43
3.5
4.0
3.5
3.0
3.5
3.5
2.5
3.5
3.5
3.0
2.5
3.27
0.47
4.0
3.5
4.0
4.0
4.0
3.5
4.5
3.0
3.0
3.0
3.0
3.0
3.54
0.54
3.5
4.0
4.0
3.0
3.5
3.5
3.0
3.5
4.0
3.0
3.0
3.45
0.42
4.0
3.0
3.5
3.5
4.0
3.0
4.5
3.0
3.0
3.0
3.0
3.0
3.38
0.53
3.0
4.0
4.0
3.0
3.5
3.5
3.0
3.5
3.5
3.5
2 . 0
3.32
0.56
4.0
3.5
3.5
3.5
3.5
3.5
4.5
3.0
3.5
3.0
3.5
3.0
3.50
0.43
3.5
4.0
4.0
3.0
3.5
3.5
3.0
3.0
4.0
3.5
2.5
3.41
0.49
3.5
3.5
3.0
3.5
4.0
3.5
4.5
3.0
3.0
3.0
3.0
3.0
3.38
0.48
3.0
4.0
3.5
3.0
3.0
3.5
3.0
3.5
3.5
3.0
2.5
3.23
0.41
3.0
3.0
3.5
3.5
4.0
3.5
4.0
2.5
3.0
3.0
3.0
3.0
3.25
0.45
3.0
3.5
4.0
3.0
3.0
3.5
2.5
3.0
3.5
3.0
2.5
3.14
0.45
3.5
3.5
3.5
3.5
4.5
3.5
4.5
3.0
3.0
3.0
3.0
4.5
3.58
0.60
3.0
4.0
3.5
3.0
3.0
3.5
3.0
3.0
4.0
3.0
2.5
3.23
0.47
3.0
3.5
3.5
3.5
4.0
3.5
4.0
3.0
3.0
3.0
3.0 Group
4.0 mean
3.42
0.42
3.43
3.0
4.0
3.5
3.0
3.0
3.5
3.0
3.0
3.5
3.0 Group
2.5 mean
3.18
0.40
3.28
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Table IX. Red c e ll counts Values are x l0 12/ l
Horse
Controls
#Sprig
mJeev/e? 
Charile 
liler
i?
LP
an
iss
Mean
S.D.
EFAs
Fella
Spring
Beau
Mike
Dick
Durando
3m y
Fred
R.Bridge 
John
Mean
S.D.
Week
0 8 16
7.0 7.4 7.7
7.6 5.9 6.4
6.4 8.1 6.8
7.5 7.3 6.6
4.9 6.1 6.9
6.1 6.2 6.3
6.2 6.8 6.1
5.8 7.0 7.1
7.4 6.5 7.4
8.3 7.1 6.6
6.1 6.8 6.3
6.5 6.5 7.6
6.65 6.81 6.82
0.94 0.62 0.53
8.9 8.3 8.0
6.6 6.5 7.4
8.1 6.7 7.9
7.1 7.2 6.8
5.9 6.4 6.3
5.7 6.3 7.5
6.9 7.0 8.0
7.1 7.5 7.2
7.9 5.2 5.5
7.0 6.3 6.2
6.6 6.4 6.9
7.07 6.71 7.06
0.94 0.80 0.82
6.76
6.95
Table X. Haemoglobin values Values are given in g/dl 
Horse Week 
Controls
t i i j '
Sprig
WJeeves 
Chariie 
Smiler 
Elspeth 
Sean 
B1 iss 
LP
Mean 12.29 12.42 12.59 12.43
S.D.
0 8 16
13.5 14.0 14.1
14.9 10.9 12.0
12.1 14.8 13.7
13.4 13.0 11.7
9.4 11.7 13.3
11.5 11.3 11.7
11.6 12.4 11.4
10.7 12.5 12.6
14.4 12.6 14.5
13.9 11.8 11.3
10.5 12.4 10.7
11.6 11.6 14.1
1.71 1.12 1.30
EFAs
Felf a 
Spring 
Beau 
Mike
Burando
Fred 
R.Bridge 
John
Mean
S.D.
15.2 14.6 [3.8
12.3 12.1 [3.6
[4.0 12.0 L3.9
12.9 13.4 L2.4
10.5 11.5 L I.2
10.0 11.1 [3.3
U-9 12.4 [3.72.6 12.9 [2.5
14.0 9.5 L0.2
[1.6 11.1 L l . l
[2.2 11.8 [2.8
12.47 12.04 12.59
1.53 1.34 1.26
12.37
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Table XI
Horse
Controls
WSprig
Jeeve?
Charlie
Smiler
Elspeth
Sean
Bliss
LP
Mean
S.D.
Packed ce ll  volumes Values are given as 1/1 
Week
0
CO 16
0..356 0,.383 0,.391
0,.401 0,.307 0,.330
0..330 0,.415 0,.315
0..368 0,.364 0,.324
0..263 0,.331 0,.366
0,.315 0,.315 0,.330
0,.324 0,.348 0,.320
0..289 0,.354 0,.354
0..394 0,.354 0..397
0,.378 0,.327 0,.312
0,.296 0,.348 0,.307
0,.329 0,.329 0,.389
0,.337 0,.348 0,.345
0,.043 0,.030 0..033
0.343
Spring
Beau
Mike
Dick
Durando
Henry
J i l l
Fred
R.Bridge 
John
Mean
S.D.
0..414 0,.395 0..384
0,.339 0,.338 0..374
0,.385 0,.338 0,.379
0..360 0,.371 0,.352
0,.299 0,.330 0..314
0..280 0,.312 0..362
0,.328 0,.356 0,.376
0..349 0..362 0..347
0..378 0,.268 0..289
0..322 0,.315 0,.312
0,.329 0,.324 0,.355
0..344 0,.337 0,.349
0,.039 0,.034 0,.031
0.344
Table X II .  Mean ce ll volumes Values given in f l
Horse
Controls
PoHy
L i lySprig
W
Jeeves
Chariie
Smiler,
Elspeth
Sean
B1 iss
LP
Mean
S.D.
Week
0 8 16
50.9 51.7 50.8
52.8 52.0 51.6
51.5 51.2 50.9
49.0 49.9 49.1
53.7 54.2 53.0
51.6 50.8 52.4
52.3 51.2 52.4
49.8 50.6 49.9
53.3 54.4 53.6
45.6 46.1 47.3
48.6 51.2 48.8
50.6 50.6 51.2
50.81 51.15 50.92
2.30 2.10 1.87
50.96
KtfaSpring
Beau
Bick!
Durando
3?TTyFred
R.Bridge 
John
Mean
S.D.
46.5 47.6 48.0
51.3 52.0 50.6
47.5 50.4 48.0
50.7 51.5 51.8
50.7 51.5 49.8
49.1 49.6 48.3
47.6 50.8 47.0
49.2 48.3 48.2
47.8 51.6 52.5
46.0 50.0 50.3
49.5 50.7 51.4
48.72 50.36 49.63
1.77 1.40 1.83
49.57
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Table X I I I .  Mean c e ll haemoglobin values Values in  pg
Horse
Controls
Polly
i i yprig
Bam 
flu???.
i le r .
Sean 
Bliss 
LP
Mean
S.D.
EFAs
Fella
Spring
Beau
Mike
Dick
Durando
W
Fred
R.Bridge 
John
Mean
S.D.
Week
18.45
0.90
17.1 
18.6 
17.3
18.2 
17.8
17.5 
17.2
17.7
17.7
16.6 
18.5
17.65
0.61
8
18.6 L8.9
19.6 [8.5
18.9 [8.3
17.9 L7.8
19.2 [9.2
18.9 L8.2
18.7 [8.7
18.4 [7.9
19.5 L9.4
16.7 [6.6
17.2 [7.1
17.8 [7.8
18.20
0.82
17.6
18.6 
17.9 
18.6 
18.0
17.6
17.7
17.2
18.3 
17.6
18.4
17.95
0.47
16
8.3 
8.8 
8.6
7.7
9.3 
8.6
8.7
7.7
9.6 
7.1
7.0 Group
8.6 mean
18.33
0.81
18.33
17.2
18.4
17.6
18.2
17.8
17.7 
17.1
17.4
18.5
17.9 Group
18.6 mean
17.85
0.52
17.82
Table XIV. Mean ce ll haemoglobin concentration 
Values are given in g/dl
Horse
Controls 
Po ly  
L i ly  Sprig
b s m
Jeeves
Chariie
Smiler
Elspeth
Sean
Bliss
LP
Week
Mean
S.D.
EFAs
Felfa
Spring
harlo tte
eau
B!ckf
Durando
m
Fred
R.Bridge 
John
Mean
S.D.
0 8 16
36.5 36.6 36.0
37.1 35.5 36.3
36.7 35.7 35.9
36.5 35.7 36.1
35.7 35.4 36.4
36.5 35.9 35.4
35.8 35.7 35.7
37.0 35.3 35.6
36.5 35.6 36.6
36.7 36.1 36.2
35.4 35.7 34.8
35.3 35.3 36.2
36.31 35.71 35.94
0.61 0.37 0.50
36.7 37.0 35.9
36.3 35.8 36.3
35.5 34.5 35.0
36.4 35.6 36.7
35.8 36.1 35.2
35.1 34.9 35.7
35.7 35.5 36.7
36.2 34.9 36.4
36.1 35.6 36.0
37.1 35.4 35.3
36.0 35.2 35.6
37.3 36.4 36.1
36.18 35.57 35.91
0.64 0.69 0.57
35.99
35.89
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Table XV.
Horse
W ols
^png
BoamJeeves
Chariie
Smiler
Elspeth
Sean
Bliss
LP
Mean
S.D.
Fe^fa
Spring
Beau
Mike
Dick
Durando
Henry
J i l l
Fred
R.Bridge 
John
Mean
S.D.
P la te le t counts Values x l0 9/ l
Week
0
70.0
20 . 0  
80.0
50.0 
00.0
,60.0
210.0
140.0
210.0
130.0
170.0
90.0
8
140.0
120.0
140.0
140.0
70.0
130.0
127.0
110.0 
200.0
130.0
127.0
90.0
16
140.0
110.0  
122.0  
110.0  
122.0  
120.0  
100.0  
120.0  
160.0
130.0
130.0 Group
100.0 mean
152.50 127.00 122.00
38.64 31.35 16.95
140.0 140.0 120.0
90.0 110.0 130.0
140.0 120.0 130.0
60.0 80.0 120.0
130.0 120.0 90.0
170.0 180.0 130.0
130.0 130.0 110.0
120.0 130.0 120.0
170.0 160.0 130.0
130.0 90.0 120.0
20.0 20.0 120.0
118.18 116.36 120.00
45.35 42.73 11.83
133.83
118.18
Table XVI. White ce ll counts Values x l09/ l
Horse
Controls
Polly
L i iySprig
BSTOJeeves 
Chariie 
Smiler 
Elspeth 
Sean
11
iss
Mean
S.D.
Week
EFAS 
Felf a 
Spring
Burando
Fred
R. Bridge 
John
Mean
S.D.
0
6 . 6
6 . 6
7.3
7.4
8.5
5.7 
8 . 2
7.7
7.7 
5.9 
6.3
5.8
8
6.3
6.0
6. 2
6.8
5.8
5.7 
6 . 2
6.5
7.6
5.6 
6 . 2
5.8
16
6.1
5.4
5.8
6.5
5.9
5.4
4.6
6.5
6.7
7.3
4.4 Group
6.5 mean
6.98 6.23 5.93
0.96 0.55 0.86
6.8 7.0 5.8
5.4 5.3 6.2
7.6 5.7 6.7
5.5 4.8 5.2
7.9 5.6 5.9
5.7 5.4 4.7
7.7 5.9 5.5
6.8 6.6 5.8
6.2 4.7 5.1
6.3 6.3 5.2
5.9 4.8 5.6
6.53 5.65 5.61
0.90 0.76 0.56
6.38
5.93
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Table X V II. Urea values Values are given in  mmol/1
Horse Week
bmiler
Elspeth
Sean
Bliss
LP
Mean
S.D.
K t t .Spring
Beau
Mike
Dick
Durando
Henry
J i l l
Fred
R. Bridge 
John
Mean
S.D.
5.5 
6.0
7.7 
6.0
4.5 
4.9
4.8
5.1
6.1
4.6 
5.4
4.6
8
5.4
4.3
3.5
3.6
3.5
3.6
3.3
3.7
3.8
3.6
3.9
4.6
16
5.4
6.4 
5.9
5.5
5.3
5.6
5.5 
6 .2
4.5
5.4
6.2 Group
6.6 mean
5.43 3.90 5.71
0.92 0.60 0.58
5.0 4.2 5.5
3.6 1.6 3.7
4.9 3.9 5.4
5.4 4.4 4.1
6.5 4.4 5.5
5.4 3.5 5.1
5.9 3.7 6.5
7.4 4.1 5.5
6.1 3.7 6.1
4.4 4.1 5.8
6.6 5.2 7.2
5.56 3.89 5.49
1.08 0.89 0.99
5.01
4.98
Table XVIII. Sodium values Values are given in mmol/1
Horse
Controls
Polly
L i lySprig
BoTTi!
Jeeves
Charlie
Smiler
Elspeth
Sean
Bliss
LP
Mean
S.D.
fa
Spring
Beau
Week
Durando
Henry
d
R. Bridge 
John
Mean
S.D.
40.0
36.0
36.0
37.0
37.0
38.0
36.0
32.0
39.0
38.0
41.0
40.0
8
136.0
137.0
138.0
139.0
140.0
141.0
137.0
138.0
138.0
139.0
140.0
140.0
16
136.0
135.0
137.0
135.0
138.0
137.0
138.0
137.0
137.0
136.0
136.0 Group
136.0 mean
137.50 138.58 136.50
2.43 1.51 1.00
139.0 137.0 134.0
139.0 139.0 138.0
137.0 139.0 135.0
139.0 139.0 135.0
135.0 139.0 135.0
140.0 140.0 139.0
138.0 138.0 136.0
136.0 140.0 137.0
139.0 140.0 139.0
136.0 138.0 138.0
136.0 139.0 135.0
137.64 138.91 136.45
1.69 0.94 1.81
137.53
137.67
71
Table XIX. Potassium values Values are given in  mmol/1
Horse
Controls 
PQ Ty 
L i ly  Sprig
eeve$ 
narne  
i l e r
Week
be<
Bliss 
LP
Mean
S.D.
Fe 11 a 
Spring 
Beau 
Mike 
Dick 
Durando 
Henry 
J i l l  
Fred
R. Bridge 
John
Mean
S.D.
3.9 
3.6 
4.5
4.0
3.9
4.1
4.1
4.3
4.4
4.4
4.3
2.4
8
3.0
3.7
3.1 
3.6
2.5
3.6
4.0 
3.9
4.1
3.8
3.7 
2.4
16
4.1
3.5
3.0
3.1
3.3
2.9
2 . 2
4.1
3.4
3.6
3.2 Group
3.9 mean
3.99 3.45 3.36
0.56 0.57 0.54
4.0 3.9 3.9
4.4 3.6 3.4
3.8 3.4 3.5
4.0 3.1 3.7
4.6 3.4 3.8
4.1 3.1 2.8
4.8 4.4 3.1
4.5 3.6 3.6
4.0 4.2 2.9
4.0 3.4 3.0
4.1 3.4 2.7
4.21 3.59 3.31
0.31 0.42 0.43
3.60
3.70
Table XX. Calcium values Values are given in mmol/1
Horse 
Controls
t s l i 'Sprig
Danny
Dolly
Jeeves
Chariie
Smiler
Elspeth
Sean 
jJliss
Mean
S.D.
Week
0 8 16
3.11 2.87 3.06
2.96 3.01 3.13
3.12 3.07 3.20
2.94 2.87 3.03
2.92 3.81 3.17
2.92 2.90 3.10
3.17 3.00 3.04
2.94 3.00 3.08
2.94 2.93 3.15
2.95 2.95 2.97
2.98 3.01 3.12
2.92 2.92 3.24
2.989 3.028 3.108
0.090 0.250 0.080
3.042
EFAs
Fella
Spring
Beau
Mike
Burando
Fred
R. Bridge 
John
Mean
S.D.
3.05 3.16 3.28
2.86 3.09 3.03
2.81 3.01 3.16
3.01 3.42 3.16
3.01 3.05 3.08
2.89 2.80 3.09
2.89 2.99 2.95
2.97 2.66 2.98
2.87 2.86 3.06
3.10 2.81 2.89
3.16 3.07 3.16
2.965 2.993 3.076
0.110 0.210 0.110
3.012
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Table XXI. C hloride values Values are given in  mmol/1
Horse
Controls
Po ly
fe jtfn g
w
f tS if f fe
l i l e r
Sean
Bliss
LP
Mean
S.D.
Week
0 8 16
96.0 97.0 97.0
99.0 98.0 97.0
95.0 100.0 98.0
97.0 95.0 96.0
101.0 101.0 102.0
97.0 97.0 99.0
98.0 97.0 100.0
98.0 99.0 100.0
98.0 100.0 95.0
99.0 98.0 95.0
98.0 95.0 97.0
99.0 99.0 96.0
97.92 98.00 97.67
1.56 1.91 2.19
97.86
Rtf.Spring
Beau
Mike
Dick
Durando
Henry
J i l l
Fred
R. Bridge 
John
Mean
S.D.
97.0 101.0 97.0
99.0 99.0 98.0
96.0 96.0 97.0
96.0 100.0 98.0
99.0 95.0 100.0
95.0 97.0 99.0
95.0 100.0 95.0
99.0 97.0 98.0
98.0 100.0 97.0
96.0 94.0 98.0
97.0 96.0 97.0
97.00 97.73 97.64
1.55 2.37 1.29
97.45
Table XXII. Magnesium values Values are given in mmol/1
Horse
Control
Polly
U iySprig 
BoTTJr
Jeeves 
Chariie 
Smiler
Week
Elspeth 
Sean 
B liss 
LP
Mean
S.D.
Rif.Spring
Beau
M]ke
Dick
Durando
W
Fred
R. Bridge 
John
Mean
S.D.
0.66
0.69
0.69
0.61
0.68
0.65
0.66
0.61
0.68
0.71
0.73
0.61
8
0.69
0.69
0.73
0.58
0.71
0.64
0.66
0.68
0.72
0.66
0.69
0.61
16
0.62
0.78
0.77
0.63
0.81
0.67
0.79
0.77
0.72
0.55
0.70 Group 
0.78 mean
0.665 0.672 0.716
0.040 0.040 0.080
0.74 0.74 0.81
0.60 0.69 0.59
0.67 0.67 0.74
0.63 0.79 0.75
0.64 0.69 0.79
0.59 0.63 0.76
0.69 0.77 0.72
0.67 0.70 0.82
0.80 0.73 0.83
0.65 0.62 0.70
0.68 0.70 0.72
0.669 0.703 0.748
0.060 0.050 0.070
0.684
0.707
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Table X X III. Inorganic phosphate values
Values are given in mmol/1
Horse Week
Controls 
Po ly  
L i lySprig
Jeeves 
Chariie 
Sailer
B?*P
LP1
speth
n
ss
Mean
S.D.
EFAs
Fella
Spring
Beau
Mike
Dick
Durando
W
Fred
R. Bridge 
John
Mean
S.D.
Values are given in IU/1
Horse Week
Controls 
Polly 
L i ly  
Sprig 
Dat
0 8 16
0.88 1.25 0.79
0.85 1.50 1.02
0.86 1.05 0.88
0.98 1.13 0.98
1.13 1.14 0.86
0.84 1.24 1.17
1.14 1.24 1.19
1.08 1.31 0.97
0.90 0.98 0.93
1.12 1.06 0.69
0.85 1.24 1.11
1.15 1.15 1.03
0.982 1.191 0.968
0.130 0.140 0.150
1.00 1.23 0.81
1.37 1.67 1.02
0.84 1.04 0.86
0.98 1.03 0.82
0.75 1.30 0.93
1.13 1.21 1.17
0.78 1.28 1.05
1.20 1.24 1.06
1.11 1.01 1.05
0.84 1.39 1.08
0.62 1.15 0.96
0.965 1.232 0.983
0.220 0.190 0.120
kaline phosphatase values
mJeeves 
Chariie 
Sailer
S^an
LP1
speth
ss
Mean
S.D.
EFAs
Fella
Spring
teau
*1ike
l ic k
Durando
W
Fred
R.Bridge 
John
Mean
S.D.
0 8 16
469.0 382.0 234.0
248.0 233.0 199.0
424.0 390.0 251.0
286.0 294.0 214.0
336.0 279.0 203.0
286.0 254.0 220.0
448.0 360.0 248.0
434.0 450.0 301.0
310.0 243.0 169.0
212.0 189.0 160.0
223.0 231.0 186.0
255.0 255.0 205.0
327.58 296.67 215.83
92.86 79.90 38.90
347.0 292.0 208.0
263.0 237.0 174.0
264.0 378.0 275.0
265.0 329.0 330.0
392.0 370.0 210.0
274.0 218.0 178.0
424.0 375.0 253.0
426.0 467.0 296.0
288.0 256.0 171.0
234.0 193.0 239.0
309.0 220.0 215.0
316.91 303.18 231.73
69.23 87.05 52.33
74
Group
mean
1.047
Group
mean
1.060
Group
mean
280.03
Group
mean
283.96
Table XXV. Aspartate ami notransaminase values
Values are given in  IU/1
Horse
m ° ' s
U lySprig
Jeeves
Chariie
Smiler
Elspeth
Sean
Bliss
LP
Mean
S.D.
EFAs
Fella
Spring
Beau
Mike
Dick
Durando
W
Fred
R.Bridge 
John
Mean
S.D.
Week
0 8 16
278.0 436.0 280.0
230.0 217.0 304.0
254.0 358.0 328.0
262.0 252.0 318.0
249.0 372.0 421.0
249.0 238.0 293.0
290.0 359.0 393.0
217.0 296.0 347.0
262.0 293.0 328.0
300.0 239.0 347.0
227.0 351.0 303.0
309.0 309.0 366.0
260.58 310.00 335.67
29.15 66.63 41.74
271.0 361.0 346.0
323.0 405.0 519.0
235.0 329.0 295.0
278.0 349.0 314.0
208.0 270.0 292.0
245.0 304.0 310.0
215.0 357.0 279.0
263.0 283.0 352.0
232.0 247.0 328.0
274.0 283.0 340.0
268.0 444.0 456.0
255.64 330.18 348.27
32.92 60.21 73.96
302.08
311.36
Table XXVI. B i l i ru b in  values Values are given in umol/1
Horse
Controls
Polly
L i lySprig
BoTTJr
Jeeves
Chariie
Smiler
Elspeth
Sean
Bliss
LP
Mean
S.D.
EFAs
Fella
Spring
Beau
Mike
Dick
Durando
9 ffly
Fred
R. Bridge 
John
Mean
S.D.
Week
0 8 16
85.0 79.0 108.0
16.0 17.0 20.0
6.0 20.0 19.0
27.0 20.0 28.0
12.0 14.0 13.0
24.0 13.0 21.0
7.0 13.0 13.0
10.0 15.0 13.0
10.0 28.0 17.0
26.0 33.0 36.0
16.0 14.0 14.0
37.0 37.0 23.0
23.00 25.25 27.08
21.68 18.77 26.40
13.0 29.0 17.0
9.0 14.0 19.0
26.0 21.0 16.0
26.0 13.0 31.0
15.0 21.0 25.0
17.0 11.0 16.0
13.0 21.0 23.0
10.0 23.0 23.0
6.0 19.0 17.0
35.0 18.0 24.0
27.0 28.0 20.0
17.91 19.82 21.00
9.20 5.72 4.69
25.11
19.58
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Table XXVII. Total plasma p ro te in  values
Values are given in  g/1
Horse
« 01s
^prig
dgeve? 
Charln Smi ler.
Elspeth 
Sean 
BT i 
LP
ss
Mean
S.D.
Week
0 8 16
70.0 73.0 68.0
66.0 71.0 62.0
76.0 78.0 73.0
70.0 67.0 69.0
62.0 65.0 73.0
63.0 60.0 64.0
77.0 68.0 68.0
79.0 70.0 66.0
74.0 64.0 73.0
67.0 67.0 68.0
66.0 65.0 68.0
68.0 68.0 72.0
69.83 68.00 68.67
5.56 4.65 3.60
68.83
KffaSpring
Beau
Mike
Dick
Durando
Henry
fliS
R.Bridge 
John
Mean
S.D.
69.0 66.0 63.0
66.0 67.0 72.0
63.0 73.0 66.0
65.0 73.0 62.0
69.0 72.0 68.0
68.0 71.0 65.0
71.0 68.0 73.0
73.0 67.0 69.0
63.0 61.0 64.0
70.0 62.0 71.0
70.0 67.0 66.0
67.91 67.91 67.18
3.27 4.09 3.71
67.67
Table XXVIII. Albumin values Values are given in g/1
Horse 
Controls
[?!}y
Sprig 
Danny 
Dolly 
Jeeves 
Chariie 
Smiler 
Elspeth 
Sean 
1 issB
Mean
S.D.
Week
0 8 16
33.0 33.0 35.0
34.0 30.0 37.0
37.0 36.0 32.0
37.0 37.0 31.0
30.0 31.0 40.0
37.0 35.0 36.0
42.0 35.0 32.0
32.0 35.0 31.0
35.0 33.0 32.0
36.0 36.0 36.0
33.0 36.0 36.0
36.0 36.0 35.0
35.17 34.42 34.42
3.10 2.19 2.81
34.67
EFAs
Fel]a
Spring
Beau
Mike
Burando
9?YTy
Fred ,
R.Bridge 
John
Mean
S.D.
36.0 34.0 34.0
43.0 35.0 42.0
35.0 42.0 36.0
37.0 39.0 33.0
32.0 34.0 32.0
30.0 33.0 34.0
30.0 38.0 35.0
39.0 37.0 37.0
34.0 31.0 29.0
44.0 29.0 30.0
39.0 32.0 35.0
36.27 34.91 34.27
4.73 3.81 3.52
76
35.15
Table XXIX. G lobulin  value Values are given in  g/1
Horse
Control
WSprigBsro
Jeeves 
Charlie 
lile r
Sean
Bliss
LP
Mean
S.D.
Week
0 8 16
37.0 40.0 33.0
32.0 41.0 25.0
39.0 42.0 41.0
33.0 30.0 38.0
32.0 34.0 33.0
26.0 25.0 28.0
35.0 33.0 36.0
47.0 35.0 35.0
39.0 31.0 41.0
31.0 31.0 32.0
33.0 29.0 32.0
32.0 32.0 37.0
34.67 33.58 34.25
5.31 5.16 4.81
34.17
K t t .Spring
Beau
Mike
Dick
Durando
Henry
:red 
L 
Jo
R. jlridge
Mean
S.D.
33.0 32.0 29.0
23.0 32.0 30.0
28.0 31.0 30.0
28.0 34.0 29.0
37.0 38.0 36.0
38.0 38.0 31.0
41.0 30.0 38.0
34.0 30.0 32.0
29.0 30.0 35.0
26.0 33.0 41.0
31.0 35.0 31.0
31.64 33.00 32.91
5.52 2.97 4.01
32.52
Table XXX. Gamma glutamyl transpeptidase values 
Values are given in IU/1
Horse
Controls
r?u '
Sprig
WJeeves
Chariie
Smiler
Elspeth
Sean
B1 iss
LP
Mean
S.D.
Week
0 8 16
31.0 39.0 36.0
22.0 24.0 22.0
34.0 30.0 20.0
27.0 21.0 25.0
22.0 28.0 28.0
37.0 26.0 30.0
30.0 40.0 33.0
22.0 16.0 20.0
26.0 19.0 16.0
29.0 19.0 21.0
16.0 14.0 14.0
37.0 37.0 20.0
27.75 26.08 23.75
6.52 8.93 6.76
25.86
EFAs
Fella
Spring
Beau
Mike
Burando
Fred
R. Bridge 
John
Mean
S.D.
33.0 22.0 26.0
30.0 37.0 57.0
21.0 28.0 26.0
23.0 26.0 27.0
26.0 24.0 31.0
21.0 16.0 24.0
21.0 20.0 22.0
34.0 20.0 26.0
31.0 20.0 28.0
22.0 14.0 23.0
19.0 18.0 22.0
25.55 22.27 28.36
5.48 6.39 9.87
25.39
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Table XXXI. T r ig ly c e r id e  values Values are given i i
Horse Week
Controls
PoJly
L i lySprig
W
Smiler
Elspeth
Sean
B liss
LP
Mean
S.D.
0 8 16
0.16 0.33 0.42
0.24 0.41 0.28
0.34 0.27 0.25
0.38 0.23 0.33
0.24 0.24 0.22
0.19 0.13 0.35
0.23 0.44 0.56
0.16 0.01 0.21
0.26 0.06 0.19
0.18 0.03 0.35
0.25 0.04 0.20
0.14 0.14 0.18
0.231 0.194 0.295
0.070 0.150 0.110
0.240
m fa
Spring
Beau
Mike
Dick
Durando
Henry
J i l l
Fred
R. Bridge 
John
Mean
S.D.
0.25
0 . 2 2
0.09
0.10
0.45
0.27
0.17
0.36
0.62
0.28
0.15
0.269
0.160
0 . 2 2
0.41
0.05
0.09
0.23
0.15
0.11
0.33
0.28
0.04
0.23
0.195
0.120
0.20
0.23
0.28
0.22
0.29
0.29
0.29
0.32
0.36
0.24 Group 
0.34 mean
0.278
0.050
0.247
Table XXXII. Cholesterol values Values are given ir
Horse
Controls
, i i ySprig
Danny
Dolly
Jeeves
Chariie
Smiler
Elspeth
Sean
jlTiss
Mean
S.D.
Week
0 8 16
2.29 2.11 2.52
1.60 1.33 1.82
1.99 2.20 2.19
2.56 1.93 2.39
1.82 2.56 2.89
2.46 2.01 2.37
2.17 2.05 2.02
1.79 1.77 1.92
2.21 2.21 2.48
2.46 2.23 2.30
1.66 2.21 2.40
2.12 2.12 2.15
2.094 2.061 2.288
0.320 0.300 0.290
2.148
EFAs
Fella
Spring
Beau
Mike
Bicr L o
ji . .
Fred ,
R. Bridge 
John
Mean
S.D.
4.14 4.15 3.99
2.33 2.51 2.41
2.28 2.57 2.54
2.62 2.86 2.44
1.70 1.82 1.89
1.91 1.88 2.07
1.35 2.34 1.73
2.15 2.37 2.12
2.29 1.49 1.55
2.31 1.57 2.05
2.21 2.00 2.11
2.299 2.324 2.264
0.700 0.740 0.650
2.295
mmol/I
mmol/I
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APPENDIX IV
NORMAL RANGES FOR HAEMATOLOGICAL AND BIOCHEMICAL PARAMETERS AND 
UNITS USED IN THEIR MEASUREMENT
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NORMAL RANGES FOR HAEMATOLOGICAL AND BIOCHEMICAL PARAMETERS
Normal Ranges for Haematological Parameters
Parameter
A ll
(Ref 1) 
RBC 7-14
Hb 10-16.9
PCV 0.29-0.47
MCV 31-43.2
MCH 12-19.2
MCHC 32-36
PL 120-360
WBC 4.1-10.1
Horse type
Hot Blooded 
(Ref 2) (Ref 3) 
6-12 6.8-12.9
11-19 11-19
0.32-0.52 0.32-0.53 
34-58 37-58.5
12.3-19.7 
32-38 31-38.6
100-350
5.5-12.5 5.4-14.3
Cold Blooded 
(Ref 2) (Ref 3)
5.5-9.5 5.5-9.5
8-14 8-14
0.24-0.44 0.24-0.44 
40-48
32-38 
100-350 
6-12 6-12
Horse type Units
TB Ponies
(Ref 4)
RBC 8.8+/-1.09 7.39+/-1.07 X1012/1
Hb 14.6+/-1.61 12.81+/-1.65 9/dl
PCV 0.398+/-0.047 0.32+/-0.011 1/1
MCV 45.5+/-2.56 48.2+/-4.0 f l
MCH 16.6+/-0.96 17.4+/-1.3 pg
MCHC 36.5+/-1.36 36.2+/-1.1 g/di
PL 132-226 223-276 X 10^/1
WBC 9.54+/-1.83 8.44+/-1.46 X109/1
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Normal Ranges fo r  Biochemical Parameters
Parameter Ref 1 Ref 2 Ref 4 Ref 5
Urea 2.5-7.0 3.6-8.6 4.48+/-0.83 3.5-8.0
Sodium 134-150 132-146 144+/-5 134-143
Potassium 2.7-5.5 2.4-4.7 4.2+/-0.6 3.3-5.3
Calcium 2.6-3.3 2.7-3.2 2.95+/-0.08 2.9-3.9
Chloride 98-109 99-109 96+/-3 89-106
Magnesium 0.7-1.2 0.53-1.02 0.79+/-0.08 0.6-0.9
Phosphate 0.8-1.8 0.52-1.45 1.25+/-0.2 0.5-1.6
Aik. Phos. <131 83-283 80+/-283 50-250
AST 45-150 153-411 107+/-20 60-230
Bil irub in 17-34 1.7-42.8 28.1+/-8.55 13-39
TPP 60-73 59-84 64.6 46-70
Albumin 25-38 28-32 37.4 17-37
Globulins 30-48 31-52 27.2 21-41
GGT - 11-44 - 10-40
Trig lycerides - - - 0.12-0.35
Cholesterol - 0.8-2.2 3 .16+/-0.47 2.4-3.7
Ref 1 (Henston, 1985-86); Ref 2 (Brobst and Parry, 1987); Ref 3 
(Schalm, 1986); Ref 4 (Je ffco tt ,  1977); Ref 5 (R icketts, 1987)
Parameter Units Parameter Units
Urea mmol/1 AST IU/1
Sodium mmol/1 B i l i ru b in umol/1
Potassium mmol/I TPP g /i
Calcium mmol/I Albumin g / i
Chloride mmol/I Globulins g / i
Magnesium mmol/I GGT IU/1
Phosphate mmol/I Trig lycerides mmol/1
A1k.Phos IU/1 Cholesterol mmol/I
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APPENDIX V
TABLES DETAILING STATISTICAL ANALYSES PERFORMED IN THE STUDY OF 
THE PHARMACOKINETICS OF EFAs IN HORSES 
C lin ica l Indices, Haematological and Biochemical Parameters and
EFA Estimations
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Clinical Indices
Coat condition
Source o f Sum of d . f . Mean F-ra tio
Variation Squares Square
Group 6.00 3 2.00 0.88
Error 100.33 44 2.28
Time 62.54 2 31.27 58.55
Group*Time 21.13 6 3.52 6.59
Error 47.00 88 0.53
S ign if ican t differences over time, and between groups over time
Nane condition
Source of Sum of d . f . Mean F-ra tio
Variation Squares Square
Group 3.39 3 1.13 0.98
Error 50.50 44 1.15
Time 60.26 2 30.13 72.65
Group*Time 2.57 6 0.43 1.03
Error 36.50 88 0.41
S ig n if ic a n t d iffe rence  over time
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Tall condition
Source o f Sum o f d . f .  Mean F -ra t io
Variation Squares Square
Group 2.30 3 0.77 0.66
Error 51.44 44 1.17
Time 98.00 2 49.00 135.93
Group*Time 2.28 6 0.38 1.05
Error 31.72 88 0.36
S ign if ican t d ifference over time
Hoof condition
Source o f Sum of d . f . Mean F-ra tio
Variation Squares Square
Group 7.17 3 2.39 1.69
Error 62.06 44 1.41
Time 110.60 2 55.30 119.83
Group*Time 2.12 6 0.35 0.77
Error 40.61 88 0.46
S ig n if ic a n t d iffe re nce  over time
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Haematologi cal Parameters
Red ce ll  count
Source o f Sum of d . f . Mean F-ra t io
Variation Squares Square
Group 3.55 3 1.18 0.74
Error 70.06 44 1.59
Time 38.22 2 19.11 59.55
Group*Time 8.82 6 1.47 4.58
Error 28.24 88 0.32
S ign if ican t differences over time, and between groups over time
Haemoglobin
Source o f Sum of d . f . Mean F-ra tio
Variation Squares Square
Group 4.34 3 1.45 0.37
Error 173.89 44 3.95
Time 15.58 2 7.79 7.36
Group*Time 26.80 6 4.47 4.22
Error 93.18 88 1.06
S ig n if ic a n t d iffe rences over tim e, and between groups over time
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Packed cell volume
Source of Sum of d . f . Mean F -ra t io
Variation Squares Square
Group 0.00 3 0.00 0.36
Error 0.17 44 0.00
Time 0.00 2 0.00 17.55
Group*Time 0.02 6 0.00 4.27
Error 0.08 88 0.00
S ign if ican t differences over time, and between groups over time
Mean cell volume
Source of Sum of d . f . Mean F-ra t io
Variation Squares Square
Group 55.59 3 18.53 1.06
Error 772.50 44 17.56
Time 497.41 2 248.70 243.94
Group*Time 4.59 6 0.77 0.75
Error 89.72 88 1.02
S ig n if ic a n t d iffe re nce  over time
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Hean c e ll haemoglobin
Source of Sum of d . f . Mean
Variation Squares Squan
Group 9.08 3 3.03
Error 103.98 44 2.36
Time 113.02 2 56.51
Group*Time 0.48 6 0.08
Error 9.06 88 0.10
S ign if ican t d ifference over time
Mean ce ll  haemoglobin concentration
Source o f Sum of d . f . Mean
Variation Squares Squan
Group 1.09 3 0.36
Error 31.64 44 0.72
Time 41.27 2 20.63
Group*Time 1.02 6 0.17
Error 39.27 88 0.45
S ig n if ic a n t d iffe re nce  over time
F-ra tio
1.28
548.73
0.78
F-ra t io
0.51
46.24
0.38
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PIatelets
Source o f Sum of
Variation Squares
Group 3208.75
Error 137008.00
Time 7583.00
Group*Time 6143.75
Error 85880.50
S ign if ican t difference
d . f .  Mean F -ra tio
Square
3 1069.58 0.34
44 3113.82
2 3791.50 3.89
6 1023.96 1.05
88 975.91
over time
White cell count
Source of Sum of d . f . Mean F-ra tio
Variation Squares Square
Group 100.28 3 33.43 3.32
Error 443.01 44 10.07
Time 50.96 2 25.48 5.11
Group*Time 33.66 6 5.61 1.13
Error 438.44 88 4.98
S ig n if ic a n t d iffe rences between groups, and over time
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Biochemical Parameters
Urea
Source of Sum of d . f . Mean F-ra tio
Variation Squares Square
Group 24.63 3 8.21 3.76
Error 96.18 44 2.19
Time 66.36 2 33.18 35.67
Group*Time 13.32 6 2.22 2.39
Error 81.86 88 0.93
S ign if ican t differences between groups, over time, and between 
groups over time
Sodium
Source of Sum of d . f . Mean F-ra t io
Variation Squares Square
Group 35.75 3 11.92 1.40
Error 373.50 44 8.49
Time 67.00 2 33.50 3.93
Group*Time 84.75 6 14.13 1.66
Error 751.00 88 8.53
S ig n if ic a n t d iffe re nce  over time
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Potassium
Source of Sum of d .f . Mean F-ratio
Variation Squares Square
Group 0.78 3 0.26 1.17
Error 9.75 44 0.22
Time 20.30 2 10.15 67.33
Group*Time 0.70 6 0.12 0.78
Error 13.27 88 0.15
Significant differences; over time
Calcium
Source of Sum of d .f. Mean F-ratio
Variation Squares Square
Group 0.01 3 0.00 0.15
Error 1.13 44 0.03
Time 0.24 2 0.12 10.33
Group*Time 0.12 6 0.02 1.67
Error 1.01 88 0.01
Significant difference over time
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Chloride
Source of Sum of d .f . Mean F-ratio
Variation Squares Square
Group 47.50 3 15.83 1.71
Error 407.88 44 9.27
Time 35.38 2 17.69 2.48
Group*Time 74.63 6 12.44 1.74
Error 628.63 88 7.14
No significant difference was seen
Magnesium
Source of Sum of d .f. Mean F-ratio
Variation Squares Square
Group 0.02 3 0.00 0.49
Error 0.73 44 0.02
Time 0.17 2 0.08 34.02
Group*Time 0.06 6 0.00 3.81
Error 0.21 88 0.00
Significant difference over time, and between groups over time
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Inorganic phosphate
Source of Sum of d .f . Mean F-ratio
Variation Squares Square
Group 0.09 3 0.03 0.59
Error 2.13 44 0.05
Time 0.83 2 0.41 14.56
Group*Time 0.56 6 0.09 3.31
Error 2.50 88 0.03
Significant difference over time, and between groups over time
Alkaline phosphatase
Source of Sum of d .f . Mean F-ratio
Variation Squares Square
Group 2706.00 3 902.00 0.06
Error 624870.00 44 14201.59
Time 15900.00 2 7950.00 3.51
Group*Time 25048.00 6 4174.67 1.84
Error 199126.00 88 2262.80
Significant difference over time
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Aspartate aminotransaminase
Source of 
Variation
Sum of 
Squares
d .f. Mean
Square
F-ratio
Group
Error
11278.00
586815.00
3 3759.33
44 13336.70
0.28
Time 16746.00 2 8373.00
Group*Time 84674.00 6 14112.33
Error 310195.00 88 3524.94
2.38
4.00
Significant difference over time, and between groups over time
Bilirubin
Source of 
Variation
Sum of 
Squares
d .f. Mean 
Square
F-ratio
Group 177.14 3 59.05
Error 2203.50 44 50.08
1.18
Time 176.26 2 88.13
Group*Time 220.23 6 36.71
Error 4105.50 88 46.65
1.89
0.79
No significant difference was seen
93
Total plasma proteins
Source of Sum of d .f . Mean
Variation Squares Square
Group 712.31 3 237.44
Error 6116.00 44 139.00
Time 1175.75 2 587.88
Group*Time 698.81 6 116.47
Error 5366.13 88 60.98
Significant difference over time
A1bumin
Source of Sum of d .f. Mean
Variation Squares Square
Group 48.58 3 16.19
Error 733.84 44 16.68
Time 10.80 2 5.40
Group*Time 143.05 6 23.84
Error 1005.48 88 11.43
No significant difference was seen
F-ratio
1.71
9.64
1.91
F-ratio
0.97
0.47
2.09
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Globulins
Source of 
Variation
Sum of 
Squares
d .f . Mean
Square
F-ratio
Group
Error
886.16 3 295.39
9394.06 44 213.50
1.38
Time
Group*Time
Error
882.94
1372.63
8217.78
2 441.47
6 228.77
88 93.38
4.73
2.45
Significant difference over time, and between groups over time
Triglycerides
Source of Sum of d .f. Mean F-ratio
Variation Squares Square
Group 0.09 3 0.03 0.89
Error 1.54 44 0.03
Time 0.09 2 0.05 1.86
Group*Time 0.20 6 0.03 1.36
Error 2.15 88 0.02
No significant difference was seen
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Cholesterol
Source of Sum of d .f . Mean F-ratio
Variation Squares Square
Group 3.88 3 1.29 5.52
Error 10.31 44 0.23
Time 0.07 2 0.03 0.33
Group*Time 1.80 6 0.30 2.89
Error 9.11 88 0.10
Significant differences between groups, and between groups over 
time
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EFA Estimations
Table of Means and One Way Analysis of Variance for Linoleic Acid
(LA) Values, Comparing Week 0 to Week 3
Means by Group
Level Count Average Stnd.Error 95% Confidence level
5g daily 12 5.35 1.11 2.91 7.78
lOg eod 12 6.21 1.24 3.77 8.64
20g daily 12 7.50 1.17 5.07 9.94
40g eod 12 4.47 1.58 2.03 6.90
Analysis of Variance
Source of Sum of d .f. Mean F-ratio Sig.level
Variation Squares Square
Between groups 60.35 3 20.12
Within groups 876.88 44 19.93
1.01 0.376
No significant differences were evident
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Table of Means and One Way Analysis of Variance for Linoleic Acid
(LA) Values, Comparing Week 0 to Week 6
Means by Group
Level Count Average Stnd.Error 95% Confidence Level
5g daily 12 5.10 1.54 1.83 8.38
lOg eod 12 4.16 2.11 0.89 7.43
20g daily 12 6.22 1.35 2.95 9.49
40g eod 12 3.99 1.84 0.71 7.26
Analysis of Variance
Source of Sum of d .f . Mean F-ratio Sig.level
Variation Squares Square
Between groups 37.95 3 12.65 0.35 0.79
Within groups 1586.89 44 36.07
No significant differences; were evident
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Table of Means and One Way Analysis of Variance for
Dihomo-gamma-1inolenic Acid (DGLA) Values, Comparing Week 0 to
Week 6
Means by Group
Level Count Average Stnd.Error 95% Confidence Leve
5g daily 12 0.08 0.02 0.03 0.12
lOg eod 11 0.04 0.02 -0.01 0.09
20g daily 12 0.11 0.04 0.06 0.15
40g eod 11 0.11 0.02 0.06 0.16
Analysis of Variance
Source of Sum of d .f . Mean F-ratio Sig.level
Variation Squares Square
Between groups 0.04 3 0.01 1.63 0.20
Within groups 0.30 42 0.01
No significant differences were evident
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Table of Means, One Way Analysis of Variance and Multiple Range
Test for Dihomo-gamma-1inolenic Acid (DGLA) Values, Comparing Week
0 to Week 6
Means by Group
Level Count Average Stnd.Error 95% Confidence Leve
5g daily 12 0.08 0.02 0.03 0.12
lOg eod 9 0.04 0.03 -0.09 0.01
20g daily 11 0.11 0.02 0.07 0.16
40g eod 11 0.11 0.02 0.07 0.16
Analysis of Variance
Source of Sum of d .f . Mean F-ratio Sig.level
Variation Squares Square
Between groups 0.16 3 0.05 8.40 0.00
Within groups 0.25 39 0.01
Significant difference was seen between groups
Multiple range analysis revealed significantly lower value for lOg 
eod than for 5g daily, 20g daily and 40g eod
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Table of Means and One Way Analysis of Variance for Arachidonic
Acid (AA) Values, Comparing Week 0 to Week 3
Means by Group
Level Count Average Stnd.Error 95% Confidence Level
5g daily 12 0.18 0.08 -0.07 0.42
lOg eod 12 0.00 0.11 -0.24 0.25
20g daily 12 0.11 0.15 -0.14 0.36
40g eod 12 -0.11 0.17 -0.36 0.14
Analysis of Variance
Source of Sum of d .f . Mean F-ratio Sig.level
Variation Squares Square
Between groups 0.57 3 0.19 0.93 0.44
Within groups 9.03 44 0.21
No significant differences; were evident
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Table of Means and One Way Analysis of Variance for Arachidonic
Acid (AA) Values, Comparing Week 0 to Week 6
Means by Group
Level Count Average Stnd.Error 95% Confidence Level
5g daily 12 0.18 0.13 -0.08 0.43
lOg eod 12 0.05 0.16 -0.20 0.31
20g daily 12 0.13 0.07 -0.12 0.39
40g eod 12 -0.13 0.16 -0.38 0.13
Analysis of Variance
Source of Sum of d .f . Mean F-ratio Sig.level
Variation Squares Square
Between groups 0.65 3 0.22 1.00 0.40
Within groups 9.62 44 0.22
No significant differences were evident
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Table of Means and One Way Analysis of Variance for
Eicosapentanoic Acid (EPA) Values, Comparing Week 0 to Week 3
Means by Group
Level Count Average Stnd.Error 95% Confidence Level
5g daily 12 -0.03 0.02 -0.12 0.05
lOg eod 12 -0.04 0.02 -0.12 0.05
20g daily 12 0.01 0.06 -0.08 0.09
40g eod 11 0.00 0.07 -0.09 0.09
Analysis of Variance
Source of Sum of d .f . Mean F-ratio Sig.level
Variation Squares Square
Between groups 0.02 3 0.01 0.22 0.88
Within groups 1.06 43 0.02
No significant differences were evident
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Table of Means and One Way Analysis of Variance for
Eicosapentanoic Acid (EPA) Values, Comparing Week 0 to Week 6
Means by Group
Level Count Average Stnd.Error
5g daily 12 -0.12 0.03
lOg eod 12 -0.06 0.03
20g daily 12 0.00 0.03
40g eod 11 -0.12 0.09
Analysis of Variance
Source of Sum of d .f . Mean
Variation Squares Square
Between groups 0.10 3 0.03
Within groups 1.14 42 0.03
• 0 . 20
•0.15
•0.09
• 0.21
- 0.02
0.03
0.09
- 0.02
1.22 0.32
No significant differences were evident
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APPENDIX VI
TABLES DETAILING STATISTICAL ANALYSES PERFORMED IN THE STUDY ON 
THE USE OF EFAs IN THE TREATMENT OF DERMATOPHILOSIS IN HORSES 
Clinical Indices, Haematological and Biochemical Parameters and
EFA Estimations
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Clinical Indices
Dermatophilosis Index - Lesion severity
Source of Sum of d .f . Mean F-ratio
Variation Squares square
Group 96.02 2 48.01 1.82
Error 842.03 32 26.31
Time 228.45 8 28.50 27.15
Group*Time 30.11 16 1.80 1.78
Error 269.23 256 1.00
Significant difference over time
Dorsal Distribution of Dermatophilosis Lesions
Source of 
Variation
Sum of 
Squares
d .f. Mean
Square
F-ratio
Group
Error
1064.98
36278.35
2
32
532.49
1133.69
0.46
Time 7088.11 8 886.01 18.81
Group*Time 156.80 16 9.80 0.20
Error 12057.80 256 47.10
Significant difference over time
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Hindiimb Distribution of Dermatophilosis Lesions
Source of Sum of d .f . Mean
Variation Squares Square
Group 1665.63 2 832.81
Error 24180.29 32 755.63
Time 13101.24 8 1637.65
Group*Time 755.32 16 47.20
Error 15607.78 256 60.96
Significant difference over time
Coat Condition
Source of Sum of d .f. Mean
Variation Squares Square
Group 0.06 2 0.00
Error 120.33 32 3.76
Time 290.46 8 36.31
Group*Time 4.32 16 0.27
Error 141.32 256 0.55
Significant difference over time
F-ratio
1.10
26.86
0.77
F-ratio
0.01
65.76
0.48
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Nane Condition
Source of Sum of d .f . Mean F-ratio
Variation Squares Square
Group 1.81 2 0.91 0.78
Error 37.16 32 1.16
Time 0.96 7 0.14 0.91
Group*Time 22.42 14 1.60 1.06
Error 338.11 224 1.51
No significant difference was seen
Tail Condition
Source of Sum of d .f. Mean F-ratio
Variation Squares Square
Group 1.12 2 0.56 0.60
Error 29.84 32 0.93
Time 243.24 8 30.40 60.22
Group*Time 9.72 16 0.61 1.20
Error 129.25 256 0.50
Significant difference over time
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Hoof Condition
Source o f Sum o f d . f . Mean F -ra tio
Varia tion Squares Square
Group 4.96 2 2.48 1.90
Error 41.83 32 1.30
Time 37.62 8 4.70 24.51
Group*Time 4.93 16 0.30 1.60
Error 49.12 256 0.19
S ig n ifica n t d iffe rence over time
Body condition score
Source o f Sum o f d . f . Mean F -ra tio
Varia tion Squares Square
Group 0.34 2 0.17 0.16
Error 34.54 32 1.08
Time 0.90 8 0.11 2.86
Group*Time 0.54 16 0.03 0.86
Error 10.06 256 0.04
S ig n i f ic a n t  d if fe rence  over time
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Haematological Parameters
Red Cell Count
Source o f Sum o f d . f . Mean F -ra tio
V aria tion Squares Square
Group 1.91 2 0.96 0.46
Error 67.29 32 2.10
Time 4.68 4 1.17 3.38
Group*Time 2.17 8 0.27 0.78
Error 44.35 128 0.35
S ig n ifica n t d iffe rence over time
Haemoglobin
Source o f Sum o f d . f . Mean F -ra tii
Varia tion Squares Square
Group 0.06 2 0.03 0.01
Error 128.15 32 4.00
Time 29.90 4 7.48 5.94
Group*Time 7.80 8 0.97 0.77
Error 161.12 128 1.26
S ig n if ic a n t  d if fe rence  over time
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Packed Cell Volume
Source o f Sum o f d . f .  Mean
V aria tion  Squares Square
Group 43.38 2 21.69
Error 919.83 32 28.74
Time 321.50 4 80.38
Group*Time 102.40 8 12.81
Error 2262.90 128 17.68
S ig n ifica n t d iffe rence over time
Mean Cell Volume
Source o f Sum o f d . f . Mean
Varia tion Squares Squan
Group 115.40 2 57.70
Error 651.30 32 20.35
Time 17.40 4 4.36
Group*Time 0.30 8 0.04
Error 62.94 128 0.49
S ig n ifica n t difference over time
F -ra tio
0.75
4.55
0.72
F -ra tio
2.83
8.87
0.09
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Mean Cell Haemoglobin
Source o f Sum o f d . f . Mean F -ra tio
V aria tion Squares Square
Group 16.88 2 8.44 3.86
Error 69.99 32 2.19
Time 3.99 4 0.99 7.89
Group*Time 1.25 8 0.16 1.24
Error 16.12 128 0.12
S ig n ifica n t d ifferences between groups and over time
Mean Cell Haemoglobin Concentration
Source o f Sum o f d . f . Mean F -ra tio
Varia tion Squares Square
Group 0.78 2 0.39 0.53
Error 23.44 32 0.73
Time 11.05 4 2.76 9.38
Group*Time 2.38 8 0.29 1.01
Error 37.70 128 0.29
S ig n i f ic a n t  d if fe rence  over time
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White Cell Count
Source o f Sum o f d . f . Mean F -ra tio
Varia tion Squares Square
Group 8.07 2 4.04 0.56
Error 229.82 32 7.19
Time 23.40 4 5.85 5.36
Group*Time 12.60 8 1.57 1.44
Error 139.57 128 1.09
S ig n ifica n t d iffe rence over time
PIatelets
Source o f Sum o f d . f .  Mean F -ra tio
Varia tion Squares Square
Group 8814.50 2 4407.25 0.97
Error 145647.00 32 4551.46
Time 9597.00 4 2399.25 4.09
Group*Time 5421.00 8 677.63 1.15
Error 75139.50 128 587.03
S ig n i f ic a n t  d if fe rence  over time
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Biochemical Parameters
Urea
Source o f Sum o f d . f . Mean F -ra tio
V aria tion Squares Square
Group 37.32 2 18.66 1.86
Error 320.25 32 10.00
Time 177.23 4 44.30 11.70
Group*Time 44.23 8 5.52 1.46
Error 484.53 128 3.78
S ig n ifica n t d iffe rence over time
Sodium
Source o f Sum o f d . f . Mean F -ra tio
Varia tion Squares Square
Group 45.25 2 22.62 3.32
Error 217.75 32 6.80
Time 420.50 4 105.12 21.19
Group*Time 46.75 8 5.84 1.17
Error 634.75 128 4.95
S ig n if ic a n t  d if fe rence  between groups, and over time
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Potassium
Source o f Sum o f d . f . Mean F -ra tio
V aria tion Squares Square
Group 1.05 2 0.53 1.46
Error 11.58 32 0.36
Time 3.04 4 0.76 2.18
Group*Time 2.49 8 0.31 0.89
Error 44.67 128 0.35
No s ig n if ic a n t d iffe rence was seen
Calcium
Source o f Sum o f d . f . Mean F -ra tio
Varia tion Squares Square
Group 0.01 2 0.00 0.17
Error 0.53 32 0.02
Time 0.89 4 0.22 16.63
Group*Time 0.05 8 0.01 0.50
Error 1.72 128 0.01
S ig n i f ic a n t  d if fe rence  over time
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Chloride
Source o f Sum o f d . f . Mean F -ra tio
V aria tion Squares Square
Group 5.38 2 2.69 0.33
Error 262.00 32 8.19
Time 762.38 4 190.59 55.58
Group*Time 26.75 8 3.34 0.97
Error 438.88 128 3.42
S ig n ifica n t d iffe rence over time
Magnesium
Source o f Sum o f d . f . Mean F -ra tio
Varia tion Squares Square
Group 0.03 2 0.01 1.49
Error 0.32 32 0.01
Time 0.27 4 0.07 12.37
Group*Time 0.12 8 0.01 2.76
Error 0.69 128 0.00
S ign ifica n t differences over time, and between groups over time
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Inorganic Phosphate
Source o f Sum o f d . f . Mean F -ra tio
Varia tion Squares Square
Group 0.09 2 0.05 1.15
Error 1.31 32 0.04
Time 0.14 4 0.04 1.47
Group*Time 0.14 8 0.02 0.74
Error 3.08 128 0.02
No s ig n if ic a n t d iffe rence was seen
A lka line  Phosphatase
Source o f Sum of
V aria tion Squares
Group 3523.00
Error 186970.50
Time 1145.50
Group*Time 7304.00 
Error 105274.50
d . f .  Mean F -ra tio
Square
2 1761.50 0.30
32 5842.80
4 25286.30 30.74
8 913.00 1.11
128 822.40
S ig n i f ic a n t  d if fe rence  over time
Aspartate Aminotransaminase
Source o f Sum o f d . f .  Mean
V aria tion  Squares Square
Group 25190.00 2 12595.00
Error 310968.00 32 9717.70
Time 52610.00 4 13152.50
Group*Time 8045.00 8 1005.60
Error 210225.00 128 1642.30
S ig n ifica n t d iffe rence over time
B iliru b in
Source o f Sum o f d . f .  Mean
Varia tion Squares Square
Group 258.70 2 129.30
Error 11750.80 32 367.20
Time 718.80 4 179.70
Group*Time 516.60 8 64.50
Error 10898.00 128 85.10
No s ig n i f ic a n t  d if fe rence  was seen
F -ra tio
1.30
8.00
0.61
F -ra tio
0.35
2.11
0.75
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Tota l Plasma Prote ins
Source of 
Variation
Sum of 
Squares
d . f . Mean
Square
F -ra tio
Group
Error
109.30
1590.20
2
32
54.68
49.69
1.10
Time 724.30 4 181.07
Group*Time 43.10 8 5.39
Error 1303.30 128 10.18
17.70
0.53
Significant difference over time
A1bumin
Source of Sum of d .f. Mean F-ratio
Variation Squares Square
Group 37.32 2 18.66 1.86
Error 320.25 32 10.00
Time 177.23 4 44.30 11.70
Group*Time 44.23 8 5.52 1.46
Error 484.53 128 3.78
S ig n if ic a n t d iffe re n ce  over time
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Globulins
Source of Sum of d .f . Mean
Variation Squares Square
Group 40.78 2 20.39
Error 1627.65 32 50.86
Time 242.54 4 60.63
Group*Time 45.79 8 5.72
Error 1472.85 128 11.50
Significant difference over time
Gamma Glutamyl Transpeptidase
Source of Sum of d .f . Mean
Variation Squares Square
Group 311.54 2 155.77
Error 2433.68 32 76.05
Time 848.89 4 212.20
Group*Time 244.06 8 30.50
Error 3215.50 128 25.12
S ig n if ic a n t d iffe re nce  over time
F -ra tio
0.40
5.26
0.49
F-ratio
2.04
8.44
1.21
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T rig ly c e rid e s
Source of Sum of d .f . Mean F-ratio
Variation Squares Square
Group 0.05 2 0.03 0.82
Error 0.93 32 0.03
Time 0.32 3 0.10 9.91
Group*Time 0.08 6 0.01 1.27
Error 1.02 96 0.01
Significant difference over time
Cholesterol
Source of Sum of d .f. Mean F-ratio
Variation Squares Square
Group 1.13 2 0.56 0.91
Error 19.85 32 0.62
Time 6.83 3 2.28 27.37
Group*Time 0.61 6 0.10 1.21
Error 7.98 96 0.08
S ig n if ic a n t d iffe re nce  over time
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EFA Estimations
Red Cell Phospholipids
Linoleic acid (18:2n6)
Source of Sum of d .f . Mean F-ratio
Variation Squares Square
Group 4.44 2 2.22 0.13
Error 570.30 33 17.28
Time 2089.30 4 522.32 44.40
Group*Time 51.27 8 6.41 0.54
Error 1552.71 132 11.76
Significant difference over time
Arachidonic acid (20:4n6)
Source of Sum of d .f. Mean F-ratio
Variation Squares Square
Group 0.57 2 0.28 1.39
Error 6.72 33 0.20
Time 24.83 4 6.21 32.82
Group*Time 1.89 8 0.24 1.25
Error 24.96 132 0.19
Significant difference over time
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Eicosapentanoic acid (20:5n3)
Source of Sum of d .f . Mean F-ratio
Variation Squares Square
Group 0.22 2 0.11 0.38
Error 9.80 33 0.30
Time 16.99 4 4.25 14.50
Group*Time 2.66 8 0.33 1.14
Error 38.69 132 0.29
Significant difference over time
Plasma Phospholipids
Linoleic acid (18:2n6)
Source of Sum of d .f . Mean F-ratio
Variation Squares Square
Group 244.53 2 122.27 2.90
Error 1393.56 33 42.23
Time 1491.38 4 372.84 16.02
Group*Time 80.75 8 10.09 0.43
Error 3072.59 132 23.28
Significant difference over time
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Dihomogammalinolenic acid (20:3n6)
Source of Sum of d .f . Mean F-ratio
Variation Squares Square
Group 0.15 2 0.08 1.26
Error 2.02 33 0.06
Time 2.00 4 0.50 11.34
Group*Time 0.77 8 0.10 2.18
Error 5.83 132 0.04
Significant difference over time
Arachidonic acid (20:4n6)
Source of Sum of d .f. Mean F-ratio
Variation Squares Square
Group 0.78 2 0.39 0.66
Error 19.68 33 0.60
Time 17.39 4 4.35 16.60
Group*Time 1.23 8 0.15 0.59
Error 34.57 132 0.26
S ig n if ic a n t d iffe re nce  over time
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Eicosapentanoic acid (20:5n3)
Source of Sum of d .f . Mean F-ratio
Variation Squares Square
Group 0.71 2 0.36 3.54
Error 3.33 33 0.10
Time 1.67 4 0.42 5.10
Group*Time 0.94 8 0.12 1.44
Error 10.79 132 0.08
Significant difference between groups, and over time
Plasma Cholesteryl Esters
Linoleic acid (18:2n6)
Source of Sum of d .f . Mean F-ratio
Variation Squares Square
Group 87.38 2 43.69 1.43
Error 1006.94 33 30.51
Time 1134.56 4 283.64 8.55
Group*Time 287.88 8 35.98 1.08
Error 4378.38 132 33.17
Significant difference over time
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Dihomogammalinolenic acid (20:3n6)
Source of Sum of d .f . Mean F-ratio
Variation Squares Square
Group 0.14 2 0.07 0.22
Error 10.24 33 0.31
Time 8.97 4 2.24 8.85
Group*Time 0.88 8 0.11 0.44
Error 33.46 132 0.25
Significant time difference
Arachidonic acid (20:4n6)
Source of Sum of d .f. Mean F-ratio
Variation Squares Square
Group 1.77 2 0.88 1.48
Error 19.68 33 0.60
Time 9.65 4 2.41 3.47
Group*Time 2.44 8 0.31 0.44
Error 91.77 132 0.70
S ig n if ic a n t d iffe re nce  over time
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Eicosapentanoic acid (20:5n3)
Source of Sum of d .f . Mean F-ratio
Variation Squares Square
Group 0.11 2 0.05 1.05
Error 1.69 33 0.05
Time 0.54 4 0.13 2.25
Group*Time 0.35 8 0.04 0.74
Error 7.86 132 0.06
No significant difference was seen
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APPENDIX V II
TABLES DETAILING STATISTICAL ANALYSES PERFORMED IN THE STUDY ON 
THE USE OF EFAs IN THE PROPHYLAXIS OF DERMATOPHILOSIS IN HORSES 
Clinical Indices, Haematological and Biochemical Parameters and
EFA Estimations
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C lin ic a l Indices
Coat condition
Source of Sum of d .f. Mean F-ratio
Variation Squares Square
Group 0.90 1 0.90 0.62
Error 30.74 21 1.46
Time 3.48 7 0.50 1.51
Group*Time 1.79 7 0.26 0.78
Error 48.42 147 0.33
No significant differences were seen
Mane condition
Source of Sum of d .f. Mean F-ratio
Variation Squares Square
Group 4.38 1 4.38 2.40
Error 38.28 21 1.82
Time 6.48 7 0.92 3.03
Group*Time 7.75 7 1.11 3.62
Error 44.90 147 0.31
Significant differences over time, and between groups over time
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T a il co nd ition
Source of Sum of d .f . Mean F-ratio
Variation Squares Square
Group 2.37 1 2.37 2.27
Error 21.96 21 1.04
Time 6.24 7 0.89 3.11
Group*Time 3.62 7 0.52 1.81
Error 42.14 147 0.29
Significant difference over time
Hoof condition
Source of Sum of d .f. Mean F-ratio
Variation Squares Square
Group 0.38 1 0.38 0.93
Error 8.52 21 0.41
Time 1.48 7 0.21 1.53
Group*Time 0.99 7 0.14 1.03
Error 20.28 147 0.14
No s ig n if ic a n t d iffe rences were seen
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Body co n d itio n  score
Source of Sum of d .f . Mean F-ratio
Variation Squares Square
Group 1.01 1 1.01 0.73
Error 29.07 21 1.38
Time 1.52 7 0.22 3.58
Group*Time 0.40 7 0.06 0.94
Error 8.93 147 0.06
Significant difference over time
Haematologi cal Parameters
Red cell count
Source of Sum of d .f. Mean F-ratio
Variation Squares Square
Group 0.52 1 0.52 0.56
Error 20.25 22 0.92
Time 0.32 2 0.16 0.37
Group*Time 0.70 2 0.35 0.81
Error 18.99 44 0.43
No significant differences were seen
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Haemoglobin
Source of Sum of d .f . Mean F-ratio
Variation Squares Square
Group 0.20 1 0.20 0.07
Error 61.91 22 2.81
Time 1.42 2 0.71 0.51
Group*Time 0.85 2 0.42 0.31
Error 60.54 44 1.38
No significant differences were seen
Packed cell volume
Source of Sum of d .f. Mean F-ratio
Variation Squares Square
Group 0.00 1 0.00 0.00
Error 0.04 22 0.00
Time 0.00 2 0.00 0.27
Group*Time 0.00 2 0.00 0.48
Error 0.04 44 0.00
No s ig n if ic a n t d iffe rences were seen
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Mean cell volume
Source of Sum of d .f . Mean F-ratio
Variation Squares Square
Group 30.13 1 30.13 3.44
Error 192.89 22 8.77
Time 10.23 2 5.12 5.34
Group*Time 4.08 2 2.04 2.13
Error 42.19 44 0.96
Significant difference over time
Mean cell haemoglobin
Source of Sum of d .f. Mean F-ratio
Variation Squares Square
Group 4.72 1 4.71 3.62
Error 28.68 22 1.30
Time 0.03 2 0.01 0.16
Group*Time 0.70 2 0.35 4.19
Error 3.67 44 0.08
S ig n if ic a n t d iffe re nce  between groups over time
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Mean c e ll haemoglobin concentra tion
Source of Sum of d .f . Mean F-ratio
Variation Squares Square
Group 0.17 1 0.17 0.35
Error 10.81 22 0.49
Time 4.38 2 2.19 9.00
Group*Time 0.03 2 0.02 0.06
Error 10.70 44 0.24
Significant difference over time
White cell count
Source of Sum of d .f. Mean F-ratio
Variation Squares Square
Group 2.53 1 2.53 2.64
Error 21.13 22 0.96
Time 12.87 2 6.44 14.36
Group*Time 0.27 2 0.14 0.30
Error 19.72 44 0.45
S ig n if ic a n t d iffe re nce  over time
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Platelets
Source of 
Variation
Sum of 
Squares
d . f . Mean
Square
F -ra tio
Group
Error
2485 1
53818.5 22
2485
2446.30
1.02
Time
Group*Time
Error
3282.25
3227.38
22875.75
2
2
44
1641.13
1613.69
519.49
3.16
3.11
No significant differences were seen
Biochemical Parameters
Urea
Source of Sum of d .f . Mean F-ratio
Variation Squares Square
Group 0.03 1 0.03 0.02
Error 27.52 22 1.25
Time 43.72 2 21.86 50.21
Group*Time 0.55 2 0.27 0.63
Error 19.16 44 0.44
Significant difference over time
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Sodium
Source of Sum of d .f . Mean F-ratio
Variation Squares Square
Group 0.75 1 0.75 0.22
Error 76.50 22 3.48
Time 58.88 2 29.44 12.70
Group*Time 0.50 2 0.25 0.11
Error 102.00 44 2.32
Significant difference over time
Potassium
Source of Sum of d .f. Mean F-ratio
Variation Squares Square
Group 0.19 1 0.19 0.77
Error 5.42 22 0.25
Time 7.53 2 3.77 17.05
Group*Time 0.16 2 0.08 0.37
Error 9.72 44 0.22
S ig n if ic a n t d iffe re nce  over time
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Calcium
Source of Sum of d .f. Mean F-ratio
Variation Squares Square
Group 0.00 1 0.00 0.04
Error 1.34 22 0.06
Time 0.20 2 0.10 3.46
Group*Time 0.01 2 0.00 0.21
Error 1.27 44 0.03
Significant difference over time
Chloride
Source of Sum of d .f. Mean F-ratio
Variation Squares Square
Group 3.56 1 3.56 0.89
Error 87.75 22 3.99
Time 1.69 2 0.84 0.29
Group*Time 2.19 2 1.09 0.37
Error 129.44 44 2.94
No s ig n if ic a n t d iffe rences  were seen
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Magnesium
Source o f Sum o f d . f . Mean F -ra tio
Varia tion Squares Square
Group 0.00 1 0.00 1.23
Error 0.12 22 0.00
Time 0.05 2 0.02 9.81
Group*Time 0.00 2 0.00 0.53
Error 0.11 44 0.00
S ig n ifica n t d iffe rence over time
Inorganic phosphate
Source o f Sum o f d . f . Mean F -ra tio
Varia tion Squares Square
Group 0.01 1 0.01 0.31
Error 0.82 22 0.04
Time 0.92 2 0.46 22.43
Group*Time 0.02 2 0.00 0.40
Error 0.90 44 0.02
S ig n if ic a n t d iffe re n ce  over time
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A lk a lin e  phosphatase
Source o f Sum o f d . f .  Mean
V aria tion Squares Square
Group 1458 1 1458
Error 265439.5 22 12065.43
Time 120162 2 60081
Group*Time 2908.50 2 1454.25
Error 82532 44 1875.73
S ig n ifica n t d iffe rence over time
Aspartate aminotransaminase
Source o f Sum o f d . f .  Mean
V aria tion Squares Square
Group 760.50 1 760.50
Error 109581 22 4980.96
Time 83008 2 41504
Group*Time 1189.50 2 594.75
Error 76481 44 1738.21
S ig n if ic a n t d iffe re n ce  over time
F -ra tio
0.12
32.03
0.78
F -ra tio
0.15
23.88
0.34
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Bilirubin
Source o f 
V aria tion
Sum o f 
Squares
d . f . Mean
Square
F -ra tio
Group
Error
0.17 1 0.17
2207.66 21 105.13
0.00
Time
Group*Time
Error
108.20
6.93
1456.20
2
2
42
54.10
3.47
34.67
1.56
0.10
No s ig n if ic a n t d ifferences were seen
Total plasma proteins
Source o f Sum o f d . f . Mean F -ra tio
Varia tion Squares Square
Group 20.06 1 20.06 0.85
Error 521.88 22 23.72
Time 17.44 2 8.72 0.62
Group*Time 7.44 2 3.72 0.26
Error 622.47 44 14.15
No s ig n if ic a n t d iffe rences were seen
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A1 bumin
Source o f Sum o f d . f . Mean
V aria tion Squares Squari
Group 5.01 1 5.01
Error 253.65 22 11.53
Time 20.53 2 10.27
Group*Time 3.03 2 1.52
Error 490.44 44 11.15
No s ig n if ic a n t d ifferences were seen
Globulins
Source o f Sum o f d . f . Mean
Varia tion Squares Squan
Group 43.55 1 43.55
Error 724.89 22 32.95
Time 2.19 2 1.10
Group*Time 11.86 2 5.93
Error 708.61 44 16.10
No s ig n if ic a n t d iffe rences were seen
F -ra tio
0.43
0.92
0.14
F -ra tio
1.32
0.07
0.37
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Gamma glutamyl transpeptidase
Source o f Sum o f d . f .  Mean F -ra tio
V aria tion Squares Square
Group 1.13 1 1.13 0.01
Error 2460.86 22 111.86
Time 83.44 2 41.72 1.66
Group*Time 220.34 2 110.17 4.39
Error 1104.22 44 25.10
S ig n ifica n t d iffe rence between groups over time
Trig lycerides
Source o f Sum o f d . f . Mean F -ra tio
Varia tion Squares Square
Group 0.00 1 0.00 0.22
Error 0.50 22 0.02
Time 0.09 2 0.05 5.14
Group*Time 0.00 2 0.00 0.48
Error 0.40 44 0.00
S ig n if ic a n t d iffe re nce  over time
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Cholesterol
Source o f Sum o f d . f . Mean F -ra tio
V aria tion Squares Square
Group 0.22 1 0.22 0.31
Error 15.67 22 0.71
Time 0.11 2 0.06 0.93
Group*Time 0.27 2 0.13 2.22
Error 2.63 44 0.06
No s ig n if ic a n t d ifferences were seen
EFA Estimations
Red Cell Phospholipids 
L ino le ic  acid (18:2n6)
Source o f Sum o f d . f . Mean F -ra tio
Varia tion Squares Square
Group 0.01 1 0.01 0.00
Error 68.43 21 3.26
Time 333.33 3 111.11 17.94
Group*Time 10.00 3 3.33 0.54
Error 390.25 63 6.19
S ig n if ic a n t d iffe re nce  over time
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Arachidonic acid (20:4n6)
Source o f Sum o f d . f . Mean F -ra tio
V aria tion Squares Square
Group 0.02 1 0.02 0.24
Error 2.10 21 0.10
Time 0.37 3 0.12 1.99
Group*Time 0.54 3 0.18 2.91
Error 3.92 63 0.06
S ig n ifica n t d iffe rence between groups over time
Eicosapentanoic acid (20:5n3)
Source o f Sum o f d . f . Mean F -ra tio
Varia tion Squares Square
Group 0.00 1 0.00 0.01
Error 0.12 21 0.00
Time 0.18 3 0.06 15.51
Group*Time 0.03 3 0.00 2.17
Error 0.24 63 0.00
S ig n if ic a n t d iffe re nce  over time
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Plasma Phospholipids
Linoleic acid (18:2n6)
Source o f Sum o f d . f .  Mean
V aria tion Squares Square
Group 19.88 1 19.88
Error 560.33 21 26.69
Time 158.30 3 52.77
Group*Time 30.02 3 10.00
Error 751.58 63 11.93
S ig n ifica n t d iffe rence over time
Dihomogammalinolenic acid (20:3n6)
Source o f Sum o f d . f . Mean
Varia tion Squares Squai
Group 0.25 1 0.25
Error 1.42 21 0.07
Time 1.00 3 0.33
Group*Time 0.08 3 0.03
Error 3.48 63 0.05
S ig n if ic a n t d iffe re n ce  over time
F -ra tio
0.74
4.42
0.84
F -ra tio
3.73
6.04
0.48
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Arachidonic acid (20:4n6)
Source o f Sum o f d . f . Mean F -ra tio
V aria tion Squares Square
Group 0.04 1 0.04 0.14
Error 5.71 21 0.27
Time 0.99 3 0.33 7.12
Group*Time 0.45 3 0.15 3.26
Error 2.93 63 0.05
S ig n ifica n t d iffe rence over time, and between groups over time
Eicosapentanoic acid (20:5n3)
Source o f Sum o f d . f . Mean F -ra tio
Varia tion Squares Square
Group 0.00 1 0.00 0.10
Error 1.02 21 0.05
Time 0.09 3 0.03 1.02
Group*Time 0.04 3 0.01 0.44
Error 1.88 63 0.03
No s ig n if ic a n t differences were seen
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